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ABSTRACT
There is special concern about the potential health effects of by-products released into the 
enviromnent after combustion or conversion of fossil fuels. Polycyclic aromatic 
hydrocarbons (PAH), while initially released largely into the atmosphere, are subsequently 
deposited in soil and water and on foods. Although the significance of PAH contamination 
with regard to environmentally caused diseases and cancer in humans is difficult to 
estimate, it is suggested that the potential hazards may be underestimated. In an effort to 
understand the potential adverse health effects of PAHs. a comprehensive study was 
undertaken to determine the metabolic 6 te of selected PAHs as individual agents and as 
components of a mixture following oral e.'qxjsure in the Fischer-344 rat. Studies included 
radioisotope binding studies to evaluate the absorption, distribution, and elimination of 
selected compoimds. acute toxicity trials to define maximum tolerated chemical 
concentration levels, and chronic studies to determine temporal effects of individual 
compounds and the mixture. Selected compounds included 2-aminoanthracene (2-AA). 
benz[a]anthracene (BA), and the 1.3-; 1,6-. and l.-8-dintropyrenes (DNP). Results of 
radioisotope binding studies and ingestion smdies clearly indicated that toxicity of BA or 
DNP were minimal in exposed rats. Administration of SOjiCi per kg [^ -B A  (lOmg/kg) or 
[if]-DNP (lOmg/kg) via oral gavage resulted in a rapid excretion of greater than 70% of 
the recovered label at 48 h. Similarly, when rats were fed BA or dinitropyrenes (DNP) at 
concentrations up to 0.1% of the diet toxic effects were not observed following 14-. 30-. or 
80-days of exposure. In contrast administration of 2-AA at concentration levels as low as 
0.0075% of the diet resulted in a temporal and dose response progression in toxic effects of 
the liver and pancreas. Hepatocellular hyperplastic nodules were detected in rat liver 
following 80 days of ingestion of 2-AA at 0.01% and 0.0075% of diet. 2-AA pancreatic
xii
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
toxicity resulted in large cytoplasmic vacuoles and almost complete depletion of insulin 
stores in the endocrine pancreas and necrotic changes in the exocrine pancreas. 
Attenuation of the toxic effects of 2-AA was demonstrated in rats fed a mixttue of the «mp 
compounds at the same dietary lev el of incorporation.
xm
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CHAPTER 1 
INTRODUCTION
The genesis of cancer is generally considered to be a multistage process with requirements for 
initiation, promotion, and progression events, and usuaUv' involves the activation of oncogenes (Farber 
and Sarma. 1987). AU cancers can be expected to involve a disruption of the normal restraints on ceU 
proliferation, and for each cell type there is a finite number of ways in which such disruption can occur 
(Bos, 1989). Moreover, some aspects for regulating cell proliferation are likely to be the same in mam 
or all cell tjpes. Perturbations of the balance between ceU gain via mitosis and ceU loss by apoptosis 
have been shown to play a pivotal role in mediating and modifiing the action of chemical carcinogens 
and other toxicants in tissues such as Ih er and brain, in the immtme s>’stem, in the gastrointestinal tract 
and in the reproductive organs (Roberts et al., 1997). Suppression of apoptosis through, for example, 
chemical interference in ceU signaling can result in pathological accumulation of aberrant ceUs and 
diseases such as tumors (Corcoran et al., 1994). Oncogenes subvert the normal signal transduction 
pathwm at various points resulting in the generation of deregulated proliferative signals and apoptosis 
(CanUev- et al., 1991). The ras oncogene product (p-21), for example, is a membrane associated GTP- 
binding/GTPase and is a key component of signal transduction pathways, linking receptor tyrosine 
kinases with cytosolic signaling proteins that ultimately impinge on the ceU nucleus (Marshall, 1995). 
Activated ras oncogenes hav e been identified in various forms of human cancers, most notably colon 
and pancreatic (Bos, 1989; Fearon and Vogelstein, 1990; Forrester et al, 1987; Shirasawa et al, 1993). 
These cancer cells, as well as cells that have been transformed with the Ras protein, exhibit gross 
morphological changes (Bos, 1989). It is therefore logical to expect that some oncogenes may be 
directly activated by interactions between the target genes and chemical carcinogens, while other 
oncogenes may be indirectly activated during the progression of chemical carcinogenesis by non­
targeted genetic events (Balmain and Brown, 1988). For example, Wiseman et al. (1986) found that 
the induction of hepatomas in B6C3F1 mice with the arylhydroxamic acids N-hydroxy-2- 
acetylaminofluorene and N-hydroxyaminoazobenzene. the metabohc products of the respective aromatic 
amines, resulted predominantly in C:G -»A:T transversions at the first position of codon 61 of the c-Ha-
1
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ras gene. These studies demonstrated that ras oncogene activation is an early event in mouse 
hepatocarcinogenesis resulting directly from reaction of the ultimate chemical carcinogens svith this 
gene in vivo. Furthermore, studies of mouse skin tumors initiated by different chemical carcinogens 
showed that for each chemical initiating agenL a distinct spectrum of ras mutations was observed and 
that the distribution of ras gene mutations differed between benign papillomas and carcinomas, 
suggesting that the nature of the molecular initiating event influenced the probability of papillomas 
progressing to malignancy (Brown et al.. 1990).
At the turn of the century, studies in humans showed that polycyclic aromatic hy drocarbons 
(PAHs) are causative factors in the development of cancer (Boyland, 1986; Lawlwy. 1994; Pitot and 
Diaganu 1996). Incomplete combustion of fossil fuels results in the formation of PAHs. and increased 
use of fossil fuels has elevated environmental PAH concentrations to which humans are exposed, 
especially near urban areas (Paridnson, 1996). The major source of human exposure to environmental 
carcinogens on a daily weight basis is from the diet (Strickland and Groopman. 1995). This exposure 
pathway is consistent with a large pcxrl of epidemiological data linking the incidence of human cancer 
(20-50%) with dietary Actors (Blot 1992; Statland. 1992; Lutz and Schlatter. 1992. 1993; Sugimura 
and Sato. 1983; Porter. 1993; Comstock et aL 1991; Sauer and Sipes. 1995). Many PAHs are potent 
carcinogens in animal models of chemical carcinogenesis, and the ability of PAHs to compromise the 
immune system is well ckxnimented in both in vitro and in vivo systems (Wojdani et al.. 1984; Kaminski 
et al.. 1989; Smialowicz et al.. 1991; Morris et al.. 1992; Hardin et al.. 1992). Humans are exposed 
concurrently or sequentially to complex mixtures containing carcinogenic PAHs up to several thousand 
micrograms per day depending on the source, lifestyles, such as occupation, enviromnental food chain. 
cigarette smoking habits, and socioeconomic status (Arif and Gupta. 1996). Hiunans exposed 
chronically to atmospheric complex mixtures of pollutants, composed primarily of PAHs. also develop 
suppression of their immune system. For example, Szczekhk et al. (1994) examined the effect of PAH 
exposure on humoral immunity in a group of male iron foundry workers in Poland who were chronically 
exposed to PAHs. as assessed by personal and area monitoring. An evaluation of the serum fiom these 
men revealed that coke oven workers exposed to high concentrations of atmospheric PAHs, including
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
benz[a]anthiacene (BA) and pyrene. had reduced serum levels of immunoglobins IgG and IgA 
compared with mill workers exposed to concentrations of PAHs 3-5 magnitudes lower than the coke 
oven workers. Furthermore, the risk of cancer is greater in humans who are immuno-compromised 
(Luster and Rosenthal. 1993; Bums et al.. 1996). For example, children with inborn deficiencies of the 
immtme system have a high incidence of malignant tumors. Patients receiving immtmosuppressive 
therapy in the treatment of rhetunatoid arthritis show a similar increase in the incidence of 
malignancies However, in contrast to the reality that human enviromnental exposure is chronic and to 
a mixture of compoimds. the vast majority of studies on the carcinogenic and mutagenic properties of 
PAHs examined acute exposures to single compoimds (Ohgaki et al., 1984. 1985; Asokan et al.. 1985; 
Imaida et al.. 1991; Smialowicz et al.. 1991; Dutcher et al., 1985; Takayama et al., 1985). Risk 
assessments of complex mixtures based on composition alone or on the effects of water-extractable 
components on microorganisms, plants, or invertebrates are not sufficient if the bioavailability for 
higher animals and man is considered. The biological consequences of human exposure to mixtures of 
PAHs depend on the toxicity, carcinogenic and non-carcinogenic. of the individual components of the 
mixture, the interactions among them, and confounding factors not fully understood (Mumtaz et al. 
1996).
The mechanisms wherdjy the PAH compounds exert their biological toxic effects are poorly 
understood. Binding to the aromatic hydrocarbon (Ah) receptor is an essential step in the 
immunotoxicity of some compounds, such as dioxin, which then activates metabolic enzymes, such as 
the cytochromes P-t501Al and P-4501A2 (Fernandez-Salguero. et al., 1995). However. 7,12- 
dimethylbenzanthracene (DMB A) suppressed both the humoral and cell-mediated immune function in 
Ah-nonreponsrve and responsive mice, suggesting that DMBA may bypass P-450-mediated metabolism 
(Thurman et al„ 1988). The immunosuppressive effects of PAHs appear to be mediated via disruption 
of cellular signal transduction pathways either through altered cytokine production and/or disruption of 
sur&ce membrane signaling. DMBA and benzo[a]pyrene were shown to suppress T-cell IL-2 secretion 
and expression in both in vitro and in vivo systems (Burchiel et al., 1987; Szczeklik et al., 1994). The 
secretion of IL-1 after lipposaccharide (LPS) stimulation was increased in macrophage exposed to
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DMBA; however, exposure of macrophage to benzo[a]pyrene had no eSect on IL-I (Nfyers et al„ 1988). 
PAHs are also known to have effects on cell viabilitv and cell proliferation in culture (Stavenow, 1988; 
BurchieL 1993). Since many of the PAHs which are immunosuppressive are also carcinogenic, their 
effects may be manifested through common signal transduction pathways (Luster and Rosenthal. 1993; 
Mudzinski. 1993).
Among the immediate consequences of mitogen contact with responsive cells are the activation 
of various ion transport systems in the plasma membrane and changes in intracellular ionic composition 
(Burchiel et al.. 1991). Mitogen-induced alterations in the levels of cytoplasmic free calcium is of 
special interest, because calcium is thought to serve as second messenger that triggers and regulates cell 
proliferation. The mobilization of intracellular calcium is one of the earliest known events which leads 
to the activation of the signal transduction pathway. Those PAHs that are neither carcinogenic nor 
immunosuR)ressive cause only a transient rise in intracellular calcium in human T-cell lines, while 
PAHs known to be potent carcinogens and immunosuppressants also produce a sustained elevation in 
intracellular calcium (Burchiel et al.. 1991; Davila et al., 1995), In generaL the rapid rise in calcium in 
response to extracellular stimuli are mediated by the second messenger inositol 1.4.5-triphosphate, 
which triggers the release of calcium from the endoplasmic reticulum. (Krieger et al., 1995; Moolenaar. 
1986).
Phosphorylation of proteins provides for direct signal amplification and is a well-recognized 
means for modulating the activities of proteins in a rapid and reversible fashion. Many products of 
oncogenes are tyrosine kinases. Phosphorylation of tyxosine residues allows other proteins that contain 
specific tyrosine phosphate binding-sites to bind to the phosphorylated protein, and phosphorylation of 
tyrosine residues can also activate other enzymes. The GTPase activating protein (pi20-GAP) which 
regulates the ras oncogene is thought to function via tyrosine phosphorylation (McCormick. 1989). 
Protein tyrosine kinawK Ml into two fam ilies- the transmembrane receptor family and the cytosolic 
nonreceptor family. is the prototype of the latter family and the best characterized of the
protein-tyTOsine kinases. It has been shown that PAHs activate protein Qrosine kinases (Davila et al.. 
1995).
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Despite all these studies, relath ely little is known about the specific mechanisms by which 
PAHs suppress immunity and initiate or promote carcinogenesis. Since many of the PAHs that are 
known carcinogens also suppress the immtme svstem. the PAHs may exert their pathogenic effects 
through commonality of pathways -signal transduction. Studies to investigate the mechanisms by which 
PAHs cause the genetic changes involved in the malignant transformation of mammalian cells ma\' help 
to elucidate the cell signaling process as immimo-competent cells become immimo-compromised upon 
exposure to PAHs and mav- provide a link between alterations in the immtme system and the process of 
carcinogenesis. Furthermore, since the biological consequences of human exposure to PAH mixtures 
depend on the toxicity of the individual components of the mixture, interactions among them, and 
confoimding factors, studies of chronic exposures to mixtures of PAHs ingestion may provide a 
profile of different toxic effects than those obtained in previous single compound studies (Simmons. 
1995). In order to delineate the interactions among PAHs. this present stucK'was unckrtaken to 
determine the impact of chronic oral ingestion of PAHs. as individual compounds and as a mixture of 
the same, for metabolic and toxicological significance in a mammalian model (Cuddihy, 1980). The 
compounds selected for stuch were anthracene- and pyrene-based compounds of relevance to human 
environmental exposures and included 1.3-. 1.6-. and 1,8-dinitropyrenes. which are particle-associated 
components of diesel exhaust: 2-AA, a representative of the arylamine class of PAHs suspected inducing 
bladder cancer and which is present in synthetic fuels and the che industry: and benz[alpha]anthracene a 
4-ring PAH prevalent in coke-oven emissions, roofing-tar emissions, and cigarette smoke.
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CHAPTER 2 
REVIEW OF LITERATURE
POLYC\ CLIC AROMATIC HYDROCARBONS
PAHs are a group of chemicals deri\’ed from the pjToh'sis of organic matter, whether natural 
(forest fires, volcanoes, etc.) or synthetic (residential wood taiming, automobile and industrial 
emissions, environmental tobacco smoke, gas cooking and heating, etc.) (Keith, 1990: Menzie et al., 
1992). In the process of pyrolysis of organic matter, instead of being completely oxidized to caibon 
dioxide, hydrocarbon fragments are created and these can interact and form complex polycyclic 
structures (DiRjle, 1983). PAHs consist of three or more fused benzene rings and may form linear (with 
all the rings in a line), angular (with the rings in steps), or cluster (with at least one ring surroimded on 
three sides) arrangements. The various arrangements of rings in PAHs differ in their stability and 
prevalence in nature. The linear arrangement of anthracene (3-rings) is the least stable and few linear 
PAHs survive in nature. Cluster arrangements of benzene rings, as in pyrene, benzo[a]pyrene and 
benz[a]anthracene are more stable and are commonly found in nature, especially in soils, sediments, 
tobacco smoke, petroleum and automobile-exhaust gases; while the angular arrangement of the 
phenanthrene series is of greatest stability and prevalence (Blumer, 1976). The composition of the by ­
products of thermal aromatization depends on the nature of the starting material and on the combustion 
temperature. The benzene rings may be unsubstituted or may carry substituent methyl or alkyl side 
chains or chemically reactive groups of nitrogen, sulfur, and oxygen. The relative distribution of 
unsubstituted and substituted PAHs in the resulting combustion process is dependent on the formation 
temperature, with the pattern of distribution favoring substitution at the lower temperatures associated 
with petroleum formation (Blumer, 1976). The coking of coaL for example, produces primarily 
unsubstituted PAHs due to the high temperatures required. On the other hand, the intermediate 
temperatures of smoldering wood from forest fires produces complex mixtures of substituted PAHs, 
although the unsubstituted PAHs still prevail in greater numbers. PAHs generally occur as complex 
mixtures (for example, as components of diesel exhaust or cigarette sm<*e). not as single compounds.
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and most of the PAHs as individual compounds, such as 7.12-dimethylbenz[a]anthracene. have no 
known use except for research purposes; although a few PAHs are used in medicines and to make (h'es. 
plastics, pesticides, and asphalt for road construction (Mumtaz et al. 1996). Among the fifty-four PAHs 
identified at one or more National Priority' List (NPL) hazardous waste sites, anthracene- and pvTene- 
based PAHs are among the most abundant representatives of the environmentally occurring PAHs and 
have been detected in ambient air. v\ater. and soil as well as in various food stufis (Jact* et ai.. 1989).
In addition to their widespread occurrence in the environmenL this class of PAHs contains some of the 
more potent experimental chemical carcinogens known (Pitot and Dragan. 1996). In fact, a PAH. 
dibenz[a.h]anthracene. was the first pure chemical compound found to exhibit the property of 
carcinogenic activity'. This potency to induce cancer is reflected in the fitcts that a single dose can 
induce tumors and that various organs, depending on the species and the route of administration, are 
susceptible to these carcinogens (Diiqjle, 1983). PAHs such as benzo[a]pyrene. dibenz[a.c]anthracene. 
dibenz[a.h]anthracene. benz[a]anthracene. and dinitropyrenes are found environmentally (Krieger et al.. 
1995). The presence of PAHs in contaminated soils continues to pose significant problems to human 
health, disease and the incidence of cancers. Levels of these compounds vary from 5 ppb for an 
undeveloped area of Alaska to 1.79 x 10^  ppb for an oil refinery out fall (Johnson and Larsen, 1985). 
Their hydrophobicity is cited as the primary reason for their persistence in soils and sediments. This is 
especially true for larger PAHs such as pyrene- and anthracene-derived compounds which exhibit very 
low water solubility [0.140 mg of pyrene liter'. 0.003 mg of benzo[a]pyrene liter', and 0.002 mg of 
benz[a]anthracene liter '] (Schneider et aL 1996). The prevalence of pyrene, benz[a]anthracene, and 
benzo[a]pyrene in contaminated soils at hazardous waste sites are, for example, 1,808 ppb, 2320 ppb. 
and 3101 respectholy, compared with 1-19.5 ppb for pyrene. 5-20 ppb for benz[a]antfaracene, and
2-1300 ppb for benzo[a]pyrene in rural soils (Schneider et al. 1996).
Human exposure to environmental carcinogens occurs through inhalation percutaneous 
absorption, and ingestion. On a daily weight basis, dietary exposure to environmental PAH carcinogens 
is the major source of human exposure (Strickland and Groopman, 1995; Rothman et al., 1993). This 
exposure pathway is consistent with a large pool of epidemiological data linking the incidence of human
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cancer (20-50%) wiih dieiaxy râaors (BIoi, 1992; Sugimura and Saio, 1983; Porter, 1993; Comstock et 
a l 1991; Saocr and Sipcs. 1995). Other general and spcciSc studies have supported this view (Lutz and 
Schlatter. 1993; Peters et a l  1989; Tubiana. 1991). Observations in animals have shown that some tvpes 
of cancer are related to ecrtain earcinogens in their hxxL and several types of eaneer simitar to that in 
humans have been induced in experimental animate by administration of carcinogens, such as 
nitrosamines and myeotoxins. suggesting that their prcscnec in human diets can increase cancer risk 
(Lijinsky. 1983). Additional evidence supporting the association of diet and cancer is that the incidence 
of cancer of specific tissues and organs varies considerably between different countries. For example the 
incidence of colorectal and breast cancer is up to 10 fold higher in Western countries than in Far Eastern 
and developing countries (Strickland and Groopman. 1995; Keys et al.. 1986; Brace. 1987).
Furthermore, substantial increases in the risks and incidences of these cancers are observed in 
populations who migrate fiom areas of low- to high-risks. suggesting that the differences observed in the 
incidences of these cancers can be attributed to environmental or lifestyle Actors rather than to a 
predisposition to genetic 6ctors (Willett. 1989).
PAHs are ubiquitous environmental contaminants and humans are exposed concurrently or 
sequentially to PAHs as components of complex mixtures up to several thousand micrograms per day 
depending on the source, lifestyles, such as occupatioiu enviromnental food chain cigarette smoking 
and socioeconomic status (Arif and Gupta. 1996). Exposure to chemical mixtures at these 
environmental levels is not thought to inv olve acute toxic responses, but it is more likely that insidious 
effects disrupting the homeostasis of the organism occur (Yang et al. 1989). Final toxicity may likely be 
expressed by the enhancement or potentiation by subsequent exposures. For example. Hong etal. (1991) 
exposed mice to a mixture of 25 fiequently detected groundwater contaminant»; in their drinking  water 
and observed suppressed bone marrow granulocyte progenitors; however this suppression disappeared in 
10 weeks following cessation of exposure. On the other hand, when mice were exposed to radiation in 
the ninth week of the recovery period, the group exposed to the combination of chemical and radiation 
showed a significantly slower recovery of bone marrow progenitors compared with the group exposed to 
radiation alone. These data indicate that the residual damage of hematopoiesis in mice exposed to the
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
12
groundwater contaminant mixture rendered the mice more sensith e to subsequent injtu\'. However, in 
contrast to the reality that human environmental exposure is chronic and to mixtures of compounds, 
either concurrently or sequentially, the vast majority of toxicology studies on the carcinogenic and 
mutagenic properties of PAHs have examined acute exposiues to single compounds (Simmons. 1995: 
Ohgaki et al.. 1984; Asokan et al.. 1985: Imaida et al.. 1991: Smialowicz et al.. 1991: Dutcher et al.. 
1985: Takayama. 1985).
The abüity to predict the biological eSêct of complex mixtures based on chemical 
characterization or on the effects of water-extractable components on microorganisms, plants, or 
invertebrates are not sufBcient if the bioavailabilitv for higher animals and man is considered (Roos et 
al.. 1996). The biological consequences of human exposure to mixtures of PAHs depend on the toxicity, 
carcinogenic and non-carcinogenic. of the individual components of the mixture, the interactions among 
them, and confounding factors not fully understood (Mumtaz et al. 1996). The absorption, distribution, 
and excretion characteristics of the chemicals in the mixtures may not be the same as those of the 
chemicals administered singly . Possible interactions may be additive, synergistic, or. less commonly, 
inhibitory (Mumtaz et al.. 1993). .Additive effects require independent mechanisms or that the rate- 
limiting step in the process not be saturated by any of the toxicants acting alone (Hodgson et al.. 1995). 
As noted previously each component of a mixture has a unique toxic potential and may influence the 
toxicity of other mixture components by affecting their toxicokinetics or toxicodynnmics. Simmons et 
al. (1988) evaluated the hepatotoxic potential of 10 samples of complex mixtures in F344 rats exposed 
via gavage and compared the observed results to that expected based on chemical characterization. An 
additivity model was assumed; however, the observed toxicity (8 of the 10 samples) could not be 
predicted readily from the chemical characterization. In fact, the most toxic samples displayed chemical 
profiles which were relatively indistinguishable fiom those of the other samples (Simmons et al., 1988, 
1989). Synergistic interactions are ones in which the efiêct is more than additive. The carcinogenicity 
associated with complex mixtures, such as cigarette smoke and diesel exhaust, is often synergistic- 
greater than that anticipated fiom the content of specific PAHs within the mixture (Nesnow et aL, 1983: 
Robinson et ah 1987). For example, studies have demonstrated that the formation of chemical-ONA
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adducts following exposure to complex mixtures is often greater than adduct levels observed with a 
single PAH (W^-and et ah 1991). Robinson et al. (1984) showed that the biological responses of mouse 
skin to (kses of coal tar and petroleum asphalt paints were greater than expected 6om their PAHs 
content and fiom mutagenic activitv' assays. Similarly. Warshawsky et al. (1993) showed that repeated 
application of low dose levels of benzofajpyrene produced no skin tumors in mice: however, a 
significant increase in tumor production (fiom 23% to 47% in mice) resulted when benzo[a]pyrene was 
applied in the presence of five noncarcinogenic PAHs. In contrast inhibitory or antagonistic 
interactions result in a less than additive effect and examples of this type of interaction by a complex 
mixture is less common. However, it has been reported by a number of investigators that the 
carcinogenicity of benzo[a]pyTene can be inhibited by the addition of anthracene, pyrene. crysene. or 
dibenz[a.h]-anthracene (Finzi et al.. 1968). Kiefer et al. (1994) examined the in vitro interactions of 2- 
aminofluorene. 2-aminoanthracene. and 1.6-dinitropyTene in Chinese hamster cells. They found that 
the cytotoxic and genotoxic effects of 2-aminoanthracene were suppressed by co-administration of 2- 
aminoanthracene and 2-aminofluorene. and suggested that arylamines may interfere with their own 
activation to the N-hydro.xylated metabolites and compete for the same acetyltransferase enzymes, 
thereby suppressing the formation of their respective ultimate genotoxic metabolite. These data suggest 
that the mechanisms by which puure PAHs initiate carcinogenesis may not accurately reflect the complete 
process and interactions that occur with mixtures.
Such interactions by mixtures may result from events at many possible levels, including 
absorpnion. distribution, metabolism, site of toxic action, excretion and/or repxiir (Hodgson et al. 1995). 
After oral upttake by mammals, for example, toxicants are e.xpx>sed to the gastrointestinal fluids where 
the extraction of contaminants, such as PAHs. fiom the matrix is likely to be influenced tw a number of 
factors. Presumably, bile acids, fatty acids, and dietary lipids as detergents and/or solvents play 
impx>rtant fecilitating roles in the release of PAHs. Other factors that influence the carcinogenic 
potential of mixtures are the content of 3-5 ring PAHs. the presence of long chain aliphatic compx)unds. 
certain sulphur conpounds. and the inhibitory effects of saturated hydrocarbons and noncarcinogenic 
PAHs (Witschi et al, 1987; Bingham et al, 1976). Therefore, the actual bioavaliabihty of PAHs in the
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gut is expected to be higher than in strictly aqueous systems, but still less than that extractable by 
toluene (Roos et aL 1996). After being extracted by intestinal fluids. PAHs become bioavailable and 
pass through the intestinal mucosa, enter circulation, and partition into organs and tissues. The 
lipophilicity of PAHs enables them to readily penetrate cellular membranes and remain in the bo<^ ' 
indefinitely and the Structural similarity of PAHs contributes to the similarities that exist in their 
biotransformation. Metabolism of PAHs occurs in all cells; however, the route by which PAHs enter the 
body may determine their fete and organ specificity. For example. Weyand et al. (1995) evaluated the 
differences in the tumorigenic activity of benz[a]pyTene following chronic (260 days) ingestion or 
following a single itraperitoneal injection in the presence and absence of manufactured gas plant residue 
(MGP) in mice. A diet containing 16 ppm benzo[a]pyrene (11 mg total dose/mouse) did not produce a 
significant tumorigenic response in the lung of mice; however, 20% of the mice developed forestomach 
tumors. On the other hand, a single intraperitoneal injection ofbenzo[a]pyTene (1.79 mg) resulted in 
100% lung tumorigenesis and an 83% forestomach tumor incidence. In contrast, ingestion of a 0.1% 
MGP diet (1.5 g of MGP containing 4.2 mg benzo[aJpvTene) resulted in 70% of mice developing lung 
tumors, but no forestomach tumors were detected in mice fed MGP-adulterated diets. These data 
indicate that route of exposure and chemical composition (individual versus mixture) produce 
significant differences in the toxic response of mammak
SELECTED POLYCYCLIC AROMATIC HYDROCARBON 
COMPOUND CLASSES
THE IVTTRQARENES: THE DINITROPYRENES
Pyrene is one of the most abundant representatives of the envirorunentally occurring PAHs and 
has been detected in ambient air, water, soil as well as in food stufis (Jacob et aL 1989). While pyrene is 
not considered a carcinogen, it is mutagenic as determined by the Ames Salmonella typhimurium 
reversion assay. Pyrene is a major extractable component of diesel exhaust particulates which also 
contains lower concentrations of nitrated pyrenes (Holder, 1985). Pyrene, for exairrple, occurs at 
3R)roximately 5000 pg/g of particulate diesel extracL while 1-nitropyrene and the dinitropyrenes are 
detected at approximately 75 and 0.4 pg/g of particulate diesel extrao, respectively (Beland et al..
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
15
1994). The complex mixtures extracted from diesel exhaust particulates have been repeatedly shown to 
contain bacterial mutagens (Belisario et al.. 1984: Pederson and Siak. 1981). A unique property of 
diesel particulates is that the extracts are direct-acting mutagens—do not require actKntion bv- 
mammalian enzyme systems (Natchman et al., 1981). Diesel emissions are known to induce tumors in 
experimental animals, and epidemiologcal data suggest an association between exposure to diesel 
exhaust and the induction of lung and bladder cancer in humans (Takayama et al., 1985: Heinrich et al.. 
1986: Hemminki et al.. 1994: Smith et al.. 1995). Urinary PAH metabolites, particularly 1- 
bydro.xypvTene. have been detected in a high percentage of human urine samples, including those from 
persons without documented occupational or smoking exposures (Schut and Shiverick. 1992: Kang el 
al.. 1995). Since the nitro groups of aromatic compotmds can be biochemically reduced to the amine  
deiivatrve \ia  nitroreductase enzymes and are thereby interrelated through metabolism to aromatic 
amines, a class of carcinogens known to cause bladder cancer in humans the nitrated pyrenes may 
contribute to the increased incidence of bladder tumors in individuals exposed to diesel exhaust (Nesnow 
el al.. 1984: Smith et al.. 1995). In contrast although nitroarenes such as 1.6-dinitropyrene are 
activated via reduction to N-hv droxyary lamines and subsequent O-acetylation, their toxicity may also be 
suppressed by the presence of arylamines (Kiefer et al.. 1994). Similarly nitroarenes may likewise 
suppress the activation of arylamines. and may imply that interactions between these two classes of 
PAHs may be antagonistic.
Nitrcaromatic compxtimds can be readily formed by derivatization of PAHs. The nitration of 
pwrenes occurs imckr conditions of incomplete combustion processes, such as diesel and airplane 
emissions, combustion emissions &om kerosene heaters and gas fuels and liquid pietroleum, airborne 
pjarticulates, coal Sy ash, cigarette smoke, and food (Asokan et al., 1985). Nitrated pmenes are also 
formed firom the reaction of PAHs with nitrogen oxides in the environment (Pitts et al., 1985; Djuric et 
al., 1988). Exposure of PAHs absorbed on filters to gaseous pxrllutants or low levels of nitrogen dioxide 
has been shown to ptroduce nitro-substituted products which are direct-acting bacterial mutagens.
Tokiwa et al. (1984) reported the in vitro formation of nitro derivatives fiom pyrene, phenanthrene, 
chrysene, and several other PAHs by expxjsure of the PAHs to 10 ppm NO:, and showed that resulting
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nitroarenes were more mutagenic than the PAHs parent compotmds. Concerning an in vivo effect of 
exposure of PAHs to NO2, Miyanishi et al. (1996) showed than when mice were administered pyrene 
and exposed to NO;. mutagenic nitropvTene derivatives were formed and excreted into the urine. Of 
the compounds associated with diesel exhaust the dinitropyrenes. including 1.3-. 1.6- and 1.8- 
dinitropyrene. constitute an interesting category for several reasons. First the dinitropyrenes exhibit a 
large variety of biological activities (Fit 1990). These activities include induction of mutations in 
bacteriaL eukaryotic cells, and human cells: neoplastic transformation of cultured normal htunan 
hepatocytes. Senear and Balb/c mice cells. Syrian hamster cells, and F344 and CD rat cells (Tokiwa et 
al.. 1984; Silvers et al.. 1994; Beland et al.. 1994; Eddy et al.. 1987; Belisario et al.. 1985; Heflich et al.. 
1985; Nesnow et al.. 1984; Maher et al.. 1993; Miyanishi et aL 1996). Nitro-PAHs of diesel exhaust 
have also been shown to induce unscheduled DNA synthesis in human hepatoma cell lines, induce 
spindle disturbances and chromosomal damage in V79 Chinese hamster cells, induce strand breaks in 
mouse and rat hepatocytes. and induce DNA repair in human and rat hepatocytes (Roscher and Wiebel. 
1992; Maher et al.. 1993 Butterworth et al.. 1983; Moller and Thorgeirsson. 1985; Bauchinger et al.. 
1988; Edch et al.. 1987). Nitro-PAHs of diesel exhaust have also been shown to bind cellular DNA in 
bacteria and mammalian cells (Scheepers et al.. 1994; Beland et al.. 1994; Norman et al.. 1990; Djiuic 
et al.. 1993; Howard et al.. 1983), and to induce tumors in experimental anim ak (Ohgaki et al.. 1984. 
1985; Takayama et al.. 1985; Imaida et al.. 1991; Smith et al.. 1990. 1995). Because these compounds 
are ubiquitous enviromnental contaminants and are genotoxic. these compounds may pose a risk to 
human health. However, some of the nitropyTenes are found to be non-genotoxic in other mammalian 
systems (Ohgaki et al.. 1985). Second, based on carcinogenicity studies in animals the carcinogenic 
potential of diesel exhaust can be assumed to be located exclusively in the particulate matter, and the 
nitrated pyTenes are particle-associated (Scheepers etal., 1994). Third, although the dinitropyTcnes 
accoimt for only a small amoimt of total PAHs in diesel particulate extracts, the dinitropyrenes represent 
a considerable portion of the carcinogenic properties of diesel exhaust particulate matter.
Approximately 30-80% of the mutagenic activity of extracts of the particulate ffaction of diesel engine 
emissions is attributable to dinitropyrenes (Ross et al.. 1987; Norman et al.. 1989). Human exposure to
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dinitropyrenes is expected to be both by inhalation and oral ingestion (respiratory tract deposition 
followed by mucociliary clearance and swallowing) (Cuddihy et al.. 1980). Inhaled particulates hav e 
been reported to be readily deposited in the respiratory tract of rodents and rabbits (Chan. 1981: Rudd, et 
al.. 1981: Heinrich et al.. 1986; Tee et al.. 1988; Bond et al.. 1990). Injected dinitropvTene have been 
shown to cause sarcomas at the site of injection in rats and mice and cause mammary gland tumors in 
rats (Ohgaki et al.. 1984: Ohgaki et al.. 1985: Imaida et al.. 1991). Since bacteria have the capacity to 
metabolize nitrated pyrenes. the potential exists that ingested nitrated pyrenes could have a different 
metabolic fate and exert different toxic effects due to microflora metabolism in the gastro-intestinal tract 
than that which would result from inhalation exposure (Dayton, 1983: Dutcher J.S.. 1985).
The metabolism of nitropyrenes is much more complicated than that of other PAHs. because 
the initial metabolism of dinitropyrenes can proceed through either oxidation of the aromatic ring 
system or reduction of the nitro functional group. (Fu. 1990) The bacterial mutagenicity of the ring- 
oxidized metabolites and the structures of the DNA adducts formed in vivo provide evidence that both 
ring oxidation and nitro reduction can be involved in metabolism of these compotmds (Stanton et al.. 
1985: E^uric et al.. 1986: Smith et al.. 1990: Manjanatha et al.. 1993). Based on the results of reductive 
and oxidative metaboUsm studies, the biotransformation of the dinitropyrenes begins in the liver, where 
it is oxidized by cytochrome P450 and conjugated with glucuronic acid. The glucuronide-conjugate is 
excreted in the bile and undergoes biotransformation in the intestine. Nitro reduction is involved in the 
metabolic activation of the dinitropyrenes. and unlike other routes of biotransfonnation. nitroreduction 
is not performed by the endogenous enzymes within the boch but by enzymes of the intestinal microflora 
(Scheepers. 1994). One or both of the nitro groups undergo a two-electron reduction to an amine by- 
nitroreductase and the glucuronide is hydrolyzed by ^-glucuronidase (Oma and Mason. 1989). The 
aminonitropyrene and diaminopyrene metabolites are absorbed and transported to the liver, where the 
formed amine group is N-hydroxylated by cytochrome P450 and conjugated with acetate, although N- 
sul&tes may also be formed (Djuric et al.. 1993: Fu. 1990; Yamazoo et al.. 1994). Acetate is a good 
leaving group which renders the nitrogen highly susceptible to nucleophilic attack by proteins or DNA 
(Djuric et al.. 1985). The dinitropyrenes were shown to maintain their mutagenicity in the
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nitroreductase-deficient Samonella typhimurium strain TA98NR but showed greatly' diminished activity' 
in the acetylase-deficient strain, TA98. suggesting that acéty lation following nitroreduction to N- 
hy droxy arylamines is involved in mutation induction by these compotmds (Orr et al., 1985; Djuric et 
al.. 1985). Nitro-reduction by' intestinal microflora is thought to play an important role in the toxicity of 
several nitroaromatic compounds including 2.6-dinitrotoluene. which causes hepatic tumors in male rats 
(Dutcher et al., 1985; Paridnson, 1996). Other research has indicated that gut flora are not obligatory in 
the metabolic activation of dinitropyrenes. 1,6-dinitropy'rene produced genotoxic metabolites in rat 
hepatocyte primary cultures without gut flora, w hile no DNA repair was observed in hepatocytes fiom 
rats orally exposed to 1 .ô-dinitropyrene (Butterworth et al., 1983). A possible explanation for the 
inactivity of 1,6-dinitropyrene in vivo is that it is either metabolically detoxified or that it is not absorbed 
fi'om the gut and delivered to the liver in amounts large enough to induce detectable DNA repair, 
suggesting that cells which come first in direct contact with this agent are more likely targets for its 
genotoxic action. This explanation may hold for the 1,3- and 1.8-dinitropy'renes as well, suggesting that 
oral exposure may present low risk of mutagenicity'.
THE ALTERNANT OR UNSUBSHTUTED POLYCYCLIC AROMATIC 
HYDROCARBONS: BENZfalANTHRACENE
Benz[a]anthracene is classified as an unsubstituted or "alternant” PAH of which 
benzo[a]py'rene and chrysene are also members. Alternant PAHs have an equally distributed electron 
density , whereas "non-alternant” PAHs, such as fluoranthene. behave almost as if they were two 
difiêrent molecules due to the uneven distribution of electron density from one part of the molecule to 
another (Mumtaz et al., 1996). Furthermore, it is known that the metabolism of alternant PAHs difiers 
fiom the metabolism of non-alternant PAHs. In general, the most reactive class of unsubstituted 
polycyclic aromatic hydrocarbons is the acenes; naphthalene, anthracene, naphthacene, and pentacene; 
yet no compounds of this group are carcinogenic. In the phene series: phenanthrene benz[a]anthracene, 
pentaphene, and benzo[b]pentaphene, reactivity is usually lower than in the acenes. In contrast to the 
acenes, addition reactions across a double bond occur Mrly easily in the phenes. In addition to a 
reactive double bond, the higher phenes also contain reactive poru-positions (e.g. the 8- and 12-positions
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of benz[a]anthracene) that will add reagents. Only benz[a]anthracene has been reported to be 
carcinogenic among the phenes, but many potent carcinogens can be found among substituted members 
and many carcinogenic hydrocarbons are considered as phenanthrene derh-atives (Dii^le et al.. 1984). 
Benz[a]anthracene is listed among the 17 PAHs considered of to.xicological importance to human health 
due to its prevalence in contaminated soils and sediments. .Approximately 41% of contaminated sites 
contain benz[a]anthracene (Schneider. 1996). Although benz[a] anthracene is considered a moderate to 
relath eh weak carcinogen, the carcinogenic activity of the parent hydrocarbon can be enhanced by 
substitution with either electron-donating or electron-withdrawing groups. For instance. 7.12- 
dimethylbenz[a]anthracene (DMBA) is a potent carcinogen in animal models of chemical 
carcinogenesis. Administration of DMBA induces erythroleukemia in the Long-Evans ra t and exposure 
to DMBA has been shown to result in suppression of both humoral and cell-mediated immune responses 
of mice and cultured splenocytes (Burchiel. 1990). DMBA has also been shown to induce apoptosis in 
murine B cells (Ladies et al..l991; Burchiel et al.. 1993). Of the processes whereby PAH contaminants 
are removed fiom the envirorunent or in which the toxicity of the parent compound is enhanced, 
microbial degradation and metabolism plav important roles. Similarly, the gut microflora in the gasto- 
intestrual tract of mammals may play an important role in the detoxification or enhanced toxicity of 
benz[a]anthracene.
The carcinogenicity of compounds of this class, in general, follow the “bay region” theory of 
metabolic activation (Guengerich et al.. 1983). This theory contends that an epoxide on a saturated, 
angular benzo ring that forms part of a bay region of the hydrocarbon is a prime candidate as an 
ultimate carcinogen.(Levin, 1978; Grover, 1986). PAHs that are complete carcinogens must undergo 
metabolic transformation to a more electrophilic compound, because the parent structures are not very 
reactive chemically (Upham et al., 1996). For benz[a]anthracene tumorigenic activity increases along 
the series; hydrocarbon. dihydrodioL and bay-region dibydrodiol epoxide. Metabolic activation of this 
class of PAHs to bay region diol-epoxides im olves the mixed-fimction oxidase system, which is 
membrane bound and requires NADH or NADPH and molecular oxygen to convert the nonpolar 
compound into more polar epoxide or hydroxy derivatives. The terminal oxidase is a &mily of
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hemoproteins called the cytochrome P45Cs. Metabolic activation requires the enzymes cytochrome 
P4501A1 and epoxide hydrolase in the formation of the proximate and ultimate carcinogens, but these 
enzymes also form products which are not harmiul through conjugation reactions with glucuronic and 
sulfuric acids. A large number of epoxides, dihydrodiols. and epoxide dihydrodiols of 1.2- 
benzanthracene derivatives have been analyzed for carcinogenicity. These results implicate that 
metabolic activation of 1.2-benzanthracene to the 3.4-dihydrodiol forms a potent bacterial mutagen with 
high tumorigenicity relative to 1.2-benzanthracene. and analyses have identified the 3,4-diol 1.2-epoxide 
as an ultimate carcinogen with at least 15-125 times more mutagenic activity than other diasteromeric 
benzanthracene diol epoxides (Slaga et al., 1978; Levin et al.. 1978). These results are consistent with 
the bay-region theory. In human cell smdies. when 1.2-benzanthracene was administered to human 
bone marrow cells, it was converted to three distinct dihydrodiols. The dihy drodiol metabolites w ere 
identified as the 5.6-dihydrodioL the 10.11-dihydrodiol and the 8.9-dihyrdodiol. Carbon monoxide and 
piperonyi butoxide. cytochrome P450 inhibitors, blocked the formation of these metabolites: whereas the 
cyclooxygenase inhibitor, indometbacin, had no effect which supported a P450 enzymatic pathway for 
metabolism. However metabolism to the ultimate carcinogen. 3.4-dihydrodiol 1.2-epoxide, was not 
demonstrated (McCord. 1996).
Prototypic PAHs. such as benz[a]anthracene. have been shown to suppress the immune 
responses (White et al.. 1985; Davila et al.. 1995). Studies have shown that 7.12- 
dimethylbenz[a]anthracene (DMBA) and benzo[a]pyTene suRjress T-dependent B cell responses after in 
vivo OT in vitro antigen stimulation (Zwilling. 1986; Ward et al.. 1984; Ladies et al.. 1991.1992b). T- 
independent B cell responses have also been shown to be suppressed by in vivo or in vitro treatment with 
DMBA or benzo[a]pvTene resulting in decreased antibody production (Ladies et al.. 1992a). Studies 
have further demonstrated that the population of the immune system cell types responsible for the 
metabolism of benzo[a]pyrene is the macrophage, and that macrophage can metabolize benz[a]pvTene by 
both a cytochrome P450-dependent and peroxyl radical (P450-independent) pathways (Ladies et al.. 
1992c; Mounho et al.. 1997).
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Oral administration of alternant PAHs. such as benz[a]anthracene and benzo[a]pyrene. indicate 
that these and possibh' other alternant PAHs are carcinogenic in rodents. Mice acutely administered 1.5 
mg/day benz[a]anthracene bv- oral gavage for 5 weeks exhibited increased incidences of hepatomas and 
pulmonary adenomas (80% and 85%. respectively) compared with incidences in control animals in 
(10% and 30%. respectively) for hepatomas and pulmonarv adenomas (Kleiru 1963). The induction of 
foci of altered hepatocytes is often seen in rats and mice that later develop liver tumors (Mmntaz et al.. 
1996). A 1-day intragastric administration of 200 mg/kg of benzo[a)pyrene or dibenz[a.h]anthracene. or 
of 180 mg/kg benz[a]anthracene to rats followed bv a diet containing 2-acetylaminofluorene and carbon 
tetrachloride induced altered foci in partially hepatectomized and not in sham hepatectomized rats. For 
partially hepatectomized rats. benzo[a]p>-rene was a more potent foci-inducer than either 
benz[a]anthracene or dibenz[a.h]anthracene (Tsuda and Farber. 1980). The hepatic effects observed in 
these studies following oral exposure to PAHs. including enzymatic alterations, induction of altered foci, 
and increased liver weight while generally not regarded as serious consequences may precede the onset 
of more serious hepatic lesions including hepatic neoplasms.
THE ARYLAMINES: 2-AMINOANTHRACENE
The aromatic amines represent one of the most extensively studied classes of procarcinogens 
and promutagens (Terada et al.. 1986:Watnanahe et al.. 1993; Humphreys et aL. 1992; Miller and 
Miller. 1981). The benchmark toxicant 2-aminoanthracene (2-AA). is a model aromatic amine since it 
is a relatively potent direct-acting carcinogen in animal models, and an inducer of mutations in 
eukaryotic and prokaryotic cells (Fu et al.. 1986; Carrière et al.. 1992; Arcos and Argus. 1974; Shubik et 
al.. 1960; Hallstrom et al., 1981; Zhu. 1995). 2-AA has also been recommended for use as a positive 
control in bacteria reversion assays, since it causes mutations in all tester strains of Salmonella rShaikh 
et al.. 1980). Although the carcinogenic and mutagenic properties of 2-AA are known, little 
information is available on the in vivo metabolic activation of 2-AA and its interaction with mammalian 
tissues (Mitchell. 1985). As a class of PAH conqx>unds, the arylamines are of human concern since 
many of the aromatic amines are known or suspected of causing bladder cancer in humans and dogs, 
and to a much lesser extent in mice, rats, guinea pigs, hamsters, and rabbits (Kadlubar  et al., 1977;
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Beland et al., 1983; Wise et al.. 1984; Cole et al.. 1972). Aromatic amines are also known to induce 
tumors at a number of other sites in e.'qperimental animals including the liver, mammary- gland, 
intestine, and lung (Beland and Kadlubar. 1985; Davis et al.. 1991; Wise et al.. 1984; Terada et al..
1986). Bladder cancer is one of the few human neoplasms where enviromnental exposures to 
carcinogens has been directly implicated (Case et al.. 1954; \Tneis. 1994). Many of the aromatic 
amines are synthetic compounds and are well known as occupational carcinogens that are used in the 
manufacture of dyes, drugs, inks, plastics, and agricultural chemicals (CartwiighL 1983; Kriek. 1979; 
Gorrod and Manson. 1986). In fact, the epidemiology of contemporary occupational bladder cancer has 
been considered synonymous with the epidemiology of arylamine-induced bladder cancer, and 
occupational-related bladder cancer accounts for perhaps 15% to 30% of the incidence of the disease in 
certain urban areas (Lower. 1983). Aromatic amines are also used as rubber antioxidants, as curing 
agents in the ^-nthesis of epoxy resins and of polyurethanes, and are present in road tars, and in 
synthetic fuels (Gamer et al., 1984; Gorrod and Manson. 1986; Snyderwine et al.. 1992). Tobacco 
smoking and cooked foods are nonoccupational sources of arylamines. and humans are fiequently 
exposed to arylamines in mainstream and sidestream cigarette smoke and chaibroiled proteinaceous 
foods (Butler et al.. 1989; Vineis. 1992. 1994). Epidemiologic observations suggest that the presence of 
arylamines might be responsible for the excess risk of bladder cancer in smokers. The attributable risk of 
cigarette smoking for bladder cancer is at least 50% (Skipper and Tarmenbaum. 1994). One possible 
explanation to accoimt for this increased risk for bladder cancer is that carcinogenic compounds, inhaled 
with or absorbed &om tobacco smoke, enhance the capacity to transform foreign compounds and convert 
some of them to mutagens (Bilimoria et al.. 1977). Cigarette smoke condensate and cigarette smokers' 
urine were tested alone and in combination with direct and indirect mutagens in the Ames Salmonella 
reversion assay system. While both cigarette smoke and smoker’s urine showed some mutagenic 
activity, each of them in combination with 2-aminoanthracene exhibited a synergistic effect on 
mutagenicity (Hannan et al.. 1981).
The timing of arylamine exposure and the risk of bladder cancer was also examined. Rothman 
et al. (1993) examined PAH-DNA ackhict levels in firefighters and found that PAH-DNA adduct levels
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were not associated with recent firefighting activities, but were positively associated with fieqnencv of 
chaibroiled food consumption in the previous 2 weeks. The effect of single and multiple intragastric 
does of 2-AA to induce mammary cancer in young Sprague-Dawlev rats was examined by Griswold et 
al. (1966. 1968). Multiple dosing was found to be no more sensitive than a single dose in the induction 
of tumors: however, repeated treatments increased the percentage of tumor-bearing anim ak and the 
multiplicitv' of the tumors. Matanosld and Elliott (1981) reported that the risk of occupational bladder 
cancer was higher in woricers exposed at a younger age. and Vineis (1994) reported that the relationship 
between timing of exposure and the risk of bladder cancer was very similar after exposure to tobacco and 
to occupational arylamines. The risk decreased with increasing time since first exposure and decreased 
with increasing time since exposure cessatiorL In one stuck all 15 workers involved in the distillation of
2-naphthylamine in a small plant in England developed bladder cancer (Case. 1966). This observation 
by Case was important because it showed that in situations of fiecpreni high levels of exposure to potent 
carcinogens, interindividual variability and susceptibility is irrelevant.
Based upon evidence that has acxumulated. it appears that activation of primarv- aromatic 
amines as a class typically recpiires oxidation of the amine group to the N-hydroxy moiety (Kadlubar et 
al.. 1977). Oxidation of a primary aromatic amine is the major route to the formation of N- 
hydroxyaryiamine compounds in animals; however. N-hydroxy derivatives can also be formed by- 
reductases which can reduce nitro groups to N-hydroxy derivativ es. Thus, the dinitropyrenes and 
arylamines may share common pathways of metabolism to ultimate carcinogens and may compete with 
each other for the same activating enzymes (Kiefer et al.. 1994). The N-oxidation reaction can take 
place in a number of organs in the Ixxk. but studies show the primary site is the liver (Skipper and 
Tarmenbaum, 1994; Traynor et al.. 1991). The enzymes responsible for oxidation in the liver are 
located in the endoplasmic reticulum. The endoplasmic reticulum membranes contain an electron 
transport system collectively known as the mixed-fimction oxidases (monooxygenases) of which the 
cytochrome P450s are members (Garrod and Mason, 1986). Cytochrome P450s are predominantly 
expressed in the liver, where the level of expression of specific P450 isozymes has been shown to vary 
widely between individuals (Smith et al., 1995). Isozyme specific P450 expression has been reported in
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extrahepalic tissues and has been associated with tissue or cell specific substrate acthntion (Carrière et 
al.. 1992). The human CYPIA gene locus has two members. CYPIAI. which is predominantly 
expressed in extrahepatic tissues, such as lung and hTnphocvtes. and the CYP1A2 isozyme which is 
Iwer specific (Kadlubar. 1994). In experiments using mammalian cytochrome P450s and flavin- 
containing monooxygenases (FMO). Hammons et al. (1985) showed that the oxidation of the fimctional 
amino group of several arylamines is catalyzed primarily by cytochrome P4501A2 (CYPlAl), a reaction 
which does not take place in the bladder since CYP1A2 is not expressed in extrahepatic tissue 
(Parkinson. 1996). Studies have also shown that the primary arylamine. 2-AA. is processed by hepatic 
N-oxidation via cytochrome CYP1A2 in mammals (Lubet et al.. 1989). Wistar albino rats iryected with 
50 mg/kg 2-AA on 3 consecutive days and killed 24 hours following final injection showed hepatic 
ethoxvTesorufin-O-deethylase (EROD) activity fourfold higher than paired controls (Iwasaki et aL 1986). 
The CYPIA enzymes catalyze the O-dealkylation of 7-ethoxyresorufin. Unlike in mammals. Watson et 
al. (1995) found that charmel catfish hepatic CYPIA is inactivated by 2-AA. although fish liver 
preparations, like mammalian liver preparations, bioactivate 2-AA to a mutagenic agent in the Ames 
test Considerable interindividual variation both in the level of hepatic expression and in the rate of 
metabolism of CYP1A2 substrates have been reported (Kadlubar. 1994). Phenoty?ing studies have 
suggested that three phenotypes of the CYP1A2 gene may be distributed among the human population— 
slow, intermediate, and rapid metabolizers: and that considerable variation in the distribution of these 
phenotypes is seen in individuals of different racial/ethnic groups (Kadlubar, 1994; Smith et al.. 1995). 
For example, induction of CYP1A2 by cigarette smoking was shown in Caucasians but not in Chinese 
or in Afirican-Americans (Kadlubar. 1994).
The hy droxy lamines shows some reactivity to DNA at slightly acidic pH values, and are 
directly mutagenic and carcinogenic (Kadlubar. 1977; Lubet. 1989; Humphreys etal. 1992). The 
protenated hydroxylamine may be converted by spontaneous heterolysis to water and an aryl nitrenimn 
ioiL which appears to be the ultimate electrophilic metabolite that binds DNA (Rodrigues et al.. 1993).
As aromatic amines already possess a functional group, the N-hydroxylation reaction may be preceded 
or followed by a wide variety of acétylation, deacetylation or conjugation reactions, such as N-
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glacuxonidation to form the N-glucurooide w hich enters the circulation and is then excreted in the urine 
(Kadlubar et al.. 1977: Butler et al.. 1989). Studies have shown that aromatic amines can react 
spontaneously with glucuronic acid to form N-glucuronides. Hepatic N-oxidation followed b\ N- 
glucuronidadon. has been the proposed route of metabolic activation for arylamine bladder 
carcinogenesis. The N-glucuronides mav enter the circulation- undergo renal filtration, and enter the 
bladder lumen (Beland et al.. 1983). These N-glucuronides can then be cleaved by acidic conditions or 
by bacterial |3-glucuronidase to yield N-hydroxy lamine (Dooley et al.. 1984: Malaveille et al.. 1992).
The normal acidity of urine in human and dogs (pH 5.6) is capable of hydrolysis of N-glucuronides to 
the N-hydroxy-arylamine. Oglesby etal. (1981) showed that infrequent voiding and an acidic urine 
would promote the hydrolysis of the N-glucuronides and reabsorption of the N-hydroxy-arylamine.
Under these acidic conditions, the N-hydroxy-arylamine can imdergo acid-catalyzed conversion to an 
aryl nitrenimn ion-carbocation electrophile which binds to macromolecules (Kadlubar et al.. 1980.
1981. 1991: Flammang et al.. 1984). The urinary bladder epithelium, like the kidney medulla, contains 
low levels of the cytochrome P450s but relatively high levels of the enzyme, prostaglandin H synthase.
As a result, in humans and dogs arylamines can imdergo metabolism in the urinary bladder epithelium 
by prostaglandin H synthase to form reactive nitrenium radicaL which can undergo nitrogen-nitrogen or 
nitrogen-carbon DNA-reactive metabolite formation that may cause bladder cancer (Gupta. R.C.. 1984).
In the ra t however, aromatic amines produce mostly liver tumors. The incidence is often 
higher in male rats than in females. For primary amines, such as 2-AA. metabolic N-oxidation by 
intestinal microflora and the liver enzyme cytochrome P450s is a critical initiation step leading to 
carcinogenesis (Paridnsoit 1996). The initiation step is then followed by O-acetylation or solution 
(Yamazoe et al.. 1994). It has been hypothesized that the hydroxylamine is acetylated to form the 
ultimate carcinogen, and hepatic cytosol contains N-acetyltransferase enzymes which can Oacetylate 
(Traynor et al., 1991). Since acylated DNA-adducts have been identified, some investigators have 
suggested that aromatic amines may sequentially undergo N-acetylation and N-hydroxylation followed 
by Oesterification (e.g. sulfotransferase), and that this pathway may best explain the hepatic tumor 
formation in rats (Martin et al., 1982; ). Other studies established the role of male-dominant sul&tion
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on the occurrence of the sex-related difference in the arylamine-induced liver carcinogenesis (Ddaun et 
al.. 1970; Shiraga et al.. 1995). The sequences in the metabolism of aromatic amines in the rat results in 
the formation of both acylated (aRjroximately 20%) and nonacylated (approximately 80%) arylamine- 
DNA adducts (Beland et al.. 1980; Yamazoo et al.. 1994). It was demonstrated that in livers of rats 
chronically fed 2-acetylaminofluorene for periods up to one month, the deacetylated adduct dG-C8-AF. 
was the predominant C8-substituted deox>'guanosine adduct (Poirier et a t 1990). Enzymatic acétylation 
of aromatic amines can promote either activation or deactivation of the substrates (Kato and Yamazoe. 
1994). The N-acetyltransferases deactivate or detoxifv aromatic amines by converting the functional 
amino group to an amide, and aromatic amides are not readih' activated to DNA-reactive metabolites by 
CYPIA. PHS. or LJDP-glucuronosvltransferase. However. N-acetyltransferases can activate aryl amines 
if N-oxidation occurs first. N-acetyltransferases can also function as Oacetyltransferases and convert 
N-hydroxylamines to acetoxv esters.
The existence of multiple alleles at loci that encode drug/xenobiotic metabolizing enzvmes can 
result in differential susceptibilities of individuals within a population to the toxic, mutagenic and/or 
carcinogenic effects of chemicals (Smith et al.. 1995). For example, if the affeaed enzyme is 
responsible for the primary metabolism of a chemical, then the phenotypic consequences of altered 
expression may be of greater clinical significance than if the enzyme acted at a later stage of 
metabolism. On the other hand if minor metabolites are more toxic than the major metabolites, then 
the phenotypic expression of a relatively minor enzyme can have significant clinical consequences. 
Humans and other mammalian species (with the exception of the dog and fox which are not able to 
acetylate compounds) express a genetic polymorphism in N-ace^lation capacity that segregates 
individuals of each species into rapid, intermediate, or slow acetylators (Hein. 1988). Rats in generaL 
and the Fischer 344 inbred rat in particular, are often utilized to study the toxicity and carcinogenicity of 
aromatic amines (Boorman et al.. 1990). This is because the inbred rat mimics the polymorphism in N- 
acetylation edacity exhibited in humans (Hein et al., 1991; Martell and Wdser, 1993). The N- 
acetylation polymorphism is of both Hiniral and toxicological importance because rapid or slow 
acetylator phenotype can influence the toxic response fiom aromatic amines. In addition, acewlator
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phenonpe has been associated with increased incidence of aromatic amine-associated cancers in hiimang 
(Hein et ai.. 1991). Slow acétylation is a predisposing factor in occupational bladder cancer (Risch et 
al.. 1995). The N-acetylation (a detoxification reaction) of aromatic amines and the O-acetylation (an 
activation reaction) of N-hydro.x>’ aromatic amines can be rev ersed by a microsomal enzyme called 
arylacetamide deacetylase (ProbsL 1994). Studies on N-acetylation in human cancers other than bladder 
cancer have yielded less definitiv e results. However, in contrast to the findings in bladder cancer, it 
appears that fest acetylator phenotypes may have increased susceptibility to colorectal cancer. Rapid 
CYP1A2 mediated N-hydroxylation was also associated with increased risk, and the combination of fast 
acétylation and rapid N-hydroxylation gav e the highest risk of all (Kadlubar et al.. 1992). The balance 
between acetylated and nonacetylated aromatic amines is. therefore, an important determinant in the 
toxicologic and carcinogenic activities of this class of compounds (Probst et al.. 1994).
THE IMMUNE SYSTEM 
CELL REGULATION AND SIGNAL TRANSDUCTION PATHWAYS
The immune system is composed of several cell populations whose maturation is subject to 
orderly control by endogenous hormones and/or exogenous bacterial products. These mediators possess 
activation, growth promotion, or differentiation properties and are under the influence of potent and 
w ell-defined cell regulators. The current knowledge about the pathogenesis of disease supports the 
possibility that chemical-induced damage to the immune ^  stem may be associated with a wide spectrum 
of diverse pathological conditions, some of which, like cancer, may only be detectable after a long 
latency period (Bums et al., 1996). From studies in rodents and limited observations in human»;, it is 
apparent that the immune system is a direct target for toxic insult by a number of environmental and 
chemical agents, often resulting in suRiression of immune system responses, and altered host resistance 
to infectious agents and/or tumor su{^nession (Luster and Rosenthal. 1993). The ability of polycyclic 
aromatic hydrocarbons (PAH) to compromise the humoral and cell-mediated immune system and host 
resistance is well documented in both in vivo and in vitro systems (Kaminski et aL 1989; Wojdana et al. 
1984; White. 1985, 1986; Sczczeklik et al. 1994). Structure-activity studies with PAHs have shown that 
the carcinogenic > 4 ring PAHs. exemplified by 7,12-dimethylbenz[a]anthracene (DMBA), and
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benzo[a]pyrene. are the most immunotoxic members of this class of chemicals, while noncarcinogenic 
PAHs like benzo[e]pyrene were found non-immunosuppressive (White and Holsapple. 1984; Hardin et 
al. 1992; Ladies et al.. 1992a; Burchiel et aL 1990; Da\ila et aL 1995). The effects of PAHs in doses 
that are higher than required to produce immunotoxicit)' are often acutely cytotoxic to lymphoid cells 
(Davila et al.. 1995). In general, in vivo exposure to high doses of PAHs results in atroph>' and 
involution of lymphoid tissue with a selective depletion of B- and T-lvmphocvtes. For example. DMBA 
was shown to reduce the number and viabüily of lymphoid cells and to produce atrophy of the thymus, 
spleen, bone marrow. Peyer's patches, and mesenteric lymph nodes following oral exposure of mice to 
doses greater than 100 mg/kg (Burchiel et al.. 1988. 1990. 1992; Davila et al.. 1995; Dean et al.. 1985). 
DMBA was also shown to increase intracellular calcium and induce DNA ftagmentation and apoptosis 
(Burchiel et al.. 1993). Although cytoto.xicity is a consequence of high exposure doses to PAHs. lower 
doses of DMBA or benzo[a]pvTene administered in vivo were found to induce immunosuppression to 
humoral and cell-mediated immunity without observed evidence of cytotoxicity (Burchiel et al.. 1990). 
Furthermore, the inununosuppression produced by DMBA was persistent, producing 
irmnunosuppression for 8 or more weeks following exposure, and was found to decrease the host 
resistance to pathogen and tumor challenge (Davis and Burchiel, 1992; Burchiel et al.. 1993). The 
doses required to demonstrate inunune system suppression (> 10 mg/kg ofbenzo[a]pyrene). however, far 
exceeded the level (< 10 ng/kg) estimated for human envirorunental exposure (Lioy et al.. 1988). When 
male guinea pigs were exposed via inhalation to diluted diesel engine exhaust with a particulate 
concentration of 1500 ^g m'  ^for 8 weeks, assavs of lymphocytes from tracheobronchial lymph nodes, 
spleens and blood of exposed animals revealed no significant changes in the viability or cell number in 
lymphocyte sul^x>pulations when compared with age-matched controls (Dziedzic, 1981).
Carcinogenic PAHs are thought to induce their immunosuj^nessive effects through aryl 
hydrocarbon (Ah) receptor-mediated mechanisms and the imrmmotoxic responses elicited by these 
compounds are similar to those observed by halogenated compounds, such as 2.3.7.8-tetrachlorodibenzo- 
p-dioxin (TCDD), which are Ah receptor agonists (Morris et al.. 1992; Harper et al., 1996).
Furthermore, Ah responsive mice in which PAHs are readily bound by Ah receptors readily metabolize
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the PAHs into mutagenic and carcinogenic metabolites which form DNA adducts. while Ah non- 
responsive mice are resistant to such effects (Luster et al.. 1987). McLemore et al. (1981) similarly- 
showed macrophage and lymphocyte Ah receptor levels were higher in human lung cancer patients 
than age-matched noncancer patients. The binding of aromatic compounds to the Ah receptor is 
thought to trigger the activation of metaboUc enzymes, in particular the activation of the P-4501 Al and 
P-*501A2 enzymes which are the primary enzymes responsible for PAH bioactivation (Mitchell. 1985). 
Metabolic activation of PAHs to reactiv e diols or dio-epo.xides has been shown to be a prerequisite for 
the initiation of carcinogenesis in many models, and research has shown that a good correlation exits 
between PAH metabolic activation and inunimotoxicity (Miller and Miller. 1981; Kawabata and White. 
1987; MudzinskL 1993). Ah-receptor deficient mice displayed hepatomegaly and hepatofibrosis. along 
with decreased accumulation of lymphocytes in their spleen and lymph node but not their thymus, 
indicating that the Ah-receptor plays a role in the development of the liver and immune system 
(Fernandez-Salguero et al.. 1995). Mudzinskd (1993) demonstrated that benzo[a]pyrene was 
immimotoxic to human peripheral blood mononuclear cells, as measured using an in vitro T cell 
mitogen assay, and that the immtmotoxicity ofbenzo[a)pyrene could be prevented by co-exposure with 
the P4501A inhibitor, a-naphthaflavone. Similarly, a-naphthafiavone was shown to block 
benzo[a]pyrene mediated cell apoptosis and lymphopoiesis suppression, suj^rting the theory that the 
Ah-receptor is important in inunune system development (Hardin et al.. 1992; Burchiel et al.. 1993). 
Davila et al. (1996) showed that benzo[a]pyrene and DMBA immtmotoxicity could be prevented in 
human T cells by a-naphthafiavone. Although there is evidence that the Ah receptor plays a role in 
PAH-induced inunimotoxicity. there is also evidence for Ah receptor independent mechanisms. DMBA 
does not have a high binding affinity for the Ah receptor, and Thurman et al. (1988) showed that 
DMBA induced immunosuppressive effects in Ah non-responsive and responsive mice, suggesting that 
similar immunotoxic effects occur regardless of the relative induction of the Ah receptor. On the other 
hand. benzo[a]pyrene and 3-methylcholanthrene were shown to exhibit greater immunosuppressive 
effects in Ah responsive than Ah noiuesponsive mice, suggesting that 3-methylcholanthrene- and 
benzo[a]pyrene-induced immunotoxidty is at least partly Ah receptor dependent However, in studies
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%ith human peripheral blood mononuclear cells, while the immunotoxicitv' of benzo[a]pyrene and 
DMBA was prevented W co-administration of a-naphthaflavone. the immimosuppression produced by-
3-methyIchoIanthrene was not reduced by a-naphthaflavone. This suggests that PAHs may exert their 
immunomodulatory effects via an Ah receptor independent mechanism (Mounho et al.. 1997). Other 
routes of PAH metabolic pathways have been described and include firee-radical-dependent mechanisms 
and metabolism Iw prostaglandin synthetase (Gupta. R.C.. 1984).
The humoral and cell mediated immime system are common targets for the toxic effects of 
PAHs (Davila et al.. 1995; Mounho et al.. 1997). The primary function of humoral immunity is to 
eliminate extracellular pathogens by the production of antibodies by B-cells in response to exposure with 
the help of T lymphocytes (T-dependent immunity), or W the production of antibodies in direct response 
to antigen without T-cells (T-independent immunity). Further, the humoral immune function appears to 
be highly sensitive to modulation by these polycyclic aromatic hydrocarbons. Both in vivo 
administration and in vitro expostue of DMBA or benzo[a]pvTene at lower than cvtoto.xic doses were 
shown to suR)ress antibot^-mediated immunity as measured by the plaque-forming cell response to 
sheep red blood cells (Burchiel et al.. 1988; Thurman et al.. 1988; Temple et al.. 1993). DMBA was 
also shown to suppress B cell lymphopoiesis and induce pre-B cell apoptosis in murine bone marrow 
cultures (Burchiel et al.. 1993). Decreased production of antibodies to a T-dependent antigen after in 
\ivo exposures to other carcinogenic PAHs. including benz[a|anthracene. dibenz[a.h]anthracene. and 3- 
methylcholanthrene were also reported (Lubet et al.. 1989). Ladies et al. (1992a) demonstrated that the 
immune system is capable of metabolically activating benzo[a]pyrene to a number of metabolites. The 
plaque forming cell (PEC) response to the T-ceU dependent antigen, sheep red blood cells (SRBC) and 
the T cell-independent antigen. dinitrophenyl-FicoU (DNP-FicoU) was suppressed by benzo[a]pyrene. 
However, the PFC response to lipopolysaccharide (LPS) was unaffeaed by benzo [a]pyrene. indicating 
that macrophages are the target of benzo[a]pvTCne (Ladies et al., 1992c; Bums et al.. 1996).
Furthermore, men exposed to benzo[a]pyrene at levels from 0.2 to 50 pg m'^ exhibited a marked 
depression in serum levels of IgA and IgG. A decrease in hiunoral immunity sensitivity has also been 
reported by in vivo exposures to other carcinogenic PAHs, including benz[a]anthracene.
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dîbenz[a.h]anthracene. and 3-methyichoianthrene (Lubet et al.. 1989. White et al. 1985). The abilit>- of 
a complex mixture to suppress humoral immunity was also examined. Suppression of plaque forming  
cell response to both T-dependent (trinitropheny l-sheep red blood cell) and T-independent 
(trinitropheny l-lipposaccharide) antigens was demonstrated in mice exposed to 2-. 3-. and > 4 ring PAH 
fractions as well as a composite complex mixture (Harper et al.. 1996). Results of this study indicated 
that the reconstituted mixture and each fraction of the mixture caused a dose-dependent suppression of 
humoral immunity, but that the fraction containing  > 4-ring PAHs was primarily responsible for the 
suppressed activity.
In contrast to the effects on humoral immunity. Dean et al. ( 1983) showed that PAHs have 
only a slight effect on cell-mediated responses. However. Thurman et al. (1988) showed that DMBA 
exposure not only suppressed (99%) humoral immune responses, but also suppressed (88% and 86%. 
respectively) cytotoxic lymphocyte responses in Ah-responsrve and nonresponsrve mice splenic 
lymphocytes. In vitro incubation of mice spleen cells with DMBA also suppressed several measures of 
cell-mediated immunity, including mixed lymphocyte responses, production of interleukin 2, 
proliferation to phytohemagglutinin and concanavalin A (Pallardy et al.. 1988). Mixed lymphocyte 
reactions of spleen lymphocytes of Ah-responsive and Ah-nonresponsive mouse with DMBA showed 
comparable suRiression. while exposure to benzo[a]pytene resulted in suppressed mixed lymphocyte 
responses only in the Ah-responsiv e mice and only to lipopolysaccharide stimulation, suggesting that the 
ability of different PAHs at similar concentrations may modulate the inunune system cells by 
mechanisms which differ in their potential for biotransfonnation (Thurman et al.. 1988). In contrast 
benzo[a]pyrene-exposed human peripheral T cells exhibited suppressed lymphoproliferative responses to 
the mitogen. Concanavalin A, but appeared to have no measureable effect on the secretion of 
interleukin 2 (Mudzinski. 1993; McCord. 1996). In general, the immunosuppressive effects of PAHs 
appear to exert a primary effect on hiunoral immunity, rather than on cell-mediated immunity, and 
these effects may result frum a direct suppression of B-cell function or may be indirectly mediated 
through other cells involved in response, such as macrophages. Ladies et al. (1992b) demonstrated that 
macrophages are spleen cell population which metabolize benzo[a]pyTene, and stated that the
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macrophages are likeh- responsible for the observ ed immune suppression. Furthermore. Ladies et ai. 
(1992b) demonstrated that the macrophages are capable of both a P450-dependent (Ah receptor binding) 
and P450-independent mechanism.
MACROPHAGES
Macrophages are unique cells within the immune system, because the)' participate in both 
innate immunit) and in acquired immunity. Macrophages contribute to different aspects of host 
defense and so are an essential cell in the immime response as antigen presenting cells, as regulatory 
cells, and as effector cells. Macrophages also display strong cytotoxic activit) to \irally infected cells 
and tumor cells, and for this purpose macrophages may svothesize an ana)' of products when 
appropriately stimulated, such as tumor necrosis &ctor (TNF). interleukins-1 and 6 (IL-1 and BL-6). 
colony stimulating factor and nitric oxide (Fuhlbrigge et aL, 1987; Beelen and Poindron. 1994). Due to 
their central role in the immune system, macrophages are widely used in experimental work (Vray and 
Plasman. 1994). Macrophages possess numerous physiologic properties that may be modulated during 
activation. These include alterations in intracellular constituents, such as phagosomes and h'sosomes: 
alterations in plasma membrane components, such as the expression of receptors for phagocytosis, for 
lymphokines. for growth feaors. and for nonphagocytic functions: and alterations in their secretory 
capacity. The expression of these capacities of macrophages is regulated by munerous classes of signal 
molecules. Regulation of the various capacities and functions of macrophages is complex, and most can 
be down- as well as up-modulated. Thus, as macrophages reside in tissues and are exposed to various 
signals, some capacities are tinned on while others are turned off (Adams and Hamilton. 1984). Studies 
have demonstrated that macrophages are the cell types which metabolize benzo[a}p)Tene and DMBA via 
P-450 enzymes within the murine spleen cell populations (Ladies et al.. 1992b; Morris et al.. 1992). 
Additionally. Ladies et al. ( 1992a.c) demonstrated that macrophages are capable of metabolizing 
benzo[a]iwrene to 7.8-dihydroxy-9.10-epoxy-7,8.9.10-tetrahydro-benzo(a]pyrene (BPDE). the metabolite 
proposed to be the ultimate carcinogen produced by benzo[a]pyrene metabolism. Several investigators 
have demonstrated that in addition to the cytochrome P450 pathway, macrophages may also utilize the 
unsaturated &tty acid hydro peroxide-dependent cyclooxygenase pathway via peroxyl radicals to
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metabolize PAHs. and these studies have suggested that macrophages mav' be predisposed to the 
immimosuppressrve effects of PAHs by virtue of their increased capacitv’ to generate metabolites by both 
these pathways (Ladies et ai.. 1992c). Reactive metabolites may then covalently bind to nucleophilic 
targets and impair macrophage function as antigen presenting cells in the immune response (Robison et 
al.. 1993). In additioiL the suppression of T-dependent antiboch responses induced by PAHs such as 
benzo[a]pvTene may be reconstituted bv interleukin-2, implying either a direct or indirect effect of 
benzo[a]pvTene on T helper cells. This effect might be mediated in part tn' altered interleukin-1 (IL-1) 
production by macrophages following benzo(a]pyrene exposure, since it was demonstrated that 
exogenous IL-1 addition to in vitro cultures of lymphocytes promoted antibody production in 
benzo[a]pyTene immunosuppressed cells (Lyle and Bick. 1986 ). Bacterial endotoxin lipopolysaccharide 
(LPS) is a potent activator of the inunune system that induces local inflammation antibody productioiL 
and even septic shock. Macrophages play a central role in the host defense against LPS and are major 
cellular targets for LPS action. Delivery of LPS to the CD14. a phosphotidylinositol-anchored protein, 
is required for LPS stimulation of macrophages. LPS has multiple effects on macrophages, including 
induction of the secretion of cytokines such as IL-1. tumour necrosis factor-alpha (TNFa). and 
arachidonic acid metabolites (Manthey et aL. 1992). Cytokines are essential transmitters of cell-to-cell 
communication in many physiological and pathophysiological processes (Le and Vilcek. 1987). LPS 
has also been shown to induce the phosphorylation on tyrosine residues of a group of40-45kDa proteins 
in macrophages (Weinstem et al.. 1991). Moreover. LPS-induced tyTOsine phosphorylation occurred in 
cells pretreated with actinonw cin D or cy cloheximide (inhibitors of transcription and translation), 
indicating that the induced phosphory lation occurred in proteins already present and. therefore, was not 
due to increased protein synthesis (Manthey et al., 1993). Mitogen-activated protein kinase (MAP-K or 
p42“ ’* ) , which corresponds to the ERK2 gene product, is strongly activated in LPS-treated 
macrophages, howev er, activation of MAP-K and arachidonic acid metabolism was inhibited both in 
vivo and in vitro by treatment with the tyrosine inhibitor herbimycin A (Weinstein et al.. 1992). MAP 
kinases appear to participate in the signal transduction pathways activated by a variety of extracellular 
ligands and are rapidly phosphorylated on tyrosine residues following cellular activation in a variety of
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cell tvpes. Phosphorylation of MAP kinases increases the enzymatic activity of these proteins and 
suggests that they ma>- regulate fundamental cellular processes (Weinstein et al.. 1992). MAPK 
activation has been associated with both cell proliferation and diSerentiation. and it has been suggested 
that the duration of MAPK activation determines whether a stimulus elicits proliferation or 
differentiation (Traverse et al., 1992).
Macrophages, when appropriately activated, selectrvelv and efbcienth' iv-se neoplastic cells in a 
contaa-depenctenL nonphagocytic process termed macrophage-mediated tumor cviotoxicity (MTC). 
Completion of MTC is a multistep process which encompasses the binding of tumor cells bv- the 
activated macrophages and the secretion bv macrophages of lytic mediators (Adame and Hamilton.
1984). TNF-a. is one of the major cytokines released bv" activated macrophages. TNF-<x was 
characterized initially bv- its abilitv' to induce the regression of cancers in animale and bv the cvtostatic 
and cvtotoxic responses that it can elicit firom transformed cells (Carswell et al.. 1975; Le and Vilcek. 
1987; Carbo et al.. 1994). In addition to its oncolvtic activitv-, TNF-a promotes immunity, antiviral 
responses, inflammation, and in some chronic diseases the syndrome of wasting and malnutrition known 
as cachexia (Beutler and Cerami. 1988; Costelli et al.. 1993). Subsequent to discover} of its oncolvtic 
effects, it was shown that TNF-a has profound effects on the growth, differentiation, and metabolism of 
normal cells and the function of normal tissues (Guo and Dormer. 1996). TNF-a affects glucose 
homeostasis in several tissues (Carbo et al.. 1994; Costelli et al.. 1993; Ranganathan and Davidson.
1996; Begum and Ragolia. 1996; Elased et al.. 1996; Kanety et al.. 1995; Ofei et al.. 1996; Hussain et 
al.. 1996). Administration of TNF-a results in increased basal glucose turnover and decreased insulin- 
stimulated peripheral glucose utilization (Ranganathan and Davidson, 1996). TNF-a is also 
implicated in the insulin resistance observed in a variety of catabolic states, for example, septic shock, 
systemic lupus erythematosus, advanced cancer, malaria, and trauma (Elased et al., 1996; Kroder et al.. 
1996; Van der Poll et al., 1991; Bennegard et al.. 1986). TNF-a has also been suggested to be the 
effector mechanism of tissue destruction in insulin dependent diabetes mellitus (Jacob. 1992). Evidence, 
therefore, indicates that the role of TNF-a may be either beneficial (protective) or deleterious 
(pathological). Guo and Dormer (1996) showed that when present acutely, TNF induced the tyrosine
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phosphorylation of the insulin receptor and its major substrate, Tn«nilin Receptor Substrate 1. and its 
association rvith cytoplasmic signaling molecules, including phosphatich’linositol 3-kinase. These 
observations showed that TNF can elicit an acute growth factor in cells and provide a mechanism 
through which TNF receptors can engage signal transduction processes. Whereas, when present 
chronically, TNF was shown to interfere with signaling  through the insulin receptor and through 
substrates that mediate responses to insulin, such as Insulin Receptor Substrate 1, resulting  in insulin 
resistance (Peraldi et al., 1996: Biased et al., 1996; Hussain et al., 1996). In a rodent model of obesitv". 
blocking TNF effects led to increased insulin sensitivity (Kanetv et al., 1995; Ofei et al., 1996). TNF-a 
production is most commonly induced by stimulation of macrophages with IPS although several other 
inducers have been reported, including phorbol myristate (PMA) (Zor et al., 1993). Studies have shown 
that during macrophages activation, protein tyrosine phosphorylation of STATla (signal transducer and 
activator of transcription lot, p91) and ERK2 (extracellular signal-regulated kinase 2, p42) proteins 
occurs as an early signal, whereas TNF-a formation and secretion doesn’t occur until 3-6 horns 
following stimulation. Herbimycin A was shown to suppress tyrosine phosphorylation of STATla and 
ERK2 and also blocked TNF-a production by resident peritoneal macrophages in mice (Zheng and 
Specter, 1996). Interferon-gamma (INF-y) and interleukin-1 (IL-4) are secreted products of two subsets 
of T-helper Ivmphocvies and have been shown to affect differentially a number of macrophages 
functions (Littman et al, 1989). These cytokines or Ivmphokines activate the ST AT class of 
transcription Actors and reportedly prime macrophages for tumor cell killing upon activation with IPS 
(Ihle. 1995). A number of exogenous mechanisms are involved with prim ing one is the production of 
cytokines such as TNF-a and IL-1, and both the EL-4 and INFy Ivmphokines appear to enhance 
secretion of TNF-a in macrophages. Suk and Erickson (1996) demonstrated that while these two 
Ivmphokines increased LPS-induced TNF-a steady-state message levels; the degradation rate of the 
TNF-a mRNA was higher in the IL-4 treated cells and resulted in a  lower steach-state level than that in 
the INFy treated cells. The implication of these events in the priming and activation of macrophages is 
not knowTL
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T- CELL LYMPHOCYTES
T cells, unlike other cells of the immune system, respond mainly to protein antigens, and these 
must be processed and presented as protein fiagments on the sur&ce of antigen presenting cells (APCs). 
The activation of antigen-specific T cells begins with the interaction of the T cell receptor (CDS) with 
the MHC class Il-peptide on the APC (Premack and Gardner. 1992). Upon antigenic or mitogenic 
activation and in the presence of IL-1 secretion b>' macrophages. T cells begin to express high-aflBnitj- 
receptors for the major T cell growth factor, interleukin-2 (IL2). In addition, the T cells begin to 
produce IL-2 which can act in an autocrine fashion to bind to receptors on the same cell or in a 
paracrine fashion to stimulate B cell receptors (Archuleta et aL 1993). Like most other growth fectors. 
EL-2 causes rapid tyrosine phosphorylation of proteins within its target cells (Gardner. 1989). One 
mechanism where PAHs have been shown to exert their immimosuppressive effects is through 
alterations in cvlokine/lymphokine secredoiL Benzo(a]pvTene has been shown to decrease the 
percentage of cells expressing IL-2 receptors among stimulated murine lymphocytes (Myers et aL.
1988).
Protein tyrosine kinases hav e been implicated in the regulation of cellular proliferatioiL 
differentiation and development. Deregulation of protein tyrosine kinase activity as a consequence of 
over expression of or mutations in. the proteins has been shown to result in a variety of pathological 
conditions including cancers and immunodeficiencies (Weiss and Litman. 1994; Ihle. 1995). And the 
inhibition of tyrosine phosphorylation has been shown to prevent the T cell receptor-mediated cell 
signaling (June et al.. 1990). The phosphorylation of tyrosine residues of proteins has been shown to be 
an essential component of signal transduction by many growth 6ctor receptors such as insulin The 
earliest measurable changes that occur after ligand binding to the T-cell receptor are the appearance of 
newly phosphorylated tyrosine residues on a variety of cytoplasmic and membrane proteins. These 
phosphorylation events, mediated by phosphotyrosine kinases (PTKs) are detectable within the first 
minute after ligand binding to the TCR. Phosphorylation of tyrosine residues on a protein has two 
general consequences. First it allows other proteins that contain specific tyrosine phosphate binding 
sites to bind to the phosphorylated protein. These binding sites are structurally conserved and are called
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1991). Therefore, phosphorylation of tyrosine residues in the cytoplasmic tail of a membrane protein 
may lead to binding of SH2-containing proteins to that site. Difiereni SH2 domains ma>' bind to 
difierent amino acid sequences containing tyrosine phosphate, and phosphorylation of multiple tyrosine 
residues in the same membrane protein can lead to assembly of multi-protein complexes. Second, 
certain enzymes may be activated by phosphorylation of tyrosine residues. Many of these enzymes, such 
as Src. contain SH2 domains and activation occms afier the enzymes adhere at a phosphotyrosine- 
containing membrane receptor. Engagement of the T-cell receptor CD3 and/or CD4 or CDS molecules 
by antigen or anti-T cell receptor antibodies activates a protein tyrosine pathway (O'Rourke and 
Mescher. 1992). CD4 and CDS are cell surface glycoproteins that recognize non-polymorphic regions 
of class n  antigens of the MHC complex and potentiate the signal induced by stimulation of the CD3—T 
cell antigen receptor complex (Ettehadieh et al.. 1992). Three cytoplasmic phosphotyrosine kinases are 
implicated in the T cell receptor signaling. Two of these p56^  and p59^ ™ are members of the Src 
family. The Src family protein tyrosine kinases share a number of common structural features that 
include 1) an N-terminal myristylated glycine at residue 2 that permits membrane localization; 2) a 
unique N-terminal amino acid sequence (-80 amino acids in length): and 3) an approximately 60 amino 
acid Src-homology 3 domain (Premack and Gardner. 1992).
The Src-family protein tyrosine kinase Lck is physically associated with the IL-2 receptor in the 
absence of IL-2 stimulation, and Lck is rapidly activated upon ligand binding to the IL-2 receptor. This 
intermolecular association occurs between the amino-terminal region of the kinase domain of Lck and a 
cytoplasmic region of the IL-2 receptor, termed the acidic region (Taniguchi. 1995). Lck appears to be 
able to interact with the T cell receptor independent of CD4 and CDS association (Weiss and Littman. 
1994). The acidic region is also required, along with the serine-rich region of the EL2-receptor, for IL-2 
mediated activation of Lck. and this activation is followed by the induction of the c-fbs and c-jun genes, 
which suggests a role for the Src-family of protein tyrosine kinases in the induction of these proto- 
oncogenes (Jain et al., 1993;TaniguchL 1995). IL-2 has also been shown to induce phosphorylation of 
Raf-1, a p72-74 kinase encoded by the c-Raf-\ oncogene (Turner et al.. 1991). IL-2 was also shown to
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enhance the formation of the active p21” -GTP. suggesting that ras p21 acts as a transducer of signals 
firom IL-2. The functional significance of Lck in T cell receptor signal transduction has been shown in 
genetic studies in mice and cell lines. Mice deficient in Lck have thymus arrest early in dev elopment, 
and the few T cells they do develop have diminished responses to receptor activation (Levin et al, 1993). 
One of the effects PAHs exert on cell-mediated responses is altered cviokine and lymphokine secretion 
and/or receptor expression. In vitro incubation of murine spleen cells with DMBA suppressed several 
measures of cell-mediated immune responses including production of lL-2 and proliferation to conA 
(Thurman et al.. 1988. MudzinskL 1993). In addition, suppression of T-dependent antibodv responses 
by benzo[a]pyrene mav be reconstituted bv- addition of lL-2, implying either a direct or indirect effect of 
benzo[a]pyrene on T-helper cells (Pallardy et al.. 1988). Lck has also been shown to associate with the 
cytoplasmic domains of CD4 and CD8 through cvsteine-dependent interactions which serves to bring 
Lck in close proximity to the other T cell receptor proteins Fyn and Zap-70(Weiss and Littman. 1994).
Genetic and biochemical studies also have suggested a role for Fyn kinase in T cell signal 
transduction. Fyn phosphotyrosine kinase activity was shown to increase 2 - 4-fold in response to T cell 
stimulation (Tsygankov et al.. 1992). Deletion of the fyn gene in mice did not result in significant 
effects of T cell development, however defects in the activation of T cells were noted Thymocytes of 
mice in which the fyn gene was disrupted by homologous recombination showed a T cell receptor 
signaling defect that was most pronounced in the mature T cells compared with the immature and 
peripheral T cells (Stein et al., 1992). As was shown with Lck. an overexpression of Fyn in thymocytes 
of transgenic mice caused hypersensitivity to T cell receptor stimulation, while a kinase-deficient form 
of Fyn was inhibitory (Cooke et al.. 1991).
The third tyrosine protein kinase phosphorylated by the formation of the T cell receptor 
complex is p70^. Unlike the Src family proteins Lck and Fyn which associate with T cell and B cell 
receptors. Zap (70Kd) is expressed exclusively in T cells and NK cells (Cban et al., 1992). Zap, which 
stands for zeta chain associated protein, is not associated with the T cell receptor in the basal state, but is 
recruited to the Ç and CD3 units, also termed the antigen recognition activation motif (ARAM), 
following receptor stimulation. In cells expressing two forms of the zeta chain—the T cell receptor
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multi-subunit and a chimera receptor—stimulation of the T cell receptor resulted in sole association of 
Zap70. while stimulation of the chimera receptor resulted La Zap solely associating with this receptor 
form. These results indicate that Zap is involved in T cell receptor function (Chan et aL 1992).
Kolanus et al. (1993) using chimera receptors in which Lck. Fyn, or Zap-70 were fused showed that 
independent activation of either the Lck or Fyn chimera receptor failed to induce ctetectable signal 
transduction, but clusters with Zap-70 chimera receptor induced a calcium rise and protein tVTOsine 
phosphorylation. These results indicate that Zap-70 has a role in T cell receptor signal transduction and 
that its function mav be regulated by either Lck or Fyn or both (Kolanus et al.. 1993). The 
immunosuppressive effects of DMBA on lymphocyte function are well described in both in vitro and in 
vivo sv'stems and appear to be mediated through signal transduction pathways. Archuleta et al. (1993) 
demonstrated that DMBA transiently increases Fyn and Lck protein tvTosine kinase activity and elevates 
tvTosine phosphorylation of PLCy in the human cell line HPB-ALL.
Ligation of the T cell receptor-CD3 complex bv- an antigenic peptide and the major 
histocompatibüitv- complex also leads to the adherence of the enzyme, phosphatidylinositol 
phospholipase -/I (PLCyl). which is then rapidly phosphorylated at a tyrosine residue (Chan et al..
1994). Tyrosine phosphorylation PLCyl increases its catalytic ability leading to the hydrolysis of 
phosphatidylinositol 4.5-bisphosphate with the generation of diacylglycerol and inositol 1.4.5- 
triphosphate. Inositol tri-phosphate and diacylglycerol are secondary messengers and are responsible for 
the rise in intracellular calcium, thought to be a result of inositol tri-phosphate stimulated release of 
membrane sequestered intracellular calcium stores (Archuleta et al.. 1993). For mature T cells, the 
involvement of the CD3-receptor with elevated calcium concentration results in cellular activation, a 
process marked by proliferatioiL production of lymphokines such as lL-2. and/or expression of other 
immime functions such as cytotoxicity . Elevated calcium concentration is also associated with the 
inactivation (negative selection) of immature T cells expressing the (ZD4 and/or CD8 molecule and 
apoptosis (Hedin et al., 1995). Both tyrosine kinases and elevation in the calcium concentration are 
important in T cell receptor signal tiansductioiL Tyrosine kinase inhibitors (herbimycin and genistein) 
abrogate inositol phospholipid hydrolysis, calcium elevation, cell proliferation, and IL-2 secretion when
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applied to mature T cells (June et al., 1990; Rabinov-itch et al.. 1986). Paiadoxicalh'. DMBA produced 
a shortened latency and a sustained elevation in intracellular calcium in in vivo and in vitro cell systems 
(Burchiel et al., 1990; Krieger et al., 1994). Prolonged elevation of intracellular calcium precedes 
apoptosis and may also precipitate PAH-induced immunosuppression (Corcoran. 1994). A structural- 
dependent relationship %as found between PAHs and disruption of calcium homeostasis in the human T 
cell line HPB-ALL T. Krieger et al. (1995) found that those PAHs with minimal to moderate 
immunosuppressive properties (i.e. benz[a]anthracene, benzo[e]p\Tene. and anthracene) produced small 
and transient calcium mobilization in the human T cell line, while those with potent iitununosuppressive 
effects, such as DMBA and benzo[a]pyrene caused a rapid and sustained calcium mobilization.
B-CELL LYMPHOCYTES 
T and B lymphocytes have structurally différent oligomeric antigen receptors that recognize 
fundamentally distinct forms of antigens. B cells function to protect the host from extracellular 
pathogens. Their receptors recognize native or denatured forms of proteins or carbohydrates in soluble, 
particulate, or cell-bound form. The T cell protects the host from intracellular pathogens and recognizes 
short peptide antigens bound to the MHC-II complex. Remarkably, the signal transduction events that 
result from the interaction of their antigen receptors is quite similar (Bums et al., 1996). The B cell 
receptor membrane immunoglobulin (mig) subunit is expressed at the plasma membrane in a stable 
complex which consists of alpha, beta, and gamma chains (Raff et al., 1970). Cross-linking of 
membrane Ig molecules serves to bring together intracellular proteins that function in signaling in the 
same way as the CD3 in T-cells. In 6ct the cytoplasmic domains of Iga and IgP and the domains of 
TCR show many sequence homologies. As in T cells, several Src family members Lck, Fyn, Lyn and 
Blk, have been reported to associate with the B cell receptor (Weiss and Littman, 1994). In the resting 
B-cell the Iga and IgP subunits of the B cell receptor are in association with src family kinases, Lyn 
and Fyn. Quiescent, non-cycling B cells appear to be regulated b\ several species in addition to antigem 
Studies have demonstrated that IL-4, also known as B cell stimulatory 6ctor 1 (BSFl); gamma 
interferon (fFNy); insulin; LPS; and MHC-II(Ia) are molecular binding ligands (Cambier and Ransom,
1987). Resting B cells express functional receptors for IL-4. To elicit a given biologic response, i.e.
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stimulation of resting B cells to proliferate, may require the concerted or sequential generation of a 
particular combination of ligands. For example, the stimulation of resting B cells to proliferate 
generally requires both an antigenic or anti-mlg signal and an IL-4 signal (Cambier and Ransom. 1987). 
IL-4 alone however is not sufBcient to induce a signal. EL-4 released by activated T cells may amplily 
the immune response by stimulating B cell la expression, but EL-4 clearly also acts as a growth and 
differentiation 6ctor for B cells (Taniguchi. 1995). Signaling bv membrane Ig regulates B cell 
maturation and activation. Crosslinking of mIg by antigen or by anti-Ig inactivates immature B cells.
By contrast crosslinking of mig promotes activation of mature B cells for clonal expansion and antibodv 
production (Gold et al.. 1990). Coggeshall and Cambier (1984) demonstrated using polyclonal anti-lg 
that B cell interaction with antigen resulted in the generation of a signal leading to increased la 
expressioiL and that this signal was transduced via polyphosphoinositide-spedfic phospholipase C-y2 
liberating inositol triphosphate and diacv lglycerol (Coggeshall et aL. 1992) These second messengers 
then produce an increase in the intracellular concentration of free calcium and the translocation of 
protein kinase C to the membrane (Fahev- and EJeFranco. 1987;Carter et al.. 1991). The membrane Ig 
complex links the recognition of antigen by B cells to activation or. conversely, to suppression of 
proliferation of these cells (Campbell et al.. 1991).
The Iga and Igp subunits of mIgM are phosphorylated upon antigen binding to the B cell.
This phosphorylation results in reorientation such that Lyn and Fyn now bind by their SH2 domains and 
become more active. Stimulation of Lyn and Fyn results in stimulation of more distant tyrosine kinase 
Syk. In B cells chimeric receptors containing Iga and IgP cytoplasmic sequences were shown to 
associate with Syk, suggesting that Syt may interact with the B cell receptor analogous to Zap-70 with 
the T cell receptor. Unlike 2^ap-70. however, stimulation of Syk chimeras induced protein tyrosine 
phosphorylation without coaggregation of with the Fyn chimera (Chan et al.. 1992). The EL-2 B cell 
receptor has also been shown to recruit Syk, and the Syk protein tyrosine kinase is activated upon T cell 
IL-2 stimulation (TanigucM, 1995). Syk activation by EL-2 receptor requires the serine-rich region, but 
not the acid-rich region, which indicates the Ixk activation is not required for Syk activation 
(TaniguchL 1995). Antibody-mediated clustering and activation of Syk protein tyrosine kina.se  in the
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BAF-BO cells resulted in the induction of the c-myc but not the c-/os genes, suggesting that the Lck and 
Syk pathways are linked to distinct proto-oncogenes (Jain et al.. 1993). Stimulation of Src-family 
kinases Lyn and Fyn and then the more distant Syk tyrosine kinase leads to the phosphorylation of She. 
and the GTPase Activating Protein (GAP), eventually leading to the activation of p21™. Activation of 
Ras. a GTPase oncogene protein, results in the activation of another protein kinase cascade—the 
serine/threonine protein kinases. GTP-Ras was shown to bind to the amino-terminus glutathione-Raf 
which subsequently phosphorylated MAP-K (Wame. et al.. 1993). Phosphatit^linositol 3-kinase is also 
stimulated by association of the SH2 domains of Lyn and Fva. and tyrosine kinase activity resulting 
from cross-linking of the BCR which activates phospholipase C (PLC). The formation of inositol 3- 
phosphate and DAG results in concomitant rise in intracellular calcium. DAG activates protein kinase 
C and translocates it to the cytoplasm where it can phosphorylate other proteins on their 
serine/threonine residues.
Increased intracellular calcium induced by the cross-linking of BCR mav* be mimicked by 
PAHs. DMBA was shown to produce a sustained rise in intracellular calcium in murine splenic B cells 
(Burchiel et al., 1991. 1992). Furthermore, apoptosis was shown to be induced by compounds which 
alter calcium homeostasis and cell activation in murine B cells (Davis and BiuchieL 1992). Burchiel et 
al. (1993) demonstrated that DMBA could induce programmed cell death in the A20.1 murine B cell bv 
calcium-dependent pathways and that an increased cell density resulted in enhanced sensitivity to 
calcium elevation, suggesting that cell to cell signal transactions may also be important in this process. 
PAHs may modulate intracellular signaling by way of tyrosine kinase activation. Results of studies 
using cell lysates of A20.1 murine lymphoma cells exposed to DMBA. DMA. anthracene. 
benzo[a]pyrene. benzo[eJpyrene, or benz[a]anthracene indicated that DMBA may exert its effects by- 
altering signal transduction at the level of the B cell receptor and. in particular, via activation of the 
Svk. Lvn and Fvn tvrosine kinases.
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ONCOGENES AND SIGNAL TRANSDUCTION
The carcinogenic nature of many chemicals, and the polycvclic aromatic hydrocartwns in 
particular, has long been associated with their ability to bind to DNA to form specific adducts. some of 
which can cause somatic mutations, deletions, or rearrangements of the genetic material (Searie. 1984). 
These lesions, if they occur at certain critical locations in the genome, are thought to efiect key functions 
in the initiation or progression of neoplastic developmenL Alterations in the cellular genome affecting 
the expression or function of genes controlling cell growth and differentiation are considered to be 
among the primary causes of cancer (Bos. 1989). While many adducts resulting firom the exposure of 
DNA or cells to chemical carcinogens have been identified, the biological significance of the formation 
of specific adducts is not clear (Perera, 1988; Schut and Shiverick. 1992; Arif and Gupta. 1996). The 
uncertainity of their significance stems fi'om the fact that some of the chemical-speciffc major adducts 
may be readily repaired in vivo while minor adducts ma\ persist and be more biologically relevant, thus 
making identification of the critical addnct and target gene difficult.
Evidence suggests that the activation of cellular proto-oncogenes to their oncogenic forms plays 
a central role in the development of neoplasia (Bland et al., 1995). The changes in cellular DNA noted 
by exposure of cells to chemical carcinogens—point mutations, translocations, deletions, and gene 
amplification—have been implicated in the activation of proto-oncogenes to oncogenes and identifies 
proto-oncogenes as possible targets for chemical carcinogens (Balmain and PragnelL 1983; Balmain and 
Brown. 1988). Mechanisms such as gene amplication, mutation, and translocation result in abnormal 
levels of proto-oncogene expression or the production of aberrant proteins (oncoproteins) w hich can lead 
to uncontrolled cell growth and tumorigenesis (Bishop. 1983; Der and (Zooper. 1983). Several proto­
oncogene and growth âctors that control proliferation are also involved in the control of appoptosis.
For example, the z~myc gene plays a central role in the death process, and the inhibition of cell cycle 
progression with high c-myc expression has been shown as a prerequisite for apo)*osis (Evan and 
Littlewood. 1993; Roberts et al.. 1997). C-myc can also sensitize cells towards apoptosis. especially 
when combined with a block in cell proliferation and or in cooperation with p53 which blocks the S 
phase progression (Colombel et al., 1992). The hepatocytes appear to be especially sensitive to cell death
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when the} have entered the cell cycle and a high expression of c-myc is present (Evans et ai.. 1995).
The c-myc gene also plays a central role in cellular proliferation and a decrease in c-myc expression is 
observed after the addition of inducers of differentiation (Farquharson et al.. 1992).
Proto-oncogenes in their native form are incapable of transforming cells, but are thought to be 
involved in the control of normal cell growth and differentiation (Chang et al.. 1982: Studzinsid. 1989; 
Littlewood and Evan. 1990). For example, dietary changes may influence the expression of certain 
proto-oncogenes, such as expression of the c-myc gene. Short-time physiological fasting resulted in a 
matted decrease of c-myc gene expression in the rat liver (Corcos et al.. 1987). This effect was 
independent of glucagon levels, since administration of glucagon lead to an increase in c-myc 
transcripts. Horikawa et al. (1986) observed a gradual increase in c-myc expression in the liver of rats 
fed protein-deficient diets, and the levels of c-myc RNA abruptly decreased when the animals were fed a 
diet containing nutritionally adequate amounts of protein. Regenerative stimuli fiom chemical insult or 
otherwise mav' also alter the expression of proto-oncogenes. For example, the adult liver parenchymal 
cells are capable of rephcating in response to tissue loss via partial hepatectomy or toxic injury. Proto- 
oncogene expression at early stages of carbon tetrachloride toxicitv was examined in the liv ers of adult 
female Sprague-Dawlev rats (Herbst et al.. 1991). Zonal hepatic destruction by carbon tetrachloride 
induced increased c-fos. c-jun. c-myc. c-Ha-roy. and c-Ki-ras protooncogene expression with distinct 
temporal and spatial patterns initiated by the most severeh damaged hepatocytes. indicating the 
involvement of these proteins in hepatocvie repair and replicatiotL These studies demonstrate in vivo 
alterations in expression of a proto-oncogene during proliferative responses under physiologic 
conditions.
Analysis of carcinogen-induced tumors has shown that carcinogens cause oncogenic mutations 
in ras genes and other proto-oncogenes, and the nature of these mutations is consistent with the known 
chemistry of the individual mutagens (Sukumar. 1989). For example. Wiseman et al. (1986) found that 
the induction of hepatomas in B6C3F1 mice with the arylhydroxamic acids N-hydroxv -2- 
acetylaminofluorene and N-hydro.xyaminoazobenzene. the metabolic products of the respective aromatic 
amines, resulted predominantly in a single C:G A:T transition at the first position of codon 61 of the
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c-Ha-ros gene. Sukumar et al. (1983) showed a C;G -»• A;T transition at the second position of codon 
12 of H-rur in rat mammary carcinomas induced by N-nitrosomethyiurea. When DMBA tvas 
substituted for N-nitrosomethylurea in the same animal system, no C;G A T mutations were 
obtained. Similarly, skin papillomas and carcinomas induced by treatment with the initiating agenL 
DMBA and subsequent applications of the tumor promoter. 12-O-tetradecanoyiphorbol-13-acetate 
(TPA), have a high incidence (> 90%) of an activated H-ras gene with an A T —>T;A transversion at the 
second base of codon 61 (Quintanilla et al., 1986). The transversion mutation of AT->T:A following 
exposure to DMBA was also shown in other studies (Dipple and Bigger. 1984).Other studies showed 
that mutations occurred at different sites in the c-H-ror gene in skin tumors initiated in mice by difTerent 
chemical carcinogens, and for each chemical initiating agent a distinct spectrum of ras mutations was 
observed (Brown et al.. 1990). These smdies also showed that the distribution of ras gene mutations 
differed between benign papillomas and carcinomas, suggesting that the nature of the chemical 
molecular initiating event influenced the probability of papillomas progressing to malignancy- Not only 
the chemical-specific nature of the initiating event but the species of animal route of administration, 
and age at toxic insult also appear to affect the spectrum of proto-oncogene mutations (Leon et al..
1987). The same carcinogen. N-nitrosomethylurea. administered to two different species (rat and 
mouse) via different routes (rat=intravascular versus mouse=intraperitoneal) and at different ages (rat=5 
weeks versus mouse=7 weeks) was shown to induce mammary  tumors in the rat and thvmic lymphomas 
in the mouse. N-nitrosomethylurea induced a single point mutation in H-ras in the rat mammary 
tiunors. while activated K-ros or N-ros genes were observed in the mouse lymphomas (Sukumar et al.. 
1983; Guerrero et al.. 1984). The preferential activation of different members of an oncogene family in 
a particular tissue/organ is also consistent with other studies which showed that epithelial tumors (skin 
mammary  liver) have H-ras activated, while mesenchymal tumors (Ivmphomas. fibrosarcomas, renal 
mesenchymal) have either K-ras or N-ras activated (Guerrero and Pellicer, 1987). The preferential 
activation of a particular member(s) of an oncogene 6mily in a tissue may simply reflect the prevalence 
of the gene in a tissue rather than a species or age difference, while the organ/tissue targeted by the 
chemical insult may reflect species or age differences in abilities to metabolize the specific toxic
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chemical. Humans and other mammalian species express genetic polymorphisms in enzyme capacities 
that separate individuals of each species. Studies indicate that the activities of chemical metabolizing 
enzymes, including N-acetyltiansferases, sulphotransferases. and cytochrome P4501A2, vary 
considerably depending on the substrate, species, age, sex. and strain (Shiraga et al.. 1995; Katflubar. 
1994; Hein et al.. 1991).
The activities of most proto-oncogenes have been shown to be closely related with fundamental 
cellular regulation such as a signal transduction, cell division, and differentiatiotL Tumor oncogenes are 
proto-oncogenes that have undergone changes that can confer a transformed phenotvpe on another cell 
(PimenteL 1989a). Oncogenes are known to encode proteins that fell into four classes: growth fectors 
(sis), growth fector receptors (erè-B, fa t), cytoplasmic transducers of growth fector responses (ras. src, 
raj), and nuclear transcription fectors that mediate growth fector-induced gene expression (jun, fas. myc. 
p53) (Cantley et al.. 1991). In general, the transcription factor-type oncogenes appear to act in 
cooperation with oncogenes from the other categories to accomplish transformation (Hunter. 1991). 
Studies suggest the specific combinations of oncogenes that are able to cooperate best to increase the 
frequency of cellular transformation are between oncogene products that act in the nucleus with those 
that act in the cytoplasm (Weinberg, 1985; Bland et al.. 1995). For example, the Myc protein cooperates 
with the cytoplasmic membrane-associated Ras protein to transform rat embryo fibroblasts (Land et al.. 
1983; Tosca et al.. 1991). Studies have shown that expression of the nuclear oncoproteins bv 
themselves does not generally alter cell morphology, or growth fector or anchorage requirements, but 
may immortalize cells. While cytoplasmic oncoprotein expression can reduce growth fector 
requirements, induce altered cell morphology, and lead to anchorage-independent growth; however 
immortilization of cells does not occur (Land. 1983, 1986; Himter. 1991). These studies suggest that 
activation of cytoplasmic oncoproteins might take place during the initiation stage of carcinogenesis, 
perhaps by direct interaction between the carcinogen and the target gene, and that signaling by the 
activated oncoprotein to the nuclear oncoprotein is needed for promotion (Bos. 1987).
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RAS
Among the most frequently detected oncogenes, both in human tumors and in many animal 
tumor model systems, are members of the ras gene family which encode highly similar proteins with 
molecular weights of 21.000.(6almain and Brown. 1988). Activated ras oncogenes have been identified 
in aRHOximately 30% of various forms of human cancer, including carcinomas of the Itmg, colon, and 
pancreas (Bos. 1989; (julbis and Galand. 1993). These cancer cells, as weU as cells that have been 
transformed by microinjection of p2l"“. show gross morphological changes (Stace%’ et al., 1987). The 
ras genes, called the ras genes because they were first identified in \iruses that cause rat sarcoma virus, 
form a family of evolutionary' conserved genes present in eucaryotes from yeast to man and include 
three members in mammalian systems—Ha- (Harvey ), Ki- (Kirsten) and N- (Normal) ras (McMahon et 
al.. 1987; PimenteL 1989b). Studies of development in Drosophila and Caenorhabditis elegans 
identified Ras as a determinant of cellular differentiation (Cantley et al.. 1991). Furthermore, when 
antibodies against the products of ras proto-oncogene were injected into mammalian cells in culture, the 
cells no longer divided in response to growth factors. It was subsequently shown that Ras blocked the 
DNA synthesis induced by receptor tyrosine kinases. (Bos, 1988). These results indicated that the ras 
gene was conserved over a wide phylogenetic span, and that the 21-kDa guanine nucleotide binding 
protein gene product. Ras. functions as a molecular switch to relay mitotic and developmental messages 
generated at the cell surface receptors to effector molecules in the cytoplasm which serves to transmit 
this signal into the nucleus (Afiab et al.. 1997).
Protein tyrosine kinases play an important role in the control of cell growth and differentiation 
(Chan et al.. 1994). In 6ct, a common motif by which growth Actors regulate cellular proliferation and 
differentiation is through transmembrane receptors with inducible protein-tyrosine kinase activity (Koch 
et al.. 1991). Aberrant expression or mutations in growth 6ctor receptors will therefore lead to either 
uncontrolled proliferation or to defects in key developmental processes. Ligand binding to the 
extracellular domain of receptor tyrosine kinases is followed by receptor clustering, stimulation of 
protein tyrosine kinase activity and auto-phosphorylatioiL Auto-phosphorylation seems to provide an 
important regulatory step which determines the selection of the signaling pathways recruited Iw' the
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growth factor (Schlessinger, 1993). It has been shown that tyrosine auto-phosphory lation sites in 
growth &ctor receptors such as platelet-derived growth factor (PDGF). epidermal growth &ctor (EGF) 
or fibroblast growth 6ctor (FGF) receptors function as high-affinity binding sites for the SH2 (src 
homology 2) domain of intracellular signaling molecules (Koch et al.. 1991). The proteins encoded by 
the ras genes are located at the iimer side of the plasma membrane where they are anchored into the 
lipid bilayer by a covalently attached palmitic acid at the carboxy terminus (Buss and Sefton. 1986).
The proteins can bind guanosine tri-phosphate (GTP) and guanosine di-phosphate (GDP) with high 
affinity and possess GTPase activity (Bos. 1988). Evidence indicates that Ras functions as a critical 
mediator of many biological responses stimulated by both receptor and non-receptor protein tyrosine 
kinases (Sjolander et al.. 1991; Avruch et al.. 1994; Satoh et al.. 1991). Furthermore, studies with cells 
using Ras antibodies and dominant-inhibitory ras mutants indicate that ras lies downstream of receptor 
and nomeceptor protein tyrosine kinases and upstream of the serine/threonine protein kinase cascade 
including Raf Mitogen-activated Protein Kinase Kinase (MAPKK) and Mitogen-Activated Protein 
Kinase (MAP-K). also known as extracellular signal-regulated kinases (ERKs). (Moodie et al.. 1993; 
Marshall. 1995). In Chang cells Hepatitis B virus protein was showa to activate Ras which subsequently 
led to the rapid phosphorylation of Raf and the tyTOsine-phosphorylation and activation of MAP-K 
(Berm and Schneider. 1994). MARK activation is associated with both cell proliferation and 
differentiation, and it has been suggested that the duration of MAPK activation determines whether a 
stimulus elicits proliferation or differentiation (Traverse et al.. 1992). Agents such as radicicol were 
shown to suppress transformation by a diversity of oncogenes by inhibiting the function of MAP kinasg 
(Zhao et al.. 1995). Stimulation of these kinases plays an important role in the transmission of signals 
fiom the cell surface receptor to the nucleus, and the role of Ras in this pathway is to act as the 
molecular switch (Schlessinger, 1993). The majority of cellular Ras in quiescent cells is in the inactiv e 
GDP-botmd conformation. Stimulation of cells with mitogen or differentiation factors increase the 
abundance of the GTP-bound form (McCormick. 1989). Formation of GTP-bound Ras is regulated by- 
guanine nucleotide releasing 6ctors. and the GTPase activity of Ras is enhanced by GTPase-actrvating 
proteins (GAPs). Ras proteins have a low intrinsic GTPase activity and their inactivation is dependent
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on GAPs in vivo. (Boguski and McConnick. 1993). Ras then binds to the Raf-1 protein kinase and 
contributes to its activation (Wame et al., 1993). Raf has been shown to phosphory late and activate 
MAPK kinase (MAPKK), which in turn phosphorylates and activates MAPK. MAPK translocates to 
the nucleus upon activation where it has the potential to activate nuclear oncogenes, such as myc 
(Cowley et al., 1994; Traverse et al., 1994: Cowley et al., 1994). It has been shown that various growth 
factors stimulate the formation of GTP-Ras thereby coupling signals from the cell surface tyrosine 
kinase cascade to the downstream serine/threonine protein kinase cascade (Marshall, 1995).
All activating mutations in ras genes have in common the function of converting the normal 
Ras proteins into proteins that are capable of transforming NIH.3T3 cells. Since ras activation has been 
detected in a proportion of human tumors but not in normal cells, it has been speculated that mutations 
affecting ras may play a role in carcinogenesis. The incidence of mutated ras genes varies strongly 
among the different tumor types. In humans, the highest incidence is found in tumors from the exocrine 
pancreas, where more than 80% of the tumors display a mutated K.-ras gene. The genetic changes 
leading to ras activation are commonly point mutations resulting from single amino acid substitutions in 
the encoded 21kDa proteins (p21"^ (Bos, 1989). For some tumor types, ras gene mutations have been 
found in either a small or a large percentage of the tumors: in these tumors the mutated ras gene product 
probably plays a role in the development of the tumor, whereas in a number of tumor types no mutated 
gene has been identified at all. The absence of identifiable ras mutations may be due to low expression 
of the mutated gene or the mutated gene does not stimulate growth (Chesa et al., 1987). An interesting 
aspect of the ras gene mutations is that they may be induced by carcinogenic agents. This implies that 
the type of mutation foimd may provide information about the type of mutagen involved in the induction 
of the mutation and, consequently about the induction of the tumor (Bos, 1989). An extensive study was 
conducted using a wide variety of chemicals to induce hepatomas in mice (Wisemane et al., 1986). 
Treatment with the arylhydroxamic acids N-hydroxy-2-acetyiaminofluorene (N-OH-AAF) and N- 
hydroxyaminoazobenzene, both metabolic products of aromatic amines, resulted predominantly in C;G 
to A:T mutation at codon 61 of H-ros. A similar pattern of specific H-ros gene mutations in mouse liver 
tumors induced by firran and furfural, which are non-mutagenic in the Ames test. In mouse skin
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systems, initiation with DMBA and promotion with phorix)! esters induced papillomas and carcinomas 
in which the H-ras gene was consistently actn-ated by an A;T to a T: A transversion at codon 61 
(Balmain and Brown, 1988). In another stu(h. Brown et al. (1990) observed that the alkalyating agents 
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), methylnitrosourea (MNU), 3-methyicholanthrene 
(MCA) and 7.12-dimethylbenz[a]anthracene (DMBA) produced a greater number of mutational 
patterns of H-ros in papillomas than carcinomas in mouse skin s '^stems initiated bv* the same 
carcinogen. It was suggested that the unequal distribution of mutations could be explained b\ the 
possibihty that in carcinomas the H-ros mutation is no longer needed to maintain the tumorigenic 
phenotype and is subsequently lost during progression of papillomas to carcinomas. The lack of 
correlation in the association of Ras activation with proliferation and malignancy remains unclear 
(Spankle et al., 1996). An alternative hypothesis offered by Hunter (1991) is that the expression of two 
or more independent oncogenes is required for tumorigenic transformation. This concept of cooperation 
among oncogenes is defined as a situation in which a pair of oncogenes acting in concert can convert a 
cell taken straight firom an animal into an established cell line, whereas neither oncogene alone has this 
capacity. The specific combinations of oncogenes that were shown able to cooperate led to the concept 
that oncogene products that act in the nucleus cooperate best with those that act in the cytoplasm. For 
instance, the nuclear Myc protein cooperates with the cytoplasmic membrane-associated Ras protein to 
transform rat embry o fibroblasts (Land et al.. 1986). The co-expression of ras and myc oncogenes was 
examined in regenerating liver tissue of rats induced by either a necrogenic dose of carbon tetrachloride 
or a partial hepatectomy (Richmond et al., 1992). The results of this study showed that both ras and 
myc were expressed during the regeneration process and that the expression of these oncogenes was 
detected only in hepatocytes occupying liver lobule zones known to contain proliferating hepatocytes. 
Conversely, the cytoplasmic oncoproteins (Ras and Src) were shown to induce morphologic changes, 
reduce growth 6ctor requirements, and lead to anchorage dependent growth, but 6iled to immortalize 
cells. In studies among clonal cell lines derived fiom chemically transformed WB rat liver epithelial 
cells, highly tumorigenic clones that over expressed c-myc also over expressed the c-H/K-ror genes. 
Whereas, clones that over expressed neither the c-ras nor the c-myc were not very tumorigenic, while
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clones that expressed one or both c-ras genes but not c-myc were variabh' tumorigenic (Lee et al.. 1991). 
These results support other finding*; that tumor development in animals is a multi-step process and 
frequently involves ras activation as an early event in the genesis of cancer.
MYC
The nuclear oncoproteins are potential mediators of the final steps in signal transduction, 
conveying information from the cytoplasm to the nucleus, with the possibility that they may have a 
direct role in the control of gene expression The human c-myc oncogene is the human cellular 
homologue of the v-myc oncogene of avian myelocytomatosis retrovirus MC29. The myc gene encodes 
nuclear phosphoproteins acting as transcription &aors (Meichle et al., 1992; Kato and Dang, 1992).
The myc family proteins are heavily phosphorylated. yet little is known about the structural sites and 
functional ramifications of their phosphory lation (DePinho et al.. 1991). Sequence-specific DNA 
binding occurs when c-myc (p-62) is part of a heterodimer complex, suggesting that c-myc participates 
in the regulation of gene transcription in normal and neoplastic cells (Kato and Dang. 1992). Like the 
ras gene, c-myc has been highly conserved phyiogenetically with homologs identified in mammals 
birds, amphibians, and fish (Eisenman el al.. 1985.1989). Like other proto-oncogenes the c-myc proto­
oncogene can be activated to its oncogenic form by one of several mechanisms: proviral insertion, 
chromosomal translocation, gene amplificatioiL or mutations that increase the rate of transcription 
elongation or alter the mRNA half-life These mechanisms deregulate c-myc expression in tumor cells 
(Spencer and Groundine. 1990). In different types of cells expression of the c-myc protein is positively 
correlated with cell proliferation (Kelly and Siebenlist, 1985. 1986; Hannan et al.. 1994). Consequently, 
deregulated myc expression contributes to unabated proliferation and tumorigenesis in a wide variety of 
cells including  those of human origin (DePhino et al., 1991). There is a rapid increase in c-myc mRNA 
and c-myc protein levels after stimulation of quiescent cells by agents that initiate competence (Kelly et 
al.. 1983; Moore et al., 1987). In addition, studies suggest that the regulation of cell proliferation may­
be through the involvement of the c-myc protein in the control of DNA synthesis and that terminal 
differentiation may be accompanied by an abrupt reduction in c-myc expression (Campisi et al.. 1984).
In stimulated B-cell lymphocytes e^qnession of c-myc was necessary for cells to enter a competence
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state, rendering quiescent cells able to enter the Gi phase of the cycle, and it was also necessary for 
progression of activated cells to DNA synthesis (Buckler et al.. 1988). Similarly. Farquharson et al.
(1992) observed that although the z-myc protein was localized in all chondrocytes of the proximal 
growth plates of rats and chicks, higher c-myc protein concentrations were restricted to the proliferating 
and differentiating chondrocytes. These studies not only provided evidence for a role of c-myc protein in 
cell proliferatioiL but also suggested a role for c-myc in cell differentiation and/or hypertrophy. 
Deregulated expression of c-myc can block differentiation in tissue culture models, and the use of 
deletion mutants has demonstrated that the domains of c-myc necessary for inhibition of cellular 
differentiation are nearly identical to those required for malignant transformation (Freytag et al.. 1990). 
These results suggest that the normal function of c-myc protein produces a proliferating, undifferentiated 
cell state, while aberrant c-myc expression mav- be in part responsible for the poorly differentiated cell 
state observed in many malignant tumors (Kato and Dang, 1992). The involvement of c-myc in the 
control of DNA sv-nthesis implicates that exposure of cells to chemical carcinogens and genotoxins mav 
result in the activation of c-myc (Balmain and Pragnell. 1983; Balmain and Brown, 1988). Hasmall et 
al. (1997) examined the induction of nuclear oncogenes as a reflection of the hepatocarcinogenic 
potential of a chemical. Rats were exposed to 1.4-dichlorobenzene (a noncarcinogenic rat liver 
mitogen), diethylhexyl phthalate (a non-genotoxic rat hepatocarcinogen). or carbon tetrachloride (a 
positive control). Hepatic labeling index, as determined by the incorporation bromodeoxvtiridine in 
liver lobes, was correlated with expression of nuclear oncogenes. Despite the disparate carcinogenic 
potential of 1.4-dichlorobenzene and diethylhexyl phthalate a similar pattern of oncogene expression 
was observed, suggesting that expression of nuclear oncogenes cannot distinguish hepatocarcinogenic 
mitogens from noncarcinogenic mitogens. Interestingly, a good correlation (r^^.85) was observed 
between c-myc expression and the hepatic labeling index, but not with the labeling index and other 
nuclear oncogenes. The level of myc was examined in livers of female B6C3F1 mice and kidneys of 
male F-344 rats to detect changes in gene expression following a single, cytotoxic dose of chloroform. 
Chloroform is thought to act through a non-genotoxic-cytotoxic mode of actioiL Northern blot analyses 
of the livers of mice and kidneys of rats showed large increases in levels of myc after treatment
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suggesting that myc could be inv olved in the regenerative cell proliferation that ultimate^ may plav a 
role in tumor induction (Sprankle et al.. 1996)..
Deregulated c-myc expression participates in the development of experimental^ induced 
tumors, and its expression appears to be abnormal in mam- naturally occurring malignancies (Kato and 
Dang. 1992). Altered c-myc expression is most fiequently associated with lymphoid neoplasia, 
particular!} B-cells. although c-myc expression has been found to be deregulated in a wide varietv' of 
human tumors, including lung, breast and colon carcinomas (Klein. 1983: Alitalo et al.. 1983: Tosca et 
al.. 1991; Bland et al.. 1995). Enhanced expression of c-myc has also been observed in animaU exposed 
to chemical carcinogens. The expression of myc oncogene proteins was examined in liver lesions of 
male Sprague-Dawlev rats after treatment with the carcinogen diethylnitrosamine. with or without 
phénobarbital promotion (Richmond et al., 1988). The stuck' found that the incidence of hepatocellular 
carcinomas rose fiom 4% to 43%, respectively, in the rats treated with diethylnitrosamine and with the 
carcinogen plus phénobarbital. Likewise, the volmne of liver expressing the myc oncogene protein was 
increased bv- 60% and 31%. respectively, in rats treated with diethylnitrosamine plus promoter or 
phénobarbital alone compared with untreated and carcinogen only treated rats. Moreover, the majoritv- 
of hyperplastic nodules and tumors fiom the fivers of the diethv lnitrosamine plus phénobarbital- or 
phenobaibital-exposed rats showed enhanced expression of myc, indicating that myc expression did 
occur in these structures. Similarly, when colon cancer was induced in rats by the administration of 
dimethylhydiazine. the carcinogenic insult altered the magnitude and positional profile of c-myc 
expression. In the colonic tissue of normal rats, only fed)le c-myc immimohistochemical staining, 
lacking focal topology, was observed In rats administered diethylnitrosamine, but which did not displav 
overt neoplasia, a substantial increase in staining intensity for c-myc was noted in colonic tissue and the 
staining was confined primarily to the region of luminal cells. Invasive adenomas, on the other hand 
displayed intense cytoplasmic c-myc immimoreactivity. Whether the altered expression of the c-myc 
gene protein was the result of enhanced cell proliferation triggered by the carcinogenic insult or whether 
it signified an alteration in the control of cellular events in colonic cells was not aHHrp«a»H (Schwartz et 
al., 1995). The expression of oncogenes {c-jun, c-myc, c-fos, and c-Ha-ras) was also examined and
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correlated with the v'arious stages of N-nitrosodiethylamine-induced hepatocardnogenesis in male AKR 
mice. The results indicated that the expressions of c-fos and c-Ha-ror did not alter during N- 
nitrosodiethylamine treatment, indicating a lack of association of these proteins with N- 
nitrosodieth} lamine treatment. Howev er, the over expression of c-jun indicated its association with 
early events prior to neoplastic changes, while the over expression of c-myc was associated with later 
stages of hepatocardnogenesis. Fiuthermore. the results of densitometric quantification indicated that 
the extent of increase in c-myc expression was less than that of c-jun early in the carcinogenesis process, 
after which the induction of c-myc exceeded the expression of c-jun. suggesting that c-myc may plav a 
critical role in the maintenance of the malignant phenotvpe (Giri and Das. 1996).
Maliganant cell transformatioiL both in vitro and in vivo, is a multistep process that proceeds 
in discrete stages (Kato and Dang. 1992). The first well-established property of the c-myc gene was its 
ability to transform normal cultured cells into malignant cells (Kato and Dang, 1992; Duesberg et al.. 
1977). The main steps of transformation are thought to involve progression from norm al, controlled 
growth to immortilization or induction of an unlimited life span, and morphological transformation 
(Sukumar et al.. 1990). Although there are exceptions. Land et al. (1986) found that expression of the 
nuclear oncoproteins (Myc. mutant p53. Fos, Jim etc.) bv themselves did not generally alter cell 
morphology, or growth fedor anchorage requirements, but that thev may immortalize cells.
Immortalized cells are capable of continued cell growth in culture, but unlike fully transformed cells, 
immortalized cells are anchorage-dependent and fail to generate tumors in syngeneic hosts (DePinho et 
al.. 1991). Newbold et al. (1982) first demonstrated that the immortilization step can be induced in cells 
bv- chemical carcinogens and is an essential prerequisite for transformation by subsequent carcinogen 
exposures. The way in which immortilization can be induced by chemical carcinogens is unclear, 
however, the myc gene has been implicated in this process and may constitute an important target gene. 
Syrian hamster cells tansfected with the myc oncogene were shown to exhibit an extended life span; 
however, unlike cultures immortalized by chemical carcinogens, cells transfected with myc senesce at 
later passages (Sukumar et al.. 1989). In contrast. Land et al. (1986) showed that a substantial 
proportion of rat embryo fibroblast cultures became established and achieved immortality (> 50
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passages) when transfected with the myc oncogene; the potency of several myc clones \aried 
considerably. Although populations of myc transfected rat embryo fibroblasts were established for long 
term growth in culture, the cells were not tumorigenic when injected subcutaneously into nude mice.
The myc oncogene, like ras. appears unable to transform cells under most conditions when acting alone, 
but requires a collaborating oncogene like ras to achieve this result Tumorigenicits has also been 
correlated with ov erexpression of single oncogenes. Oncogene expression was examined in N-methyl- 
N' -nitro-N-nitrosoguanidine- (MNNG) induced transformed rat liver epithelial cell lines. Only the 
expression of the c-myc gene correlated with tumorigenicity among all transformed clones. When c-myc 
expression in clones was greater than 5-fold the expression level in wild type clones, the level correlated 
with tumorigenicity; whereas low clonal expression levels of c-myc were not associated with 
tumorigenicity (Lee et al., 1991). Land et al. (1986) similarly observed that the ras oncogene was able 
to create a tumorigenic cell clone when expressing high levels of Ras (> 10 times that observed in most 
spontaneous tumors). These studies suggest that the environment of an individual cell directly influences 
the responsiveness of the cell to an oncogene. For example, rat embryo fibroblasts carrying myc 
oncogenes can be transformed by low levels of abnormal Ras protein that are comparable to the levels of 
normal Ras protein in normal cells, or they can be transformed by non-physiologically. experimentally 
high levels of either oncogene acting alone (Lee et al.. 1991). Such results indicate that oncogenes like 
ras and myc act in distinct and complementary ways on cellular phenotype (Land et al. 1986).
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CHAPTER 3 
THE UPTAKE, EXCRETION AND METABOLIC 
DISTRIBUTION OF RADIOISOTOPE LABELED 
BENZ[a]ANTHRACENE AND 1,6- AND 1,8- 
DINITROPYRENES IN THE FISCHER 344 RAT 
FOLLOWING ORAL GAVAGE
INTRODUCTION
PAHs are a group of chemicals derived from the pvTolysis of organic matter, whether natural 
(forest fires, volcanoes, etc.) or synthetic (residential wood burning, automobile and industrial 
emissions, environmental tobacco smoke, gas cooking and heating, etc.) (Keith. 1990; Menzie et aL 
1992). In the process of pvTolvsis of organic matter, instead of being completely oxidized to carbon 
dioxide, hydrocarbon fragments are created and these can interact and form complex polycyclic 
structures (Dipple. 1983). Cluster arrangements of benzene rings, as in pvrene and benz[a]anthracene 
are stable and are commonly found in nature, especialh in soils, sediments, tobacco smoke, petroleum 
and automobile-exhaust gases (Blumer. 1976). The benzene rings may be unsubstituted or mav’ can}' 
substituent methyl or alkyl side chains or chemically reactive groups of nitrogen, sulfur, and oxvgett 
Unsubstituted and nitro-substituted polycyclic aromatic hydrocarbons (PAH), such as benz[a]anthracene 
and the dinitropyrenes. are widespread emiromnental pollutants.
The toxicity and carcinogenicity of unsubstituted PAH compounds like benz[a]anthracene. in 
general, follow the “bay region” theory of metabolic activation (Guengerich et al., 1983). This theorv' 
contends that an epoxide on a saturated, angular benzo ring that forms part of a bay region of the 
hydrocarbon is a prime candidate as an ultimate carcinogen.(Levin. 1978; Grover. 1986). Metabolic 
activation requires the enzymes cytochrome P4S01A1 and epoxide hydrolase in the formation of the 
proximate and ultimate carcinogens, but these enzymes also form products which are not harmful 
through conjugation reactions with glucuronic and sulfuric acids. A large munber of epoxides, 
dihydrodiols, and epoxide dihydrodiols of 1,2-benzanthracene derivatives have been analyzed for 
carcinogenicity. These results imply that metabolic activation of 1,2-benzanthracene to the 3.4-
78
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dibydiodiol forms a potent bacterial mutagen with high tumorigenicity relativ e to 1.2-benzanthracene. 
and analyses have identified the 3.4-diol 1.2-epoxide as the ultimate carcinogen with at least 15-125 
times more mutagenic activity than other diasteromeric benzanthracene did epoxides (Slaga et al..
1978: Levin et al.. 1978). In human cell studies, the administration of 1.2-benzanthracene to human 
bone marrow cells resulted in the conversion of benz[a]anthracene to three distinct dihydrodiols. The 
dihydrodiol metabolites were identified as the 5.6-dihydrodiol. the 10.11-dihydrodioL and the 8.9- 
dihvTdodiol: however, metabolism to the 3.4-dihydiodiol 1.2-epoxide ultimate carcinogen was not 
demonstrated (McCord. 1996).
Oral administration of benz[a]anthracene indicates that this compotmd is carcinogenic in 
rodents. Mice acutely administered 1.5 mg/day benz[a]anthracene by oral gavage for 5 weeks exhibited 
increased incidences of hepatomas and pulmonary adenomas (80% and 85%. respectively) compared 
with control animal incidences (10% and 30%. respectively) for hepatomas and pulmonary adenomas 
(Klein. 1963). The induction of foci of altered hepatocytes is often seen in rats and mice that later 
develop liver tiunors (Mumtaz et al.. 1996). A 1-day intragastric administration of 180 mg/kg 
benz[a]anthracene to rats followed by a diet containing 2-acetyiaminofiuorene and carbon tetrachloride 
induced altered foci in partially hepatectomized and not in sham hepatectomized rats (Tsuda and Farber. 
1980). The hepatic effects observed following oral exposure to benz[a]anthracene in these studies which 
included enzymatic alterations; the induction of altered foci: and the increase in liver weights: while 
generally not regarded as serious consequences, may precede the onset of more serious hepatic lesions 
not to exclude hepatic neoplasms.
Nitro-substitiaed PAH compounds are readily formed by derivatization of PAHs. For example, 
the nitration of pyrenes occurs under conditions of incomplete combustion processes, such as diesel and 
airplane emissions, combustion emissions fiom kerosene heaters and gas fuels and liquid petroleum, 
airborne particulates, coal fly ash. cigarette smoke, and the broiling and smoking of food (Asokan 
P.. 1985). Nitrated pyrenes are also formed from the reaction of PAHs with nitrogen oxides in the 
environment (Pitts et al.. 1985; Djuric et al., 1988). A predominant source of nitro-PAHs is diesel 
emission. and while the dinitropvTenes compose a small faction of the emission particulate matter
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studies have shown that these compounds are potent mutagens and tumorigens (Rosenkranz and 
Mermelstein. 1985; Tokiwa and OhnishL 1983: Fifer et al.. 1986; Ohgaki et al.. 1984, 1985; Takayama 
et al.. 1985). Nitro reduction is involved in the metabolic activation of the dinitropvTenes, and unlike 
other routes of biotransfonnation. nitroreduction is not performed by the endogenous enzymes within the 
bo<^ but by enzymes of the intestinal microflora (Scheepers, 1994). Nitro-reduction by intestinal 
microflora is thought to play an important role in the toxicity of several nitroaromatic compounds 
including 2,6-dinitrotoluene, which causes hepatic tumors in male rats (Dutcher et al., 1985; Parkinson. 
1996). Other research has indicated that gut flora are not obligatory in the metabolic activation of the 
dinitropyTenes. 1,6-dinitropyTene produced genotoxic metabolites in rat hepatocyte primary cultures 
without gut flora, while no DNA repair was observed in hepatocytes from rats orally exposed with 50 
mg/kg of 1.6-dinitropyrene (Butterworth et al.. 1983). The reason for the lack of a response in vivo is 
not known. One possible explanation for the inactivity of 1,6-dinitropyTene in vivo is that it is either 
metabolically detoxified or that it is not absorbed from the gut and delivered to the liver in amounts 
large enough to induce detectable DNA repair, suggesting that cells which come first in direct contact 
with this agent are more likely targets for its genotoxic action. This explanation may hold for the 1,3- 
and 1,8-dinitropyTenes as welL suggesting that oral exposure may present low risk of mutagenicity.
Although the significance of unsubstituted and nitro-substituted PAHs with regard to 
enviromnentally caused diseases and cancer is difficult to estimate, it is suggested that the potential 
hazard of environmental exposures to PAHs may be underestimated (Grimmer et al., 1995). Among the 
fifty-four PAHs identified at one or more National Priority List (NPL) hazardous waste sites, 
anthracene- and pyiene-based PAHs are among the most abundant representatives of the 
environmentally occurring PAHs and have been detected in ambient air, water, soil as well as in various 
food stufts (Jacob et aL 1989). In facL 41% of contaminated sites have reported significant levels of 
benzanthracene, and there is special concern about the potential health eflects of emissions products and 
by-products like the dinitropyrenes which are released into the environment after conversion of fossil 
fuels (EPA 1975). However, there is little information available on the metabolism, distributioiL and 
excretion of benz[a]anthracene and the dinitropyrenes in mammalian systems following oral ingestion.
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More detailed metabolic information would be useful in understanding the metabolic basis for the 
differential results observed between bacteria and mammalian cells. Furthermore, mammalian cells in 
vivo could be exposed to metabolic products from bacteria in the G.I. tract causing a toxic efrect 
different from that predicted by in vitro mammalian cell cultures, and whole animals are necessary to 
extrapolate in vitro toxicity data to determine the potential for human risk. This study was conducted to 
address the relationship between acute oral expostue and the metabolic distribution and excretion of 
benz(a]anthracene and the nitro-aromatics. 1.6- and l-S-dinitropyxene in the F-344 rat. This study 
represents the first part of a comprehensive program designed to examine the differences in toxic 
responses of F-344 rats to chronic ingestion of pure, individual PAH compounds and the toxic responses 
of F-344 rats to chronic ingestion of the same compounds as components of a mixture.
MATERIALS AND METHODS 
.MATERIALS
1.6-Dinitro[4. 5. 9. 1 0 - ^  pyrene. 1.8-Dinitro [4, 5. 9. 1 0 - ^  pyrene. and generally labeled 
benz[a]anthracene were custom synthesized by Chemsyn Science Laboratories (Lenexa. KA). 
Radiochemical purity of [if] 1.6-dinitropyrene. [^1.8-dinitropyTene, and [G-H] benz[a]anthracene 
was > 98% as determined by radioisotope thin layer chromatography, using silica gel plates and a 
benzeneihexane (2:1) solvent system for the dinitropyrene and benzeneihexane (1:1) for 
benz[a]anthracene. Using an extinction coefficient of 1.6 x 10"". the specific activity of 1.6-dinitropyTene 
was determined to be 6.6738Ci/mmol by UV-visible spectroscopy (absorbance at 287.8nm was 0.139) . 
while the specific activity of 1.8-dinitropyTene using an absorbance of 0.129 at its absorption maximal of 
290.4nm was determined to be 9.288Ci/mmol. The specific activity of benz[a]anthracene was 
508.0mCi/mmol by UV-Msible spectroscopy at a wavelength of 285 nm and an extinction coefficient of 
8.75 X 10'.
ANIMALS
This snufr consisted of three separate experiments and was conducted under federal guidelines 
for the use and care of laboratory animals and was approved by the Institutional Department of 
Radiation Safety, and the Institutional Animal Care and Use and the Carcinogen Use Committees of
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Louisiana State University, School of Veterinary Medicine. Male Fischer-344 rats (4-10 weeks of age) 
were obtained from the breeding colony (Louisiana State Univ ersity . Division of Laboratory Animal 
Medicine) and were used for the course of these studies. This inbred rat strain was selected based on 
extensive use in chronic carcinogenicity studies by the National Cancer Institute (Rao and Boorman. 
1990). Animals were housed in individual hanging stainless steel wire mesh metabolism cages in an 
Association for the Assessment and Accreditation of Laboratory Animal (]aie (AALAC) approved 
facility. Rats were housed under controlled conditions with a 12 hour light-dark cycle. A pelleted semi- 
purified diet (AIN-93M. ICN. Costa Mesa, CA) and water was provided to rats ad libitum.
SAFETY PRECAUTIONS
Due to the potential risk of radiation and toxicity by exposures to test compounds, all animal 
caretakers were provided with full-free respirators equipped with replaceable, disposable activated- 
charcoal filters designed to exclude organic particulate and vaporized compounds. All personnel 
entering animal housing were required to wear protective clothing and disposable gloves and shoe 
covers. In order to conform to radiation limitations for disposal of carcasses by incineration, oral dosing 
of rats was conducted to yield < 0.05 ^ iCi per gram of live weight tissue. The necropsy of animaU was 
conducted in a radioisotope-use designated areas approved by the Louisiana State University Department 
of Radiation Safety. Animal carcasses were sealed in plastic zipper-Iock bags and properly disposed of 
for incineration. All animal excreta was collected in under-cage metabolism units and processed for 
isotope distribution. At the close of each sturh', residual label was removed fiom cages by rinsing with 
water and methanol. The water was subsequently collected, measured and added to urine samples for 
radiometric analyses. The methanol and swipe tests of all potentially contaminated surfrces were also 
performed and analyzed separately.
ANIMAL BIOASSAYS
and 13-Dinitropyrene
Three adult male F-344 rats (8-10 weeks old and weighing  between 161.5 g and 195.0 g) were 
placed in metabolic cage units 48 hours prior to dosing. Rats were frsted overnight and orally dosed by 
a single gavage. A Hamilton 1 ml syringe equipped with rodent feeding needle (Harvard perfectum.
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Popper & Sons, Inc.. Newhyde Park, NY) was filled with a trioctanoin (90%, Sigma) solution of the 
tritiated compounds to volume amounts equivalent to a maximum of 0.05uCi ( 110,000 DPM ) per gram 
of bodv- weight The isotope labeled trioctanoin solution was prepared as follows. Briefly. 54.8 mg of 
unlabelled dinitropyrenes [1,3-: 1,6-: 1,8-dinitropyrene (DNP) 18:35:42 wt %] was dissolved in 1.35 mL 
trioctanoin (90%) and served as a carrier for the labeled compotmds. Evaporation of 23|il [TI] 1,8- 
dinitropyrene and 15 nl [Tl] 1,6-dinitropyrene fiom the solvent to dryness was performed under a 
nitrogen stream in a finne hood and was followed by immediate dissolution of the radiolabeled 
compotmds in I50pl dimethyl sulfoxide (DMSO, Sigma) The trioctanoin/DNP soltition was added to 
150|il DMSO which contained the labeled compotmds. A 2pl ahquot of this mixture yielded 25,150 
disintegrations per minute (dpm) by radiometric hqtiid scintillation counting
In order to illustrate the dosing scheme, the following is offered. The maximum c^nn which 
can be administered to a rat and remain within the conformations of the stated guidelines for carcass 
and tissue incineration is 0.05p.Ci per gram of five animal weight. The 1.5 ml [3H]-trioctanoin/DNP 
mixtiue had a total coimt of 57.505,500 dpms, and a 250g rat could be administered 717|d of this 
solution or 2.75 x 10 dpm and remain within the guidelines of < 0.05 .^Ci per gram of tissue. Gavage 
exposures were conducted 48h prior to euthanasia of the animals by carbon dioxide asphyxiation.
Urine from each rat was collected into ice-filled containers until euthanasia. Each cage was 
rinsed with 20ml distilled water which was subsequently added to the total urine collection. Urine 
collections were measured and kept under refrigeration (4°C) until analyses were conducted. Rat 48 
hour fecal excretions were collected and placed into graduated 50 mL polypropylene centrifuge tubes. 
Water was added to each tube to bring the voliune to 45 mL. AH samples were weighed then mixed for 
48 hours in a wrist action shaker (Burrell Model 75, Burrell Corporation, Pittsburg, Pa). At the time of 
euthanasia samples of whole blood were collected by heart puncture using a 22 gauge needle attached to 
a 5 mL syringe Uned with heparin. The thymus, heart Itmg, liver, spleert gastro-intestinal tract 
(stomach, proximal duodenunt ceciun, proximal ascending colon), kidneys, bladder, skin, epididymal 
fat skeletal muscle, brairt and testes were excised, trimmed, and weighed, A small portion of
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representative tissue firom each organ (approx 100 pg) was sectioned, weighed, and placed into a pre­
labeled 6.5 mL polyethylene scintillation counting vial.
[^H] 1,6-Dinitropyrene
In order to determine the eflfects of repeated dosing on the absorption, metabolism, distribution, 
and excretion pattern of exposure to radio-labeled 1.6-dinitropvTene in the F-344 rat. a second stud\ was 
conducted. Three adult male F-344 rats (8-10 weeks old and weighing 190 - 205.0 g) were placed in 
metabolic cage units 48 hours prior to dosing. A Hamilton 1 ml syringe equiRxd with a rodent feeding 
needle (Harvard perfectum. Popper & Sons. Inc.. Newhyde Park. NY) was filled with a trioctanoin 
(90%. Sigma) solution of the tritiated compound to a 1 ml volume amount The isotope labeled 
trioctanoin solution was prepared as follows. Briefly, 75.6 mg of unlabelled dinitropyrenes [1.3-; 1.6-: 
1.8-dinitropvTene (DNP) 18:35:42 wt %] was dissolved in 10.0 mL trioctanoin (90%) and served as a 
carrier for the labeled compounds. E\aporation of 64.5(il 1.6-dinitropjTene fiom the solvent system 
to dryness was performed under a nitrogen stream in a finne hood and was followed by immediate 
dissolution of the radiolabeled compounds in 300ul DMSO (Sigma). The trioctanoin/DNP solution was 
added to the 300|fl DMSO which contained the labeled compounds. The volume was brought to 12.6 ml 
with trioctanoin addition. A lO^d aliquot of this mixture yielded 101.212 dpms by radiometric liquid 
scintillation counting. Each rat received the same volume (1 ml) at each dose of label regardless of 
animal weight Gavage exposures were conducted at 48h and 24h prior to euthanasia of the animale bv 
carbon dioxide asphv’xiation.
Urine fiom each rat was collected into ice-filled containers imtil euthanasia. Each cage was 
rinsed with 20ml distilled water w hich was subsequently added to the total urine coUectioit Urine 
collections were measured and kept under refiigeration (4°C) until analvaes were conducted. Rat 48 hour 
fecal excretions were collected and placed into graduated 50 mL polvpropylene centrifuge tubes. Water 
was added to each tube to bring the volume to the 35 mL mark. All samples were weighed, then mixed 
for 24 hours in a wrist action shaker (Burrell Model 75. Burrell Corporation. Pittsburg, Pa). Volumes of 
solubilized fecal matter equivalent to 10 ml were subsequently extracted with 20 ml of toluene by mixing 
an additional 24 h in a wrist action shaker. At the time of euthanasia samples of whole blood were
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colleaed b>' heart puncture using a 22 gauge needle on a 5 mL syringe lined with heparin. The thymus, 
heart lung, liver, spleen, gastro-intestinal tract (stomach, proximal duodenum, cecum, proximal 
ascending colon), kidneys, bladder, skin, epididymal fa t skeletal muscle, braiit and testes were excised, 
trimmed, and weighed. The gastrointestinal tract as a unit was opened longitudinally and washed twice 
in potassium chloride buffer. The G.I. tract was subsequently placed in a 50 ml screw-cap tube and 
stored at -20°C until assay ed. A small portion of representative tissue fiom each organ (approx. 100 n-g) 
was sectioned, weighed, and placed into a pre-labeled 6.5 mL polyethylene scintillation counting vial for 
tissue preparatioiL 
[^H]Benz[a]anthracene
The third set of experiments was conducted to determine the metabolism, distribution and 
excretion patterns of benz[a]anthracene. Three adult male F-344 rats (4 weeks old and weighing 140 - 
167 g) were placed in metabolic cage imits 48 hours prior to dosing. Rats were fasted overnight and 
orally dosed by gavage with a trioctanoin (90%. Sigma) solution of the tritiated compound using a 
Hamilton 1ml syringe equipped with rodent feeding needle (Harvard perfectum. Popper & Sons. Inc.. 
Newhyde Park. NY). Briefly. 35 mg of unlabelled benzanthracene was dissolved in 400ul DMSO and 
served as the carrier for the label. Evaporation of 14.5|d [^-1.2-benzanthracene from the solvent 
system to dryness was performed under a nitrogen stream in a fiune hood and was followed by 
immediate dissolution of the radiolabeled compound in the 400pi DMSO containing the imlabeled 
compound The DMSO mixture was brought up to 6.0 ml by the addition of 5.6 ml trioctanoin (90%). 
The trioctanoin solution was sonicated and stored at 4°C. A 2 pi aliquot of the trioctanoin solution 
yielded llS lldp tas. Each rat received a total voliune of the mixture equivalent to 0.05pCi per gram of 
live animal both weight. Gavage exposures were conducted 24h and 48h prior to euthanasia of the 
animals by carbon dioxide asphyxiation.
Urine from each rat was collected into ice-frUed containers until euthanasia Each cage was 
rinsed with 20ml distilled water which was subsequently added to the total urine collection. Urine 
collections were measured and ke(X under refrigeration (4°C) until analyses were conducted At the 
time of euthanasia samples of whole blood were collected by heart puncture using a 5 mL syringe lined
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with heparin and a 22 gauge needle. The thymus, heart, lung, liver, spleen, kidney s, bladder, skin 
epididymal fat skeletal muscle, brain, and testes were excised, trimmed, and weighed. A small portion 
of representative tissue from each organ (approx. 1(X) pg) was sectioned, weighed, and placed into a pre­
labeled 6.5 mL polyethylene scintillation counting vial. The gastro-intestinal tract of each animal was 
collected individually and the mucosa exposed by a longitudinal incision the entire length of the tract 
The tissue was washed twice in potassium chloride buffer and stored in a freezer at -20'^ C until analysis 
Likewise the contents of the gasto-intestinal tract and the 48 hour fecal excretions were combined and 
stored at -20°C in screw-caR)ed tubes.
TISSUE PREPARATION FOR LIQUID SCINTILLATION COUNTING 
The matrix of biological samples prevents direct radiometric analyses by liquid scintillation 
counting with the exception of urine. The 48 h urine collections of each rat were combined, measured, 
and a 2(X) pJ representative sample was placed directly into a pre-labeled 6.5 mL polyethylene liquid 
scintillation counting vial. Five ml of liquid scintillation cocktail (Hionic-Fluor™. Packard Instrument 
Co.. Meriden. CTT) was added for radiometric counting
Heparin collected blood samples (50 pi) were added to 1ml of isopropanol : Soluene-350 (50:50 
%vol) for digestion and the mixture incubated for 30 min at 50°C in a shaking  water bath. Samples 
were decolored by dropwise addition of 500pi of a 30% hydrogen peroxide solution. The samples were 
incubated for an additional hour at 50°C in a shaking water bath, and then 4.5ml scintillation cocktail 
(Hionic-Fluor™. Packard) was added for radiometric analysis.
The mixed fecal solutions from the 1,6- and 1.8-dinitropyrenes study (experiment #1) were 
similarly processed. Following the 48h mixing by the wiist-action shaker, a 100pi sample of the fecal 
solution was added to 1 ml of Soluene-350. and the sample was incubated for 2 h at 50°C in a shaking 
water bath. Isopropyl alcohol (0.5 ml) was added and the mixture vortexed Following a 2 h incubation 
at 50°C in a shaking water bath, 300pi of a 30% hydrogen peroxide solution was added dropwise and 
the mixture incubated an additional 1 h at room temperature. Scintillation cocktail (4 mL Hionic- 
Fluor™. Packard) was added for radiometric counting
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Following 24h of mixing in a wrist-action shaker, the water and toluene phases of the extracted 
48h mixed fecal collections of rats &om the 1.6-dinitropvTene stuck were allowed to separate. The 
toluene phase (200 ^i) of the toluene-extracted 48h mixed fecal solution were placed directly into a 
scintillation \ial and 4.5 ml of scintillation cocktail (Hionic-Fluor™. Packard ) were aHriM for 
radiometric coimting.
The intestinal tracts and fecal collections of rats exposed to [îf]-benz[a]anthracene were 
thawed, weighed and homogenized in a Potter-Elevehjem Grinder (Wheaton, Millville. NJ). Three 
replicate aliquots of each sample were separately weighed and subjected to tissue oxidation in a sample 
oxidizer (Model 307. Packard Instrument Co., Meriden, CT). Briefly, the sample to be processed is 
placed in a cellulose ignition basket which is then placed in the instrument and an electrical current is 
passed through the ignition basket for a time period adequate to completely combust the sample in the 
presence of an 0= atmosphere. The oxidized tritium exits the system in the form of tritiated water. The 
tritiated water is collected into a collection vial along with scintillation cocktail fluid (Pico Fluor™40. 
Packard).
One mL of Soluene-350 was added to all tissue sample vials. Each sample vial was incubated 
for 4 h at 50°C in a shaking water bath. Hydrogen peroxide (200 ml of 30% solution), was added bv 
dropwise addition to decolorize samples, if necessarv", and incubated for 1 h at 50°C. After digestion,
4.5 ml Hionic-Fluor™ scintillation cocktail was added for counting. All sample vials were dark-adapted 
over night to quench fluorescence, and counted for ten minutes in a Packard TR1900 Liquid 
Scintillation Counter. Normalization and quench curves were conducted before each run of samples was 
counted.
RESULTS
In order to determine the distribution of an administered dose in each tissue sampled, the whole 
organ weight was needed. The skin, stomach, small intestine, ceaim , colon, fat, skeletal muscle, and 
blood presented difBcultv in determining needed whole orgair/tissue weights. A compromise to this 
problem was to collect weights of these organs from five untreated rats and substitute an average relative 
weight percentage for the actual weight of the organ/tissue. To minimize variation the following
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assumptions were made based on relative organ weight percentages [(organ weight/both" weight) x 100]; 
For the skin, skeletal muscle, and fat the percent of both weight values used were 15%. 40%, and 7.6% 
respectw eh . The relative weight percentages for blood, stomach, cecum, duodemun. and colon were7% 
0.58% 0.46%, 1.5%. and 0.4% respectively.
The sample weights, whole tissue weights and tissue distribution as a percentage of the 
administered dose of [îf]-1.6- and -1.8-dinitropvTenes are shown in Table 3.1. For the orally dosed 
rats, recoveries of the administered label was only 8.04% 4.93% and 24.12% for the individual 
animals. The body weights of respective animals were 189.5 g, 195.0 g, and 161.5 g. As shown on 
Table 3 .1. the actual weights of whole organs and tissues and assumed weights of tissues for which 
actual values were not obtainable accounted for 81.10% 80.83% and 83.40% of the total body weight of 
respective animals. Ac^usting the recoveries for the discrepancy in weights could only account for 
9.91% 6.09% and 28.92% of the administered dose or a total mean percent recovery of only 15%.
A chart of the mean ± SEM distribution of three rats for the recovered label bv tissue or organ 
is shown in Fig. 3.1. Although significant variations were observed in the distribution of the label in the 
tissues and organs of the rats, the data consistently showed the greatest detection of recovered label was 
found primarily in the rat excreta, which accotmted for 71.76% + 19.76% of the recovered label. The 
skeletal muscle tissue accounted for 10.76% of the distribution of mean recovered label: however, the 
distribution data for this tissue varied significantly. ± 9.67% and may be more a reflection of the 
assiuned relativ e body weight for this tissue. The gastrointestinal tract (stomach, duodenum ceciun. and 
colon) accounted for only 9.18% + 4.37% of the recovered label but represented 33.07% of tissue-bound 
label. However, the recovery of label was only 15% and therefore inhibits speculation regarding the 
distribution. No attempt was made in the preparation of samples fix)m the gastrointestinal tract to 
remove residual fecal contents, and therefore the data collected on these samples reflect tissue bound 
label as well as label adsorbed on the fecal contents.
The sample weights, whole tissue weights and tissue distribution of the administered label of 
three rats following repeated doses of [^-1,6-dinitropyrene are shown in Table 3.2. For the orally 
dosed rats administered the labeled compound by gavage at 24 h and 48 h prior to euthanasia, recoveries
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of the label were 81.12%, 103.79%. and 38.23%, respectively. The bod\' weights of respecth e animals 
were 190 g, 205 g  and 190 g. As shown on Table 3.2, the actual weights of whole organs and tissues 
and assumed weights of tissues for which actual values were not obtainable accounted for 88.62%. 
84.85%. and 85.26% of the total bo<^ weight of respective animals. Adjusting the recoveries for the 
discrepancy in weights accounted for 91.5%, 122.3% and 44.8 of the administered dose for a total mean 
percent recovery of 86.23%.
The mean + SEM distribution for the recovered label by tissue, organ and excreta of three rats 
is shown in Fig 3.2. Although significant variations were observed in the distribution of the label in the 
tissues and organs of the rats, the data consistently showed the greatest detection of recovered label was 
found primarily in the rat excreta, which accounted for 98.09% ± 5.95% of the recovered label. Figure 
3.3 shows the same data with the exclusion of the excreta-recovered label. As shown, when data are 
reported as tissue-bound recovered label, the skeletal muscle tissue accotmted for 46.58% of the 
distribution of mean recovered label; however, the distribution data for this tissue varied significantly. ± 
20.68% and mav- be more a reflection of the assumed relative bodv weight for this tissue. The 
gastrointestinal tract (stomach, duodenum, ceciun. and colon) accounted for 16.02% + 10.95% of tissue- 
boimd recovered label. Unlike in the previous studv on the distribution of 1.6- and 1.8-dinitropvTene. in 
this stuc^ the gastro-intestinal tract was washed to remove residual fecal contents, and therefore the data 
collected on these samples reflects only tissue boimd label. The skin also showed a significant amoimt 
of tissue-bound label (14.96% ± 6.16%). The skin samples were taken fi'om the hind thigh region of 
each rat and included both the epidermis and dermis skin layers. The hair was clipped, but not 
completely removed, prior to obtaining the weight of the sample. Label accumulation on the siuface and 
the distribution to this region may reflect the transfer of label fiom the saliva and tongue of the rat to the 
skin and hair as a result of grooming
The sample weights, whole tissue weights and tissue distribution of the administered label of 
three rats following repeated doses of [^-benzanthracene are shown in Table 3.3. For the orally dosed 
rats administered the labeled compoimd by gavage at 24 h and 48 h prior to euthanasia, recoveries of the 
label were 33.43%, 48.13%  and 58.60%, respectively. The body weights of respective animals were
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Table 3.1. Distribution of administered 1.6- and L8-dinitropyrene in F-344 rat tissues and organs.
RAT#1 RAT #2 RAT #3
Tissue/ Sample Organ Percent Sample Organ Percent Sample Organ Percent
Organ Wt/vol Wt/vol Admin. Wt/vol Wt/vol Admin. Wt/vol Wt/vol Admin.
Urine 0.2 27.5 0.611 0.2 27.5 0.532 0.20 27.5 4.058
MeOh 0.2 20 0.032 0.2 20 0.016 0.20 20.0 0.198
Blood 0.05 13.265 0.030 0.05 13.65 0.035 0.05 11.305 0.049
Fat 0.1 14.402 0.118 0.11 14.82 0.063 0.06 12.274 0.142
Skin 0.08 28.425 0.099 0.11 29.25 0.352 0.09 24.225 0.096
Muscle 0.95 75.8 0.038 0.11 78.0 1.485 0.085 64.6 0.414
Thymus 0.095 0.3 0.004 0.1 0.36 0.008 0.07 0.25 0.001
Heart 0.095 0.61 0.013 0.115 0.68 0.012 0.11 0.59 0.003
Lung 0.07 0.67 0.009 0.09 0.84 0.049 0.09 0.83 0.007
Spleen 0.09 0.41 0.003 0.07 0.34 0.010 0.07 0.37 0.002
Liver 0.10 8.95 0.172 0.1 8.54 0.163 0.09 10.05 0.129
Kidney- 0.08 1.465 0.049 0.11 1.55 0.034 0.06 1.40 0.040
Stomach 0.05 1.099 0.018 0.09 1.131 0.377 0.06 0.967 0.005
Bladder 0.05 0.05 0.003 0.05 0.05 0.006 0.075 0.075 0.015
Duod 0.07 2.843 0.030 0.1 2.925 0.115 0.065 2.423 0.058
Cecum 0.07 0.872 0.299 0.055 0.897 0.308 0.04 0.743 0.887
Colon 0.08 0.758 0.026 0.05 0.78 0.072 0.065 0.646 0.308
Testes 0.1 2.33 0.006 0.08 2.10 0.004 0.1 2.47 0.007
Brain 0.12 1.44 0.002 0.07 1.7 0.004 0.07 1.5 0.004
Feces 0.10 45.0 6.4780 0.1 45.0 1.391 0.1 45 17.702
Dose 12121200 21644422 17927254
Bocb-Wt 81.10% 80.83% 83.4%
Recover 974679 8.041% 1068110 4.934% 4324822 24.12%
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Figure 3.1. Percentage of tissue, organ, and excreta distnbutioa of recovered [3H] 1,6-, 1.8- 
dinitropyrene in F-344 rats. Animals were dosed with labeled 1,6- and 1,8-dinitropyiene compounds b>^ 
gavage. The label was dispensed in a trioctanoin solution and administered in dose amount»; equivalent 
to a maximum radioisotope concentration of 0.05 nCi per gram of live animal weight. Each bar 
represents the mean + SEM dpm of 3 rats.
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Table 3.2. Distribution of administered 1.6-dinitropyTene in F-344 rat tissues and organs.
RAT#1 RAT #2 RAT #3
Tissue/ Sample Organ Percent Sample Organ Percent Sample Organ Percent
Organ Wt/vol Wt/vol Admin. Wt/vol Wt/vol Admin. Wt/vol Wt/vol Admin.
Fat 0.120 14.44 0.03 0.090 15.58 0.04 0.90 14.44 0.04
Skin 0.110 28.5 0.08 0.075 30.75 0.19 0.110 28.5 0.16
Muscle 0.110 76.0 0.22 0.090 82.0 0.58 0.090 76.0 0.52
Th\Tnus 0.125 0.27 0.00 0.100 0.20 0.00 0.08 0.13 0.00
Lung 0.08 0.93 0.00 0.120 1.11 0.01 0.120 0.84 0.00
Heart 0.111 0.88 0.00 0.100 0.89 0.00 0.07 0.74 0.01
Spleen 0.100 0.58 0.00 0.110 0.53 0.00 0.090 0.35 0.00
Testes 0.120 2.68 0.01 0.120 2.86 0.01 0.130 2.42 0.02
Bladcter 0.07 0.24 0.00 0.110 0.111 0.00 0.060 0.06 0.00
Kidne) 0.110 1.66 0.02 0.130 1.60 0.00 0.120 1.32 0.03
Liver 0.120 11.67 0.05 0.100 10.79 0.05 0.100 6.31 0.07
GI Tract 0.252 15.39 0.09 0.268 12.45 0.05 0.261 15.85 0.23
Brain 0.08 1.84 0.00 0.100 1.78 0.01 0.115 1.74 0.02
Feces 0.20 35.0 75.38 0.20 35.0 94.56 0.20 35 31.27
Urine 0.2 35.0 5.10 0.2 35.0 8.07 0.20 35 5.51
MeOh 0.2 20 0.10 0.2 20 0.15 0.20 20 0.31
Blood 0.05 13.3 0.04 0.05 13.30 0.07 0.05 13.3 0.07
Dose* 20242400 20242400 20242400
Body-Wt*’ 88.62% 84.85% 85.26%
Recover' 16421357 81.12% 21009120 103.79% 7739545 38.23%
" Dose reported in total administered (^nn. Percent of recovered weight to measured botfy weight 
ratios. " Total dpm of recovered labeled compound and percentage of dose to recovered dpm ratios.
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Figure 3.2. Tissue, organ and excreta distribution of recovered [^1,6-dinitropyrene in F-344 rats. 
Animals were dosed with labeled 1,6-dinitropyrene compound by gavage 24 h and 48 h prior to 
euthanasia The label was dispensed in a trioctanoin solution and administered in 1 ml doses for a 
maximum radioisotope concentration of 0.05p,Ci per gram of live animal weight. Each bar represents 
the mean + SEM c^nn of 3 rats. Order of legend (leA to right) corresponds with sequence of bars QeA to 
right).
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Figure 3.3. Tissue and organ distribution of recovered L6-dinitropyrene in F-344 rats. Animals 
were dosed with labeled 1.6-dmitropyrene compound by gavage 24 h and 48 h prior to euthanasia. The 
label was dispensed in a trioctanoin solution and administered in 1 ml doses for a maximum 
radioisotope concentration of 0.05p.Ci per gram of live animal weight. Each bar represents the mean ± 
SEM dpm of 3 rats. Order of legend (left to right) corresponds with sequence of bars (left to right).
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
95
167 g. 168 g, and 140 g. As shown in Table 3.3, the actual weights of whole organs and tissues and 
assumed weights of tissues for which actual values were not obtainable accounted for 94.90%. 93.29%. 
and 96.09^ -0 of the total bock weight of respective animals. Adjusting the recoveries for the discrepanc) 
in weights accounted for 35.22%. 51.59%. and 60.98% of the administered dose for a total percent 
recovery of 49,26%.
The mean + SEM distribution for the recovered label by- tissue, organ, and excreta of three rats 
is shown in Fig. 3.4. The distribution of the label in the tissues, organs and excreta of the rats 
consistently showed the greatest detection of recovered label was found primarily in the rat excreta, 
which accounted for 88.42% ± 4.63% of the recovered label. Figure 3.5 shows the data expressed as 
tissue-bound recovered label. As shown, when data are reported as a percentage of tissue-bound 
recovered label, the gastro-intestinal tract accounted for 51.78% + 10.88% of the distribution of mean 
recovered label. The gastro-intestinal tract (stomach, duodenum, cecum, and colon) was washed to 
remove residual fecal contents, and thereafter were subjected to tissue homogenization and oxidation. 
The sample matrix was not a confounding issue, therefore the data collected on these samples reflects 
only tissue bound label. As with the dinitropyrenes. the skeletal muscle and skin showed significant 
accumulation (21.37% and 8.47%. respectively) The skin samples were taken from the hind thigh 
region of each rat and included both the epidermis and dermis skin layers. The hair was clipped, but not 
completely removed, prior to obtaining weight of sample Label accumulation in this tissue may reflect 
transfer from mouth and saliva during grooming
DISCUSSION
Hitmans are exposed to enviromnental chemicals that are released into the environment at an 
increasing rate. The sources of many pollutants are chemical manu&cturing plants refineries energy 
production ücilities, and automotive vehicle exhaust (Blumer, 1976). There is a special health concern 
about emission products and by-products that are released into the environment after combustion or 
conversion of fossil fuels (EPA. 1975). The dinitropyrenes and benz[a]anthracene are associated with 
particles found in the atmosphere, in soils, and in sediments, and human exposure to these compounds is 
expected to be by both inhalation and ingestion (MitcheU, 1985). In diesel exhausL 1,3-, 1,6-, and 1.8-
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Table 3.3 Distribution of administered benz[a]anthracene in F-344 rat tissues and organ»;
RAT#1 RAT #2 RAT #3
Tissue/ Sample Organ Percent Sample Organ Percent Sample Organ Percent
Organ Wt/vol Wt/vol Admin. Wt/vol Wt/vol Admin. Wt/vol Wt/vol Admin.
Fat 0.79 12.692 0.06 0.044 12.768 0.06 0.105 10.64 0.06
Skin 0.077 25.05 0.27 0.052 25.20 0.66 0.049 21.0 0.32
Muscle 0.078 66.8 1.13 0.077 67.2 1.57 0.094 56.0 0.13
Thymus 0.119 0.32 0.01 0.099 0.191 0.00 0.114 0.267 0.01
Lung 0.114 0.785 0.02 0.110 0.841 0.02 0.169 0.634 0.02
Heart 0.114 0.538 0.01 0.090 0.541 0.01 0.092 0.513 0.01
Spleen 0.080 0.419 0.01 0.096 0.421 0.01 0.100 0.351 0.01
Testes 0.086 1.874 0.03 0.100 2.111 0.05 0.073 1.196 0.08
Bladder 0.048 0.048 0.00 0.054 0.054 0.00 0.037 0.037 0.00
Kidney 0.120 1.345 0.06 0.111 1.273 0.09 0.093 1.061 0.09
Liver 0.146 7.955 0.32 0.186 6.921 0.48 0.246 6.011 0.35
GI Tract 0.154 28.96 1.66 0.139 27.44 4.56 0.152 25.44 1.28
Brain 0.104 1.46 0.03 0.105 1.70 0.04 0.216 1.569 0.02
Feces 0.151 19.94 24.12 0.151 27.88 33.72 0.157 39.21 48.04
Urine 0.2 30.0 5.21 0.2 30.0 6.15 0.20 30 7.44
MeOh 0.2 30.0 0.36 0.2 30.0 0.38 0.20 30 0.47
Blood 0.05 11.69 0.15 0.05 11.76 0.32 0.05 9.80 0.27
Dose* 18022160 18022160 15769390
BochWt*’ 94.9% 96.3% 96.1%
Recover* 6024157 33.43% 8674812 48.13% 9240489 58.60%
'  Dose reported in total administered dpm.  ^Percent of recovered weight to measured body weight 
ratios. ‘ Total dpm of recovered labeled compound and percentage of dose to reco\eied <^ pm ratios.
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Figure 3.4. Tissue, organ, and excreta distribution of recovered [^H]benz(a]anthracene in F-344 rats. 
Animals were dosed with generally-labeled benz[a]anthracene by gavage 24 h and 48 h prior to 
euthanasia. The label was dispensed in a trioctanoin solution and administered in divided doses for a 
maximum radioisotope concentration of O.OSpCi per gram of live animal weight Each bar represents 
the mean + SEM dpm of 3 rats. Order of legend (left to right) corresponds with sequence of bars (left to 
right).
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Figure 3.5. Tissue and organ distribution of recovered [^H]benz[a]anthracene in F-344 rats. Animais 
were dosed with generally labeled benz[a]anthracene b\ gavage 24 h and 48 h prior to euthanasia.. The 
label was dispensed in a trioctanoin solution and administered in divided doses for a mayiiniim 
radioisotope concentration of 0.05^Ci per gram of live animal weight Each bar represents the mean + 
SEM c^mi of 3 rats. Order of legend (left to right) corresponds with sequence of baas (left to right).
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dinitropyrenes account for only a small amount of the total nitro-PAHs. However, since these 
compoimds are among the most mutagenic compounds ever tested in the S. typhimurium reversion 
assay, they make a significant contribution to the mutagenicity associated with diesel exhaust particulate 
matter and to the concerns with regard to human health (Rosenkranz and Mermelstein. 1983).
Numerous studies have demonstrated the mutagenic and carcinogenic effects in animal exposures to the 
dinitropyrenes, especially 1.6-dinitropyrene, following topical application, subcutaneous injections, or 
lung instillation (Asokan et al.. 1985; Ohgaki et al.. 1984. 1985; Djuric et al.. 1988; Smith et al.. 1995). 
In these reported studies, the toxic effects occurred most frequently at the site of administration, 
suggesting that cells which come first in direct contact with these agents are more likely targets for their 
genotoxic action. Because the gut microflora may actively participate in the metabolism of 
nitroaromatic compounds, the metabolic fate and toxic effects of ingested dinitropyrenes may be quite 
different than would result from inhalation and deposition in the lungs. In contrast benz[a]anthracene 
is generally considered to be noncarcinogenic in most in vivo animal tumorigenesis models. However 
studies using oral administration of benz(a]anthracene as a route of exposure indicated that this 
compound is carcinogenic in rodents (Klein. 1963; Mumtaz et al.. 1996;Tsuda and Farber. 1980). It is 
hypothesized that human exposure to fossil fuel combustion products occurs at low concentrations but 
with relatively high frequency of assault and that such events may enhance G.I. absorption and 
bioaccumulation. The reported differences observed following ingestion of benz[a]anthracene compared 
with other exposure routes may reflect enhanced absorption of the compound via the gastrointestinal 
tract
In this stuck, [^ -1 .6 -  and 1,8-dinitropvTenes were administered to rats by oral gavage. 
Excretion of the radioactivity was rapid with 71.77% of the recovered, labeled compound having been 
eliminated within 48 hours of a single dose containing both [^ -1 ,6 -  and 1,8-dinitropvTenes, or with an 
elimination of 98.08% of the recovered label within 24 h following the second of two doses of [^ -1 .6 -  
dinitropyrene. It is unlikely that this high elimination is due strictly to unabsorbed dinitropyTene 
passing through the G.I. tract, because urinary radioactivity was also high.
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The skeletal muscle and gastrointestinal tract were the tissues of greatest accumulation, 
accounting for 46% and 16%. respectively, of the tissue-bound label but representing less than 1% of the 
total recovered label. The compounds w ere labeled with tritium and. since water comprises 70% of lean 
body mass, detection of label in skeletal muscle tissue may reflect hydrogen exchange with tritium. The 
gastrointestinal contents were removed and the tract rinsed in buffer prior to radiometric analyses. No 
measures were used to scrape or remove any remaining fecal or undigested matter, therefore, detected 
label in the gastrointestinal tract following 1.8- and/or 1.6-dinitropvTene administration may represent 
compound adsorbed to protein or unabsorbed parent compound.
The amount of chemical entering the systemic circulation after oral administration depends on 
several factors. First, the amount absorbed into the mucosa cells which line the gastrointestinal tract 
Penetration of amphoteric substances across the gastrointestinal wall occurs according to the principles 
of physical chemistry, with the unstirred water layer representing the rate-limiting barrier for more 
lipophilic compounds and the epithelial cell membranes representing that for more hydrophilic 
compounds. Second, before a chemical enters the systemic circulatiotL it can be metabolized by the 
gastrointestinal cells or extracted by the liv er and excreted into the bile with or without prior 
biotransfonnation. a process termed the first-pass effect (Rozman and Klaassen. 1996). Distribution of 
the labeled dinitropvTcnes in the circulatory system and in the liver of rats were similar with each 
compartment accounting for approximately 0.1% of the recovered label or 6% of tissue-bound label.
The low percentage of recovered label detected in the liver relative to that detected in the gastrointestinal 
tract suggests either rapid biliary elimination or slow absorption through the intestinal wall. Reduction 
of the nitro group has been postulated to be an obligatory step in the transformation of nitroaromatic 
compounds to bacterial mutagens (Rosenkranz et al.. 1980). The reduction of the nitro group to an 
amine is then followed by N-oxidation to form a hy droxy lamine, which is then conjugated to form 
rapidly excreted glucuronide or acetylamino metabolites. While the low percentage of recovered label in 
the blood relative to that in the urine suggests rapid renal excretion, urinary labeled compounds were not 
identified. Dutcher et al. (1983) examined the excretion and metabolism of 1-nitropyrene in rats 
following oral administration and found that 55% and 30% of the label was detected in the urine and
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feces, respectively. The majority of the label in both the urine and feces \vas associated %ith polar 
metabolites. Subsequent analyses revealed that the metabolites were formed by nitroreduction to amino- 
and acetylamino-compounds. Studies to identiA" the in vivo metabolites would help to further 
understand the pathways of in vivo toxication and detoxication of dinitropyrenes in mammak following 
oral ingestion.
A rapid elimination also followed oral administration of [Tf]-benz[a]anthracene with 88.4% of 
the recovered label having been excreted within 48 h following the initial gavage dose. Because urinary 
excretion of the label was also high, accounting for appro.ximateiy 14% of the recovered label, it is 
unlikely that this high elimination in the feces is due strictly to unabsorbed benz[a]anthracene passing 
through the G.I. tract As with the binding of the dinitropyrenes. the greatest amount of tissue-bound 
label was detected in the skeletal muscle and gastrointestinal tract of benz[a]anthracene dosed rats and 
accounted for approximately 72% of the tissue-bound label. Since the gastrointestinal tracts were 
cleared of contents, thoroughly washed, and subjected to tissue oxidation, the detection of label in this 
tissue more likely represents bound compound rather than unabsorbed parent compound. Unlike the 
dinitropyrenes. benz[a]anthracene is highly non-polar and urinarv excretion would require metabolic 
oxidation of the benzene ring carbons followed bv- conjugation with a functional group. The metabolite 
of benz[a]anthracene which was shown to be the ultimate genotoxic agent is the 3.4-diol-l,2- 
epo.xide(Levin et al., 1978). The enzymes which participate in the transformation of benz[a]anthracene 
to its ultimate metabolite are the epoxide hydrolases and the cytochrome P450s or prostaglandin H 
svmha.se. Although the levels vary , epoxide hydrolases have been found in virtually all tissues including 
the liver and intestine. However, the initial transformation of benz[a]anthracene requires ring oxidation 
and this step is catalyzed either by cytochrome P450s. which resides primarily in the liver, or Iw 
prostaglandin H synthase, which is found in high levels in the intestine (Parkinson, 1996). The liver- 
bound label accounted for approximately 8% of the tissue-bound recovered label, while the 
gastrointestinal tract accounted for aiqnoximately 52% of the tissue-bound label, suggesting that the 
intestinal tract may be the primary site for the metabolism and detoxication of benz[a]anthracene via 
prostaglandin H synthase pathway. However, since it is highly improbable that the large amount of
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label recovered in the fecal excretions is strictly unabsorbed parent compound, these results also suggest 
that biliary excretion by the liver may account for a substantial amount of the recovered label. Studies to 
identify the in vivo metabolites would help to further understand the pathways of in vivo toxication and 
detoxication of benz[a]anthracene in mammals
Fecal excretion is a major pathway for the elimination of xenobiotics from the body and may 
represent unabsorbed ingesta and/or biliary excretion. The biliary route is perhaps the more important 
contributing route of fecal excretion for xenobiotics. since most xenobiotics are metabolized primarily in 
the liver following absorption of the toxic agent from the gastrointestinal tract However, for a large 
number of div erse chemicals (e.g. digitoxin and dinitrobenzamide) excretion into the feces cannot be 
explained either by unabsorbed excretion or biliary excretion Transfer of these toxins into the gastro­
intestinal tract is thought to proceed by passive difrusion directly from the blood into the intestinal 
contents (Roseman and Klaassen 1996). Intestinal excretion is a relatively slow process, and is. 
therefore, a major pathway of elimination only for compotmds that hav e low rates of biotransfonnation 
or low renai/büiary clearance. The fecal contents were not examined for parent compound—only for 
radioactivity. Therefore, while the fecal contents accounted for a significant amount of the labeled 
compoimd. whether the label in the feces represents compoimd metabolized by the liver and excreted in 
the bile or compound simply not absorbed was not determined. Studies to further identify the in vivo 
metabolites of these compounds will help to further understand the pathways of PAH toxication and 
detoxication and may provide a better understanding of PAH environmental contamination and the risks 
of exposures to human health.
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CHAPTER 4
EVALUATION OF AN ACUTE TOXICITY STUDY 
IN THE FISCHER-344 RAT FOLLOWING 
DIETARY ADMINISTRATION OF 2- 
AMINOANTHRACENE, BENZ[a]ANTHRACENE,
OR DINITROPYRENES
INTRODUCTION
In the first stages of toxicologic testing programs, acute toxicit) studies are fi-equentiy used to 
categorize the agent(s) in terms of relative toxicity. Rodents are most often employed to e\ aluate 
potential harmful effects and to determine dose levels at which no toxic efiects are detected (Kennedy 
and GraepeL 1991). Acute toxicitv studies evaluate the short-term effects for up to 14 days and, when 
involving oral dosing, these studies provide a useful insight into the potentially toxic biological effects of 
repeated exposures to a compound Various dose ranges are employed for these short dosing studies, 
often with the dosage in the highest dose group being increased in a geometric or logarithmic &shion 
until toxic effects occur, and these provide data useful for later chronic or sub-chronic trials (Briggs and 
Oehme. 1980).
At the turn of the century, studies in humans showed that polycyclic aromatic hydrocart»n 
(PAH) compounds are causative factors in the dev elopment of cancer (Boyiand 1986: Lawlwy. 1994: 
Pitot and Dragan. 1996). Incomplete combustion of fossil fuels results in the formation of PAHs. and 
increased use of fossil fuels has elevated environmental concentrations of PAH compounds to which 
humans are exposed especially near urban areas (Paridnson. 1996). Levels of these compounds vary 
fiom 5ppb for an undeveloped area of Alaska to 1.79 x lO^ppb for an oil refinery out-611 (Johnson and 
LarseiL 1985).
The major source of human exposure to environmental carcinogens on a daily weight basis is 
fiom the diet (Strickland and Groopman, 1995). This exposure pathway is consistent with a large pool 
of epidemiological data linking the incidence of human cancer (20-50%) with dietary 6ctors (Blot.
1992; Statland 1992; Lutz and Schlatter, 1992.1993; Sugimura and Sato, 1983: Porter, 1993:
106
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Comstock et aL 1991: Sauer and Sipes. 1995). Also, observations in animal»; have shown that some 
types of cancer are related to certain carcinogens in their food, and several types of cancer similar to that 
in humane have been induced in experimental animals by administration of carcinogens, such as 
nitrosamines and my cotoxins, suggesting that their presence in human diets can increase cancer risk 
(Lijinsky. 1983).
PAH compounds are ubiquitous environmental contaminants and humans are exposed 
concurrently or sequentially to PAH compounds up to several thousand micrograms per day depending 
on the source, lifestyles, such as occupation, emironmental food chain, cigarette smoking and 
socioeconomic status (Arif and Gupta. 1996). Among the fifty-four PAHs identified at one or more 
National Priority List (NPL) hazardous waste sites, anthracene- and pyrene-based PAHs are among the 
most abundant representatives of the environmentally occurring PAHs and have been detected in 
ambient air. water, and soil as well as in various food stuSs (Jacob et al. 1989). In addition to their 
widespread occurrence in the enviromnenL anthracene- and pyrene-based PAHs contain some of the 
more potent experimental chemical carcinogens known (Pitot and Dragan 1996).
This study investigated the potential toxic effects of three different classes of polycyclic 
aromatic hydrocarbon compounds—nitroarenes. arylamines, and alternant aromatics— when 
administered in the diet. Although numerous studies have evaluated these and other similar compounds 
individually for their biological effects following topicaL subcutaneous, intraperitoneal. gavage, or direct 
instillation administration, limited studies have investigated the effects associated with ingesdotL Since 
ingestion represents a major route of human exposure and since the absorption and metabolism of 
compounds may be altered by ingestion, this route of exposure may more accurately reflect the effects of 
such compounds in humans. This stuc^ * also examined ingested lev els of tolerance of the individual 
classes of PAH compounds to establish the formulation of adulterated diets for a chronic study to 
evaluate these same compounds individually and as components of a mixture for toxicological effects 
following ingestioiL
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EXPERIMENTAL 
TEST MATERIALS 
Rationale for Selection of Compounds
Although the significance of PAH compounds with regard to environmentally caused diseases 
and cancer in humans is difBcult to estimate, it is suggested that the potential hazard of environmental 
exposures to PAHs mav be underestimated (Grimmer et al.. 1995). For this studv. three compound 
classes of pyrene- or anthracene-substituted PAHs were selected which are relevant to human exposure 
(Fig. 4.1). Among the first chemicals to be recognized as human carcinogens, the aromatic amines are 
known or suspected of causing bladder cancer in humans (Humphreys. 1992) Arylamines are found in 
tobacco smoke, synthetic fuels, agricultural chemicals, and the (he industry (CartnrighL 1983). 2- 
Aminoanthracene (2-AA) was selected as the representative of arylamines (Fig. 4.1.. Top row. Center). 
2-AA is a potent carcinogen (Shear. 1938). Its most unusual characteristics are its specificity for 
epithelial tissues and ability to produce a variety of tumor types in rodents (Fu et al.. 1986; Carrière et 
al.. 1992; Arcos and Argus. 1974; Shubik et al.. 1960; Hallstrom et al.. 1981; Zhu. 1995). 2-AA is also 
a potent bacterial mutagen and has been recommended for use as a positive control in bacteria reversion 
assays, since it causes mutations in all tester strains of Salmonella (Shaikh et al., 1980). Although the 
carcinogenic and mutagenic properties of 2-AA are known, little information is available on the in vivo 
metabolic activation of 2-AA and its interaction with mammalian tissues (Mitchell. 1985).
Benz[a]anthracene (BA) is a prototype of the alternant aromatics and is commonly found in 
contaminated soil (Fig. 4.1. Top row. Right). In fact approximately 41% of contaminated sites œntain 
this compound at levels which range from 5-20 R3b in rural areas to 2.320 ppb at a hazardous waste site 
(Schneider et al., 1996). BA is considered a mcxkrate to relatively weak carcinogen and is proposed to 
follow the “bay theory” of activation similar to benzo(a]pyrene. BA has been associated with suR)ressed 
humoral immunity in humans, has been identified in the urine and blcxxi of occupationally exposed 
men. and epidemiologic studies have shown increased mortality due to lung cancer in individuals 
exposed to coke oven. loofing tar. and cngarette smoke emissions which contain benzanthracene
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(Szczeklik et al.. 1994; Becher et al.. 1984; Redmond et al.. 1976; Hammond et al.. 1976; Maclure and 
MacMahon. 1980).
The dinitropvTenes. 1.3-; 1.6-; and 1.8-dinitropyrene (Fig. 4.1. Bottom row), are nitroaromatic 
environmental contaminants that are produced during the combustion of diesel fuel (Draper. 1986). In 
diesel exhaust, which is a complex mixture composed of particulate, gas. and vapor phases. 1.3-; 1.6-; 
and 1.8-dinitropy-rene account for only a small amoimt of the total nitroaromatics. Howev er, since these 
compoimds are among the most mutagenic compoimds for S. typhimurium that have been identified, 
thev make a significant contribution to the toxicitv associated with diesel exhaust. The dinitropvTenes 
are known to induce tumors in experimental anitnaU (Takavama et al.. 1985; Heimich et al.. 1986; 
Hemminki et al.. 1994; Beland et al.. 1994;Smith et al.. 1995). Upon direct limg instillation to F344
PARENT COMPOUNDS
NH.
Anthracene 2-Aminoanthracene 1.2-Benzantiiracene
Pyrene 1.3-DinitropyTeae 1.6-Dinitropyreae 1.8-Dinitropyrene
Figure 4.1. Chemical structures of parent-based compounds and selected compotmds used for stucfy. 2- 
Aminoanthracene, 1.2-benzanthracene. and the dinitropyrenes of 1,3-, 1,6- and 1.8-dinitropyrene were 
incorporated into a nutritionally adequate powdered rodent diet (AIN-93M) and fed continuously to F- 
344 rats for 14 days at concentrations of 0.0.001%, 0.01%. or 0.1% of the diet
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
110
rats. 1.6-diaitropyrene induces squamous cell carcinomas, and epidemiological data suggest an 
association between exposure to diesel exhaust and the induction of lung and bladder cancer in humans 
(Maeda et al.. 1986; Silverman et al.. 1992; Garshick. et al.. 1988). Since the nitro groups of aromatic 
compounds can be biochemically reduced to the amine deriv-ative via nitroreductase enzymes present in 
gastro-intestinal tract bacteria and are therebv interrelated through metabolism to aromatic amines a 
class of carcinogens known to cause bladder cancer in humans, the nitrated pyrenes may contribute to 
the increased incidence of bladder tumors in individuals exposed to diesel exhaust (Nesnow et al.. 1984; 
Smith et al.. 1995).
Chemicals
2-AA (98-99% purity) was obtained fiom Aldrich Chemical Company. Inc. (Milwaukee. WI) 
and BA (99.0% purity) was obtained from Sigma Chemical Company (Sl Louis MO). The 1.3-. 1.6-. 
and 1.8-DNP were synthesized in the laboratory. Basically, the nitration of pyrene (Sigma. SL Louis. 
MO) was carried out using the acetic anhydride-nitric acid system under controlled heat conditions. The 
nitrated pyrene products were analyzed by HPLC and consistently yielded less than 5% 1-nitropyrene 
(%/wt) and 95% DNP as 1.3-; 1.6-; and 1.8-DNP with yields of 18%. 35%. 42%, respectfully (%Avt). 
The DNP used throughout this paper refers to this composite mixtiue of l-nitropyrene. 1.3-. 1.6-. and 
1,8-dinitropyrenes at 5%. 18%. 35%. and 42%. respectfully . Chemicals used in the formulation of the 
semi-purified rodent basal diet were purchased from ICN Biomedicals. Inc. (Costa Mesa. CA).
DIET PREPARATION
A basal powdered diet (AIN-93M) was prepared using ingredients according to the 1993 
formulation recommendations of the American Institute of Nutrition (1993). In brief, dry dietary 
ingredients [purified, high nitrogen casein (I(ZN. Costa Mesa. CA); com starch (ICN); alphacel (ICN); 
dextrinized com starch (ICTN); tert-butylated hydroquinone (ICN); L-cystine (ICN); AIN-93M mineral 
mix (Harlan Teklad. Madison. WI); AIN-93M vitamin mix (Harlan Teklad); choline bitartrate (Harlan 
Teklad); sucrose (L.S.U. residential food stores)] were mixed in a commercial floor model mixer, after 
which the prescribed amoimt of soybean oil (ICN) was added and mixing continued until a 
homogeneous mixture was obtained. The basal diet was prepared in 5 kg batches once a month and
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stored at -20°C. The unadulterated basal diet serv ed as the control diet. Adulterated diets were prepared 
by’ incorporation of the specified PAH test compound into the basal diet Each of the three represented 
compound classes (dmitropytenes. 2-aminoanthracene. or benzanthracene) was incorporated into the 
basal diet based on the amount of basal diet used in preparing the adulterated diet Concentration lev els 
used for each of the test compounds were set at 0.001%, 0.01%. and 0.1%. and the respectiv e 
adulterated diet contained 0.01. 0.10. or 1.00 grams of test compound(s) per lOOOg of basal diet Human 
PAH exposure amounts are assumed to be up to several thousand micrograms per day (Arif and Gupta. 
1996). Rodents, in general, consume an amount of food equivalent to aRrroximately 10% of their both 
weight For example, a 150 gram rat would consume approximately 15 grams of diet per day . A 
maximum concentration limit of 0.1% of the diet (1 gram/kilogram of diet) was defined at the onset of 
this study based of this estimate of rodent food consumption patterns. A 0.1% adulterated diet would 
provide a rodent weighing 150 grams with 15 milligrams of test compound—a far greater amount than 
the estimated human exposure amount. Incorporation of the test compound(s) into the basal diet was 
accomplished by blending on an electric bottle-roller bar assembly for 3 hours at room temperature. 
Adulterated diets were prepared for the DNP. BA. and 2-AA test compounds at the specified 
concentrations. Adulterated diets were prepared firesh on a weekly basis in kilogram batches. Kilogram 
batches of unadulterated basal diet were also subjected to blending on the bottle-roller assembly each 
week along with the adulterated diets. After thorough blending, the unadulterated and adulterated diets 
were packaged and stored in the dart at -20°C.
ANIMALS
This study was conducted under federal guidelines for the use and care of laboratory animals 
and was approved by the Institutional Animal Care and Use Committee and the Carcinogen Use 
Committee of Louisiana State University, School of Veterinary Medicine. Sixty adult male Fischer-344 
rats (4-6 weeks of age at the begirming of the experiment) were purchased fiom the Charles River 
Breeding Laboratories, Inc. (Raleigh. NC). This inbred rat strain was selected based on extensive use in 
chronic carcinogenicity studies by the National Cancer Institute (Rao and Boorman, 1990). Animals 
were housed in individual hanging  stainless steel wire mesh cages in an Association for the Assessment
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and Accreditation of Laboratory- Animal Care (AALAC) approv ed fedlity. Rats were housed under 
controlled conditions with a 12 hour light-dark cy cle and provided water and diet ad libitum. Rodents 
were acclimated to the animal facility and fed basal powdered diet for 1 week prior to use. Animals 
were randomised by weight into exposure treatment groups. Animals were first rank-ordered by weight 
(initial weight) ; second, the ordered weights were divided into the number of replicates per treatment; 
and third, members within each replicate rank were randomly assigned to an experimental diet 
treatment group.
SAFETY PRECAUTIONS
Due to the potential risk of toxicity by repeated e?qx}sures to test compounds, all animal 
caretakers were provided with fiill-face respirators equipped with replaceable, disposable activated- 
charcoal filters designed to exclude organic particulate and vaporized compounds. All persormel 
entering animal housing were required to wear protective clothing and shoe cov ers. All bedding, 
uneaten diet, disposable a^ i^areL and animal excreta were contained and disposed of as biohazard 
wastes.
ANIMAL BIOASSAY
Twenty rats were randomly assigned to one of four experimental diet treatment groups and 
were fed an untreated control basal diet or an adulterated diet containing 0.001%. 0.01%. or 0.1% of 
either DNP. BA or 2-AA. Weekly animal bocb- weight and daily food consumption were monitored on 
individual rats throughout the stu^. The basal diet provided a full complement o f essential nutrients to 
meet the needs of laboratory rodents (Reeves et al.. 1993). Batches of diet were prepared for each 
treatment dose at weekly intervals. After 14 days of continuous diet administration, the rats were 
anesthetized with isoflourane anesthesia followed by withdrawal of blood firom the abdominal inferior 
vena cava until exsanguination. The order of sacrifice was random among all treatment groups. Blood 
fiom the abdominal inferior vena cava was collected in sterile ethylenediaminetetraacedc acid (EDTA) 
containing Vacutainer® brand tubes or Vacutainer® brand SST® gel and-clot activator tubes (Becton 
DickinsotL Franklin Lake. NJ) and serum and plasma prepared for c linical chemical and hematological 
evaluations. Upon exsanguination, the limgs, liver, kidneys, spleen, heart, thymus, and testes were
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excised and weighed. All organs were examined for gross lesions and subseqnenth' a representative 
sample of each tissue was placed in 10% neutral buffered formalin for histological examination.
Samples of skeletal muscle, epidermis and dermis skin layers, epidichmal fat. colon, cecum, duodenum, 
and ileum were similarly processed. Organs minus histology sections were fiozen by emergence in 
liquid nitrogen and subsequent!} stored at -80°C.
TISSUE PREPARATION FOR HISTOLOGY AND LIGHT 
MICROSCOPY
Sections of tissues were Sxed in a solution of 10% neutral-buffered formalin and subsequently 
Sxed sections of tissues were dehy drated through increasing concentrations of ethanol and embedded in 
paraffin. The formalin-fixed paraffin embedded tissue blocks were cut to 5 microns and sectioned on 
albumin-coated slides. The slides were deparafSnized and hydrated through graded xylene and alcohol 
processed, and stained with hematoxy lin and eosin (H&E). Sections were then cleared and mounted 
with non-aqueous coverslip resin (PermoimL Fisher Scientific. Cincinnati. OH). Stained tissue sections 
fiom each rat were analyzed for morphometric alterations.
CLINICAL PATHOLOGY 
Serum samples were prepared by allowing the blood sample collected in gel clot tubes to clot at 
room temperature for 15 to 30 min. The sample was centrifuge for 10 mm at 2000 g. Serum chemistry 
profiles were obtained by automated procedures (Olympus Reply, Olympus American. Inc.. Lake 
Success. NY) and included determinations of the activities of aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT). Levels of Angiotension Converting Enzyme (ACE), as an indicator of 
general health, and Sorbitol Dehydrogenase (SDH), as an indicator of hepatocellular injury, were 
detected using commercially available enzyme kits (Sigma. St Louis. MO). Hematological profiles 
were conducted on firesh blood collected in microtainer® EDTA tubes (Becton Dickinson). The 
hematological parameters were measured in an automated instrument (Baker 9000. Baker Instruments 
Corp.. Allentown. PA) which determined the white and red blood cell counts, the packed cell volume, 
and hemoglobin content while differential erythrocyte cell count evaluations were performed manually 
using a hemocylometer.
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STATISTICAL ANALYSES
The data were analyzed by one-way analysis of variance (ANOVA) using SAS. The data for 
both' weight and dietary intake were analyzed using a repeated measures desigiL The procedures used to 
test for significance among the main treatment effects was the General Linear Model (GLM). and to test 
for significant differences between treatment groups and the parameter the Tukey-Studentized multiple 
comparisons test was applied. The univariate and fiequency procedures were employed to obtain 
information about the distribution of these parameters among the different treatment groups. Weight 
and intake data were analyzed using a repeated measures design and differences between groups were 
determined using a Tukey-Studentized multiple comparisons test
RESULTS
Cage side observations of untreated and treated rats indicated that animals readily consumed 
the untreated controL DNP-. or BA-adulterated diet when compounds were represented at a 0.001% or 
0.01% concentration levels. No mortality or adverse effects in general healthiness of animals was 
detected among rats fed DNP- or BA-adulterated diet at the 0.001%. 0.01%, or 0.1% chemical 
concentration levels. Although mortality did not occur in rats following ingestion of 2-AA-adulterated 
diet, a general decline in healthiness was observed among these animals when 2-AA was incorporated at 
a 0.1% concentratiorL
Initial both weight of rats and body weights of rats following one and two weeks of diet 
administration of the DNP-adulterated diet are shown in Fig 4.2. When compared with respective 
untreated control animals, no differences were detected in initial body weights of rats or in both weight 
tjeterminations of rats following one and two weeks of continuous administration of DNP-adulterated 
diet at a chemical concentration level of 0.001%. 0.01% or 0.1%. Similarly no tJifferences were 
detected in initial botfy' weights of rats or in the both weight of rats following one and two weeks of 
continuous administration of BA-athilterated diet at a chemical concentration level of 0.001% 0.01% or 
0.1% when compared with respective untreated control animals (Fig. 4.3). However, beginning with 
day 7 of dietary atlministration and continuing until dlay 14. significantly retiuced btxh weight gains 
were detected in rats consuming 2-AA-atiulterated diet at the 0.1% 2-AA concentration level when
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Figure 4.2. Mean boc^ weight of untreated and DNP-exposed tats as a function of duration of 
administiatioiL Mean body weight of rats are shown at the start of the DNP diet administration and 
again following one and two wedts of continuous ingestion of the DNP-adulterated diet Each bar 
represents the mean + SEM of 5 rats.
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Figure 4.3. Mean bcx^ weight of untreated and BA-exposed rats as a function of duration of 
administration. Mean bocfy weight of rats are shown at the start of the BA diet administration and again 
following one and two weeks of continuous ingestion of the BA-adulterated diet Each bar represents 
the mean + SEM of 5 rats.
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Figure 4.4. Mean bcxfy weight of untreated and 2-AA exposed rats as a function of duration of 
administratiotL Mean bocfy weight of rats are shown at the start of the 2-AA diet administration and 
again following one and two weeks of continuous ingestion of the 2-AA-aduIterated diet Each bar 
represents the mean ± SEM of 5 rats. For each time point means with different letters are significantly 
different Tukey’s Studentized Range Test alpha = 0.05.
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compared with untreated control animal»; (Fig. 4.4). Reduced bod\ weight gains were also detected in 
rats fed 2-AA-adulterated diet at the 0.01% 2-AA concentration leveL however differences did not attain 
significance until dav 14 of the diet administration In general, for each group of animals the mean 
bodv" weights afterl4 days of diet administration followed the relative order of 0.1% < 0.01% < 0.001% 
< untreated control independent of chemical dietary adulteration.
Table 4.1 presents the average weekly intake levels of rats exposed by ingestion to 2-AA. DNP, 
or BA at various dietary concentrations. As expected, animals with the highest body weight gains 
consumed more diet than animals with lower weight gains and the amount of food consumed by 
animals, in general, paralleled the observed differences in animal boc^ weight A significant decrease 
in the amount of diet consumed was detected for all rats following the first week of exposure, regardless 
of chemical treatment when the compounds were included at the 0.1% dietary concentration level. 
Table 4.1. Levels of dietary intake of F-344 rats following ingestion of 2-AA BA or DNP.
Treatment Groun Week 1 Intake (2 > Week 2 Intake (e)
Untreated (DNP) 19.1057 + 0.6293*^ 15.2000 + 0.4493 *
DNP (0.001%) 19.6914 + 0.6293* 15.8343 +0.4493*
DNP (0.01%) 18.9943 + 0.6293 *^ 15.4829 + 0.4493*
DNP (0.1%) 17.1229 + 0.6293*’ 14.1886 + 0.4493*
Untreated (2-AA) 18.4486 + 0.4577* 17.9714 + 0.56778*
2-AA (0.001%) 18.7943 ±0.4577* 16.9171 ±0.56778*
2-AA (0.01%) 15.8314 + 0.4577*’ 13.3971 ±0.56778*’
2-AA (0.1%) 7.7171 +0.4577' 6.9914 ± 0.56778'
Untreated (BA) 21.9343 +0.56384* 15.5429 ± 0.54780*
BA (0.001%) 21.0371 +0.56384**’ 15.3800 ±0.54780*
BA (0.01%) 21.0829+0.56384**’ 16.0971 ±0.54780*
BA (0.1%) 19.3886+0.56384*’ 15.7229 ±0.54780*
Data represents the Mean + SEM of 5 rats. Means with the same letter are not significantly different 
alpha = 0.05.
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However, no difTerences were detected for anim ak ingesting DNP- or BA-adulterated diet at a chemical 
concentration of 0.1% at the end of the second week, suggesting acclimation of rats to the chemically- 
altered diet administration. When compared with the respective untreated control animals, only rats 
administered the 2-AA.-adulterated diet showed a significant reduction in intake following one week of 
ingestion at the 0.01% 2-AA. concentration level and following 2 weeks of treatment at both the 0.01% 
and 0.1% concentration levels. From day 1 forward until day 14. a significant reduction in diet intake 
was detected for rats consuming 2-AA at the 0.1% concentration level. Daily intake averages for these 
animals were 12.0 grams. 9.96 grams, and 6.32 grams for days 1. 7. and 14. respectively, while 
untreated control rat average intake amounts were 17.02 grams. 17.54 grams, and 15.76 grams, 
respectively for the same time periods.
All animals, including untreated controls, exhibited a decrease in consumption levels when 
week 1 and week 2 were compared. Since animal»; were acclimated to the basal diet for one week prior 
to treatment the decline in intake during the second week mav' be due to a plateau in maturation level. 
The effects of ingestion of DNP-adulterated diet on serum chemistry is shown in Fig 4.5. As shown, 
serum levels AST, ALT. ACE. or SDH did not differ between untreated control animal»; and anim ak fed 
DNP-adulterated diet at the concentration levels of dinitropvTcnes used in this studv . suggesting that 
hepatic health was not compromised by dietary exposure to the nitroarene compound class. Even at the 
highest level of dietary inclusion (Ig/kg of diet). no detectable effects were observed on these enzymatic 
indicators of liver function. No significant differences in levels of AST, ACE, or SDH were observed in 
the serum of rats following 14 days of dietary exposure to BA-adulterated diet regardless of 
concentration level (Fig 4.6). A significanth* lower level of ALT was detected in the serum of rats fed 
BA-adulterated diet for 14 days at a 0.1% chemical concentration level: however, the detected value was 
within the normal clinical pathology reference range for ALT levels (<90) in rodents. Significantly 
increased levels of ALT were detected in the serum of rats following 14 days of ingestion of 2-AA- 
adulterated diet at the 0.1% 2-AA concentration level (Fig. 4.7). However, no differences in the levels 
of ALT were observed in the serum of rats following 14 days of 2-AA-adulterated diet administration at 
the two lower 2-AA dietary concentrations (0.01% or 0.(X)1%) when compared with respective untreated
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Figure 4.5. Effect of ingestion of DNP-adulterated diet on serum chetnistiy parameters. Male rats were 
continuously fed diet containing DNP at 0,0.01 g/kg, 0.1 g/kg. or 1.0 g/kg of diet for 14 days. Each bar 
represents the mean ± SEM of 5 rats.
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Figure 4.6. Effect of ingestion of BA-adulterated diet on senun chetnistiy parameters. Male rats were 
continuously fed diet containing BA at 0. 0.01 g/kg, 0.1 g/kg. or 1.0 g/kg of diet for 14 days. Each bar 
represents the mean + SEM of 5 rats. Means with the same letter are not significantly differenL Alpha 
= 0.05.
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Figure 4.7. Effect of ingestion of 2-AA-aduIterated diet on serum chemistry parameters. Male rats were 
continuously fed diet containing 2-AA at 0,0.01 g/kg, 0.1 g/kg, or 1.0 g/kg of diet for 14 days. Each 
bar represents the mean ± SEM of 5 rats. Means with the same letter are not significantly different 
Alpha = 0.05.
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control animals. Although elevoted levels of AST (402 U/L) were detected in the serum of rats 
administered 2-AA-adulterated diet at a 2-AA concentration of 0.1% when compared with levels for 
untreated controls (165.7 U/L). these \alues did not attain significance due to wide variation (+ 72.43 
U/L) in the detected levels of this enzvme.
Likewise, there were no detectable differences in levels of ACE or SDH in the serum of rats 
following 14 dav’S of administration of 2-AA-adulterated diet at the concentration levels of 2-AA used in 
this stuck . The diagnostic value of AST. ALT. and SDH as indicators of hepatic function rest in the 
location of these enzymes. Cell cytosol contains AST. ALT. and SDH whereas only mitochondria 
contain AST (Suber. 1988). Serum AST levels have been reported in humans with hepatic disease, 
myocardial necrosis, skeletal muscle necrosis, and often with metastatic carcinoma. The low ALT and 
SDH concentrations in other tissues make any increase indicative of hepatic disease. Human serum 
ALT and AST levels are usually equally elevated in cases of acute hepatic necrosis, extrahepatic 
obstruction, congestive hepatomegalia and infectious mononucleosis. The rats exposed to 2-AA at a 
concentration of 0.1% showed elevated serum ALT and AST levels compared with rats from the other 
exposure groups and untreated controls: however, serum AST levels were not significant. Still the data 
indicate that hepatocellular disease may result from exposure to 2-AA at 0.1% dietary inclusion. The 
animals at the highest level of dietary exposure to 2-AA failed to thrive (as measured by weight gain) 
and a significant reduction in intake was noted afier only one day of diet administration The rats 
continued to show a decrease in consumption throughout the exposure period and appeared emaciated at 
the time of death.
Clinical hematological data are presented on Table 4.2. When compared with respective 
untreated control rats, no significant differences in cell numbers or volumes were detected in the blood 
fiom rats administered either the DNP- or BA-adulterated diet, regardless of chemical dietary 
concentration level. With the exception of eosinophils, levels of all hematological parameters were 
elevated Iw dietary administration of 2-AA-adulterated diet at the 0.1% 2-AA concentration leveL but 
were not elevated when 2-AA was included in the diet at 0.001% or 0.01% concentration levels. 
Hematopoiesis is usually restricted to the bone marrow after birth, but the spleen and liver retain the
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TREATMENT n WBC (10 )^ RBC (10") HGB (g/dl) PCV SEGS(Abs)- LYMPH(AI)s) M0N0(AI)8> EOS(AbN)
CONTROL 5 4.360+0.242" 8.224+0.208“ 14.66+0.33" 40.80+0.87" 0.82+0.12" 3.32+0.44" 0.0610.04" 0.0610.03"
DNP (().()() 1%) 5 5.220+0.177* 8.202+0.208" 14.58+0.33" 42.00+0.87" 1.16+0.12" 3.8610.44" 0.12+0.04" 0.0610.03"
DNP (0,01%) 5 4.220+0.177" 7.816+0.208" 14.04+0.33" 40.20+0.87" 0.86+0.12" 3.22+0.44" 0.10+0.04" 0.08+0.03"
DNP (0.1%) 5 4.840+0.598" 8.218+0.208“ 14.78+0.33" 41.60+0.87" 0.92+0.12" 3.5410.44" 0.12+0.04" 0.0610.03"
CONTROL 3 6.560+0.312" 7.860+0.243" 14.56+ 0.39"" 40.80+1.10" 1.16+0.17" 5.1610.72“" 0.19+0.06" 0.07+0.03"
2-AA (0.001%) 5 5.420+0.266" 7.574+0.243" 13.96+0.39" 39.60+1.10" 1.32+0.17" 3.9210.72" 0.10+0.06" 0.07+0.03"
2-AA (0.001%) 5 6.680+0.266" 8.322+0.243" 15.28+0.39"" 42.60+1.10"" 1.13+0,17" 5.2910.72"" 0.1810.06" 0.0710.03 "
2-AA (0.1%) 5 10.66+0.000" 9.546+0.243 " 15.90+0.39" 46.20+1.10" 2.71+0.17" 7.4510.72" 0,5010.06" 0.0210.03 "
CONTROL 5 3.880+0.345" 8.248+0.266" 14.72+0.41" 41,60+1.12" 1.12+0.1.3" 2.7110.40" 0.0410.02" 0.0110.01"
BA (0.001%) 5 3.180+0.162" 7.732+0.266" 1.3.92+0.41" .38.60+1.12" 0.8310,1.3" 2.2910.40“ 0.0310.02" 0.0210.01"
BA (0.01%) 5 4.240+0.162" 8.248+0.266" 14.78+0.41" 42.40+1.12" 0.8210.1.3" 3.3510.40" 0.0.3+0.02 " 0.0.310.01"
BA (0,1%) 5 4.380+0.117" 8.216+0.266" 14.66+0.41" 41.00+1.12“ 1.0810.1.3" 3.2210.40" 0.07+0.02" 0.0210.01"
Data arc the group mean + SEM. Within the same chemical treatment group parameter means with same letter arc not significantly difl'crcnt.
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hemaiopoienc potential, which ma\' be reexpressed in times of stress (Suber. 1989). Although measured 
parameters were within the normal hemogram r a n ^  har the rat. the elevations of these parameters to 
significance when compared with the untreated control rats suggest that ingestion of 2-AA-adulterated 
diet at the C. 1% 2-AA concentration level may produce animal stress.
Administration of DNP-aduIteraied diet to rats for 14 days had no measurable efiect on the 
aisoiute (Fig. 4.8) or relative (Fig. 4.9) w ei^ts of liver, lung, spleen, heart, kidnej'. thymus, or testes at 
the concentranons of DNP used in this studv'. Even when included at 0.1% of the diet. DNP did not 
significantly effect the weights of organs fiom treated rats when compared with organs fiom untreated 
control rats. Similarly, as shown in Fig. 4.10. dietary administration of BA had no apparent efiect on 
the organ wei^its of exposed rats regardless of the concentration, nor did ingestion of BA-adulterated 
diet afiect the relative w eights of organs when compared with untreated control rats (Fig. 4.11). In 
contrast to the lack of apparent effeds in organ wei^Ks of rats fijllowing 14 day? ingesting DNP- or BA- 
adulterated diet administration of 2-AA-adulterated diet at a 0.1% concentration of 2-AA resulted in 
significant decreases in ateoltite organ weights compared with respective untreated control animals (Fig. 
4.12). The weights of liver, spleeit heart testes, thymus, and kidneys were significantly (kpressed. 
while rat lungs were spared of the n%rotizing effects of 2-AA at the 0.1% concentration level. No 
difierences in absolute organ weights were observed in rats after ingesting 2-AA-adulterated diet at a 2- 
AA concentration of 0.01% or 0.001%. The body weights of rats administered 2-AA(0.1% and 0.01%)- 
adulterated diet were significantly low er than weights of respective untreated control rats, and this had 
significant consequences when the relative weights of the organs were examined (Fig. 4.13). While 
relative liver weights were not différent relative weights of limg, spleen, heart testes, thymus, and 
kidney were significantly increased in rats following a 14 day administration of 2-AA(0.1%)-adulterated 
diet Fiuthermore, while absolute organ weights were not difierent fiom untreated control rats when 2- 
AA was included in the diet at 0.01%. the relative weights of liver, splwn. testes, and kidney? were 
significantly elevated in these animais Microscopic examinations for treatment-related lesions were 
performed on tissues t*tained from rats maintained on an untreated
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Figure 4.8. Organ weights following DNP ingestioiL The effect of ingestion of DNP-adulterated diet on 
absolute organ weights of F-344 male rats was determined following 14 days of continuous 
administration of diet containing DNP at 0 ,0.Olg/kg, 0.1 g/kg, or 1.0 g tg  of diet. Each bar represents 
the mean + SEM of 5 rats.
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Figure 4.9. Organ weight to both’ weight ratios x 100 following dietary ingestion of DNP-adulterated 
diet. Male F-344 rats were continuously' fed diet containing DNP at 0.0.01 g/k%. 0.1 g/kg, or 1.0 g/kg 
of diet for 14 days. Each bar represents the mean + SEM of 5 rats per group. Means with the same letter 
are not significantly different Pairwise comparisons were performed using the Tukeys Studentized 
Range Test alpha = 0.05.
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Figure 4.10. O gan weights following BA ingestioii. The eSect of ingestion of BA-aduIterated diet on 
absolute organ weights of F-344 male rats was determined following 14 d ^  of continuous 
administration of diet containing BA at 0, 0.01 g/kg, 0.1 g/kg. or 1.0 g/kg of diet.
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Figure 4. II. Organ weight to both' weight ratios x ICO following dietary- ingestion of BA-adulterated 
diet Male F-344 rats were continuously fed diet containing BA at 0, 0.01 g/kg, 0.1 g/kg, or 1.0 g/kg of 
diet for 14 days. Each bar represents the mean + SEM of 5 rats per group.
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Figure 4.12. Ogan weights following 2-AA ingestkm. The effect of ingestion of 2-AA-adulterated diet 
on absolute organ weights of F-344 male rats was determined following 14 days of continuous 
administration a i diet containing 2-AA at 0, 0.01 g/kg, 0.1 g/kg, or 1.0 g/kg (k  diet Each bar represents 
the mean + SEM of 5 rats. Means with the same letter are not significantly different. Tukey’s 
Studentized Range Test al^Aa = 0.05.
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Figure 4.13. Organ weight to body weight ratios x 100 following dietary ingestion of 2-AA-adulteiated 
diet. Male F-344 rats were continuously fed diet containing 2-AA at 0, 0.01 g/kg, 0.1 g/kg, or 1.0 g/kg 
of diet for 14 days. Each bar represents the mean ± SEM of 5 rats per group. Means with the same letter 
are not significantly différent Pairwise comparisons were performed using the Tukeys Studentized 
Range Test alpha = 0.05.
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controL DNP-. BA-, or 2-AA-adulteraied diet for 14 days. In brief, histological examination of 
hematoxylin-eosin stained paraffin organ and tissue sections failed to detect lesions specific to chemical 
adulteration of the diet. Microscopic lesions observed included minimal to moderate hydropic changes 
and the formation of vacuoles in some hepatocytes. Altered foci were not detected and observed lesions 
appeared to be incidental and not related to chemical diet adulteration since <nmi1ar lesions were 
observed equally in untreated and treated rat tissues alike
DISCUSSION
The predictive value of knowing the toxicity of a compound b\" one route and predicting a 
similar toxicitv- by another route is limited Disagreement can be considerable as. for example, with 
regard to the dinitropvTenes. Sarcomas in rats at the site of subcutaneous injections, lung carcinomas 
following intratracheal instillation, and papillomas following dermal application were some of the 
reported findings following administration of dinitropyTenes at \arious sites and by various 
routes(Nesnow et al.. 1984; Takayama et al.. 1985; Ohgaki et al.. 1984). Such effects are consistent 
with the hypothesis of Nebert (1985) who proposed that the toxicity after administration of polycyclic 
aromatic hydrocarbons can be expected to occur in proximal tissues of susceptible species at sites that 
come into direct contact with the xenobiotic agent. Since the major source of human exposure to 
enviromnental contaminants on a daily weight basis is fi-om the diet not to include a measure of acute 
ingestion data in the toxicologic profile, as in this case with PAH compounds, may be inappropriate if a 
conqjlete profile of toxicity is required This stuck investigated the potential toxic effects of various 
PAH classes of compounds when administered in the diet, and was an attempt to identify the aRiropriate 
Ie\ els of dietary concentration of each test compound for a^i^lication in a chronic exposure study.
The selection of test compounds included in this stuck was intended to encompass those PAH 
compounds with relatively widespread distribution in the environment for w hich there is a likely 
potential for human exposures to occur, or which exhibit properties (chemical or toxic) representative of 
other PAH compounds. Although no attempt was made to select on the basis of annual usage in either 
the United States or the world all selected compounds were substituted derivatives of pyrene or
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anthracene parent compounds, and pyrene- and anthracene-based compounds are among the most 
prevalent of the environmentally occurring PAHs (Jacob et aL 1989).
Benz[a]anthracene is listed among the 17 PAHs considered of toxicological importance to 
human health due to its prevalence in contaminated soils and sediments. In fact, approximately 41% of 
contaminated sites contain benz[a]anthracene (Schneider, 1996). Of the processes whereby PAH 
contaminants are removed fiom the environment or in which the toxicity of the parent compound is 
enhanced, microbial degradation and metabolism play important roles. Similarly, the gut microflora in 
the gasto-intestinal tract of mammals may play an important role in the detoxification or enhanrpd 
toxicity of benz[a]anthracene. The toxicity and carcinogenicity of compounds of the alternant PAH 
class, in general, follow the "^ bay region” theory of metabolic activation (Guengerich et al.. 1983). This 
theory contends that an epoxide on a saturated, angular benzo ring that forms part of a bay region of the 
hydrocarbon is a prime candidate as an ultimate carcinogen.(Levin. 1978: Grover. 1986). Metabolic 
activation requires the enzymes cytochrome P4501A1 and epoxide hydrolase in the formation of the 
proximate and ultimate carcinogens, but these enzymes also form products which are not harmful 
through conjugation reactions with glucuronic and sulfuric acids. A large number of epoxides, 
dihydrodiols, and epoxide dihydrodiols of 1.2-benzanthracene derivatives have been analyzed for 
carcinogenicity. These results implicate that metabolic activation of 1.2-benzanthracene to the 3.4- 
dihydrodiol forms a potent bacterial mutagen with high tumorigenicity relative to 1.2-benzanthracene. 
and analyses have identified the 3.4-diol 1.2-epoxide as an ultimate carcinogen with at least 15-125 
times more mutagenic activity than other diasteromeric benzanthracene diol epoxides (Slaga et al..
1978; Levin et al.. 1978). These results are consistent with the bay-region theory. In human in vitro 
cell studies, the administration of benz[a]anthracene to human bone marrow cells resulted in the 
conversion of benz[a]anthracene to three distinct dihydrodiols. The dihydrodiol metabolites were 
identified as the 5.6-dihydrodiol. the 10.11-dihydrodiol and the 8.9-dihyTdodiol; however, metabolism 
to the 3.4-dihydrodiol 1.2-epoxide ultimate carcinogen was not demonstrated (McCord. 1996).
Oral administration of alternant PAHs. such as benz[a]anthracene. indicate that alternant PAHs 
are carcinogenic in rodents. Mice acutely administered 1.5 mg/day benz[a]anthracene by oral gavage
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for 5 weeks exhibited increased incidences of hepatomas and pulmonary adenomas (80% and 85%. 
respectively) compared with control animals incidences (10% and 30%, respectively) for hepatomas and 
pulmonary adenomas (Klein, 1963). The induction of foci of altered hepatocytes is often seen in rats 
and mice that later develop liver tumors (Mumtaz et al.. 1996). A 1-day intiagastric administration of 
180 mg/kg benz[a]anthracene to rats followed by a diet containing 2-acetyIaminofIuorene and carbon 
tetrachloride induced altered foci in partially hepatectomized and not in sham hepatectomized rats 
(Tsuda and Farber. 1980). The hepatic effects observed in these studies following oral exposure to 
PAHs. including enzymatic alterations, induction of altered foci, and increased liver weight, while 
generally not regarded as serious corrsequences ma>' precede the onset of more serious hepatic lesions 
not to exclude hepatic neoplasms. In the present study, the hepatic effects observed in other studies 
following oral exposure to PAHs. including enzymatic alterations, induction of altered foci, and 
increased liver weight were not detected in rats following the 14 days of ingestion of a BA-adulterated 
diet A low constant exposure of rats to BA was achieved by introduction of BA through the diet and 
such adrrrirristration resulted in an approximate 17 mg intake of BA a day over the 14 days for an 
approximate total intake of 246 mg of benzanthracene. The reason for the lack of response in rats in 
this stuck' is not known, but may relate to absorption, detoxification or distribution. Components in the 
diet, perhaps the fiber content or the microflora in the G.I. tract ma\ adsorb the compound and impede 
absoiptioit distribution, or activation.
Nitroarenes can be readily formed by derivatization of PAHs. which occurs under conditions of 
incomplete combustion processes, such as diesel and airplane emissions, combustion emissions fiom 
kerosene heaters and gas fuels and liquid petroleum, airborne particulates, coal fly ash, cigarette smoke, 
and focxi (Asokan P.,1985). Nitrated pyrenes are also formed fiom the reaction of PAHs with nitrogen 
oxides in the environment (Pitts et al., 1985; E)juric et al., 1988).
The metabolism of nitropyrenes is much more complicated than that of other PAHs, because 
the initial metabolism of dinitropyrene can proceed through either oxidation of the aromatic ring system 
or reduction of the nitro functional group. (Fu, 1990). Nitro reduction is involved in the metabolic 
activation of the dinitropyrenes, and unlike other routes of biotransformation, nitroreduction is not
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peifonned W the endogenous enzymes within the both but by enzymes of the intestinal microfloia 
(Scheepers- 1994). One or both of the nitro groups undergo a two-electron reduction to an am ine by- 
nitroreductase (Oma and MasotL 1989), The aminonitropvTene and diaminopyrene metabolites are 
absorbed and transported to the liver, where the formed amine group is N-hydro.xylated W cytochrome 
P450 and conjugated with acetate, although rapidly excreted glucuronides or N-sulfates may also be 
formed (Djmic et al.. 1993; Fu. 1990: Yamazoo et al.. 1994). Acetate is a good leaving group which 
renders the nitrogen highly susceptible to nucleophilic attack by proteins or DNA (Djuric et al.. 1985). 
The dinitropyrenes were shown to maintain their mutagenicity in the nitroreductase-deficient Samonella 
typhimurium strain TA98NR but showed greatly diminished activity in the acetvlase-deficient strain. 
TA98. suggesting that acétylation following nitroreduction to N-hydroxy arylamines is involved in 
mutation induction by these compounds (Orr et al.. 1985; Djuric et al.. 1985). Nitro-reduction by 
intestinal microfiora is thought to play an important role in the toxicity of several nitroaromatic 
compounds including 2.6-dinitrotoluene. which causes hepatic tumors in male rats (Dutcher et al., 1985; 
Parkinson. 1996). Other research has indicated that gut flora are not obligatory in the metabolic 
activation of dinitropyrenes. 1.6-dinitropyrene produced genotoxic metabolites in rat hepatocyte 
primary cultures without gut flora, while no DNA repair was observed in hepatocytes from rats orally- 
exposed with 50 mg/kg of 1.6-dinitropyrene (Butterworth et al.. 1983). A possible explanation for the 
inactivity- of 1.6-dinitropyrene in vivo is that it is either metabohcally detoxified or that it is not absorbed 
from the gut and delivered to the liver in amounts large enough to induce detectable DNA repair, 
suggesting that cells which come first in direct contact with this agent are more likely targets for its 
genotoxic action. This explanation may hold for the 1.3- and 1,8-dinitropyrenes as well, suggesting that 
oral exposure may present low risk of mutagenicity. In the present stuc^. inclusion of the dinitropyrenes 
in the diet administered to rats at a concentration of up to 0.1% did not produce noticeable toxic effects 
following 14 days of administration. Average daily intakes of rats exposed to DNP at this concentration 
were 15.6 grams of diet or 15.6 milligrams of DNP per day. One possible explanation for the inactivity 
of the dinitropyrenes in vivo may be that too small a dose was giveiL However, other mutagenic 
compounds, such as 2-acetylaminofiuorene which are not as active as the DNPs in in vitro studies.
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produce a strong response in vivo at equal and lower doses. The findings of this stuck suggest that, as 
with BA. components in the diet or micro flora in the intestine mav' adsorb or interfere with the uptake, 
distribution, or activation of the DNPs. In this regard, it should also be noted that the potent carcinogen. 
benzo[ajpyrene. does not produce tumors in feeding studies (lARC. 1973).
Although the carcinogenic and mutagenic properties of 2-AA are known, little information is 
available on the in vivo metabolic activation of 2-AA and its interaction with mammalian tissues 
(Mitchell. 1985). Based upon evidence that has accumulated, it appears that activation of primarv 
aromatic amines as a class typically requires oxidation of the amine group to the N-hydroxy moiety 
(Kadlubar et al.. 1977). Studies have shown that 2-AA is processed by hepatic N-oxidation via 
cytochrome CYPl A2 in mammals (Lubet et al.. 1989). In the rat the initiation step is followed by O- 
acetylation or sulfation (Yamazoe et al.. 1994). It has been hypothesized that the hydroxylamine is 
acetylated to form the ultimate carcinogen, and hepatic cytosol contains N-acetyltransferase enzymes 
which can Oacetylate (Traynor et al.. 1991). Since acylated DNA-adducts have been identified, some 
investigators have suggested that aromatic amines may sequentially undergo N-acetylation and N- 
hydroxylation followed by Oesterification (e.g. sulfotransferase). and that this pathway may best explain 
the hepatic tumor formation in rats (Martin et al.. 1982: ). Humans and other mammalian species (with 
the exception of the dog and fox which are not able to acetylate compounds) express a genetic 
polymorphism in N-acetylation capacity that segregates individuals of each species into rapid, 
intermediate, or slow acetylators (Hein. 1988). Rats in general, and the Fischer 344 inbred rat in 
particular, are often utilized to stut^ the toxicity and carcinogenicity of aromatic amines (Rao et al.. 
1990). This is because the inbred rat mimics the polymorphism in N-acetylation capacity exhibited in 
human.»; (Hein et al., 1991; Martell and Weber. 1993). The N-acetylation polymorphism is of both 
clinical and lexicological importance because rapid or slow acetylator phenotype can influence the toxic 
response fiom aromatic amines. The balance between acetylated and nonacetylated aromatic amines is. 
therefore, an important determinant in the toxicologic and carcinogenic activities of this class of 
compounds (Probst et al., 1994).
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A few studies have examined the effects of oral exposure to 2-AA. The induction of mammary 
tumors in Sprague-Dawiev- following single and multiple intragastric doses of 2-AA was examined by- 
Griswold et al. (1966. 1968). Multiple dosing was found to be no more sensitive than a single dose in 
the induction of tumors: however, repeated treatments increased the percentage of tumor-bearing 
animals and the multiplicity of the tumors. In the present study continuous administration of 2-AA at a 
concentration of 0.1% in the diet for 14 days to F-344 rats resulted in overt toxic effects. Tumors were 
not detected. However, rats failed to thrive, consumption was severely depressed, and indices of liver 
(h^fimction and injury were observed. The findings of this study indicates that a 0.1% 2-AA-aduIterated 
diet was not well tolerated by F-344 rats and were strongly suggestive of probable lethality with long­
term ingestion periods. When rats were administered a 0.01% 2-AA-adulterated diet consumption was 
lowered, but other toxic effects were curbed and rats thrived.
In summary, the predictive value of one route of exposure for another is limited The results of 
the present feeding stuck clearly indicate that the toxicity of DNP and BA is minimal when administered 
in the diet at a concentrations up to 0.1% for 14 days. Although consumption and weight gains were 
generally lower in rats administered chemically-adulterated diet at the 0.1% concentration level of DNP 
or BA, no mortality or adverse effects in general health of rats were detected Food consumption 
patterns, clinical chemistries and hematology data were within normal range values for the ra t and 
organ weights did not differ significantly from untreated control animals. Furthermore, histological 
evaluations revealed no significant lesions in organ or tissue morphology. These data demonstrate that 
F-344 rats tolerate a chemically adulterated diet when the concentration of DNP or BA is less than or 
ecpial to 0.1%. In contrast, when 2-AA was administered in the diet at the same 0.1% concentration 
level morbidity resulted At a concentration of 0.01%. however, symptoms of toxicity were less evident 
and rats thrived. Lethality was not a desired end point in this acute stuck’. Rather, a definition of 
maximum tolerated concentrations of selected compoimds by ingestion in the F-344 rat was the purpose 
of the design. It was also desired that ingestion of selected compounds might mimic the human 
condition in terms of relative amounts. The results of these studies suggest that the maximum tolerated
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dieiai} concentrations of selected compounds for aR)lication in chronic studies are 0.1% for both DNP
and BA and 0.01% for 2-AA.
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CHAPTER 5 
A DEPARTURE FROM ADDITIVITY BY A 
COMPLEX MIXTURE: SUPPRESSION OF 
ARYLAMINE ACTIVATION EN THE FISCHER-344 
RAT FOLLOWING INGESTION
INTRODUCTION
At the turn of the century, studies in humans showed that polycyclic aromatic hycirocarbons 
(PAHs) are causative factors in the development of cancer (BoylancL 1986: Lawlwy, 1994; Pitot and 
Dragan. 1996). Incomplete combustion of fossil fuels results in the formation of PAHs. and increased 
use of fossil fuels has elevated environmental PAH concentrations to which humans are exposed, 
especially near urban areas (Parkinson. 1996). Instead of being completely oxidized to carbon dioxide, 
hydrocarbon fragments are created and these can interact and form complex polycyclic structures 
(Dipple. 1983). Among the PAHs identified at one or more National Priority List (NPL) hazardous 
waste sites, anthracene- and pyrene-based PAHs are among the most abundant representatives of the 
environmentally occurring PAHs (Jacob et al. 1989). Although the significance of PAHs with regard to 
environmentally caused diseases and cancer is difficult to estimate, it is suggested that the potential 
hazard of enviromnental exposures to PAHs may be underestimated (Grimmer et al.. 1995). The class of 
anthracene- and pyrene-based PAHs. in addition to their widespread occurrence in the environmenL 
contains some of the more potent experimental chemical carcinogens known (Pitot and Dragan. 1996).
The major source of human exposure to environmental PAH contaminants on a daily weight 
basis is fiom the diet (Strickland and Groopman, 1995). This exposure pathway is consistent with a 
large pool of epidemiological data linking the incidence of human cancer (20-50%) and disease with 
dietary Actors (Blot. 1992; Statland. 1992; Lutz and Schlatter. 1992. 1993; Sugimura and Sato. 1983; 
Porter. 1993; Comstock et aL 1991; Sauer and Sipes, 1995). Other general and specific studies have 
suRxirted this view (Lutz and Schlatter, 1993; Peters et al, 1989; Tubiana, 1991). Observations in 
animals have shown that some types of cancer are related to certain carcinogens in their food, and 
several types of cancer similar to that in humans have been induced in experimental animals by
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administration of carcinogens, such as nitrosamines and mycotoxins. suggesting that their presence in 
human diets can increase cancer risk (Lijinsk>\ 1983).
Many PAHs are potent carcinogens in animal models of chemical carcinogenesis, and the 
ability of PAHs to compromise the immune system is well documented in both in vitro and in vivo 
systems (Wojdani et al.. 1984; Kaminski et al.. 1989; Smialowicz et al.. 1991; Morris et al.. 1992;
Hardin et al.. 1992). The immunosuRiressrve effects of carcinogenic PAHs such as benzo[a)pyrene and
7.12-dimethyIbenzanthracene have been extensively investigated in animal models and have shown that 
both cell-mediated and humoral immunity are suppressed by PAHs (Ward et al., 1984; Dean et al..
1986; Lubet et al.. 1984; Luster et al.. 1987; Davis et al.. 1991; Ladies et al.. 1991;Thurman et al.. 
1988;Burchiel et al.. 1987; Szczeklik et al.. 1994). PAHs are also known to have effects on cell viability 
and cell proliferation in culture (Stavenow, 1988; Burchiel. 1993). In addition, humans exposed 
chronically to atmospheric complex mixtures of pollutants, composed primarily of PAHs. were also 
shown to develop suppression of their immime system (Szczeklik et al.. 1994). Despite all these studies, 
relatively little is known about the specific mechanisms by which PAHs suppress immunity and initiate 
or promote carcinogenesis. Since many of the PAHs which are immunosuppressive are also 
carcinogenic, their effects may be manifested through common signal transduction pathways (Luster and 
RosenthaL 1993; MudzinskL 1993).
The vast majority of studies conducted on the carcinogenic, mutagenic, and immuno­
suppressive properties of PAHs have focused on single compounds (Ohgaki et al.. 1984; Asokan et al.. 
1985; Imaida et al.. 1991; Smialowicz et al.. 1991; Dutcher et al.. 1985; Takayama). These studies of 
mechanisms of the acute toxic action of individual compounds has provided valuable insights into 
potential events at the molecular level. However. PAHs are ubiquitous environmental contaminants and 
generally occur as complex mixtures (for example, as components of diesel exhaust or cigarette smoke), 
not as single compoimds (Mumtaz et aL 1996). Human PAH exposure usually involves concurrent or 
sequential contamination with small amounts of many chemicals, rather than of one or two chemicals, 
and exposure amounts may be up to several thousand micrograms per day depending on the source, 
lifestv’les, such as occupation, environmental food chain, cigarette smoking and socioeconomic status
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(Arif and Gupta. 1996). The mechanisms of the toxic action and biological consequences of human 
exposure to a PAH mixture are, therefore, largely dictated by the biological interactions of these m any 
chemicals rather than the independence of the individual components (Calabrese. 1995). Exposure to 
chemical mixtures at these environmental levels probably does not involve acute toxic responses, rather 
insidious effects disrupting the homeostasis of the organism are more likely to occur (Yang et al. 1989).
The absorption, distribution, and excretion characteristics of chemicals in mixtures may not be 
the same as those of chemicals administered singly. Possible interactions may be additive, synergistic, 
or. less commonly, inhibitory (Mumtaz et al.. 1993). Additive effects require independent mechanisms 
or that the rate-limiting step in the process not be saturated by any of the toxicants acting alone 
(Hodgson et al.. 1995). As noted previously, however, each component of a mixture has a unique toxic 
potential and mav influence the toxicitv' of other mixture components by affecting their toxicokinetics or 
toxicothmamics. Simmons et al. (1988) evaluated the hepatotoxic potential of 10 samples of complex 
mixtures in F344 rats exposed via gavage and compared the observed results to those expected based on 
chemical characterization. An additivity model was assumed; however, the observed toxicity (8 of the 
10 samples) could not be predicted readily from the chemical characterization. In fact, the most toxic 
samples displayed chemical profiles which were relatively indistinguishable from those of the other 
samples (Simmons et al.. 1988. 1989). Synergistic interactions are ones in which the effect is more than 
additiv e. The carcinogenicity associated with complex mixtures, such as cigarette smoke and diesel 
exhaust, is often synergistic—greater than that anticipated from the content of individual PAHs within 
the mixture (Nesnow et al. 1983; Robinson et al, 1987: Weyand et aL 1991). Robinson et al. (1984) 
showed that the biological responses of mouse skin to doses of coal tar and petroleum asphalt paints 
were greater than expected from their PAHs content and from mutagenic activity assays. Similarly, 
Warshawsky et al. (1993) showed that repeated application of low dose levels of benzo[a]pyrene 
produced no skin tumors in mice; however, a significant increase in tumor production (fiom 23% to 
47% in mice) resulted when benzo[alpvTene was applied in the presence of five noncarcinogenic PAHs. 
The potential of non-additive interactions on the immunosuppressive effects of PAH mixtures was 
examined in B6C3F1 mice using a mixture derived from a manu&ctured gas plant residue. The potency
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of the PAH mixture to suppress T-cell-dependent and -independent immunitv' was higher than expected 
firom the components, suggesting that there were possible synergistic interactions among the different 
classes of PAHs in the mixture (Chaloupka et al.. 1993). Subsequently, a comparison of the 
immunoto.xic responses of a reconstituted mixture derived &om a manufactured gas plant and the 
corresponding > 4-ring PAHs indicated that the latter were the primary responsible agents for the 
activity of the mixture (Harper et al., 1996). In contrast, inhibitory or antagonistic interactions result in 
a less than additive effect, and examples of this type of interaction by a complex mixture are less 
common. However, it has been reported by a number of investigators that the carcinogenicity of 
benzo[a]pyrene can be inhibited by the addition of anthracene, pyrene. ctysene. or dibenz[a.h]- 
anthracene (Finzi et al.. 1968). Kiefer et al. ( 1994) examined the in vitro interactions of 2- 
aminofluorene. 2-AA. and 1,6-dinitropyTene in Chinese hamster cells. They found that the cytotoxic 
and genotoxic effects of 2-AA were suppressed by co-administration of 2-AA and 2-aminofluorene, and 
suggested that arylamines may interfere with their own activation to the N-hydroxylated metabolites and 
compete for the same acetyltransferase enzymes, therdry suppressing the formation of their respectiv e 
ultimate genotoxic metabolite. These data suggest that the mechanisms by which pure PAHs initiate 
inununosuppression and carcinogenesis may not accurately reflect the complete process and interactions 
that occur with mixtures.
Such interactions by mixtures may result firom events at many possible loci, including 
absorption, distribution, metabolism, site of toxic action, excretion and/or repair (Hodgson et al. 1995). 
After oral uptake by mammals for example, toxicants are exposed to the gastrointestinal fluids where 
the extraction of contaminants, such as PAHs. fiom the matrix is likely to be influenced W a number of 
6 ctors (Simmons. 1995). Presumably, bile acids, fetty adds, and dietary lipids as detergents and/or 
solv ents play important facilitating roles in the release of PAHs. Other factors that influence the 
carcinogenic potential of mixtures are the content of 3-5 ring PAHs. the presence of long chain aliphatic 
compounds, certain sulphur compounds, and the inhibitory effects of saturated hydrocarbons and 
noncarcinogenic PAHs (Witschi et aL 1987; Bingham et al. 1976). Therefore, the actual bioavaliability 
of PAHs in the gut is expected to be higher than in strictly aqueous systems, but still less than that
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extractable bv- toluene (Roos et aL 1996). After being extracted by intestinal fluids. PAHs become 
bioavailable and pass through the intestinal mucosa, enter the circulation, and partition into organs and 
tissues. The lipophilicity of PAHs enables them to readily penetrate cellular membranes and remain in 
the body indefinitely, and the structural similaritv- of PAHs contributes to the similarities that exist in 
their biotransformation. Metabolism of PAHs occurs in all cells; however, the route by which PAHs 
enter the bodv may determine their &te and organ specificity. For example, Wev-and et al. (1995) 
evaluated the differences in the tumorigenic actrvitj- of benz[a]pyrene following chronic (260 days) 
ingestion or follow-ing a single intraperitoneal injection in the presence and absence of manufactured gas 
plant residue (MGP) in mice. A diet containing 16 ppm benzo[a)pyrene (11 mg total dose/mouse) did 
not produce a significant tumorigenic response in the limgs of mice: however. 20% of the mice 
developed forestomach tumors. On the other hand, a single intraperitoneal injection of benzo[alpy-rene 
(1.79 mg) resulted in 100% lung tumorigenesis and an 83% fore stomach tumor incidence. In contrast, 
ingestion of a 0.1% MGP diet (1.5g of MGP containing 4.2 mg benzo{alpy-rene) resulted in 70% of mice 
developing lung tumors, but no forestomach tumors were detected in mice fed MGP-adulterated diets. 
These data indicate that route of exposure and chemical composition (individual versus mixture) 
produces significant differences in the toxic response of mammals
Relatively little is known about the specific mechanisms by- which PAH compounds exert their 
toxic effects, and the mechanisms by which components of complex mixtures interact are only poorly- 
understood. Mechanistic studies need to be developed to assess PAHs singly- and in mixtures for their 
metabolic and immunologic toxicity, carcinogenicity, and oncogene activation in target tissues. The 
issue that needs to be assessed is whether or not low levels of oral exposure to PAHs in mixtures, which 
by- themselves may or may not produce a toxic or carcinogenic response, influence the toxic or 
carcinogenic potency of a mixture. This present study was undertaken to evaluate the efiect of oral 
ingestion of selected anthracene- and pyrene-based PAHs as individual con^x)imds and as sole 
components of a mixture for metabolic, immunologic and carcinogenic significance in the rat model.
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EXPERIMENTAL 
TEST MATERIALS 
Rationale for Selection of Compoonds
Among the 54 PAHs identified at one or more National Priority List (NPL) hazardous waste 
sites, anthracene- and pyrene-based PAHs are among the most abundant representatives of the 
environmentally occurring PAHs (Jacob et al. 1989). Although the significance of PAHs with regard to 
environmentally caused diseases and cancer in humans is difficult to estimate, it is suggested that the 
potential hazard of enviroiunental exposures to PAHs may be underestimated (Grimmer et al.. 1995).
For this stuck three compound classes of pyrene- or anthracene-substituted PAHs were selected which 
are relevant to human exposure. Among the first chemicals to be recognized as human carcinogens, the 
aromatic amines are known or suspected of causing bladder cancer in humans, and ary lamines are found 
in tobacco smoke, synthetic fuels, agricultural chemicals, and the dye industry (Cartwright 1983). As a 
representative of arylamines, 2-AA is a potent carcinogen with its most nmiqial characteristic being its 
specificity for epithelial tissues of different animal species. Although the carcinogenic and mutagenic 
properties of 2-AA are known, little information is available on in vivo metabolic interactions in 
mammals. BA is a prototype of the unsubstituted PAiHs and is a prevalent environmental contaminant.
In fact, approximately 41% of contaminated sites contain this compound. BA is considered a moderate 
to relatively weak carcinogen and is proposed to follow the "Tsay theory” of activation similar to 
benzo[a]pyrene. Of the compounds associated with diesel exhaust, the DNPs are among the most 
mutagenic compounds for Salmonella that have been identified. Diesel emissions are known to induce 
tumors in experimental animals, and epidemiological data suggest an association between exposure to 
diesel exhaust and the induction of lung and bladder cancer in humans (Takayama et al.. 1985; Heiruich 
et al.. 1986; Hemminki et al., 1994; Smith et al.. 1995). Since the nitro groups of aromatic compounds 
can be biochemically reduced to the amine derivative via nitroreductase enzymes present in gastro­
intestinal tract bacteria and are therdw interrelated through metabolism to aromatic amines a class of 
carcinogens known to cause bladder cancer in humans, the nitrated pyrenes may contribute to the 
increased incidence of bladder tumors in individuals exposed to diesel exhaust (Nesnow et al., 1984;
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Smith et al.. 1995). Because these compounds are environmental contaminants and are all mutagenic 
and/or genotoxic. these selected compounds may pose a risk to human health.
Chemicals
2-AA (98-99% purity ) was obtained from Aldrich Chemical Company . Inc. (Milwaukee. WI) 
and BA (99.0% purity) was obtained from Sigma Chemical Company (St. Louis. MO). The 1.3-, 1.6-. 
and 1.8-DNP were synthesized in the laboratory. Basically, the nitration of pyTene (Sigma. St Louis. 
MO) was carried out using the acetic anhydride-nitric acid system under controlled heat conditions. The 
nitrated pvTcne products were analyzed by HPLC and consistently yielded less than 5% 1-nitropyrene 
(%/wt) and 95% DNP as 1.3-; 1.6-; and 1.8-DNP with yields of 18%, 35%. 42%. respectively CWwt). 
The DNP used throughout this paper refers to this composite mixture of 1-nitropyTene, 1.3-, 1.6-. and 
1.8-dinitropyrens at 5%. 18%. 35%. and 42%. respectfully. Chemicals used in the formulation of the 
semi-purified rodent basal diet were purchased from ICN Biomedicals. Inc. (Costa Mesa. CA).
D IE T  P R E P A R A T IO N
A basal powdered diet ( AIN-93M) was prepared using ingredients according to the 1993 
formulation reconunendations of the American Instimte of Nutrition ( 1993). In brief dry dietary 
ingredients [purified, high nitrogen casein (ICN. Costa Mesa. CA); com starch (ICN); alphacel (ICN); 
dextrinized com starch (ICN); tert-buty lated hydroquinone (ICN); L-cysrine (ICN); AIN-93M mineral 
mix (Harlan Teklad, Madison. WI); AIN-93M vitamin mix (Harlan Teklad); choline bitartrate (Harlan 
Teklad); sucrose (L.S.U. residential food stores)] were mixed in a commercial floor model mixer, after 
which the prescribed amount of soybean oil (INC) was added and mixing continued until a 
homogeneous mixture was obtained. The basal diet was prepared in 5 kg batches once a month and 
stored at -20°C. The unadulterated basal diet served as the control diet. Adulterated diets were prepared 
by incorporation of the specified PAH test compound into the basal diet From preliminary acute studies 
it was established that the concentration of the different PAH compounds used for the present stuck were 
either non-lethal or had the potential to cause marginal lethality in chronic studies. The level of test 
compound(s) incorporated into the basal diet was the maximum tolerated level of each compound 
established in the acute stuck' (data not published), while the amount of test compound(s) incorporated
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into the diet was based on the amount of basal diet used in preparing the adulterated diet The 0.21%. 
0.1%, 0.01%. 0.0075% and 0.0050% adulterated diets contained 2.1.1.0. 0.1.0.075. and 0.050 grams, 
respectively, of test compound(s) per lOOOg of basal diet Incorporation of the test compoimd(s) into the 
basal diet was accomplished by blending on an electric bottle-roller bar assembly for 3 hours at room 
temperature. Adulterated diets were prepared for the DNP (0.1%), BA (0.1%). and 2-AA (0.01%. 
0.0075% and 0.0050%) test compoimds. In addition to the single test compound adulterated diets, an 
adulterated diet was prepared for the ternary mixture (MIX) and included the incorporation of DNP at 
0.1%. BA at 0.1%. and 2-AA at 0.01% test compoimds into the amount of basal diet for a total test 
compoimd addition of 2 .1 g per 1000 g of basal diet Adulterated diets were prepared fiesh on a weekly 
basis in kilogram batches. Kilogram batches of unadulterated basal diet were also subjected to blending 
on the bottle-roller assembly each week along with the adulterated diets. After thorough blending, the 
unadulterated and adulterated diets were packaged and stored in the dark at -20°C.
A N IM A L S
Male Fischer-344 rats (4-6 weeks of age) were obtained from the breeding colon} (Louisiana 
State University. Division of Laboratory Anim al Medicine) and were used for the course of these studies. 
This inbred rat strain was selected based on extensive use in chronic carcinogenicity studies by the 
National Cancer Institute (Rao and Boorman. 1990). Animal»; were housed in individual hanging 
stainless steel wire mesh cages in an Association for the Assessment and Accreditation of Laboratoiy 
Animal Care (AAALAC) appro\ ed &cility. Rats were housed under controlled conditions with a 12 
hour light-dark cycle and pro\ided water and diet ad libitum.
S A F E T Y  P R E C A U T IO N S  
Due to the potential risk of toxicity by repeated exposures to test compounds, all animal 
caretakers were provided with friU-&ce respirators equipped with replaceable, disposable activated- 
charcoal frlters designed to exclude organic particulate and vaporized compounds. All persoimel 
entering anim al housing were required to wear protective clothing and disposable shoe covers. All diet 
not previously consumed and disposable apparel were contained and disposed of as hazardous wastes.
All animal excreta collected in under-cage pans was disposed of daily by flushing with water directly
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into the floor drain receptacle located in the center of the animal room. The animal room was kept 
locked at all times and entry was restricted to researchers and caretakers
A N IM A L  B IO A S S A Y
This stuck consisted of three experiments and was conducted under federal guidelines for the 
use and care of laboratory animals and was aRtioved bv' the Institutional Animal Care and Use 
Committee and the Carcinogen Use Committee of Louisiana State Universit\% School of Veterinai) 
Medicine. In each e^qteriment^ animals were first rank-ordered by weight (initial weight) ; second, the 
ordered weights were divided into the number of replicates per treatment; and third, members within 
each replicate rank were randomly assigned to an experimental diet treatment group.
Five groups consisting of 20 male rats were fed a control basal diet or an adulterated diet 
containing 0.1% DNP, 0.1% BA. 0.01% 2-AA or 0.21% MDC in the first set of experiments. Weekly 
animal bock weight and daily food consumption were monitored on individual rats throughout the study. 
After 14 days and again after 30 days of continuous diet administration. 5 animals in each group were 
sacrificed by light anesthesia with CO: followed by withdrawal of blood firom the abdominal inferior 
vena cava distal to the pancreas until exsanguination. The order of sacrifice was random among all 
treatment groups. Blood firom the abdominal inferior vena cava was collected in sterile 
ethylenediaminetetraacetic acid (EOTA) containing  Vacutainer® brand tubes or Vacutainer® brand 
SST® gel and-clot activator Cubes (Becton Dickinson. Franklin Lake, NJ) and serum and plasma 
prepared for clinical chemical and hematological evaluations. Upon exsanguination, the trachea of the 
rat was carmulated in situ and the lungs, along with the attached heart and thymus, removed fiom the 
thoracic cavitv . The lungs were lavaged three times with 20 ml of warmed (37°C) calciiun and 
magnesium fiee phosphate bufifered saline (PBS), pH 7.2 (GIBCO Laboratories, Grand Island. NY) 
accompanied by gentle massage of the lungs for the emuneration of broncho-alveolar lavage (BAL) 
macrophages. Lavage fluid was collected into 50 ml centrifuge tubes and held on ice until all samples 
were completed. All organs were examined for gross lesions and subsequently representative samples of 
tissue were placed in neutral bufifered 10% formalin. The spleen was asepdcally removed, weighed. 
aRtroximately 0.1 g of distal end sectioned, the organ minus the section was re-weighed, and the organ
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placed on ice in a 15 ml centrifuge tube containing phosphate-buffeted saline (PBS) with 5% (v/v ) fetal 
bovine serum (FBS). Similarly, the liver, thymus, heart, and kidneys of rats were excised, weighed and 
sectioned. Organs minus sections were frozen by emergence in liquid nitrogen and subsequently stored 
at -80°C. The remaining  10 animals in each group were maintained on diets. After 80 days on 
continuous diet administration, these animals were sacrificed and organs and blood similarly processed.
The second set of experiments was of the same design as the first set of experiments and served 
to provide additional samples for histological and cytochemical determinations and to provide cells for 
cytokine expression evaluations. Five groups consisting of 3 male rats were fed a control basal diet or 
an adulterated diet containing 0.1% DNP. 0.1%BA. 0.01%2-AAor 0.21%MIX for 80 days in the 
second set of experiments. Weekly animal boch weight and daily food consumption were monitored on 
individual rats throughout the stuck'. After 80 days of continuous diet administration, the rats were 
lightly anesthetized with CO2 and blood was withdrawn from the abdominal inferior vena cava distal to 
the pancreas until exsanguination. Blood from the abdominal inferior vena cava was collected in sterile 
EDTA containing Vacutainer® brand tubes or Vacutainer® brand SST® gel and-clot activator tubes 
(Becton Dickinson. Franklin Lake. NX) and serum and plasma prepared for clinical chemical and 
hematological evaluations. The order of rat sacrifice was random among all treatment groups. Upon 
exsanguinatiotL the trachea of the rat was cannnlatpH in situ and the lungs, along with the attached heart 
and thymus, removed from the thoracic cavity. The lungs were lavaged three times with 20 ml of 
warmed (37°C) calcium and magnesium free phosphate buffered saline (PBS). pH 7.2 (GIBCO 
Laboratories, Grand Island, NY) accompanied by gentle massage of the lungs to obtain bronchi-alveolar 
lavage (BAL) macrophages. Lavage fluid was collected into 50 ml centrifuge tubes and held on ice until 
all samples were completed. All organs were examined for gross lesions and subsequently tissue 
sections were stored in neutral buffered 10% formalin The spleen was aseptically removed, the whole 
organ weighed, approximately 0.1 g of distal end sectioned, the organ minus the section was re­
weighed. and the organ placed on ice in a 15 ml centrifuge tube containing 10 ml phosphate-buffered 
saline (PBS) with 5% {vN) fetal bovine senun (FBS). Similarly the liver, thymus, heart and kidneys
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of rats were excised, weighed and sectioned. Organs minus sections were frozen bv* emergence in liquid 
nitrogen and subsequently stored at -80°C.
In the third set of experiments, three groups consisting of 5 rats were each fed a control basal 
diet or an adulterated diet containing 2-AA at concentrations of 0.0075% or 0.005% for 80 days.
Weekly animal bo(h weight and daily food consumption were monitored on indhidual rats throughout 
the stud) . After 80 days of continuous diet administration, animals in each group were sacrificed by 
light anesthesia with CO: followed by withdrawn! of blood from the abdominal inferior vena cava distal 
to the pancreas until exsanguinatiotL The order of sacrifice was random among the three treatment 
groups. Serum was obtained and plasma prepared for clinical chemical and hematological evaluations. 
Upon exsanguinatioiL the trachea of the rat was caimulated in situ and the lungs, along with the 
attached heart and thymus, removed from the thoracic cavity. The limgs were lavaged three times with 
20 ml of wanned (37®C) calcium and magnesimn free phosphate buffered saline (PBS). pH 7.2 (Gibco. 
Grand Island NY) accompanied by gentle massage of the lungs to (*tain broncho-alveolar lavage 
(BAL) macrophages for the evaluation of cytokine expressioiL Lavage fluid was collected into a 50 ml 
centrifuge tube (Coming. Coming, NY) and held on ice until all samples were completed All organs 
were examined for gross lesions and subsequently a section of each tissue removed was placed in neutral 
buffered 10% formalin. The spleen was aseptically removed. the whole organ weighed approximately 
0.1 g of the distal end was sectioned for fixatioiL the organ minus the section was weighed and the 
organ placed on ice in a 15 ml centrifuge tube containing phosphate-buffered saline (PBS) with 5% (vA) 
fetal bovine serum (FBS). Similarly, the liver, pancreas, thymus, heart, and kidneys of rats were 
excised weighed and sectioned
T IS S U E  P R E P A R A T IO N  F O R  H IS T O L O G Y  A N D  L IG H T  
M IC R O S C O P Y
Sections of tissues were fixed in a solution of neutral-buffered 10% formalin for 24 hours, and 
subsequently fixed sections of tissues were dehydrated through increasing concentrations of ethanol and 
embedded in paraffin. The formalin-fixed paraffin embedded tissue blocks were cut to 5 microns and 
sectioned on albumin-coated shdes. The slides were deparafbnized and hydrated through graded xylene
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
154
and alcohol, processed, and stained with hematoxylin and eosin (H&E). Sections were then cleared and 
mounted with non-aqueous covershp resin (PermounL Fisher Scientific. Cincinnati. OH). Stained tissue 
sections fiom each rat were used for morphometiic analysis.
C L IN IC A L  P A T H O L O G Y  
Serum samples were prepared b\' allowing the blood sample collected in gel clot tubes to clot at 
room temperature for 15 to 30 min The sample was centrifuge for 10 min. at 2000 g. Serum chemisti} 
profiles were obtained by automated procedures (Olympus Reply. Olympus American. Inc.. Lake 
Success. NY) and included determinations of the activities of aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT) and glucose. Hematological profiles were conducted on fiesh blood 
collected in microtainer® tubes (Becton Dickinson). The hematological parameters were measured in 
an automated instrument (Baker 9000. Baker Instruments Corp.. Allentown. PA) which determined the 
white and red blood cell counts, the packed cell volume and hemoglobin content while difierential cell 
counts were performed manually using a hemocytometer.
M A C R O P H A G E S  P R E P A R A T IO N  A N D  S T IM U L A T IO N  
BAL macrophage cells were washed once in PBS. (pH 7.2) and cell number and viability were 
assessed bv^  trypan blue (Sigma) exclusion with a hemocytometer. BAL cells as alveolar macrophages 
were determined by morphological features on nonspecific esterase stained cytocentrifuge (Cytospin2; 
Shandort Inc.. Pittsburg, PA) preparations. BAL cells were resuspended in RPMl-1640 complete media 
which contained antibiotic/antimycotic (GIBCO Life Technologies. Grand Island. NY; 100 units/ml 
penicillin and streptomycin and 0.25fig/ml fungizone): 2mM L-glutamine (GIBCO). 25mM Hepes 
(GIBCO). 2mM sodium pyruvate (GIBCO), and 10% fetal bovine serum (FBS; Sigma). An alveolar 
macrophage monolayer (2 x 10^  cells/ml RPMI-complete media) was prepared in 24 well culture plates 
(500pJ/well) and incubated for 2 hours at 37°C in a 5% CO: (vA) chamber. After the initial 2h 
incubation period, the spent media and non-adherent cells were removed fiom macrophage monolayers 
In- suction and each well was rinsed with PBS (1 ml at 4°C, pH 7.4). The plate of macrophage 
monolayers was incubated in the presence and absence of the known TNF-a inducer, lipopolysaccharide 
(LPS, Ipg/ml RPMI complete media), for an additional 4 hours at 37°C in a 5% CO: chamber.
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T U M O R  N E C R O S IS  F A C T O R -A I.P H A  BTO A SSA Y
To detenmne the effects of dietan exposure to DNP, BA. 2-AA, or the MDC on the immune 
responsiveness of rat alveolar macrophage immune responsiveness, the bioactivit>' of TNFa was 
measured in the 4-hour spent culture media of alveolar macrophages of each rat using the TNF-a- 
sensitive L929 cell line (American T\pe Culture CoUectioiL Rockville. MD) in a cjtotoxicitv' assa) 
(Hogan and VogeL 1990). Briefly. lOOul of RPMI culture medium containing 3 x 10^  trypsinized and 
actinonn cin D-treated (2ug/ml) (Sigma. St. Louis. MO) L929 cells were distributed in each well of a 96- 
well culture plate (Costar. Cambridge. MA) and incubated with 100 ul of duphcate serial dilutions of 
stimulated and unstimulated macrophages media supernatants at 37°C for 24 hours. A standard curve 
was constructed using 6 wells of the actinomycin D treated-L929 cell suspension serving as 0% cell 
death and 100% cell death represented by 6 wells of the actinomycin D treated-L929 cells lysed. 
subsequent to the 24 hour incubation period, by the addition of lOOul/well of 3 M guanidine 
hydrochloride (Sigma. St. Louis. MO). The standard curve served as a cytotoxicity curve representing 0- 
100% cell death. Media was removed &om all the wells and the cells stained with 0.1% crystal violet 
for 10 mimites. The crystal violet solution was removed by emptying and forcibly submerging the 
inverted plate 4 times into a container of running  tap water. The plate was allowed to air dry and the 
adherent crystal violet resolubilized in 100 |il 0.1% sodium dodecyi sulAte (Sigma) at room 
temperature. The absorbance at 570 run was determined using an ELISA plate reader. A dose response 
was measiued by comparing the percentage of cell death from the media samples to that of the 
cytotoxicity standard curve. One unit of TNF-a was defined as the amount of TNF-a required to lyse 
50% of cells.
SPLENOCYTE ISOLATION AND TREATMENT
A single-cell splenocyte suspension was prepared ly  teasing the spleen apart in PBS containing 
5% FBS. The spleen was first placed in a culture dish ((Zostar, Cambridge. MA) and was minced with 
the scissors action of two surgical blades followed by gentle mashing of the minced spleen pieces 
between the fiosted ends of two glass slides. Cell debris was allowed to sediment and the splenocytes 
were depleted of erythrocytes by use of a red blood cell lysis buffer (Sigma) followed by two washes in
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PBS with 5% FBS. Splenocvies were resuspended in 10 ml RPMI-1640 complete media which 
contained antibiotic/antimycotic (GIBCO: 100 units/ml penicillin and streptomycin and 0.25pg/ml 
fungizone). 2mM L-glutamine (GIBCO). 25mM Hepes (GIBCO), 2mM sodium pyruvate (GIBCO). 
50pM P-mercaptoethanoL and 10% fetal bovine serum (FBS: Sigma). Spleen cell enumeration and 
viability were assessed by trypan blue exclusion in a hemocytometer. Spleen cell numbers were divided 
by the weight of the organ minus the section (see above animal bioassay section) and multiplied by the 
whole organ weight to obtain cell number/total spleetL
L Y M P H O C Y T E  P R O L IF E R A T IO N  A S S A Y S  
The ability of dietary exposure to DNP. BA. 2-AA. or the MDC to suppress the cell mediated 
and humoral irmnime function of splenocytes in response to the T cell mitogen Concanavalin A (Sigma) 
or the B cell mitogen LPS (Sigma) was assessed by lymphocyte proliferation assays. Briefly, lOOul of 
RPMI complete media containing 1 x 10® splenocytes/ml/rat were distributed in quadruplicate to wells 
of a 96-well round-bottom culture plate (Costar. Cambridge. MA) and then incubated for 72 hours with 
lOOul of an optimiun concentration of mitogen or complete media at 37°C in a humidified 5% CO; 
chamber. The optimiun concentration for each mitogen was determined in a pilot study and was found 
to be 4|ig/ml of Concanavalin A and 5pg/ml of LPS. The cultures were pulsed with 1 pCi of 
[^thymidine (New England Nuclear. Boston. MA) per well 18 hoius prior to harvesting with a 
semiautomatic cell harvester (Tomtec. Orange. CN). The cells were harvested on glass fiber filters and 
the [^thymidine was incorporated into a liquid scintillation fluid ftaction (New England Nuclear. 
Boston. MA). Lymphocyte proliferation was determined by measuring the amount of incorporated label 
by liquid scintillation fluoroscopy.
M IX E D  L Y M P H O C Y T E  R E S P O N S E  A S S A Y  
The lymphocyte proliferative response of spleen cells to allogeneic spleen cells is widely- 
accepted as a sensitive indicator for cell mediated immune suRiression induced by chemicals. In this 
stuck the ability of DNP, BA, 2-AA. or the MIX to suppress cell mediated immunity was assessed with 
the unidirectional mixed lymphocyte response (MLR) assay . Splenocytes of male Wistar-Furth rats 
(Harlan Sprague Dawley, Indianapolis, IN) 8 weeks of age were isolated as previously mentioned The
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cells were resuspended in RPMI complete media at a concentration of 3 x 10 ceUs/ml and the immune 
responsiveness of these stimulator cells was inactivated by pretreatment with mitomycin C (Sigma: 
25(rg/ml ). Following a 20 minute incubation in the dark at 37°C. the stimulator cells were washed 
three times in FBS and the cells were resuspended at 3 x 10  ^cells/ml in RPMI complete media. The 
splenocytes of rats fed the basal and chemically adulterated diets served as responder cells. Briefly. 
lOOpi each of stimulator and responder cell suspensions were distributed in quadruplicate to wells of a 
96 well round-bottom culture plate (Costar. Cambridge. MA). Control wells consisted of 100pi of the 
responder cell suspension plus 100 pi of RPMI complete media Cultures were incubated for 96 hours at 
37°C in a humidified 5% CO; chamber. The cultures were pulsed with 1 pCi of [%]thymidine (New 
England Nuclear. Cambridge. MA) per well 18 hours prior to harv esting with a semiautomatic cell 
harvester (Tomtec. Orange. CN). The cells were harvested on glass fiber filters and the [^thym idine 
was incorporated into a liquid scintillation fluid fiaction (New England Nuclear. BostoiL MA). 
Lvmphocvte proliferation was determined by measuring the amount of incorporated label by liquid 
scintillation fluoroscopy.
A D E Œ R E N T  C E L L  D E P L E T IO N
Spleen cells were depleted of macrophages and other adherent cells by incubating them on 
FBS-coated plastic 75cm^ culture (Costar. (Cambridge. MA). The suspension of splenocytes 
obtained fiom one spleen minus cells removed for the proliferative assays (~1 x 10® cells) were placed 
on a 20% FBS coated 75 cm' culture flask and incubated ov ernight at 37°C in a humidified chamber 
with 5%C0;. Afier the overnight incubation, the nonadherent cell population was removed and washed 
once in RPMI complete media. Cell recovery varied but routinely was 60-80% of the initial cell 
number.
T  C E L L  A N D  B C E L L  E N R IC H M E N T
Non-adherent cell types were separated into enriched T- or B-cell populations by passage over 
nylon wool columns (Polysciences. Inc., Warringon. PA) as per manu&cturer's instructions. Routinely, 
2.5 + 0.1 g of bulk nylon wool was used per 20cc fringe and autoclaved prior to use. The enriched T- 
and B-cell populations were fiuther enriched by immunomagnetic bead separation using Mag-Bead
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particles (PerSeptive Diagnostics. Cambridge, MA.) directed against sur6ce markers. T-ceils were 
enriched by a 30 minute incubation at 4°C of T-cell nylon wool-enriched populations with BioMag® 
goat anti-rat IgM magnetic bead particles (5 x 10® magnetic particles/1 x 10 total cells) followed by 
magnetic removal of B-cell/bead particle complexes with a 30 minute incubation at 4°C with a 
BioMag® Separator. B-cells were further enriched by a 45 minute incubation of B-cell nylon wool- 
enriched populations with FTTC-labeled anti-rat CD3 (PharMingen. San Diego. CA) followed by 
incubation with BioMag® sheep anti-fluorescein IgG magnetic bead particles, and finally magnetic 
removal of CD3-labeled T-cell/bead complex. Monoclonal antibodies fluorescein isothiocvanate- 
conjugated (FTTC) anti-rat CD3. phycoeiythrin-conjugated (PE) anti-rat CD45RA. and the polyclonal 
anti-rat Ig were firom PharMingen (San Diego. CA). Bio-Mag magnetic bead particles (Goat anti-rat 
IgM and Sheep anti-fluorescein) were fiom Perspective Diagnostics (Cambridge. MA).
ID E N T IF IC A T IO N  O F  S P L E N IC  C E L L  T Y P E S  
To determine purity of the different enriched cell preparations, immunofluorescent cell staining 
in conjunction with flow cytometry were performed. To identify B cells, eruiched B cell preparations (1 
X 10® ) were incubated for 30 minutes with Phycoerythrin-(PE) anti-rat CD45RA (0.5pg/l x 10® cells. 
PharMingen, San Diego, CA ). T-cell populations (1 x 10® ) were similarly stained using FTTC- 
conjugated anti-rat CD3 (lpg/1 x 10® cells, PharMingen. San Diego. CA). A control dual-stained sample 
of each population was similarly processed. Optimum concentrations of the fluorescent antibodies and 
reagents were determined in preliminary assays. All antilxxh dilutions and cell washes were made in 
PBS. Cells were washed twice and resuspended in a 4% paraformaldehyde (4°C. pH 7.4) fixative 
solution. Samples were analyzed on a FACScan flow cytometer (Becton Dickinson. San Jose, CA) 
equipped with a 15nW air-cooled 488nm argon-ion laser. The green fluorescence or FTTC staining was 
collected with a 530/30 tun band pass filter and detection of the red fluorescence or PE stain emission 
was filtered through a 585/42 tun band pass filter. Data were collected on a minimum of 10^  events in 
the list mode maimer on a HP 340 computer system (Hewlett-Packard. San Jose, CA). Electronic gating  
on a dot display of cell size versus internal granularity was used to separate the lymphocytes firom other 
populations within the spleen samples.
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T CELL STIMULATION AND EL-2 BIOASSAY
T-cell-enriched cultures firom untreated and treated rats were resuspended at 2 x 10'^  cells/ml in 
RPMI complete media and distributed (1 ml/well) in each well of a 24-well culture plate (Costar. 
Cambridge. MA). The plate was incubated in the presence and absence of phorbol-12-m\Tistate-13- 
acetate (PMA; (Zalbiochem. La Jolla. CA) at a concentration of lOOng/ml of media overnight (12 hours) 
at 37^C in a humidified chamber with 5% CO .^ Following the overnight incubation period media from 
each well was centrifuged and culture supernatants were collected and assayed for ability to support 
proliferation of the IL-2-dependent CTLL-2 indicator mouse T cell line (American Type Culture 
CoUectioiL RockviUe, MD). The IL-2 secretion in supernatant spent media from treated and untreated 
rat T-cells was determined using the colorimetric assay of Tada et al. (1986). The assas' is composed of a 
tétrazolium compoimd (3-(4.5-Dimethylthiazol-2-yI)-2,5diphenyltetrazolium bromide (MTT; Sigma) 
which is bioreduced by cells into a fonnazan that is soluble in tissue culture medium This reaction is 
accomplished by dehydrogenase enzymes found in metabolically active cells. The quantity of formazan 
product formed is directly proportional to the number of Uving cells in culture. Since the CTLL-2 ceU 
line is IL-2 dependent the ability of these cells to survive is dependent on the IL-2 secreted in the 
supernatant of chemicaUy exposed rat T ceUs. Briefly. MTT was dissolved at 5mg/ml in PBS. sterilized 
by filtration and stored at 4°C in a foil-covered tube. Fifty ul of 8 x 10^  (ZTLL-2 cells/ml were added to 
each weU of a 96 weU culture plate (Costar, (Cambridge. MA) containing duplicate serial 2-fold dilutions 
(50 pi) of test samples or Rat T-stim® standard (Collaborative Biomedical Products. Bedford. MA) with 
RPMI complete media. The Rat T-stim® standard supplied 100 biological response modifier program 
units per ml with 1 unit defined as the reciprocal of the dilution required to cause 50% maximal 
stimulation of CTLL cells. The cells were cultured for 24 hours at 3 ^ 0  in a humidified chamber with 
5% CO2 and then 20 pi of MTT solution (5mg/ml) were added to each well and re-cultured an 
additional 4.5 hours. 100 pi of 10% sodium dodecyi sulfate (Sigma) in 0.0 IN  HCl were used to dissolve 
the MTT formazan crystals. The plate was re-incubated overnight, and absorbance (As» ) was 
measured by an ELISA plate reader. The IL-2 content (U/ml) was defined as the ratio of the dilutions of 
the test sample and IL-2 standard giving the 50% value.
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IMMUNOCYTOCHEMISTRY FOR THE DETECTION OF ras AND mvc 
ONCOGENE EXPRESSION
For the procedure, paraffin-blocked liver and pancreas tissue was sectioned at 5 pm and fixed 
to albumin-coated microscope slides. The technique utilized in part the Vectastain ABC procedure 
(Vector Laboratories. Burlingame. CA). Tissue sections were deparaffinized in xylene, hydrated 
through decreasing concentrations of ethyl alcohol, and rinsed in deionized water. Endogenous 
peroxidase activity was reduced fi'om the section by a 30 minute incubation in methanol with 0.3% 
hydrogen peroxide. Antigenic determinants masked by fbrmalin-fixation and paraffin-embedding were 
fineed bv' pretreatment of tissue sections with 0.1% trypsin (pH 2.3) in 50mM tris with 0.1% calcium 
chloride at room temperature for 30 minutes. Sections were incubated for 45 minutes at room 
temperature with normal blocking serum (as suR)lied in the Vectastain kit) to suppress non-specific 
binding of immunoglobuliiL The prepared tissue sections were then submitted to the following avidin 
biotin complex (ABC) treatment to localize Ras and/or Myc expression in cells for immunocytochemical 
examination (Hsu et al.. 1981). Sections were washed once in PBS and incubated for 1 hour at room 
temperature with either 2.5pg/ml of anti-ray or 1:50 dilution of anti-myc or mouse IgG which served as 
a negative control. Both antibodies were commercially available. The clone pan-rosi0 anti-ros. 
(Oncogene Research Products. Cambridge, MA) was a purified mouse monoclonal to an undetermined 
epitope of the Ras protein common to K-ras. H-ros and N-ros. Pan-ras (Ab-3) was shown to react with 
the ras p21 proteins of human, mouse and rat origin by Western blotting, immunoprécipitation, 
immunofluorescence, and immunohistochemistry. The anti-myc antibody (Santa Cruz Biotechnology. 
Santa Cruz, CA) was an affinity-purified rabbit polyclonal antiboth raised against a peptide 
corresponding to amino acids 1-262 mapping at the amino terminus of c-\fi c (N-262) of human origin 
and was shown to react with c-Myc p67 of mouse, rat and human origin by Western blotting, 
immimoprecipitation. and immunohistochemistry. The sections were incubated for 30 minutes at room 
temperature with appropriate biotinylated secondary antibody directed against the host for the primary 
antibody (as directed in the Vectastain kit). Sites of positive antibody reaction with the ras or myc 
proteins were visualized with the chromogen substrate, amino-ethyl carbazole (ABC), and counter
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staining was with Meyer’s hematoxylin. Sections were cleared and mounted with an aqueous mounting 
medium (Aquamoimt. Baxter Laboratories).
STATISTICAL ANALYSIS
The data were analyzed bv' one-way analysis of variance (ANOVA) using SAS. A repeated 
measures analysis of variance design was used in the analvses ofboth weight and consumption data.
The procedures used to test for significance among the main treatment effects was the General l.inpar 
Model (GLM). and to test for significant differences between treatment groups and the parameter the 
Tukey-Studentized multiple comparisons test was applied. The univariate and firequencv- procedures 
were employed to obtain information about the distribution of these parameters among the different 
treatment groups.
RESULTS
Cage side observations of untreated and treated rats indicated that animals readily consiuned 
the Control, DNP (0.1%). BA (0.1%), 2-AA (0.005%), or MIX (0.21%) adulterated diet throughout the 
80 days of the study. No mortahtv . no signs of overt toxicity or adverse effects in general health of 
these animals was detected during the period of diet administration. However, a gradual decline in 
general health and a 30% and 66% mortalitv-. culminating in the tenth week of study, was detected in 
rats fed 2-AA at 0.01% in the first and second set of experimental studies. Overt signs of toxicity were 
observed in animals fed 2-AA (0.0075%) adulterated diet during the third experimental stuck , but 
mortality did not result fiom consumption of this diet thin'ng the 80 day study period.
Body weight gains of rats exposed to the individual PAH compound classes or the mixture are 
shown in Fig 5.1. As shown in FigS.lA and 5.IB, there were no differences in the initial body weight 
of rats treated with DNP-(0.1%). BA-(0.1%), 2-AA-(0.01%, 0.0075%, 0.005%) or the MIX- (0.21%) 
adulterated diet when analyzed with their respective untreated control group. There were no differences 
in weight gains of rats following ingestion of DNP-, 2-AA (0.005%) or BA-adulterated diet when 
analyzed with respective untreated control groups at any time point during the 80 day stuck period. 
However, when rats that were fed 2-AA-adulterated diet (0.01% or 0.0075%) and their respective 
untreated control groups weight gain data were analyzed, a significant decrease in body weight gain was
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detected following the second week (2-AA at 0.0075%) or following the third week (2-AA at 0.01%) of 
stuck , and significant decreases in weight gain by rats fed 2-AA-adulterated diet (0.01% or 0.0075%) 
were detected at each of the following weeks for the remainder of the eleven week stuck. A significantly 
lower mean bock" weight gain was detected when rats fed the MDC-adulterated diet were compared with 
the untreated control group during the sixth week of study, and this significant decrease in body weight 
gain continued through the eleventh week.
The average daily amount of untreated or chemically-adulterated diet ingested by animals per 
week is shown in Fig 5.2. The amount of diet consumed by rats, in general, paralleled the observed 
differences in animal bock weight As expected animale %ith the highest bock weight gains, consumed 
more diet than chd the animale with lower weight gaine Beginning at week two and continuing 
throughout the stuck, a significantly lower amount of intake was detected for rats fed 2-AA (0.01%) 
adulterated diet when compared with the untreated control group (Fig 5.2. A). The average ingested 
amount in the second week of stuck- was 12.06 g per day for 2-AA rats and 15.16 g per day for untreated 
rats. Daily intake amounts were consistently lower for 2-AA treated rats when compared with untreated 
control and other groups of treated animals, reaching the lowest dietary intake level (9.04g/day) at ten 
weeks. Lower dietary intake amounts were observed for rats fed the MDC-adulterated diet when 
compared with untreated control rats; however significance was only reached at week eleven of the 
study, 12.37g for the MDC group compared with 15.20 g for untreated controls. Lower dietary intake 
amounts were also observed for rats fed 2-AA(.0075%) beginning at week three of the study (Fig 5.2B); 
however, significant differences were cktected for weeks seven and eight only. No differences in dietary 
intake amounts were detected for rats fed DNP(0.1%), BA(0.1%), or 2-AA(0.005%) adulterated diets 
when compared with their respective imtreated œntrol groups at any time point during the study. 
Fiuthermore, when relative intake (intake/ kg bock- weight) was examined (Fig 5.3) no differences were 
detected at any week regardless of diet treatment throughout the course of this stuck . Although animaU 
ingesting 2-AA(0.01%) for 80 days showed significantly reduced intake levels, these values correlated
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Figure 5. l.A, Effea of PAH mgestion on animal bocfy weight Male F-344 rats were maintained on a 
Control 2-AA (0.01%). BA (0.1%), DNP (0.1%). or MDC (0.21%) adulterated diet for 80 days. Data 
represent the weekly average borfy weight of 10 animals for each treatment group.
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Figure 5.1.B. Eflfea of 2-AA ingestion at 0.005% and 0.0075% of diet on animal boch'weight Male F- 
344 rats were maintained on an untreated control, 2-AA (0.0075%). or 2-AA (0.005%) adulterated diet 
for 80 dav'S. Data represent the weekly average body weight of 10 animals for each treatment group.
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Figure 5.2A. The effect of PAH ingestion on dietai>’ intake. Male F-344 rats were maintained on a 
Control. 2-AA (0.01%), BA (0.1%). DNP (0.1%), or MIX (0.21%) adulterated diet for 80 days. Daily 
dietary intake records were maintained on individual rats. Data represent the weekly averaged daily diet 
intake of 10 animaR for each treatment groiq).
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Figure 5.2.B. The effect of 2-AA ingestioti at 0.005% and 0.0075% of diet on amount of diet consumed 
Male F-344 rats were maintained on an untreated control. 2-AA (0.0075%), or 2-AA (0.005%) 
adulterated diet for 80 days. Daily dietary intake records were maintained on individual rats. Data 
represent the weekly averaged daily diet intake of 10 animals for each treatment group.
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Figure 5.3. Relative intake [(intake/kg body wt) x 1000] of F-344 rats at each of the 11 weeks of dietary 
exposure to untreated control, DNP(0.1%), BA(0.1%), 2-AA(0.01%), or MIX(0.21%). Each bar 
represents the mean ± SEM of ten rats.
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with their equally significant reductions in weight gain thereby* negating the effects when relative intake 
was calculated.
The effects of ingestion of PAH adulterated diet on clinical hematology parameters is shown in 
Table 5.1. Although differences were detected in the packed cells volume (PCV) data, the results in 
general, indicate a lack of any consistent alterations in blood cell volume, blood, cell counL or 
differential cell count by ingestion of 2-AA-. DNP-. BA-, or MDC-adulterated diet Furthermore, 
detected values of each of the different clinical parameters examined did not appear to vary by duration 
of adulterated diet ingestion. Compared with a compilation of published hemograms for the rat. all 
clinical parameters were within the published normal ranges for rats. Written comments of visual 
examination of blood plasma which accompanied the automated hematology evaluations indicated 
normal plasma color for the majority of untreated and treated rats: however, the plasma of many of the 
2-AA (0.01%) rats (5 of 7) were described as opaque or lipemic which were suggestive of possible 
metabolic or hepatic abnormalities.
Several immune fimction tests were examined in rats fed untreated DNP-(0.1%), 2-AA- 
(0.01%). BA-(0.1%), or MDC-(0.21%) adulterated diet Determinations of lymphoid organ weights 
demonstrated a significant loss in spleen absolute weight (Fig. 5.4. A) and an increase in relative weight 
(Fig.5.4.B) due to ingestion of 2-AA-<0.01%) adulterated diet for 80 days. Ingestion of 2-AA-(0.01%) 
adulterated diet for 14-and 80-days or the MDC (0.021%) adulterated diet for 80-days resulted in a 
significant decrease in thymus absolute weight (Fig. 5.5.A.); however these differences disappeared 
when relative organ weight was considered (Fig. 5.5.B). Exposure of rats for 80 days to DNP (0.1%),
BA (0.1%), or for 30-days to 2-AA (0.01%) adulterated diet had no aRiarent effect on spleen or thymus 
absolute or relative organ weight when compared with untreated control rats. Enumeration of splenic 
lymphocytes, shown in Fig. 5.6. correlated well with the observed spleen weight determinations and 
demonstrated that ingestion of 2-AA (0.01%) adulterated diet for 80 days significantly decreased the 
number of spleen cells obtained fi’om treated rats. Exposure of rats by ingestion to DNP (0.1%). BA 
(0.1%), or the MDC (0.21%) adulterated diet for 80 days or to 2-AA (0.01%) for less than 80 days did 
not alter the number of cells
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Table 5.1 The cflcct of ingestion 
TREATMENT(n) TIMEPT.
of untreated and PAH-adulteratcd diet on rat clinical hcinatolog}'. 
WBC (10Y RBC (itf) HGB (g/dl) PCV............ SEGS(Abs)-' LYMPH(Abs) MONO(Abs) EOS(Abs)
CONTROL (5) 14-DAY 9.040+1.145" 8.596+0.291" 16.08+0.38" 49.4011.57" 1.2610.20" 7.1210.93" 0.5210.11" 0.2310.02"
2-AA (5) 14-DAY 8.400+1.281" 9.192+0.325" 16.78+0.43" 51.0011.74" 1.2810.22" 6.9511.04" 0.1510.13 ” 0.1010.04"
DNP (5) 14-DAY 8.340+1.145" 8.288+0.291" 15.52+0.38" 46.4011.57" 0.8210.20" 4.2210.9.3“ 0.2410.11" 0.1010.03"
BA (5) 14-DAY 7.560+1.145" 8.738+0.291" 16.12+0.38" 49.2011 57" 0.9610.20" 6.3210.93" 0.2610.11" 0.1010.04"
MIX (5) 14-DAY 8.375+1.128" 8.932+0.325“ 16.50+0.43" 50.2511.74" 1.5510.22" 6.2211.04" 0.5510.12" 0.1010.03"
CONTROL (5) 30-DAY 8.680+0.935" 9.280+0.168" 16.32+0.29" 49.40+0.57" 1.92+0.19" 6.3810,77" 0.2810.12" 0.1310.03"
2-AA (5) 30-DAY 8.680+0.935" 9.284+0.168" 16.08+0.29" 50.6010.57" 2.0010.19" 6.1210.77" 0.48+0.12" 0.1310.0.3"
DNP (5) 30-DAY 9.400±0.935" 9.060+0.168" 16.2410.29" 49.0010.57" 1.4810.19“ 7.3410.77" 0.4810.12" 0.1810.0.3"
BA (5) 30-DAY 9.020+0.935 " 9.256+0.168" 15.9810.29" 48.8010.57" 1.5810.19" 6.88+0.77" 0.5010.12" 0 1010.04"
MIX (5) 30-DAY 9.480+0.935" 9.456+0.168" 16.3610.29" 49.4010.57" 1.8410.19" 7.2210.77" 0.3410.12" 0.1010.03"
CONTROL (10) 80-DAY 8.630+0.699" 9.407+0.154" 16.1210.19" 49.2010.50" 1.3810.10" 6.6210.59" 0.5110.08“ 0.1810.04"
2-AA (7) 80-DAY 6.10()H).837“ 9.41.3+0.184“ 15.3310.23" 46.4310.60'■ 1.0310.12" 4.7810.71" 0.3610.09" 0.1510.04“
DNP (9) 80-DAY 7.000+0.738“ 8.93010.162" 15.5710.20" 47.4410.53"'’ 1.2010.11" 5.3.310.62" 0.4110.08" 0.1810.04"
BA (10) 80-DAY 8.290+0.699" 9.488+0.154" 15.7510.19" 48.1010.50"'’ 1.3910.10" 6.4810.59" 0.3710.08" 0.1310.0.3"
MIX (9) 80-DAY 7.200+0.7.38" 9 551+0 162" 15.5810.20“ 47.7810.53"'’ 1.1910.11" 5.5510.62" 0.3910.08" 0.1010.04"
Data arc the group mean +SEM At tlic same time point and parameter, group means with same letter are not significantly different
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CONTROL
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Figure 5.4.A. Spleen weight following mgestion of PAHs or a mixture. Values represent the group 
mean + SD of 5 rats per group for the 14- and 30-d^ time points or 10 rats per group for the 80-da>’ 
time point except for the 2-AA group 80-da>' time point which represents the mean of 7 rats. Means 
with the same  letter are not significantly different at the specified time point (Alpha = 0.05).
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Figure 5.4.B. Spleen to bo<fy weight ratios x 100 following dietai) ingestion of individual PAHs or a 
mixture in F-344 rats. Each bar value represents the group mean ± SD of 5 animale per group for the 
14- and 30-day time points or 10 rats per group for the 80-day time point, except for the 2-AA group 80- 
day time point which represents the mean of 7 rats. Means with same letter are not significantly 
difierent at the spedfied time point. ( Alpha = 0.05).
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Figure 5.5. A. The effect of mgestion of different PAHs or a mixture on thvmxis weight of rats. Values 
represent the group mean + SD of 5 rats per group (13- and 30-day) or 10 rats per group (80-day), 
except for the 2-AA group 80-day time point which represents the mean of 7 rats. Means with same 
letter are not significantly different at the specified time point ( Alpha = 0.05).
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Figure 5.5.B. Rat thymus weight to bo<fy weight ratios x 100 following ingestion of PAH compounds or 
a mixture. Each bar value represents the group mean + SD of 5 animalf; per group for the 13- and 30- 
day time points or 10 rats per group for the 80-day time point except for the 2-AA group 80-day time 
point which represents the mean of 7 rats.
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Figure 5.6. The effea of mgestion of PAH compounds or a mixture on number of splenocytes in rats. 
Each bar value represents the group mean + SD of 5 rats per group (13- and 30-day) or 10 rats per group 
(80-da} ), except for 2-AA (80-day) time point which represents the mean of 7 rats. Means with the same 
letter are not significantly different at the spedfied time point. ( Alpha = 0.05).
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obtained firom the spleen of rats when compared with the number of cells obtained fiom untreated 
control rat spleens.
As shown in Fig. 5.7., ingestion of PAH chemicalh adulterated diet by rats for 14 or 30-days 
did not alter macrophage/monocyte levels in the broncho-alveolar lavage fluid when compared with 
imtreated control rats at the same time point. On the other hand, ingestion of P.AH-adulterated diet by- 
rats for 80-days reduced the macropbage/monocyie levels obtained fiom lavage fluid irrespective of 
treatment Significant reduction in the macrophage/monocyte levels were delected in lavage fluid of rats 
fed DNP (0.1%), 2-AA (0.01%) and the MDC (0.21%) adulterated diet, but macrophages/monocytes 
levels, although reduced, in lavage fluid of rats fed BA (0.1%) did not attain significance. As an 
approach to define alterations in the signaling mechanism and/or fimction of macrophage which may be 
induced by PAH ingestion, tumor necrosis factor-a secretion was evaluated in macrophages of rats 
assigned to the second and third experimental studies. [A 66% mortality was observed in rats fed 2- 
AA(0.01%) adulterated diets in the second experimenL which resulted in the survival of only one rat. 
Therefore, results of the data for 2-AA(0.01%) reflect that obtained fiem one animal.] When 4 hour 
culture media supernatants of LPS-stimulated and unstimulated macrophages were harvested and 
assayed for TNF-a activity (Fig 5.8A). no differences in LPS-stimulated TNF-a activity le\els were 
detected in macrophages culture media fiom rats fed PAH adulterated diet for 80 days regardless of 
compound(s) or dose when compared with respective untreated control rats. As shown in Fig 5.8B. 
however, a dose-dependent relationship was detected in the activity levels of TNF-a in unstimulated 
macrophages culture media supernatants obtained fiom rats fed 2-AA Furthermore, although a wide 
variation was detected in TNF-a levels fiom rats fed 2-AA(0.0075%) adulterated dieL higher levels of 
TNF-a were detected in macrophages culture media of animal»; whose health was overtly compromised 
at the time of termination, e.g rats in the lowest range of both weight Elevated levels of TNF-a were 
not detected in unstimulated macrophages culture media supernatants of rats fed DNP. BA or the MDC 
when compared with untreated control rats.
Spleen cell proliferative responses following in vivo exposure to individual PAHs or a PAH 
mixture were determined to the B-cell mitogen LPS and to the T-cell mitogen Con A. while cell-
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
176
I2E+07
1.0E4C7
8.0E+06 T
Macrophage 
Cell Count 6.0E+06
4.0E-+O6
10E-+O6 T
O.OE-tOO
CONTROL DNP 2AA BA M K
114-DAY m 30-DAY B 80-DAY i
Figure 5.7. The number of rat alveolar macrophages obtained by lung lavage following ingestion of 
Control, DNP (0.1%), BA (0.1%), 2-AA (0.01%), or M K  (0.21%) adulterated diets. Each bar value 
represents the group mean + SD of 5 rats per group (13- and 30-day) or 10 rats per group (80-day), 
except for 2-AA (80-day) time point which represents the mean of 7 rats. Means with the same letter 
are not significantly different at the specified time point ( Alpha = 0.05).
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Figure 5.8.A. Tumor necrosis &ctor-a in stimulated alveolar macrophages 4 hour culture media 
supernatants. Data are the mean +SD of n=5. 4, 4, 3, L 3. and 3 for 2-AA(0.005%), 2-AA(0.0075%), 
Control(75&50), ControL 2-AA(0.01%), DNP, BA, and MIX, respectively. ( Alpha = 0.05).
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Figure 5.8.B. Tumor necrosis feaor-a in unstimulated alveolar macrophages 4 hour culture media. 
Data are the mean +SD of n=5.4. 4, 3, I, 3, and 3 for 2-AA(0.005%), 2-AA(0.0075%), 
Control(75&50), Control, 2-AA(0.01%), DNP, BA. and MDC, respectively. Means with the same 
letter are not significantly difierent ( Alpha = 0.05).
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mediated immunity was evaluated following in vivo exposure to individual PAHs or a PAH mixture by 
the mixed lymphocyte reaction (MLR). Mitogenesis to LPS was significantly suR)ressed in splenocytes 
firom rats fed 2-AA(0.01%) adulterated diets for 30 days. As shown in Table 5.2. mean counts per 
minute (cpm) for untreated rats were 1822.3 cpm while that for 2-AA(0.01%) treated rats was 90.8 cpm. 
When the data was expressed as a stimulation index (SI) . which is the ratio of the mean cpm of 
experimental cultures to the mean cpm of control cultures, significant dififerences remained. However, 
these suppressed responses appear to be somewhat anomalous since there were no indications of an 
association between the duration of 2-AA ingestion and these changes. Furthermore, there were no 
effects of 2-AA ingestion on the lymphoproliferative response to the T cell mitogen. ConA or on the 
MLR response to allogeneic cells at this same time period nor at 14- or 80-day time periods.
Mitogenesis to ConA or LPS in rat splenocytes was not .significantly affected by ingestion of DNP 
(0.1%). BA (0.1%) or the MIX (0.21%) adulterated diet for 14-. 30- or 80 days. Results of the MLR 
evaluations indicated suppressed effects by ingestion of DNP (0.1%). BA (0.1%) or MIX (0.21%) 
adulterated diet for the 30-day time period. However, these effects were nullified when the stimulation 
index values were determined. The MLR was not suppressed by any treatment at the 14- or 80-day time 
point nor were there differences detected in SI determinations.
Determination of the lymphokine. IL-2. secreted in 12-hour culture media supernatants by 
spleen T cell eruiched populations was used to test cell-mediated immune function. Flow cytometric 
identification of stained enriched T cell populations consistently yielded values of 85-90% purity. As 
shown in Fig. 5.9. there was no discernible differences detected by comparing untreated control animals 
and rats fed DNP. BA 2-AA (0.0075%. 0.005%) or the MIX adulterated diet on PMA-stimulated 
production of IL-2. Athough CTLL-2 proliferation was much less when exposed to 2-AA (0.0075%) 
treated rat-generated supernatants (suggesting smaller amounts of IL-2 produced in the media), wide 
intra-group variations and low number of replicates reduced the chance of detecting significance. For 
example, the units of IL-2 determined in 12-hour supernatants of 2-AA (0.0075%)-treated rats ranged 
from a low of -40.5 units/ml to a high o f+1.1 units/ml. Similar to the TNFa and
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Table 5.2. Lymphocyte proliferation in response to mitogens and allogeneic cells following ingestion o f untreated and PAH-adulterated diet.
TREATMENT (n) TIME PT. ConA (4pg/ml) LPS (5pg/ml) MLR SI (ConA) SI(LPS) SI (MLR)
C0NTR0L(5) 14-DAY 42025+8035" 4962+765" 16301+2736“'' 52.98+16.42" 7.58+1,35“ 19.26+8,87“
2-AA(5) 14-DAY 52224+8035" 3859+165" 8828+2736 '' 88.72+16.42" 7.66+1,35" 27.92+8,87"
DNP(4) 14-DAY 39734+8984" 4702+855" 18679+3059"'’ 81.52+18.36" 10.57+1.51" 26.53+9.16"
BA(5) 14-DAY 63111+8035“ 4930+765" 20920+2736“ 89.48+16,42“ 7,52+1,35" 28.60+8,87“
M1X(5) 14-DAY 55428+8035" 4583+765" 14838+2736"'’ 83.28+16.42" 8,46+1.35" 22.80+8,87"
C0NTR0L(4) 30-DAY 16875+3791 1822+118" 4923+332" 40.05+6.67" 5,55+0,80“ 10.47+1.49“'’
2-AA(4) 30-DAY 8507+3791 '■ 91 + 118'’ 3660+332“'’ 54.90+6.67“ 1,58+0.80'’ 13,35+1.49"
DNP(5) 30-DAY 22305+3391 1648+105“ 2174+296" 50.98+5.96“ 4.76+0,72“'’ 6.32+1,33'’
BA(4) 30-DAY 26633+3791“ 1825+118" 2774+332'’" 57.67+6,67" 6.27+0,80" 6.58+1.49'’
M1X(5) 30-DAY 27877+3391 “ 2039+105“ 2909+296'’" 40.86+5.96" 4,06+0,72“'’ 6.60+1,33''
CONTROL! 10) 80-DAY 26521+2444" 2512+324“'" 6845+1099" 45.57+15.26“ 4.23+0.50“ 13.14+4,12“'’
2-AA(7) 80-DAY 25535+2921" 1453+388" 7248+1099" 85,38+18,24" 4,46+0,59“ .30,14+4,93"
DNP(9) 80-DAY 29984+2576" .3041+342 *'■ 6487+1158“ 36,01 + 16,08“ 4,07+0,52" 7,06+4.35'’
BA(IO) 80-DAY 33214+2444" 3690+324" 7254+1099" 32.90+15,26“ 4.57+0,50" 8.7.3+4.12'’
MIX 10) 80-DAY 28322+2444" 2266+324'" 6330+1099“ 41,22+15.26“ 4.22+0,50“ 8,71+4,12'’
Data represent group mean cpm +SEM . At the same time point and parameter, group means with same letter are not significantly dilTerent.
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Figure 3.9. IL-2 bioacthity in spleen T-cell-eniiched cultures &om untreated and treated rats. Cells 
were resuspended at 2 x 10  ^cells/ml and incubated in the presence phorbol- 12-myristate- 13-acetate 
(PMA; lOOng/ml) for 12 hours. Bars represent the mean EL-2 bioactivity + SEM of 4untreated controL 
or 3 DNP-. 3 2-AA(0.0075%)-, 2 2-.AA(0.005%)-, 2 BA-, or 2 MDC-exposed rats.
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lymphoCTte assa> s determinations, animals displaying ov ert signs of morbidity were determined to hav e 
the lower values of IL-2 within the group, while animals observed to be less affected by dietary ingestion 
of 2-AA had values of IL-2 closer to the range of EL-2 values detected in untreated animals. In general, 
untreated control rats produced a greater amount of EL-2 in response to PMA than did treated animale- 
however differences were not significant
In contrast to the lack of any consistent alterations in immune parameters following 80 days of 
ingestion of DNP-. 2-AA-. BA-. or MIX- adulterated diet by rats, temporal and dose dependent 
hepatotoxicity was observed in rats exposed to 2-AA and these effects were absent or substantially- 
reduced in rats exposed to the MDC As shown in Figure 5.10. a significant increase in absolute liver 
weight (A) and relative liver weight (B) was observed in rats fed 2-AA (0.01%) adulterated diet for 80 
days. An increase in relative liver weight was also observed for rats fed the MDC-adulterated diet when 
compared with untreated controls: however, the mean value for the MEX was significantly lower than 
the mean value for 2-AA at 80-days of treatment. Ingestion of either DNP- or BA-adulterated diet for 
80 days had no apparent effea on rat absolute or relative liver weight When rats ingested 2-AA- 
adulterated diet for 80 days at two lower inaements of incorporation [2-AA (0.005%) and 2-AA 
(0.0075%)], the rats fed 2-AA (0.005%)-adulterated d ia  showed no difference in absolute or relative 
liver weight when compared with untreated control rats (Fig. 5.II). However, while the rats fed 2-AA 
(0.0075%) showed no difference in absolute liver weight a significant difference was observed in 
relative liver weight.
Amino-transferases are widely distributed in body tissues: however, the greatest concentrations 
of aspartate aminotransferase (AST) are found in the heart liver, and kidneys, while the highest levels 
of alanine aminotransferase (ALT) are found in fiver and kidneys. Tissue destruction leads to the 
release of these intracellular enzymes into the circulating blood. While elevated AST levels are 
observed in various pathological conditions, such as myocardial inârction. elevated lev els of ALT are 
reasonably specific indicators of fiver disease. Biochemical determinations of these fiver-related serum 
enzymes were used to evaluate the involvement of the fiver in PAH toxicity in rats fed DNP, 2-AA, BA 
or the MDC adulterated diets for 80 days. As shown in Figures 5.12. serum levels of AST (A) and
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Figure 5.10.A. Rat liver weight following PAH ingestion. Each bar value represents the group mean + 
SD of S animals per group for the 13- and 30-da\' time points or 10 rats per group for the 80-day time 
point except for the 2-AA group 80-day time point which represents the mean of 7 rats. Means with the 
same letter are not significantly different at the specified time point ( Alpha = 0.05).
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Figure 5.10B. Relative liver weight (liver weight/bo<fy weight ratios x 100) in rats following PAH 
ingestioiL Each bar value represents the group mean + SD of 5 animals per group for the 13- and 30-day 
time points or 10 rats per group for the 80-day time point, except for the 2-AA group 80-day time point 
which represents the mean of 7 rats. Means with the same letter are not significantly difierent at the 
specified time point ( Alpha = 0.05).
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5.11. Liver organ weight and ratios of liver to Ixxfy weight percents of rats following 80 days of 
untreated or 2-AA (0.005% and 0.0075%) adulterated diets. Each bar represents the mean + SEM of 5 
rats for 2-AA (0.005%) or 4 rats for untreated and 2-AA(0.0075%). Means with the same letter are not 
different, (alpha = 0.05).
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Figure 5.12. A  Levels of AST in senun of rats.. Each bar value represents the group mean + SD of 5 
animale per group for the 13- and 30-d^ time points or 10 rats per grotq) for the 80-da>’ time point, 
except for the 2-AA group 80-dav time point which represents the mean of 7 rats. Means with the same 
letter are not significantly different at the specified time point. ( Apha = 0.05).
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Figure 5.12.B. Levels of ALT in the serum of male F-344rats following 14-, 30- or 80-days of ingesting 
ControL DNP- (0.1%), BA- (0.1%), 2-AA- (0.01%), or MIX- (0.21%) adulterated diet Rat liver weight 
following PAH ingestion. Each bar value represents the group mean + SD of 5 animals per group for 
the 13- and 30-day time points or 10 rats per group for the 80-day time point except for the 2-AA group 
80-day time point which represents the mean of 7 rats. Means with the same letter are not significantly 
different at the specified time point ( Alpha = 0.05).
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ALT (B) were assied  in rats fed DNP-. 2-AA (0.01%), BA-. or MDC-adulterated diet for the 14-, 30-, 
and 80-da}lime periods and compared to values of the same time point detected in untreated control 
animals. The mean AST levels were significantly elevated by ingestion of 2-AA-adulterated diet W rats 
at both the 14- and 80-day sub-samples. The mean levels of AST were higher (122.6 U/L) at the 14 day 
time point than the mean level (105.571U/L) at 80 days: however, the values are both significantly 
(fifferent than their respective untreated controls. There were no differences in mean AST levels of rats 
ingesting DNP-. BA-. or the MDC-adulterated diet when compared with untreated control rats at any 
sub-sampling time point. A similar trend was observed when serum levels of ALT were compared.
The mean level of ALT was significantly elevated in serum of rats fed 2-AA(0.01%) adulterated diet at 
both the 14- and 80-day sub-sample time points, and no differences were found at the 30 day time point 
ALT levels in rats fed 2-AA(0.01%) at 14-. 30-. and 80-day time points were 104.0. 99.6. and 129.3. 
respectively; while levels of respective untreated control rats were 40.8, 56.6. and 50.2 for the same 
three time points, respectively. When 2-AA was incorporated into adulterated diet at 0.005% and 
0.0075% and fed to rats for 80 days, a dose response was detected in serum levels of AST and ALT. As 
shown in Fig. 5.13, compared with untreated control rats serum levels of AST were higher but not 
significant in serum of rats fed a diet in which 2-AA was incorporated at 0.005%. However, when 2-AA 
was incorporated into diet at 0.0075% significantly elevated levels of AST and ALT were detected in 
rats fed this diet for 80 days.
Morphological examination of rat tissues provided some insight into the extent of 2-AA 
toxicity. No obvious tumors were observed in untreated animals or in animals constantly maintained on 
a PAH-adulterated diet. However, the liver fi-om rats fed 2-AA for 80 days were not normal. Visibly 
evident and numerous nodules were observed on the parietal and visceral sur&ces of livers fium 2-AA 
exposed animals. As shown in Fig 5.14. hematoxylin and eosin (H & E) stained liver tissue sections of 
rats fed the untreated or a PAH-adulterated diet were examined for pathology. Histological examination 
revealed a marked treatment and temporal response in hepatotoxicity by ingestion of 2-AA (0.01%)- 
adulterated diet and an attenuation of these effects by the MDC In an untreated control liver lobule (A)
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Figure 5.13. Serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in 
rats following 80-days of ingesting untreated or 2-AA-adulterated diet at 0.005% or 0.0075% of diet 
Each bar represents the mean ± SEM of 5 rats for 2-AA( 0.005%) or 4 rats for untreated and 2- 
AA(0.0075%). Means with the same letter are not different (alpha = 0.05).
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hepatocvtes appear homogeneous and are arranged in radiating plates about the central vein. Bv 
contrast, in the development of liver toxicity, new altered cell populations often appear, and these new 
hepatocvie populations function as sites of origin for yet another altered hepatocyte population.
Following 14 days of ingestion, evidence of altered hepatocyte populations were observed in liver 
sections from 2-AA(0.01%) exposed rats (B). The liver sections of 14-day 2-AA(0.01%)-exposed rats 
also revealed hydropic changes in hepatocvtes. as evidenced by clear cell foci and the presence of 
vacuoles due to lipid accumulatioiL These lesions are characteristic of foci of cellular alteratioiL 
Following 30 days of ingesting 2-.AA(0.01%) adulterated diet areas of hyperplasia or an increase in 
hepatocyte size and distortion of the hepatic lobular architecture, characteristic of focal hepatocellular 
hyperplasia, was observed in liver sections of 2-AA-exposed rats (C). These lesions progressed to 
hepatocellular hyperplastic nodules which were observed in liver sections of rats (D) that consumed 2- 
AA(0.01%) for 80 days. These nodules were well demarcated Iw compression of the adjacent tissue 
surrounding the nodules and altered staining properties. There was a loss of the normal lobular 
architecture, and nodules within nodules were observed. On the other hand, following 80 days of 
ingestion of the MDC-adulterated diet, which contained 2-AA at the same dietary level as the 2- 
AA(0.0 l%)-adulterated diet, liver sections of rats showed a small number of altered foci of clear cells or 
cytoplasmic vacuoles (E). These alterations were of equivalent severity as the lesions described in rat 
liver following the 14 days of ingestion of 2-AA(0.01%)-adulterated diet. Hepatic lesions were not 
observed in H & E stained liver sections of animals exposed to DNP or BA or from liver sections of 
control animals. The progression of liver lesions to hyperplastic nodular formation was examined in H 
& E stained liver sections of rats that consumed 2-AA for 80 days at the 0.005% and 0.0075% dietary 
levels. As shown in Fig. 5.15, ingestion of 2-AA-adulterated diet also showed a dose response in 
exposed rats. As in other indices of liver toxicity, e.g. organ weight and serum enzyme levels, no 
hepatocyte alterations were (^served in the liver of rats that ingested 2-AA(0.005%) adulterated diet for 
80 days (A). However, hepatic hyperplastic nodules with compression around the circumference of the 
nodules were observed in the liver of rats that consiuned 2-AA(0.0075%) adulterated diet for 80 days
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Figure 5.14. H & E sections of liver from untreated and PAH treated rats. A. A liver section from a 
control rat fed basal diet for 80 daysfmagnification x 200). B. Foci of altered hepatocytes and hydropic 
changes resulting in the accumulation of fat is shown in an H & E section of a liver from a rat following 
ingestion of 2-AA(0.01%) for 14 days ( 200 x). C. Areas of hepatocellular hyperplasia (magnification 
200 x) in a liver section of a male rat following ingestion of 2-AA(0.01%) for 30 days (200 x).
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Figure 5.14. D. Hyperplastic nodular formations are evident in this H & E section of liver from a rat 
following 80 days of ingestion of 2-AA(0.01%) (Magnification 200 x). E. Altered and clear cell foci 
are shown in an H & E liver section of a rat following 80 days of ingestion of a mixture of PAH 
compounds consisting of [DNP(0.1%), BA(0.1%), 2-AA(0.01%)]. Magnification 400 x.
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Figure 5.15. Dose effects of 2-AA ingestion on rat liver to.xicitv'. A. H & E section of liver from a rat 
following ingestion of 2-AA(0.005%) for 80 days, magnification 200 x. B. Hepatic hyperplastic nodule 
formation in a liver H & E section from a rat following 80 days ingestion of 2-AA(0.0075%). (200 .x).
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(6). The degree of nodular formation was morphologically and histologicalh* less pronounced than that 
observ ed following 80 days of ingestion of 2-AA(0.01%) of diet.
Histological examination of tissue sections other than the Irv er further revealed the extent of 2- 
AA toxicity in the F-344 rat, and the suppression of these effects bv the mixture. As shown in Fig. 5.16, 
a similar dose response progression of toxic effects observed in the liver following 2-AA ingestion was 
also observed in the pancreas of these animals. The control rat pancreas (A) is contiguous, with 
endocrine Islets of Langerhans randomly interspersed within regions of acinar or exocrine cells. 
Histological examination by light microscopy could not detect a change in the endocrine islet cells or in 
the architecture of the exocrine pancreas following 14 days and 30 days of the exposure to 2- 
AA(0.01%). nor were differences observed in the pancreas of rats fed DNP (0.1%) or BA (0.1%) 
adulterated diets for 80 dav s. Histopathological lesions were also completely absent in the pancreas of 
rats exposed to the MDC-adulterated diet for 80 days, and no histological changes were detectable in the 
endocrine or exocrine pancreas of these animals. The effect of the dose of 2-AA on pancreatic 
histopathology was examined by light microscopy. Histological examination by light microscopv of H & 
E sections could not detect a change in the endocrine islet cells or in the architecture of the exocrine 
pancreas in rats following 80 d ^  of exposure to 2-AA (0.005%) adulterated diet for 80 days. However, 
histological examination by light microscopy of the pancreas of rats exposed to 2-AA (0.0075%) for 80 
days detected alterations in the architecture of both the endocrine and exocrine pancreas. As shown in 
Fig. 5.16 (B), cells in almost all of the islets examined had large cytoplasmic vacuoles, which were 
faintly and homogeneously stained with eosin, and a large portion of the exocrine pancreas was 
disrupted with the presence of membrane ghosts and voided space occupying sites which were once the 
place of functional acinar cells. Ingestion of 2-AA (0.01%) adulterated diet for 80 days produced 
similar but much more severe pancreatic lesions as did consiunption of 2-AA (0.0075%) for 80 days. 
Disruption of the normal islet and acinar integrity (C), resulted in almost complete depletion of islets 
and substantially diminished acinar cells in the pancreas of exposed animals Large cytoplasmic 
vacuoles were observable in most islet cells, except for the few remaining cells on the peripherv of the 
islets. The size of the vacuoles varied to the extent that some of the vacuoles were large enough to
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
195
%
9.
Figure S. 16. H & E sections of rat pancreas following PAH ingestion. A. The endocrine and exocrine 
pancreas from an untreated rat (400 x). No differences were detected in the pancreas of DNP-, BA-. or 
MDC-e.xposed rats. B. Large cytoplasmic v-acuoles and diminished acinar cells are evident in this 
section of rat pancreas following 80 days of ingestion of 2-AA(0.0075%) (400 x). C. Large cytoplasmic 
vacuoles in the endocrine pancreas and necrotic remnants in the exocrine pancreas are shown in this 
section of rat pancreas following 80 days of ingestion of 2-AA(0.01%) (200 x).
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occupy a major portion of the cytoplasm and displace the nuclei. Gross morphological changes in the 
exocrine pancreas of these animals were observed as well. Membrane ghosts of acinar and islet cells 
were observed throughout much of the pancreas of these rats. There was no observable infiltration of 
lymphocytes or macrophages in the pancreas of control or treated rats suggestive of an inflammatory 
response.
Histopathological alterations in the kidneys of rats exposed to 2-AA (0.01%) for 80 days were 
also observed (Fig 5.17). As shown, compared with kidneys of untreated control animak (A), distention 
of the proximal tubules and occlusion of tubules with protein casts were observ ed in the kidneys of rats 
following 80 days of ingestion of 2-AA (0.01%) adulterated diet (B). No histological lesions were 
detected in the kidneys of rats following ingestion of DNP (0.1%), BA (0.1%). or MDC (0.21%) at any 
of the measured time points. Also, histological examination of kidneys from rats fed 2-AA (0.005%). or 
2-AA (0.0075%) adulterated diet for 80 days failed to detect lesions in these animals, nor were lesions 
detected in the kidneys from rats consuming 2-AA (0.01%) for 14- or 30 days.
The lesions revealed by histological examination of the liver, pancreas, and kidneys of rats 
following 2-AA adulterated diet administration, along with the reported decline in health and premature 
mortality in animals while consuming 2-AA adulterated dieL prompted re-submission of previously 
frozen 80-day 2-AA (0.01%) serum samples from the first experiment along with freshly obtained serum 
samples from the second and third set of experiments for clinical determination glucose levels. As 
shown in Fig 5.18. glucose levels in general paralleled pancreatic histopathological findings A 
significant elevation in the mean glucose level (474.71 mg(dl + 175.76) was detected in serum of rats 
following 2-AA (0.01%) adulterated diet administration for 80 days compared with the untreated control 
rat mean glucose level of 286.43 mg/dl + 72.27. No differences were detected in rats administered DNP. 
BA, or MDC adulterated diets for 80 days. An increased but insignificant level of glucose was detected 
in rats administered 2-AA (0.0075%). Four animals composed this experimental group and detected 
glucose levels in the serum of these rats were 755. 1122, 151, and 517 mg/dl. The range of glucose 
determinations for the seven 2-AA(0.01%)-exposed rats ranged from a low of 236 mg/dl to a high of 
752 mg/dl, and glucose determinations of the 4 control rats for the 2-AA(0.0075%)-exposed rats were
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Figure 5.17. H & E sections of untreated and 2-AA treated rat kidney A. H & E section of a kidney 
from an untreated control rat displaying normal tubule and glomerulus architecture (200 .x). B. 
Distention of tubules and protein casts are eyident in the kidney of a rat ingesting 2-AA(0.01%) 
adulterated diet for 80 day (200 .x).
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
198
1200
1000
800
Gucose
og/dl
0  CONTROL Hn2AA(0.01%) NDNP(0.1%)
a MDC(0.21%) □ CONTRCt/Exp. #3) ■ 2AA(0.005%)
■ BA(0.1%)
■ 2AA(0.0075%)
Figure 5.18. Serum levels of glucose in rats. Eachbar represents the mean + SEM of 7 rats for 
CONTROL and 2AA(0.1%), 13 rats for DNP and BA. 12 rats for MIX, 4 rats for second Control and 
2AA(0.0075%), and 5 rats for 2AA(0.005%). Means with the same letter are not significanL
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214, 252, 218. and 253 mg/dl. A review of this data indicated that the rat serum which gave a glucose 
determination of 151 mg/dl was suspiciously lower than even the respective control animak for the 
group.
The histological observations in the liver of 2-AA exposed rats and the timely progression of 
these lesions to hepatic nodular hyperplasia, suggested that these nodules may be early stages of 
neoplasia. Several lines of evidence indicate that some of the known oncogenes exist in rat tissue and 
are expressed under a variety of phy siological conditions, including regeneration and neoplasia 
(Richmond et al.. 1988). Using oncogene proteins as pre-carcinogenic lesion markers, 
immunocytochemistry was performed to examine enhanced ras and/or c-myc oncogenes expression in 
the liver and pancreas of rats. Histological examination by light microscopy did not detect differences in 
the levels of ras oncogene protein in the liver or pancreas of 2-AA treated rats regardless of dose or 
duration. No discerning differences in ras reaction products were observed between the liver and 
pancreas tissues of untreated versus 2-AA-treated rats. Histological examination did not detect 
differences in the levels of ras in the liver or pancreas of 2-AA-exposed versus MDC-exposed rats, and 
there were no differences in the levels of ras between nodules of hyperplastic cells or altered foci and 
normal hepatocvtes lying outside these lesions. Staining of ras protein was observed in positive control 
parafhn-embedded human <;ldn slides processed along with and under the same conditions as the rat 
parafhn-embedded tissue sections. A very faint, non-specific positive stain was observed in the 
cytoplasm of almost all hepatocytes and acinar cells whether the liver or pancreas originated fiom an 
untreated, 2-AA. DNP- BA-. or MDC-treated rat Since observations Mled to detect heightened 
expression of ras in hepatocellular lesions of treated rats, the faint staining was deemed constitutiv e 
expressioiL
As shown in Fig. 5.19. A  a distinctive pattern of peripheral islet-cell staining with reaction 
products to the c-myc oncogene protein was detected in the islets of pancreas derived finm untreated 
rats. This pattern of staining was also common in the pancreas of rats treated for less than 80 days with 
2AA(0.01%). and in the pancreas of rats treated for 80 days with DNP-. BA-. MK-. and 2-AA(0.005%) 
adulterated diet As shown in Fig 5.19.B, the pancreas of ratsexposedfbr 80 days to 2-AA at 0.01% or
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Figure 5.19. The detection of c-mvc oncogene expression in rat pancreas. A. Immunoc>tochemisti\' 
staining of c-myc protein (arrow) is evident in the ceils lining the periphery of islets of Langerhans of a 
pancreas from an untreated control rat. B. Immunocytochemical detection of c-myc protein appeared in 
acinar cells surrounding islets (arrows) which sustained severe injury, as shown in this section of 
pancreas from a rat ingesting 2-AA(0.01%) adulterated diet for 80 days.
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0.0075% of adulterated diet showed a different pattern of staining with the positive staining m the c-myc 
oncogene protein compared with untreated animals. Unlike the peripheral islet cell-confined staining 
pattern observed in untreated rats and those treated with 2-AA for 14- and 30-days or at 0.005% of 
adulterated dieL clear positive staining for c-myc were observed in the cytoplasm of many acinar cells. 
The pattern of most intense staining for c-myc reaction products was observed in the acinar cells 
surrounding islets which were observed to have sustained the greatest amount of toxic insult e.g. the 
presence of large cytoplasmic vacuoles. The observed pattern of adnar cell staining was detected only 
in the pancreas of rats exposed for 80 days to 2-AA-adulterated diet at 0.01% or 0.0075% and not at 
0.005%. Histological evaluation by light microscopy could not detect differences in staining for c-myc 
in liver of untreated rats. No differences were detected in the red reaction staining pattern or intensity to 
c-myc in the liver of treated rats regardless of treatment dose, or duration when compared with 
untreated control.
DISCUSSION
Humans and animal»; are rarely exposed to individual compounds. More often, thev- are 
exposed to combinations of compounds, either concurrently or sequentially, which can have differing 
effects on individual cells and organ systems (Sauer and Sipes. 1995). The interactions of differing 
compounds can alter the biological toxic response relative to that expected of an individual compound. 
The interactions of compounds in a mixture mav potentiate the response (produce a synergistic 
response), mav inhibit the response (produce an antagonistic response) or. less likely, produce an 
additive effect (produce an independent response). The interactions of differing conqx)unds can affect 
the metabolism or disposition of a compound. For example interactions can be mediated by the 
induction or inhibition of enzymes involved in the activation or detoxification of a compotmd. resulting 
in either enhanced or suppressed toxic activities. Examples of such interactions abound in the 
interactions of therapeutics agents, such as the decrease in renal excretion of penicillin when co­
administered with pn*enecid (Moller and Sheikh. 1983). Interactions of compounds can also affect the 
susceptibility of a tissue to toxic injury. For example, interactions of compounds mav- result in the 
suR)ression of the immune system which can alter a tissue’s reqxmse to toxic insult or may change the
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hemodynamics. This study investigated the potential toxic effects of three different classes of polycyclic 
aromatic hydrocarbons—nitroarenes. arylamines. and alternate aroznatics— when administered in the 
diet as individual agents and when administered concurrently as composites of a ternary mixture. 
Although numerous studies have evaluated these and other similar compounds individually for their 
biological effects following topicaL subcutaneous, intraperitoneal. gavage, or direct instillation 
administration, limited studies have investigated the effects associated with ingestion. In addition, fewer 
studies have been performed which simultaneously examined the effects of chronic ingestion of 
individual compoimds along with the interactive effects of chronic ingestion of the same compounds 
when administered concurrently as components of a mixture.
The results of the present 80 day feeding study clearly indicate that the toxicity of the 
dinitropvTenes and 1.2-benzanthracene is minimal when administered in the diet at concentrations up to 
0.10%. Although insignificant decreases in animal diet intakes were observed, no decrease in body 
weight, no mortality or adverse effects in general health of animaU ingesting DNP- or BA-adulterated 
diet were detected Morphological examination of tissues at necropsy 6iled to reveal any gross 
abnormalities. Furthermore, while several immime function tests were examined the results indicate 
that ingestion of DNP- or BA-adulterated diet for 80 days was not immimosuppressive when 
administered at concentrations of 0.10% of the diet. Atrophy of lymphoid organs or depression of 
lymphoid cell populations were not observed Liver absolute and relative weights did not differ 6om 
untreated animals and hematological and serological parameters were within normal range values for 
the rat. No hepatic tumors or altered hepatocytes were observed histologically, and no lesions were 
identified in the examination of other tissues. The results foimd in this study, however, were not 
confirmed by a review of other published studies. Intragastric administration to rats of benzanthracene 
at lOOmg/kg/day for 4 days was shown by Torronen et al. (1981) to induce cytosolic anti-diiuetic 
hormone levels and increased relative liver weight in exposed animals by 19% when compared with 
imtreated control animals While in another stuth the induction of foci of altered hepatocytes was 
shown following a 1 day intragastric administration of 180 mg/kg benzanthracene to rats followed by a 
diet containing 2-acetylaminofiuorene and carbon tetrachloride (Tsuda and Farber. 1980). Ingestion of
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benzanthracene at a concentration of 0.1% of the diet did not produce toxic effects in the liver or in the 
immune system under the protocols and tests of this sturh . However, inhalation of high concentrations 
(1500(xg m'^) of diesel exhaust for 8 weeks revealed no significant changes in differential counts of B 
and T lymphocytes in exposed guinea pigs when compared with age-matched controls (Dziedzic. 1981). 
The author concluded, as was the conclusion of this stuck , that exposure to diesel particles did not exert 
major effects on the parameters of the immune system that were measured. Unfortunately, no smdies 
were found which examined dietary exposure to BA or DNP compounds in mammalian systems, and a 
direct comparison of these cited studies with the present study is problematic, since the route of e.yposure 
and experimental protocols differed significantly. A previous stud)' in this laboratory which examined 
the metabolic distribution and excretion of DNP and BA (data not shown), showed that both the 
dinitropvTenes and 1.2-benzanthracene were apparently only poorly absorbed from the gastrointestinal 
tract Fort)-eight hours following oral gavage of radioisotope-labeled compounds of dinitropvTenes or 
benz[a]anthiacene. 89.6% and 74.7%. respectively of the recovered labeled compound was detected in 
fecal excreta. The fecal contents were not examined for parent corttpound—only for radioactrvit)'. 
Therefore, while the fecal contents accounted for a significant amount of the recovered labeled 
compound, whether the feces contents represented compound metabolized b) the liver and excreted in 
the bile or compound simply not absorbed was not determined. The lower absorption rate from the 
gastrointestinal tract may account for the lowered toxicity shown in this study compared with smdies 
demonstrating a toxic response in rats and mice following either injection or direct instillation of these 
compounds into the animal
In contrast to the lack of toxic responses in rats following the 80 da) DNP- or BA-adulterated 
diet administration, a dose-dependent and temporal progression of toxic effects following dietary 
exposure to 2-AA was demonstrated by this smch' in the F-344 rat Furthermore, a ternary mixture 
composed of 2-AA, DNP. and BA was shown to attenuate the toxic effects of 2-AA, suggesting that one 
or more components in the mixture su^rressed the activation of 2-AA to its ultimate cytotoxic and/or 
genotoxic metabolite. The results were suRX)rted at several levels of investigatioiL
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Firstly, observational data along with intake and both- weight data indicated a temporal 
response in toxic effects in- ingestion of 2-AA when included in the diet at a concentration of 0.01%. 
and a dose response in toxic effects were observed when 2-AA was incorporated into the diet at 0.005% 
and 0.0075%. In animals fed diet containing 2-AA(0.01%) a premature mortality of 30%, and overt 
signs of morbidity-, anorexia, and cachexia were observed. Decreases in weight gain and diet intake 
showed significant deviations finm control animals at the end of three weeks and two weeks, 
respectively. On the other hand rats fed the MDC-adulterated diet which contained 2-AA at the same 
level of dietary concentration (0.01%). did not exhibit obvious signs of toxicity and anorexia, and 
premature mortality was not observed. While weight gain was slowed b\ ingestion of the mixture, 
weight differences were not detected until the sixth week of diet ingestion. Since the concentration of 2- 
AA in the mixture was the same as 2-AA in the individual diet, differences in intake could not be 
accounted for In* differences in palatability.
Secondly, a comparison of clinical hematology and clinical chemistry data between 80 da>- 2- 
AA treated and untreated, or MDC-treated rats indicated that although statistical significance was not 
attained. 2-AA-treated rats had decreased W6C counts primarily due to decreased numbers of 
circulating lymphocytes. Chemical evaluations detected significant elevations in the serum enzyme 
levels of AST and ALT following 80 days, and enzyme levels were elevated, though not significantly 
following 14- and 30-days of dietary administration of 2-AA to rats. Differences in these enzyme levels 
w ere not detected following 80 days of dietary administration of the mixttue. The elevation in both ALT 
and AST in the 2-AA-exposed rats was moderate. Both enzymes are present in the rat liver and are 
increased in serum following chemical damage to hepatocytes (Goodman et al.. 1979). The serum 
indicators AST and ALT are. therefore, nonspecific for hepatic damage because the senun activity of 
these enzymes can be elevated in marw disease states (Comish, 1971). Also, Cornelius (1963) found a 
relation between bo<^ size and the amount of hepatic ALT activity. The smaller the animal is within 
the weight range studied, the greater the ALT activity. The rats ingesting 2-AA(0.01%) for 80 days 
demonstrated significantly reduced bodk weights compared to the untreated control rats. The
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implication of these results was suggestive, but not definitive, of hepatocellular liver disease in the 2- 
AA-exposed rats and a lack of such effects in animaU fed the PAH compound mixture for 80 days.
Thirdly, reduced lymphoid organ weights for thymus and spleen along with the lower WBC 
counts were suggestive of an immimosuppressive effea by dietary exposure to 2-AA. The significantly 
reduced splenocyte populations detected following dietary administration of 2-AA at a 0.01% 
concentration level were similarly conformationaL and the increase in relative spleen weight could be 
explained by vascular changes resulting fiom the loss of parenchymal cells (splenocytes) within the 
tissue. The observed alterations in lymphoid organ weight and cell counts showed temporal effects 
becoming more pronounced with increased duration of exposure. In general ingestion of anv- of the 
PAH-adulterated diets showed temporal effects in the reduction of lymphoid organ weights and cell 
counts: however, onh rats exposed to 2-AA attained significance. While animale exposed to the 
mixture showed a similar trend differences were not significant. Several classes of chemical agents and 
some drugs are known to produce cyiotoxicitv' in lymphoid cells and tissues. Exposure of mice to 
DMBA has previously been reported to produce thymic atrophy and to decrease the recovery of viable 
cells fiom the spleen (Burchiel et al.. 1990). These results suggest that ingestion of 2-AA is cvtotoxic to 
lymphoid populations. Based upon evidence that has accumulated it appears that activation of primarv 
aromatic amines as a class typically requires oxidation of the amine group to the N-hydro.xy moietv 
(Kacflubar et al.. 1977). Hammons et al. (1985) showed that the oxidation of the functional amino group 
of several ary lamines is catalyzed primarily by cytochrome P4501A2 (CYPl A2), a reaction which does 
not take place in lymphocytes since CYP1A2 is not expressed in extrahepatic tissue (Parkinson, 1996).
In the rat however, metabolic N-oxidation of certain primary amines, such as 2-AA, can be performed 
by intestinal microflora (Parkinson, 1996). The hydroxylamines show some reactivity to DNA at slightly 
acidic pH values, and are directly mutagenic and carcinogenic (Kacflubar, 1977: Lubet 1989:
Humphreys et a t  1992). The protenated hydroxylamine may be converted by spontaneous heterolysis to 
water and an aryl nitrenium ioiL which may be the electrophilic metabolite that results in cytotoxicity 
(Rodrigues et al., 1993).
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Although significantly reduced splenocyte counts were detected in the 2-AA exposed rats, the 
immune responses of lymphocytes firom exposed rats did not confirm suppressed functional immunity 
and the data were somewhat inconsistent. No alterations in the proliferativ e responses of splenocvies to 
the T cell mitogen ConA or of mixed lymphocytes to allogeneic cells were detected firom rats exposed to 
dietary administration of the PAH compounds regardless of treatment However, as stated bv White et 
al. (1984) certain chemicals, including non-carcinogenic PAH compounds, can enhance some immime 
responses while suppressing other immune functions. Dean et al. (1983) postulated that PAH 
compounds may interfere with interleukin-2 (IL-2) synthesis. Substantially diminished secretion of the 
autocrine hormone IL-2 could inhibit the T cell traverse fiom G, to Gs phase (Stem and Smith. 1986). 
Consistent with the ConA proliferative data, however, the ingestion of PAH-adulterated diet had no 
significant effect on the IL-2 activity detected in the enriched T cell culture supernatants. A seemingly 
anomalous suppressed response of splenocytes to the B cell mitogen LPS were detected by 30 days 
exposure to dietary 2-AA at a concentration o f 0.01%. The response was lower but not significant 
following 80 days of dietary exposure and unchanged following 14 days of dietary ingestion of 2-AA 
The responses were not diSerent at any time point in the rats exposed to dietary administration of the 
mixture. Other studies using the rodent model have shown that exposure to PAH compoimds 
significantly suppressed the B cell mediated humoral immime response and produced dose-dependent 
suppression of the lymphoproliferative response to the B cell mitogen LPS (Dean et al.. 1983; White et 
al.. 1985. 1986). However, the mixed lymphocyte responses of spleen cells in conjunction with the 
proliferation assays indicated that ingestion of PAH-adulterated diet for 80 days had no demonstrativ e 
effect on the proliferative functional capacity of lymphocytes under the conditions of this study.
A similar lack of consistent results supporting an immune suppression was found fiom 
examination of pulmonary alveolar macrophages. Several investigators have demonstrated that in 
addition to the cytochrome P450 pathway, macrophages may also utilize the unsaturated fatty acid 
hydroperoxide-dependent cyclooxygenase pathway via peroxyl radicals to metabolize PAHs. and these 
studies have suggested that macrophages may be predisposed to the immunosuppressive effects of PAHs 
by virtue of their increased capacity to generate metabolites by both these pathways (Ladies et al..
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1992c). Reactive metabolites may then covalenth’ bind to nucleophilic targets and impair macrophage 
function as antigen presenting cells in the immune response (Robison et al.. 1993). Although the 
numbers of macrophages obtained from lung lavage fluid were significantly reduced following 80 days 
ingestion of either 2-AA- or MDC-adulterated diet the activity of the macrophage-secreted cytokine. 
TNF-cu-detected in culture supernatants was not suppressed, once again suggesting that 2-AA is 
cytotoxic and not immunosuppressive. In feet the TNF-a results were suggestive of a potentiation of 
activitv by macrophages fiom rats following 80 days ingestion of 2-AA(0.01%). Elevated TNF-a levels, 
although not significant were detected in unstimulated macrophages culture sipematants. These results 
are in contrast to those reported elsewftere which showed significant immune suppression following 
expx)sure of mammalian systems to PAH compounds (Adams and Hamilton. 1984. Thurmond et 
al . 1988: Ladies et al.. 1992a. 1992c; Wojdani et al.. 1984; and Dean et al.. 1985). The differences 
between the lack of consistent immune suppression respx)nses reported in this study and those described 
elsewhere may be due to the nature of the conpounds and/or the route of exposure. Other px)ssibilities 
also exist. In generaL in vivo expx>sure to high doses of PAH conpounds is associated with atrophy of 
hmphoid tissues and is often acutely cvtoto.xic to lymphoid cells, rather than immuno-suppressive 
(Davila et al.. 1995). Chronic ingestion of 2-AA which is the most relevant route, may be a more 
eflBcient route for the upjtake. metabolism, and dispxtsition of 2-AA in the rat model. The potential 
enhanced toxicity via ingestion may result in cytotoxic rather than immuno-suppressive effects. Also, 
the F-344 rat model used in these studies is an inbred strain and was selected on its genetic basis to 
minimize intra-group variability! however, the toxicity of 2-AA ingestion showed widely disparate inter­
animal effects which increased the variability and decreased the px)wer of the test statistics.
2-Aminoantfaracene is a pxitent carcinogen and is one of the few aromatic amines found to 
induce hepiatomas and skin tumors (Letmox. 1955; Shear. 1938). A decrease in liver weight at 14 days 
followed by a progressive increase in weight to significance at 80 days in rats expx)sed to 2-AA(0.01%) 
adulterated diet was suggestive of toxic liver insult, while the absence of such effects in rats expx)sed to 
the mixture of conpounds was suggestive of attenuation of such effects. Chemically-induced rodent 
hep)atocarcinogenesis is thought p  progress fiom normal bepiatocytes through histologically identifiable
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hepatocellular lesions and finally to neoplasms (Farber and Sarma. 1987). The classifications of 
hepatocellular lesions are marked by distinct histologically identifiable alterations which differ in 
severity of toxic injury. A temporal and ctose progression of hepatocellular lesions was detected in liver 
sections of rats following dietary administration of 2-AA(0.01%). whereas lesions of less severity were 
detected in liver sections of rats following 80 days of dietary administration of the PAH mixture. Foci of 
cellular alteration following 14 days of dietary administration which progressed to focal hepatocellular 
hyperplasia following 30 days of dietary administration and on to hepatocellular adenomas following 80 
days of dietary administration was observed in rats consuming 2-AA(0.01% or 0.0075%) adulterated 
diet. On the other hand, only foci of cellular alteration were observed in rats administered the mixture 
of PAH compounds, even after 80 days of consumption.
Experimental models suggest that foci and hyperplastic nodules are precursors of hepatocellular 
neoplasms, and several studies have demonstrated expression of ras and myc oncogene proteins in 
spontaneous and chemically induced rodent liver tumors (Corcos et al.. 1984; Cote et al.. 1985;
Richmond et al.. 1992). The ftmction of the ras and myc protein in either normal or neoplastic growth is 
at present poorly understood Neither protein is unique to neoplasms, since both hav e also been 
described during tissue regeneration (Goyette et al.. 1982). This study examined ras and myc in 
formalin-fixed, parafftn-embedded sections of male F-344 rat liver, however, qualitative microscopic 
examination could not (fetect enhanced expression of these oncogenes in PAH-treated rat liver. Both 
altered foci and large diameter hyperplastic nodules were demonstrated by chemical exposure to 2-AA. 
suggesting that these lesions may be sites for malignant transformations. Since positive control human 
skin and breast carcinoma paraffin-embedded tissue was included in the immimocvtochemical method 
used in the detection of ras and m yc, and positive reaction products were detected in these tissues, the 
negative observations were aR)arently real and suggest that either enhanced expression of ras or myc 
was not present in the rat tissues or the antibodies could not detect the ras or myc gene product in rat 
paraffin-embedded tissue The lack of substantial increases in ras and myc e?q}ression after 80 days of 
dietary treatment with 2-AA is different than that observed after other known chemical carcinogen 
treatments in the rat fiver (Spankle et al. 1996; Butteworth et al., 1994; Goldsworthy et al.. 1994).
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However, the observed increases in oncogene expression in rat Irver induced bv treatment with fiiran and 
chloroform were acute studies. The lesser degree of cvtotoxicity and subsequent regenerative cell 
proliferation induced by- 2-AA over the period of 80 days may have been accompanied by increases in 
ras and myc expression that were too small to be measured by immimocvtochemical ev aluation.
2-Aminoanthracene is a potent carcinogen, and perhaps its most unusual characteristic is its 
specificity for epithelial tissues of different animal species (Mitchell. 1985). Histological evaluation by- 
light microscopy of tissues other than liver revealed a unique and currently unreported toxic effect of 
2AA in the rodent model, that of pancreatic toxicity and the induction of diabetes. The results of 
glucose assays which indicated severe hyperglycemia and histological review of the kidneys provided 
further support for these findings. Moreover, the toxic effects induced by 2-AA in the pancreas of rats 
showed a similar dose and temporal response as did the liv er of these same animals. Whereas, rats 
exposed to the mixture of PAH compounds showed no pancreatic lesions even though 2-AA was 
ingested at the same concentration of 0.01% in the diet. The lesions observed in the pancreas w-ere 
apparently secondary to hepatic lesions. Histological alterations in the pancreas were only detected in 
rats follow-ing ingestion of 2-AA for 80 days, whereas liver lesions were detected follow-ing 14 day s.
After consideration of these findings, the results are not surprising since the fiv er and pancreas are 
related embryologically and phylogenetically- (Eustis et al.. 1990). Furthermore, the lesions observed in 
both the endocrine and exocrine pancreas provided a basis for elucidating the debilitating health effects 
observ ed in these animals during the latter weeks of exposure. And. since hyperglycemia inhibits 
cellular regeneration and tissue repair in hepatocytes. the injury- sustained in the pancreas may have 
accelerated the progression of fiver injury- inflicted by 2-AA ingestion (Chanda and Mehendale. 1995)..
Some important cytological and immunocytochemical findings were obtained in this study 
which might open a possibility- to the elucidation of the mechanism by which 2-AA induces pancreatic 
and perhaps fiver toxicity. The mechanisms through which chemical-induced p-cell toxicities are 
mediated remain controversial; however, two main theories emerge (Malaisse. 1986). The first 
mechanism of chemical-induced pancreatic islet-cell toxicity, for which alloxan is an example, is 
disruption of the plasma membrane integrity, resulting fiom the generation of oxy gen radicals. The p-
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cell of the islets is extreme!} sensitiv e to reactive radical species (Pieper et al., 1996. Rabinovitch et al.. 
1996a.b). The histological changes in islets after alloxan poisoning have been reported and indicate that 
the P-cell nucleus undergoes karvoh'sis. the cytoplasm disintegrates, the cell boundaries disappear and 
finally a mass of dd^ris containing fragments of nuclei appear during the final phases of the necrotizing 
process. Acinar cells, however, are only slightly afiected. and there is a complete absence of a 
mononuclear cell response. No other histological changes are encoimtered (Cooperstein and Watkins. 
1981). A second mechanism of chemical-induced pancreatic islet-cell toxicitv . for which cvproheptadine 
is an example, is inhibition of the transfer of insulin precursors firom the rough endoplasmic reticulum to 
the Golgi apparatus (Hanai. 1984). The effects of the antihistaminic drugs are characterized 
histologically by a depletion of secretory granules and formation of large cvtoplasmic vacuoles in the p- 
cells. vésiculation of the rough endoplasmic reticulum, but necrosis is absent (Hanai. 1984; Renip. 1970; 
Longnecker et al.. 1972). The morphologic and biochemical changes are reversible upon termination of 
exposure and the pancreotoxicitv- is species-specific, being observed only in the rat Also, the toxic 
efiects were greater after oral exposure than after intraperitoneal injection.
The cynological, immunocynochemical. and histological results presented in this stu*- indicate 
that 2-AA-induced pancreatic toxicity followed neither of these reported mechanisms precisely; 
however, a mechanism involving radical species is imphcated. As with alloxan toxicity , observed 
histological changes resulting fi’om 2-AA exposure included the disintegration of cytoplasm of P-cells. 
the disappearance of cell boimdaries and necrosis. The metabolism of 2-AA is thought to proceed via 
hepatic N-oxidation followed by acéty lation and since the acetyl is a good leaving group, an aryl 
nitrenium ion group may be formed during prior or post uptake of this compound by the pancreas. The 
nitrenium ion appears to be the ultimate electrophihc metabohte that binds DNA (Rodrigues et al.,
1993). Studies have shown that the N-acetylase activity in the fiver closely correlates with the activity of 
that enzyme in the pancreas (Martell and W*er, 1993). Furthermore, epidemiological studies indicated 
a prevalence of the rapid acetylator phenotype among IDDM patients, and the F344 rat expresses a rapid 
acety lator phenotype (Burrows et al., 1978).
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A radical species may similarly explain the injury sustained in the exocrine pancreas In' dietary 
exposure to 2-AA. Studies have shown that reactive oxygen species may contribute to acute pancreatitis 
and necrotic death of acinar cells (Kaiser et al.. 1996; Rivard et al., 1995). The exocrine pancreas is 
under both short- and long-term neuronal and hormonal control. Pancreatic short-term regulation 
consists mainly of the stimulation of secretion during food digestion, while long-term regulation consists 
of the regulation of pancreatic mass and content of digestive enzymes according to the need of the 
organism (Scaglia et al., 1997). It has been shown that nuclear oncogenes function as mediators 
coupling short-term signals, which are rapidly elicited by cell surface stimulation, to long-term 
responses, such as growth and differentiation, by regulating the expression of speci&c genes (Lu and 
Logsdon. 1992). The enhanced expression of c-myc, an immediate early gene, and the lack of enhanced 
expression of ras. is consistent with the role of c-myc in cell proliferation and suggestive of an attempt 
by the pancreas to restore its architectural integrity (Farquharson et al.. 1992; HasmaU et al.. 1997). 
These results imply that the myc oncogene may function in pancreatic response to toxic insult and may 
play a role in the mechanism of 2-AA-induced pancreatic toxicity.
The present study was aimed at investigating whether, and to what degree, a mixture of three 
classes of pyrene or anthracene based PAH compounds would alter the toxic effects of the individual 
components of the mixtme. To this end rats ingested powdered diet containing either an individual 
component or the mixture for a period of up to eighty days. The classes of PAH compounds and selected 
representatives included the nitroarenes represented by the dinitropyTenes, arylamines represented by 2- 
aminoanthracene. and the alternate aromatic compounds represented by benzanthracene. Only the 
ary lamine. 2-aminoanthracene. exhibited toxic effects, as measured by the parameters of this study in 
the rat model by ingestion. Ingestion of the mixture attenuated the toxic effects of 2-AA and the results 
of this study support a toxicokinetic mechanism.
The activation of arylamines involves N-hydroxylation by microsomal cytochrome P-450. 
notably the hepatic specific P-4501A2, and O-acetylation of the N-hydroxylated products by cytosolic 
transferases (Kato and Yamazoe, 1994; Gorrod and Manson, 1986; Carrière, 1992). Considerable 
interindrvidual variation both in the level of hepatic expression and in the rate of metabolism of
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CYP1A2 substrates have been reported (Kadlubar. 1994). Phenotyping studies have suggested that three 
phenotypes of the CYPl A2 gene may be distributed among the human population—slow, intermediate, 
and rapid metabolizers: and that considerable variation in the distribution of these phenotypes is seen in 
individuals of different racial/ethnic groups (Kadlubar, 1994; Smith et al.. 1995). For example, 
induction of CYPl A2 by cigarette smoking was shown in Caucasians but not in Chinese or in African- 
Americans (Kadlubar. 1994: Butler et al.. 1989). The initial N-hydroxylation step is then, followed by 
O-acetylation (Yamazoe et al.. 1994). It has been hypothesized that the hydroxv’lamine is acetv lated to 
form the ultimate carcinogen, and hepatic cytosol contains N-acetyltransferase enzymes which can O  
acetylate (Traynor et al.. 1991). Humans and other mammalian species (with the exception of the dog 
and fox which are not able to acetylate compounds) express a genetic polymorphism in N-acetylation 
capacity that segregates individuals of each species into rapid, intermediate, or slow acetylators (Hein. 
1988). Rats in general, and the Fischer 344 inbred rat in particular, are often utilized to study the 
toxicity and carcinogenicity of aromatic amines (Rao and Boorman, 1990). This is because the inbred 
rat mimics the polymorphism in N-acetylation capacity exhibited in humans (Hein et al., 1991; Martell 
and Weber. 1993). The N-acetylation polymorphism is of both c linical and toxicological importance 
because rapid or slow acetylator phenotype can influence the toxic response fiom aromatic amines 
(Rischetal. 1995).
The nitroarenes. such as the dinitropyrenes, are activated via reduction by microflora in the 
gastrointestinal tract to N-hydroxvarylamines and subsequently by O-acetylation of the N-hydroxylaied 
products by cytosolic transferases (Rosenkranz and Mermelstein. 1983). Thus, the dinitropyTenes and 
arylamines may share common pathways of metabolism to ultimate carcinogens and may compete with 
each other for the same activating enzymes (Kiefer et al., 1994). The mixture of PAH compounds 
contained 2-AA; DNP;BA at concentrations of 0.01%:0.1%:0.1%. respectively. Thus, the 
dinitropyrenes were represented at a 10 fold greater concentration than 2-AA. It is likely that the 10 
fold greater concentration of the dinitropyrenes in the mixture successfully competed with 2-AA for 
acétylation, thereity conferring an attenuating eftect with the mixture. Further support for this 
hypothesis comes ftom studies which show that the N-acetylation polymorphism is expressed similarly
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in the liver and pancreas of inbred rats (Martell and Weber. 1993). Further exploration at the 
biochemical leveL utilizing the tools of molecular biology , may help to elucidate the basis of the 
association between dinitropyrenes and 2-aminoanthracene. Further study is also needed to examine the 
association of 2-aminoanthracene with other arylamines. The results of this stu*' demonstrate the 
importance of examining multiple tissues in an integrated organism in order to evaluate the interactions 
of compounds in mixtures.
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CHAPTER 6 
PANCREATIC TOXICITY INDUCED IN THE 
FISCHER-344 RAT BY DIETARY 
ADMINISTRATION OF 2-AMINO ANTHRACENE: 
A MORPHOLOGICAL AND 
IMMUNOCYTOCHEMICAL STUDY
INTRODUCTION
The rat pancreas has frequently been used as an animal model to smd\ changes in islet cells in 
pathological conditions, such as diabetes mellitus and pancreatic tumors (Elayat et al.. 1995). The islets 
of Langerhans synthesize, store and secrete a variety of polypeptide hormones and form the endocrine 
portion of the pancreas. The endocrine portion of the pancreas consists of the individual islets scattered 
throughout the acinar parenchyma, and the volume of the islets comprise only a few percent of the entire 
pancreas (Lacy et al.. 1967). The application of immunocytochemical techniques has allowed the 
identification of four individual islet cell types by the presence of their stored secretory products; a-cells 
(containing glucagon granules), p-cells (containing insulin granules) 5-cells (containing somatostatin 
granules) and PP cells (containing pancreatic polypeptide granules). In the human and rat pancreas, the 
insulin-producing p-cells occupy a central position in the islets, while cells producing glucagon (a-cells) 
and somatostatin (5-cells) are foimd preferentially in clusters along the periphery of the islets 
(Goldsmith et al., 1975; McEvoy and Hegre. 1977; Smith. 1983). It has been hypothesized that the 
arrangement of cell types within the islet and the resulting cell-to-cell commimication may be of 
physiologic significance in the control of glucose homeostasis (Orci and Unger, 1976; Orci. 1982; Elayat 
et al.. 1995). In insulin-dependent diabetic animals and man there is a marked disruption of the normal 
histologic relationships (McEvoy and Hegre, 1977). Insulin-dependent diabetes mellitus (IDDM) restilts 
fi^ om specific destruction of the pancreatic islet insulin-secreting P-cells (Ste&n et al., 1982; Rabinovitch 
et al., 1996). An autoimmune response (insulitis) precedes P-cell destruction in human subjects with 
IDDM as well as in animals with spontaneous forms of autoimmune diabetes, such as the non-obese 
diabetic mouse and the Biobreeding (BB) rat (Lee et al., 1988; Jansen et al., 1994). Impaired fimction
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and destruction of the P-cells may* result firom direct contact with infiltrating macrophages and 
lymphocytes, or exposure to secreted products of these inflammatory cells, such as cytokines and oxygen 
radicals. Cytokines released by activated mononuclear cells ha\ e been hypothesized to play a critical 
role in the dev elopment of IDDM (Jansen et al.. 1994: Lee et al.. 1988; Mandrup-Poulsen et al.. 1990: 
Rabinovitch. 1993; Rabinovitch et al.. 1996a.b.c; Corbett et al.. 1992; Lang et al.. 1992; Mandrup- 
Poulsen et al.. 1994; Hussain et al.. 1996; Dunger et al.. 1995). Tumor necrosis factor-a. a cytokine 
secreted by macrophages, has been shown to impair insulin action and elevated levels of this cytokine 
precede and accompany the onset of IDDM (Hussain et al., 1996).
For decades a number of toxic agents have been used to induce diabetes meUitus in 
experimental animals. Streptozotocin and alloxan are the best known of these agents which exert their 
adverse effects via selective necrotic changes in the Islets of Langerhans resulting from the production of 
highly reactive oxygen radicals. Other well known p-cell toxic agents include the antihistaminic drugs 
such as cyclizine and cyproheptadine which are thought to exert their effects via depletion of secretory 
granules (Hanai, 1984; Rerup. 1970; Longnecker et al.. 1972). In humans diabetes mellitus represents a 
heterogeneous disorder in both its pathogenesis and etiology, and the possibility of an association 
between errviromnental exposure to toxic agents and the development of this disease appears reasonable. 
In a previous study to evaluate the toxic potential of selected anthracene- and pvTene- based compounds, 
dietary exposure to the polycyclic aromatic amine. 2-aminoanthracene. was shown to be hepatotoxic and 
induced hepatic nodular hyperplasia in the F-344 rat. 2-Aminoanthracene is a potent carcinogen with 
an unusual characteristic of having a high specificity for epithelial tissues of different animal species 
(Mitchell. 1985). The liver and the pancreas are closely related embryologically and pfayiogenetically. 
and since both develop fiom a ventral outgrowth of the gut similarities in their phenotypic expression of 
drug metabolizing enzymes has been demonstrated in rats (Eustis and Boorman. 1990; Martell and 
Weber. 1993). Cage side observations of rats exposed to the toxic effects of 2-AA indicated that these 
animals displayed cachexia, polydipsia, polyuria, and a distinctive hypersensitivity in their fore paws. 
These observations prompted the collection of urine fiom these animals and the resulting findings of
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diuresis, proteinuria, and ghcosuria. In this paper we report on the novel discov ery of the diabetogenic 
efiects of 2-aminoanthiacene as both an endocrine and exocrine pancreatic toxin.
EXPERIMENTAL 
SAFETY PRECAUTIONS
Due to the potential risk of toxicity by repeated exposures to test compounds, all animal 
caretakers were provided with full-face respirators equii^jed with replaceable, disposable activated- 
charcoal filters designed to exclude organic particulate and vaporized compounds. All personnel 
entering animal housing were required to wear protective clothing and shoe covers. All diet not 
previously consumed, and disposable apparel were contained and disposed of as hazardous wastes. All 
animal excreta collected in under-cage pans or metabolic cage units was disposed of daily bv flushing 
with water directly into the floor drain receptacle located in the center of the animal room.
ANIMAL BIOASSAY
This study was conducted under federal guidelines for the use and care of laboratory animals 
and was af^roved by the Institutional Animal Care and Use Committee and the Carcinogen Use 
Conunittee of Louisiana State University. School of Veterinary Medicine. In this studv animals were 
assigned to a treatment group in the following manner: first, rank-ordered by weight (initial weight) ; 
second the ordered weights were divided into the number of replicates per treatment; and third 
members within each replicate rank were randomly assigned to an experimental diet treatment group.
Male Fischer-344 rats. 4-6 weeks of age were used for this studv . The animals were housed in 
an Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) accredited 
facility in individual suspended stainless steel wire mesh cages with fiee access to water and diet. 2- 
Aminoanthracene (Sigma. S t Louis. MO) was incorporated into a semi-purified nutritionally adequate 
rodent powdered diet (AIN-93M) at lOOmg/kg, 75mg/kg and 50mg/kg of diet and provided to rats 
(American Institute of Nutritiott 1993). The unadulterated powdered A1N-93M diet was provided to 
approximately the same number of rats and served as controls. Fresh diet was provided daily. During 
the exposure period of 80 days, the animals were followed by weekly measurements ofboch weight and
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daily dieuiy intake. During the treatment period of 80 day's, five 2-AA (lOOmg/kg diet) treated rats and 
four control rats were randomly selected for sub-samplings at 14- and 30-days. A glucose tolerance test 
%as performed on five overnight fasted 2-AA (lOOmg/kg diet) and five overnight âsted control rats at 
62-days. The rats, administered the glucose tolerance test were used 24 hr after the administration of 
the glucose load for a sub-sampling at 63 days. Three 2-AA-treated (lOOmg/kg diet), five 2-AA-treated 
(75mg/kg diet), five 2-AA-treated (50mg/kg diet) and seven control animals were sub-sampled at 80 
days of exposure. At the end of the specified exposure periods, the non-fasted rats were anesthetized by 
carbon dioxide inhalation. Blood was removed fiom the abdominal inferior vena cava distal to the 
pancreas until exsanguination for the measurement of plasma glucose and for serum chemistry 
evaluation.
CLINICAL PATHOLOGY
Serum samples were prepared by allowing the blood sample collected in gel clot tubes to clot at 
room temperature for 15 to 30 min. The sample was centrifuge for 10 min. at 2000 x g  Serum 
chemistry profiles were obtained by automated procedures (Olympus Reply. Olympus American. Inc.. 
Lake Success. NY) and included determinations of the activities of aspartate aminotransferase (AST) 
and alanine aminotransferase (ALT), blood urea nitrogen (BUN), creatinine, and total protein. Glycated 
hemoglobins were measured using a commercially available kit (Isolab. Inc.. Akron. OH).
MACROPHAGE ISOLATION AND CELL PREPARATION
Upon exsanguination, the trachea of the rat was carmulated in situ and the lungs removed fiom 
the thoracic cavity. To obtain broncho-alveolar lavage (BAL) macrophages, the lungs were lavaged with 
60 mL. of warmed (37®C) calcium and magnesium fiee phosphate buffered saline (PBS), pH 7.2 (Gibco, 
Grand Island, NY) accompanied by gentle massage of the lung Cells were washed once in PBS. and 
cell number and viability were assessed by trypan blue exclusion in a hemocytometer. BAL cells as 
alveolar macrophages were determined by morphological features on nonspecific esterase stained 
cytocentrifuge preparations. BAL cells were resuspended in RPMI-1640 complete media which 
contained antibiotic/antimycotic (GIBCO, ICO units/ml penicillin and streptomycin and 0.25pg/ml
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
226
fungizone), 2mM L-glutamine (GIBCO), 25mM Hepes (GIBCO). 2mM sodium pyruvate (GIBCO) and 
10% fetal bovine serum (FBS; Sigma), and an alveolar macrophage monolayer (2 x 10*^ cells/mL) was 
prepared in 24 well culture plates (500^1/well) and incubated for 2 hours in a CO2 chamber. After the 
macrophage monolayers were incubated for 2 hoim. spent media and non-adherent cells were removed 
by suction and the wells rinsed with PBS ( 1 mL at 4°C, pH 7.4). One half of prepared macrophage wells 
for each rat were stimulated with the known TNFa inducer. ÜRX)polysaccharide (LPS. lug/mL RPMI 
complete media), and incubated for an additional 4 hours. The 4-hour spent media from stimulated and 
non-stimuiated macrophage were collected, centrifuged, and assayed for TNF-a bioactrvity in a 
cytotoxicity assay using actinomycin D-treated L929 cells.
TISSUE PREPARATION
For histological light microscopy and inmiimocytochemistry studies, the pancreas of the rats 
were immediately excised and tissues were hxed in a solution of 10% neutral-buffered formalin for 24 
hours. Sections of tissues were dehydrated through increasing concentrations of ethanol, and the 6xed 
sections were embedded in paraffin The paraffin blocks were sectioned on albumin-coated slides. 
deparafBnized and hydrated through graded xylene and aicohoL processed, and stained with 
hematoxylin-eosiiL Sections were then cleared and moimted with non-aqueous coverslip resin 
(PermounL Fisher Scientific. Cinciimati, OH). Stained sections fiom each rat were used for 
morphometric analysis.
GLUCOSE TOLERANCE TEST
A glucose tolerance test was performed on the ninth week in overnight fasted rats by oral 
administration of a 40% aqueous solution of glucose (Sigma. St Louis. MO) at a dosage of 4 g per kg 
bocK' weight. Rats were anesthetized by isofiuorane inhalation at each blood collection time point 
Blood samples were taken fiom alternate retroorbital plexus sites ( 1 ml/collection/rat) at 0. 30. 60. 120 
and 180 min after the oral glucose dose for the measurement of plasma glucose and insulin levels.
Plasma glucose was measured spectrophotometrically using the glucose oxidase method and insulin
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levels were (fctennined by radioimmunoassay using a commercially available '^Iodine kit for human 
insulin (Coat-A-CounL Diagnostic Products Corp.. Los Angeles, CA).
TUMOR NECROSIS FACTOR-ALPHA BIOASSAY
TNFa bioactivit} was measured in the macrophage spent media 4-hour supernatants of each rat 
using the TNF-a-sensitive L929 cell line (American Type Culture Collection. Rockville, MD) in a 
cytotoxicity assay (Hogan and Vogel, 1990). Briefly, lOOul of RPMI culture medium containing 3 x 10^  
trypsinized and actinomycin D (2pg/ml) (Sigma. St, Louis. MO) treated-L929 cells were distributed in 
each well of a 96-well culture plate and incubated with 100 ul of duplicate serial dilutions of media 
supernatants at 37°C for 24 hours, A standard curve was constructed using 6 wells of the actinomycin 
D treated-L929 cell suspension serving as 0% cell death and 100% cell death represented by 6 wells of 
the actinomycin D treated-L929 cells lysed, subsequent to the 24 hour incubation period, by the addition 
of lOOul/well of 3M guanidine hydrochloride (Sigma). The standard curve served as a cylotoxicity curv e 
representing 0-100% cell death. Media was removed from all the wells and the cells stained with 0.1% 
crystal violet for 10 minutes. The absorbance at 570 nm was determined using an ELISA plate reader.
A dose response was measured by comparing the percentage of cell death from the media samples to that 
of the standard One unit of TNF-a was defined as the amount of TNF-a required to lyse 50% of cells.
IMMUNOCYTOCHEMISTRY FOR THF DETECTION OF INSULIN BY 
LIGHT MICROSCOPY
For the procedure, paraffin-blocked tissues on albumin-coated slides were deparaffinized in 
xylene, hydrated through decreasing concentrations of ethyl alcohol, rinsed in deionized water and 
finally rinsed in PBS (pH 7.4). The technique utilized, in part, the Vectastain procedure (Vector 
Laboratories. Burlingame, CA). Endogenous peroxidase activity was reduced from the section by a 30 
minute incubation in methanol with 0.3% hydrogen peroxide at room temperature. Antigenic 
determinants masked by formalin-fixation and paraffin-embedding were freed pretreatment of tissue 
sections with 0.1% pepsin in 0.0IN hydrochloric acid (pH 2.3) at room temperature for 15 minutes. 
Enzyme digestion was terminated Iw repeated washing in PBS and finally by washing in PBS with 0.1%
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Tween-20. The prepared tissue sections were then submitted to the following avidin biotin complex 
(ABC) treatment to localize insulin-producing P-cells for immunocytochemical examination (Hsu et al.. 
1981). In each case the diluting buffer was phosphate buffered saline (pH 7.4). Non-specific blocking 
was accomplished using normal guinea pig serum (I00pl;5 ml buffer) as suppUed in the Vectastain kit 
Guinea pig anti-porcine in<mlin (Dako Corp.. Carpinteria. CA) and normal guinea pig serum was 
applied to the tissues as the primary antiserum after a 1:150 dilution and incubated for 45 minutes at 
room temperature. Subsequently, biotirrylated rabbit anti-guinea pig immunoglobulin was employed as 
the secondary antiserum at a dilution of 1:200 (Vector Laboratories). The chromogen substrate used for 
visualization of insulin wus amino ethvicarbazole (AEC) and counter staining wus with Meyer's 
hemaioxylitL Sections were cleared and mounted with an aqueous cov erslip resin.
IMMUNOCYTOCHEMISTRY FOR THE DETECTION OF ras AND mvc 
ONCOGENE EXPRESSION
For the procedure, parafhn-blocked pancreas tissue was sectioned at 5 pM and fixed to 
albumin-coated microscope slides. The technique utilized in part the Vectastain ABC procedure (Vector 
Laboratories, Burlingame, CA). Tissue sections were deparaffinized in xylene, hydrated through 
decreasing concentrations of ethyl alcohol, and rinsed in deionized water. Endogenous peroxidase 
activitv' was reduced fiom the section bv a 30 minute incubation in methanol with 0.3% hvdrogen 
peroxide. Antigenic determinants masked bv formalin-fixation and paraffin-embedding were fireed bv 
pretreatment of tissue sections with 0.1% trypsin (pH 2.3) in 50mM tris with 0.1% calcium chloride at 
room temperature for 30 minutes. Sections were incubated for 45 minutes at room temperature with 
normal blocking serum (as suRtlied in the Vectastain kit) to suRtress non-specific binding of 
immunoglobulirL The prepared tissue sections were then submitted to the following avidin biotin 
complex (ABC) treatment to localize Ras and/or fv^c expression in cells for immunocytochemical 
examination (Hsu et al., 1981). Sections were washed once in PBS and incubated for 1 hour at room 
temperature with either 2.5pg/ml of anti-ros or 1:50 dilution of 3S\i-myc or mouse IgG which served as 
a negative control. Both antibodies were commercially available. The clone pan-rorlO anti-ros, 
(Oncogene Research Products. Cambridge, MA) was a purified mouse monoclonal to an imdetermined
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epitope of the Ras protein common to K-ras. H-ras and N-ras. Pan-ras (Ab-3) was shown to react with 
the ras p21 proteins of human, mouse and rat origin by- Western blotting, immunoprécipitation, 
immunofluorescence, and immunohistochemistry. The anti-mvc antiboth (Santa Cruz Biotechnology. 
Santa Cruz. CA) was an afflnity-purifled rabbit polyclonal antiboth raised against a peptide 
corresponding to amino acids 1-262 mapping at the amino terminus of c-Myc (N-262) of human origin 
and was shown to react with c-Myc p67 of mouse, rat and hum an origin by Western blotting, 
immunoprécipitation, and immunohistochemistry. The sections were incubated for 30 minutes at room 
temperature with a{^opriate biotinylated secondary anulxxfy directed against the host for the primary 
antibody (as directed in the Vectastain kit). Sites of positive antibody reaction with the ras or myc 
proteins were visualized with the chromogen substrate, amino-ethyl carbazole (AEC). and counter 
staining was with Meyer's hematoxylin. Sections were cleared and mounted with an aqueous mounting 
medium (Aquamount Baxter Laboratories).
STATISTICAL ANALYSIS 
The data were analyzed using SAS. The procedures used to test for significance among the 
main treatment efiects was the General Linear Model (GLM), and to test for significant difierences 
between treatment groups and the parameter the Tukey-Studentized multiple comparisons test was 
applied. The univariate and firequency procedures were employed to obtain information about the 
distribution of these parameters among the difierent treatment groups. Weight and intake data were 
analyzed using a repeated measures design and difierences between groups were determined using a 
Tukey-Studentized multiple comparisons test
RESULTS
Body weight gain and dietary intake levels were compared between 2-AA treated and untreated 
rats during the 80 days of the experiment Significant decreases in body weight gain were observed in 
rats fed diets adulterated with the addition of 2-AA at 75mg/kg and lOOmg/kg of diet As shown in Fig. 
6.1. a significant decrease in boc^ weight gain was noted in the group of rats exposed to 2-AA (75mg/kg 
diet) at the end of week 2 and at a similar time point (the end of week 3) for the group of rats exposed to 
2-AA (lOOmg/kg diet) when compared with control animals. The departure in weight gain compared
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Figure 6.1. Effect of 2-AA on animal bod) weight Male F-344 rats were maintained on an untreated, 
or 2-AA adulterated diets at lOOmg/kg, 2-AA at 75mg/kg, or 2-AA at 50 mg/kg of diet for 80 days. 
Each data represents the average group weekly bocb weight of ten rats for 2-AA at lOOmg/kg or 
untreated(100mg) or five rats for 2-AA at 75mg/kg and 50mg/kg and imtreated (50 & 75mg/kg) of diet
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with control animals remained significant in both these groups of 2-AA exposures for the remainder of 
the experimental period. On the other band, no significant departure fiom control animals in boch* 
weight gain was observed among rats treated with 2-AA (50mg/kg diet). Similarly, as shown in Fig.6.2. 
a significant decrease in dietary intake was observed for anim als exposed to 2AA (lOOmg/kg diet) at 
week 2 of the experiment and anorexia persisted in this group of anim als throughout the rem ainder  of 
the stuck". On the other hand, in contrast to the significant decrease in body weight gain observed in rats 
exposed to 2-AA (75mg/kg diet), a significant decline in dietary intake was observed in these anim als 
only for weeks 7 and 8 of the sturk". suggesting the presence of cachexia in spite of normal dietary levels 
of intake. The rats exposed to the lowest lev el of 2-AA (50mg/kg diet) did not differ significantly from 
control animals in dietary intake at anv" time point during the comse of this sturk .
Plasma glucose levels are shown in Fig 6.3. The range of normal male rat plasma glucose is 
108-224+/-28.6. while a streptozotocin-induced diabetic rat displays a range of 418-802+/-108.3. As 
indicated in Fig 6.3. the levels of plasma glucose at termination were elevated by dietary exposure to 2- 
AA at lOOmg/kg and 75mg/kg respectivek . Plasma glucose values were 474.71 and 636.25 for non- 
fasted rats exposed to 2-AA at lOOmg/kg and 75mg/kg of diet, respectively. Glucose in elevated 
concentrations can attach to a varietv of proteins nonenzymatically (Broderick et al.. 1993). For 
instance, glucose can interact with red blood cell hemoglobin to form stable covalent bonds, a reaction 
that occurs in proportion to blood glucose concentration (Bunn 1981). Glycated hemoglobin therefore 
provides an accurate measure of serum glucose levels, independent of diet and festing state. The per­
cent of glycated hemoglobins (Fig 6.4) was elevated by exposure to 2-AA at lOOmg/kg diet and 
75mg/kg diet, respectively. The normal percentage of glycated hemoglobins in a rat range from 3.1 - 
4.7% + 0.38%, while a range of percentage of glycated hemoglobins are 7.9-10.8%+/-0.95% in a 
streptozotocin-induced diabetic rat. Mean percentages of glycated hemoglobin were 13.03 and 14.5 in 
rats exposed to 2-AA at lOOmg/kg and 75mg/kg of diet, respectively. Assessment of the effects of a 
chemical on kidney function can be performed by evaluating serum chemistry levels of blood urea 
nitrogen, serum protein levels and creatinine levels. The values for these clinical chemistry parameters 
are shown in Fig 6.5 and 6.6. As shown in Fig 6.5, blood urea nitrogen (BUN) was significantly
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Figure 6.2. The effect of 2-AA ingestion on rat dietary intake. Rats were maintained on an untreated or 
2-AA adulterated diet at lOOmg/kg, 2-AA at 75mg/kg, or 2-AA at 50 mg/kg of diet for 80 days. Each 
data represents the average group weekly bod) weight of ten rats for 2-AA at lOOmg/kg or 
untreaW(100mg) or five rats for 2-AA at 75mg/kg and SOmg/kg and untreated (50 & 75mg/kg of diet
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Figure 6.3. Plasma glucose levels measured in treated and untreated non-âsted rats at terminatioiL 
Each bar represents the treatment group mean (+ SEM ) of five rats for treated and of four rats 
untreated, except treated and untreated lOOmg which is the mean of 7 rats.
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Figuie 6.4. The effect of 2-AA adulterated diet on the percentage of glycated hemoglobin in rat serum 
at termination. Each bar represents the treatment groiq> mean (+ SEM ) of five rats for treated (50mg/kg 
&75mg/kg) and for lOOmg/kg 14- and 30-days, or three rats for 2-AA at lOOmg/kg diet for 80-days.
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deN-ated by- dietary exposure to 2-AA at 100 and 75mg/tg diet when compared with respective controls, 
while serum protein levels were decreased as shown in Fig. 6.6. Creatinine levels were unaffected by 2- 
AA exposure levels. Chemically induced increases in BUN may not necessarily reflect kidney damage 
but may be secondary to dehydration and/or protein catabohsm. both of which are sym^oms of diabetes.
The results of the glucose tolerance test are shown in Table 6.1. Plasma glucose levels of 2- 
AA-treated rats were significantly higher in all samples taken at time intervals following oral glucose 
administration, as compared with those of untreated rats. In the former cases, moderate increases in 
glucose levels was shown in the plasma at 30 and 120 minutes, but no obvious change could be found in 
the imtreated animals. In contrast, insulin levels of 2-AA treated rats were remarkably similar to those 
of untreated rats in all samples taken at the times shown in Table 6.1.
Table 6.1. Glucose tolerance test Alteration of plasma glucose and insulin levels after oral glucose 
administration to control and 2-AA treated animals
Treatment 0 min. 30 min. 60 min. 120 min. 180 min.
Glucose Untreated 100.2+5.49' 187.4±69.2" 191.6+54.7^ 219.4+80.7° 212.0+40.7°
(m gdl') Treated 97.0+14.74* 390.2+141.0* 410.0+138.3* 493.6+215.6* 422.2+109.8*
Insulin Untreated 169.8+33.7 * 282.4+172.4* 230.8+60.1* 201.2+80.8* 176.5+68.3*
(|iUmT‘) Treated 185.8+44.5 * 331.4+155.5* 268.0+112.3* 209.2+90.0 * 268.0+142.3 *
Each data represents the mean (+ SD) of five animals. Means with the same letters are not statistically 
different fix)m untreated animals.
Cytokine production has been implicated as a causative 6ctor in the development of DDDM.
The enhanced production of TNF-a by unstimiilated macrophage from rats exposed to 2-AA at 
lOOmg/kg and 75mg/kg of diet are shown in Figiue 6.7. Although the level is 10-fold lower than that 
obtained by stimulation with IPS (Fig. 6.8), it has been hypothesized that secretion of chronic low levels 
of this cytokine are more cytotoxic than transient higher levels. A large intra-group variation was 
observed in the levels of TNF-a secreted by the alveolar macrophages of exposed rats. It was observed
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Figure 6.5. Serum levels of BUN of rats fed 2-AA adulterated diets at 50mg/kg, 75mg/kg, or lOOmg/kg 
of diet Each bar represents the treatment group mean (+SEM ) of five rats for treated (50mg/kg 
&75mg/kg) and for lOOmg/kg 14- and 30-days, or seven rats for 2-AA at lOOmg/kg diet for 80-days.
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Figure 6.6. Levels of total protein and creatinine in the serum of untreated and 2-AA treated rats. Each 
bar represents the treatment group mean (+SEM ) of five rats for treated (50mg/kg &75mg/kg) 80 days 
and (lOOmg/kg) 14- and 30-days, or seven rats for 2-AA at lOOmg/kg diet for 80-days.
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Figure 6.7. Bioactrvitv’ of tumor necrosis factor alpha in spent media of rat alveolar macrophages. (Top) 
Levels of TNF-a in unstimulated alveolar macrophage &om untreated and 2-AA treated rats. (Bottom) 
Levels of TNF-a in lipopolysacchaiide stimulated alveolar macrophage fiom untreated and 2-AA 
treated rats.
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that rats which exhibited overt ^mptoms of morbidity at time of termination (e.g. diuresis, cachexia, 
hypersensitivity of extremities) secreted higher levels of TNF-a. while rats exhibiting a more "‘normal” 
state of health had more normal values of TNF-a. Although the data are not significant, trends were 
observed in the levels of TNF-a.
Histological examination bv light microscopy could not detect a change in the islet cells of the 
pancreas or in the architecture of the exocrine pancreas during 14 days and 30 days of the exposure to 2- 
AA at lOOmg/kg diet, nor were histologic changes observed in the endocrine or exocrine pancreas of 
rats fed 50mg/kg of 2-AA adulterated diet, as shown in Fig. 6.8A. At 63 days of treatment, a few cells 
in almost all of the islets examined had some cytoplasmic vacuoles, which were fainth* and 
homogeneously stained with eosin. as shown in Fig. 6.8B. In animals treated for longer than 63 davs 
with 2-AA adulterated diets at lOOmg/kg and 75mg/kg diet the cytoplasmic vacuoles were observable in 
most cells, except for the few remaining cells on the periphery of the islets. The size of the vacuoles 
varied to the extent that some of the vacuoles were large enough to occupv a major portion of the 
cytoplasm and displace the nuclei as shown in Fig. 6.8C-D. Gross morphological changes in the 
exocrine pancreas of these animals were observed as well. Membrane ghosts of acinar and islet cells 
were observed throughout much of the pancreas of rats exposed to lOOmg/kg and 75mg/kg of 2-AA 
adulterated diets for 80 days. There was no observable infiltration of lymphocytes or macrophages in 
the pancreas of control or treated rats suggestive of an inflammatory response.
Using guinea pig anti-porcine insulin as primary antiserum, clear positive reaction products to 
insulin were observed in almost all of the islet cells of pancreas, except for peripheral cells, fiom 
imtreated animals. A similar staining pattern was also observed in the pancreas of rats treated for 14- 
and 30-days with 2-AA at lOOmg/kg of adulterated diet and fiom rats treated with 2-AA at 50mg/kg of 
adulterated diet, as showu in Fig 6.9A-D. In the case of 2-AA exposure for longer than 63 days, as 
shown in Fig. 6.9E-F. the staining intensity became fainter with duration and dose of 2-AA 
Sev eral lines of evidence indicate that some of the known oncogenes exist in rat tissue and are expressed 
under a variety of physiological conditions, including regeneration and neoplasia (Richmond et al..
1988). Using oncogene proteins, immuncxytochemistry was performed to determine whether
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Figure 6.8. H & E sections of untreated or 2-AA treated rat pancreas. A  Islet and surrounding acinar 
cells from an untreated rat H&E. 400 .x. B. Islet and surrounding acinar cells fiom a 2-AA treated rat 
( lOOmg/kg diet) at day 63. H&E. 200 x. The central portion of nearly all islets contain large cytoplasmic 
vacuoles but the acinar architecture appears normal. C. Islet and surrounding acinar cells fiom a 2-AA 
treated rat (75mg/kg diet) at day 80. Large vacuoles and necrosis of acinar cells are evident H&E. 400 
X D. Islet and surrounding acinar cells fiom a 2-AA treated rat ( lOOmg/kg diet). Cell ghosts, large 
vacuoles, and necrosis are present in islets and surrounding exocrine tissue. H&E. 200 x .
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Figure 6.9. Inununocytochemical staining for insulin in rat pancreas. A. Islet and surrounding acinar 
cells from an untreated rat (magnification 200x). Intense reaction products (arrow) to insulin are 
present in most of the islet cells except the periphery cells, using guinea pig anti-porcine insulin as 
primary antiserum. B. Islet and surrounding acinar cells demonstrating insulin (arrow) in the pancreas 
from a 2-AA treated rat at lOOmg/kg of diet for 14 days.(magnification x 200). C. Islet and surrounding 
acinar cells 6om a 2-AA treated rat at lOOmg/kg diet for 30 davs. Insulin is denoted with arrow 
(magnification x 200). D. Islet and surrounding acinar cells Grom a rat exposed to 2-AA (50mg/kg diet) 
for 80 days, (magnification x 200). E. Islet and surrounding acinar cells fiom a rat exposed to 2-AA 
(75mg/kg diet) for 80 days. Large vacuoles and only slight reaction products to insulin (arrow) are 
present. Necrosis of acinar cells is evident F. Islet and siurounding acinar cells fiom a rat exposed to 2- 
AA at lOOmg/kg diet for 80 day’s, (magnification x 400). Large vacuoles and only slight reaction 
products are present in the islets (arrow). Necrosis of acinar cells is evidenced ly  opened voided areas 
normally occupied by cells.
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enhanced ras and/or c-myc oncogenes expression as present in the pancreas of rats. Histological 
examination bv' light microscopy did not detect differences in the positive reaction products to ras 
oncogene protein in the pancreas of 2-AA treated rats regardless or dose or duratiotL and no discerning 
differences in Ras reaction products were observed between the pancreas of untreated versus treated rats. 
A very faint, non-specific stain was observed in the cytoplasm of almost all acinar cells whether the 
pancreas originated from an untreated or 2-AA treated rat Since observations failed to detect 
heightened expression of ras in treated animals, the faint staining was deemed constitutiv e expression.
A distinctive pattern of peripheral islet-cell staining of reaction products to the c-myc oncogene protein 
was detected in the islets of pancreas derived from untreated rats. This pattern of staining was also 
common in the pancreas of rats treated for less than 63 days, and in the pancreas of rats treated for 80 
days with 2-AA at 50mg/kg diet as shown in Fig.6.10 A  As shown in Fig. 6. lOB. the pancreas of rats 
exposed for greater than 63days to 2-AA at 75mg/kg or lOOmg/kg diet displayed a different pattern of 
staining for the myc oncogene protein compared with untreated animals. Unlike the peripheral islet cell- 
confined staining pattern observed in untreated rats and those treated with 2-AA for less than 63 days, 
clear positive reaction products to c-myc were observed in many of the acinar cells. The pattern of most 
intense staining for c-myc reaction products was observed in the acinar cells surrounding islets which 
showed the greatest amount of toxic insult^ e.g. large cytoplasmic vacuoles. The observed pattern of 
acinar cell staining was detected only in the pancreas of rats exposed for greater than 63 days of 2-AA 
treatment and fed 2-AA adulterated diets at lOOmg/kg or 75mg/kg of diet.
DISCUSSION
One of the first signals thar alerts the possible presence of diabetes mellitus is hyperglycemia, and 
hyperglycemia is often one of the first signals that suggests a chemical compound is a pancreatic g-cell 
toxin (Porte and Schwartz, 1996). In humans, clinical manifestations of diabetes mellitus includes 
hyperglycemia (serum glucose >180mg/dl), diuresis (increased urine ouqnit). proteinuria (presence of 
protein in the urine), glucosuria (presence of glucose in the urine), polydipsia (increased drinking), 
cachexia (a wasting appearance), elevated blood urea nitrogen (BUN), dehydration, and neuropathy. The
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Figure 6.10. The detection of c-myc oncogene expression in rat pancreas. A. Immunocytochemistr} 
detection of positivity (arrow) to c-myc are evident in the cells lining the periphery of islets of 
Langerhans of a pancreas fiom an untreated control rat. A similar staining pattern was observ ed in rats 
treated for less than 62 days at 0.01% or at 0.005% (400 x). B. Immimocytochemical detection of 
positivity to c-myc appeared in acinar cells surrounding islets (arrows) of rat pancreas which sustained 
severe injury following ingestion 2-AA(0.01%) adulterated diet for 80 days (400 x).
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observational, serological, and pathological results presented in this stud} support the find ings that 
chronic dietaiv exposure to 2-AA at lOOmg/kg of diet or 7Smg/kg of diet for 80 days induces diabetes in 
the F-344 rat model. Qualitative cage side observations of exposed rats indicated the presence of 
polydipsia, diuresis, cachexia, and perhaps symptoms of neuropathy—a heightened sensitivity in fore 
paw’s most likely resulting fiom ketoacidosis. The elevated serum glucose and BUN levels, percentage 
of glycated hemoglobins, the low serum protein lev els, the depressed dietary intake and weight g a in  are 
indicative of diabetes mellitus. The glucose tolerance test administered to rats at 62 days of dietary 
exposure to 2-AA. provided further support for this find ing and served as a useful tool for evaluating 
endocrine pancreatic function. A rapid rise in blood glucose levels was observed immediately following 
ingestion of the glucose load in treated and untreated rats. However, unlike the steady decline in blood 
glucose levels at subsequent time points as observed in untreated rats, the blood glucose levels in rats 
exposed to the toxic effects of 2-AA remained elevated and were still significantly elevated 3 hours after 
the glucose load The significantly elevated levels of blood glucose in the presence of normal insulin 
levels is suggestive of insulin resistance (a subnormal biological response to insulin), and suggests that 
the insulin secreted by the |3-cells is nonfunctional or poorly functional in the 2-AA treated rats. The 
cytokine TNF-a was shown to be involved in inducing insulin  resistance in cachexia (Kanety et al..
1995. Tessitore et al., 1993; Begum and Ragolia. 1996). As was shown in Fig. 6.7. levels of this 
cytokine were increased following 2-AA exposure and may play a role in the insulin resistance observed 
in this stuck’. Immuncxytochemical ev’aluation with light microscopy and using  porcine anti-insulin as 
the primary antiserum, demonstrated that insulin was detected in the ^-cells of both 2-AA treated and 
untreated animals, and the pattern of staining intensity became weaker with increasing dose and 
duration of 2-AA e)qx)sure. Only Mntly stained reaction products were detected in the p-œlls of rats 
exposed to 2-AA at lOOmg/kg and 75mg/kg of diet for 80 days, suggesting that insulin stores were 
almost entirety depletecL Additionally, the cytoplasmic vacuoles were absent of stain, indicating a loss 
of p-cell granules. Although the detection of normal serum insu lin  levels for the glucose tolerance test 
and the histological observations of depleted P-cell insulin  stores in rats exposed to 2-AA at lOOmg/kg 
and 75mg/kg of diet seems contradictory, the data can be reconciled While the measurements of the
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peripheral serum insu lin  concentrations provide valuable information, there are significant limitations 
inherent in estimates of pancreatic insulin  secretion rates based entirely on peripheral insulin 
concentrations (Polonskv'. 1995). Insulin is secreted directly into the portal vein rather than into the 
peripheral circulation, and the liver is the major site of insulin  clearance and extracts approximatelv 
50%  of the hormone on first pass (Jaspan and Polonsky. 1982). Fractional hepatic insulin extraction 
may vary under different physiological conditions, especially conditions which alter insulin 
concentrations (Farber et al.. 1981). Another limitation of the glucose tolerance test is the 
radioimmunoassay kit used to measure insulin  Virtually all the polyclonal anti-insulin antibodies used 
to measure insu lin  have a high degree of cross-reactivitv with proinsulin and the proinsulin-conversion 
intermediates. Since the anti-insulin antiboch' provided in the radioimmunoassav kit used in this stuch’ to 
measure insulin levels has a reported cross-reactivity with pro-insulin of 45% . the total insulin 
immunoreactrvitv measured with the anti-insulin antibody represents the sum of ‘‘true” insulin plus the 
proinsulin and proinsulin-conv ersion intermediates. This systematic overestimation of the insulin 
concentration is relative in normal an im als whose proinsulin and intermediates are low: however, in 
cases of impaired glucose metabolism the proinsulin forms may be disproportionately higher (Heaton et 
al.. 1988). Pro-insulin could be released from the rough endoplasmic reticulum iqx>n cell disintegration, 
a portion of the insulin  detected in the blood of exposed rats may have been in the nonfunctional pro­
insulin form (Morgan and Lazarow. 1963). Diabetes often presents itself in phases and insulin and 
glucose levels fluctuate between these phases of disease. Plasma in su lin  levels were shown to decrease 
during the early phase of hyperglycemia in alloxan-induced diabetic mice and then increase markedly to 
above normal levels during a hypoglycemia phase. After the establishment of overt diabetes, plasma 
insulin  levels returned to below control levels and became very low or inuneasurable in the course of a 
few weeks (Rerup, 1970). Serological and histological evaluations indicate that prior to 63 days of 2- 
AA dietary exposure, there is no evidence of diabetes or pancreatic toxicitv- in exposed rats. Histological 
observations of the pancreas of rats exposed for 63 days indicate the presence of cytoplasmic vacuoles 
in the P-cells of m any of the islets, yet non-fasting serum glucose values were normal. The rats at this
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time period of 2-AA pancreatic toxicity (63 days) may have entered the hypoglycemic phase of the 
diabetic process.
Some important cytological and immunocytochemical findings were obtained in this study 
which might facilitate the elucidation of the mechanism by which 2-AA induces pancreatic toxicitv'.
The mechanisms through which chemical-induced P-cell toxicities are mediated remain controversial: 
however, two main theories emerge (Malaisse. 1986). The first mechanism of chemical-induced 
pancreatic islet-cell toxicity, for which alloxan is an example, is disruption of the plasma membrane 
integrity. Alloxan causes increases in P-cell permeability' due to binding of sulfhydryl groups on the 
plasma membrane. Degenerative changes ensue due to the production of oxygen radical species and the 
heightened sensitivity of the P-cell to reactive oxygen species (Pieper et al., 1996. Rabinovitch et al.. 
1996a.b). The histological changes in islets after alloxan poisoning have been reported and indicate that 
the P-cell nucleus undergoes kaiyolysis. the cytoplasm disintegrates, the ceU boundaries disappear and 
finally a mass of ddnis containing fiagments of nuclei appear during the final phases of the necrotizing 
process. Acinar cells are only slightly afiected. and there is a complete absence of a mononuclear cell 
response. No other histological changes are encountered (Cooperstein and Watkins. 1981). A second 
mechanism of chemical-induced pancreatic islet-cell toxicity, for which cyproheptadine is an example, 
is inhibition of the transfer of insulin precursors firom the rough endoplasmic reticulum to the Golgi 
apparatus. Cyproheptadine toxicity results in the accumulation of the synthesized precursors in the 
rough endoplasmic reticulum (Hanai, 1984). The effects of the antihistaminic drugs are characterized 
histologically by a depletion of secretory granules and formation of large cytoplasmic vacuoles in the P- 
cells and vésiculation of the rough endoplasmic reticulum, while necrosis is absent (Hanai. 1984: Rerup. 
1970: Longnecker et al.. 1972). The morphologic and biochemical changes are reversible upon 
termination of exposure and the pancreotoxicity is species-specific, being observed only in the rat. Also, 
the toxic effects were greater after oral exposure than after intraperitoneal injection.
The cytological. immunocytochemical. and histological results presented in this s tu 4  indicate 
that 2-AA-induced pancreatic toxicity followed neither of these reported mechanisms precisely, but 
rather characteristic changes of each mechanism were observed, suggesting that 2-AA may exert its
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effects through an independent mechanism yet to be defined. As with alloxan toxicitv . observed 
histological changes resulting from 2-AA exposure included the disintegration of the cytoplasm of P- 
cells. the disappearance of cell boundaries and necrosis. Further support for this mechanism comes 
from the TNF-a assay results. The macrophage-derived cvtokine. TNF-a, has been implicated in 
human and animal P-cell destruction which is mediated bv oxygen free radicals, and elevated serum 
levels of this cytokine have been shown to precede and accompany the onset of IDDM (Hussain et al.. 
1996). Although a lack of evidence for an immune response was observed, it was shown that low 
chronicly elevated levels of TNF-a are more toxic than acutely higher levels (Hussain et al.. 1996). The 
vacuolization and destruction of the histoarchitecture of the acinar cells may also be explained, in part 
by a cytokine-mediated free radical mechanism. A fiee radical mechanism would also explain the 
apparent necrosis observed in the exocrine pancreas. The metabolism of 2-AA is thought to proceed via 
hepatic N-oxidation followed by acétylation and since the acetyl is a good leaving group, an ary l 
nitrenium ion group may be formed prior to or after uptake of this compound by the pancreas. The 
nitrenium ion appears to be the ultimate electrophilic metabolite that binds DNA (Rodrigues et al..
1993). Smdies have shown that the N-acetylase activity in the fiver closely correlates with the activity of 
that enzyme in the pancreas (Martell and Weber. 1993). Furthermore, epidemiological studies indicated 
a prevalence of the rapid acetylator phenotype among EDDM patients, and the F344 rat expresses a rapid 
acetylator phenotype (Burrows et al.. 1978).
On the other hand, degranulation and the formation of large cytoplasmic vacuoles were 
observed in the insulin-secreting p-cells of the pancreas of 2-AA treated animals and as observed with 
cyproheptadine. Fortuitously, the rat was the mammalian study model and ingestion the route of 
exposure in this study. These may have been contributing 6ctors to 2-AA-induced pancreatic toxicity. 
Immunocytochemical evaluation with fight microscopy and using porcine anti-insulin as the primary 
antiserum, demonstrated that insulin was detected in the beta cells of both 2-AA treated and untreated 
animals, and the pattern of staining intensity became weaker with increasing dose and duration of 2-AA 
exposure. Additionally, the cytoplasmic vacuoles were absent of stain, indicating a loss of beta cell 
granules. These results suggest that the mechanism of beta cell vacuolization by 2AA does not originate
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from the rough endoplasmic reticulum since the cytoplasm did not stain positive, but rather suggests that 
cytoplasmic vacuolization may be caused by hydropic degeneration. Furthermore, unlike either alloxan 
or cyproheptadine, vacuoles were observed in the pancreatic acinar cells of rats exposed to 2-AA for 
greater than 63 days at both lOOmg/kg and 75mg/kg of diet Increases in expression of growth control 
genes in response to cell loss or toxicity have been characterized in many organ systems(Roberts et al.. 
1997; Spankle et al.. 1996). To investigate the possibility that oncogenes serve as signals mediating 2- 
AA pancreatic toxicity and that the detection of these proteins in specific regions of the pancreas may 
aide in elucidating the toxic mechanism, the expression of ras and c-myc were examined. In untreated 
and treated rat pancreas the expression of ras was near the threshold of detection in acinar cells and islet 
cells alike. Only few isolated non-parenchymal cells along capillaries showed a distinct signal. In 
untreated rat pancreas, expression of c-myc was detectable at low level in most peripheral islet cells, and 
was assumed to represent alpha and delta cells. In treated rat pancreas, a similar staining pattern and 
intensity was observed for 2-AA at 14 days. 30days. and at 50mg/kgfor 80 days. Both the pattern and 
intensity of c-myc reaction products were altered by 2-AA exposure at lOOmg/kg and 75mg/kg diet for 
80 days. Grains of deep intensity were predominantly localized over the acinar cell cytoplasm. A low- 
level of c-myc reaction products was also observed in the islet periphery cells as in the islet cells of the 
untreated rats. The exocrine pancreas is under both short- and long-term neuronal and hormonal 
control. Pancreatic short-term regulation consists mainly of the stimulation of secretion during food 
digestion, while long-term regulation consists of the regulation of pancreatic mass and content of 
digestive enzymes according to the need of the organism (Scaglia et al., 1997). It has been shown that 
nuclear oncogenes function as mediators coupling short-term signals, which are rapidly elicited b\- cell 
surface stimulation, to long-term responses, such as growth and differentiation, by regulating the 
expression of specific genes (Lu and Logsdon. 1992). The enhanced expression of c-myc. an immediate 
early gene, and the lack of enhanced expression of ras. is consistent with the role of c-myc in cell 
proliferation and suggestive of an attempt by the pancreas to restore its architectural integrity 
(Farquharson et al., 1992; Hasmall et al., 1997). These results imply that the mvc oncogene may 
function in pancreatic response to toxic insult and may play a role in the mechanism of 2-AA-induced
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pancreatic toxicity. However, that the toxicity of 2-AA may involve extrapancreatic factors cannot be
eliminated. Additional studies are needed to elucidate the mechanism of 2-AA induced pancreatic
toxicit}’ and the potential of See radical involvement in thi^ mechanism
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CHAPTER 7 
SUMMARY AND CONCLUSIONS
The mechanisms wherd^- the PAH compounds exert their biological toxic efifects are poorly 
understood. However, the association between PAH compounds and environmentally or occupationally 
caused diseases, such as cancer, dates back to Pott’s initial suggestion in 1775 that the high incidence of 
scrotal cancer in chimney sweeps resulted from their occupational exposure to soot (Pott, 1963). 
Therefore, while environmental contamination by PAH compounds is not unique to contemporary times, 
the increased use of fossil fuels has resulted in an increasing rate of release of these compounds into the 
environment (Grimmer et al.. 1995). In addition to their widespread occurrence in the environment the 
PAH compounds contain some of the more potent experimental chemical carcinogens known. This 
potenc%’ is reflected in the fact that a single dose can induce tumors at various sites, depending on the 
animal species and route of administratioit Although the significance of PAH compoimds with regard 
to environmentally caused diseases and cancer in humans is difficult to estimate, the combination of 
wide distribution and potent toxic activity requires that these compounds be regarded as suspect agents 
(Dipple. 1983; Grimmer et al.. 1995).
The major source of PAH compounds in the environment arises from various forms of 
inefficient combustion. Instead of being completely oxidized to carbon dioxide, hydrocarbon fiagments 
are created which can interact and fuse with one another to build complex ring structures. These 
complex structures can further react with nitrogen, sulphur, and oxvgen to form substituted derivatives. 
The PAH compounds are particulate associated and, while initially released largely into the atmosphere, 
they are subsequently deposited in soil and water. In the water, the PAH compounds concentrate in the 
sand or bottom sediment, and concentrations can be between 2 to 5 orders of magnitude greater than in 
the surface water (Shahad, 1980). Aquatic life, including shellfish (oysters and clams) and fin fish, can 
take up PAH compounds from their environment This is of particular concern for the more palatable 
fish with higher fat content such as salmon. PAH compounds are also widely distributed in the soil 
and. emissions may settle on edible plants or PAH compounds may be incorporated into the chloroplast 
lipids of green vegetables. PAH compounds have been detected in plant by-products such as flour and
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vegetable oil (Baunu 1978). PAH contamination of food can also arise during the processing and 
cooking of proteinaceous foods.
The major source of human e^qx>sure to environmental PAH contaminants on a daily weight 
basis is from the diet (Strickland and Groopman, 1995). This exposure pathway is consistent with a 
large pool of epidemiological data linking the incidence of human cancer (20-50%) and disease with 
dietar}' factors (Blot, 1992; Statland. 1992; Lutz and Schlatter. 1992, 1993; Sugimura and Sato. 1983; 
Porter. 1993; Comstock et aL 1991; Sauer and Sipes. 1995). Other general and specific studies have 
supported this view (Lutz and Schlatter. 1993; Peters et al. 1989; Tubiana. 1991). Observations in 
animals have shown that some types of cancer are related to certain carcinogens in their food, and 
several types of cancer similar to that in humans have been induced in experimental animale by 
administration of carcinogens, such as nitrosamines and mycotoxins. suggesting that their presence in 
human diets can increase cancer risk (Lijinsky. 1983).
Humans and animals are rarely exposed to individual compounds. More often, they are 
exposed to combinations of compounds, either concurrently or sequentially, which can ha\ e difiering 
effects on individual cells and organ systems (Sauer and Sipes. 1995). The interactions of differing 
compounds can alter the biological toxic response relative to that expected of an individual compound. 
The interactions of compounds in a mixture may potentiate the response, may inhibit the response, or 
less likely produce an additive effect. The interactions of differing compounds can affect the metabolism 
or disposition of a compound Interactions of compounds can also affect the susceptibility of a tissue to 
toxic injury.
The studies described in this document investigated the potential toxic effects of three different 
classes of polycyclic aromatic hydrocarbons—nitroarenes. aiylamines. and alternant aromatics— when 
administered in the diet as individual agents and when administered concurrently as composites of a 
ternary mixture. The selected representative compounds incluckd the 1.3-, 1.6- and 1.8-dinitropyTenes 
(DNP) as nitroarenes; 2-aminoanthracene (2-AA) as an arylamine; and benz[a]anthracene (BA) as an 
altemam PAH. Although numerous studies have evaluated these and other similar PAH compounds 
individually for their biological effects following topicaL subcutaneous. intraperitoneaL or intratracheal
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insrillation administration, limited studies have investigated the effects associated with ingestion. More 
detailed metabolic information would be useful in understanding the basis for the differential results 
observed between bacteria and mammalian cells. Furthermore, mammalian cells in vivo could be 
exposed to metabolic products firom bacteria in the gastrointestinal tract causing a toxic effect different 
firom that predicted b> in vio-o mammalian cell cultures, and whole animals are necessary' to extrapolate 
in vitro toxicity' data to determine the potential for human risk. In addition, few studies have been 
performed which simultaneously exarttined the effects of ingestion of individual compoimds along with 
the interactive effects of ingestion of the same compounds when admirtistered concurrently as 
components of a mixture. To this end a comprehensive program was undertaken to examine the 
differing effects of compounds when ingested as individual agents and as components of a mixture in 
the F-344 rat model. Radioisotope metabolic binding studies were performed to evaluate the absorption, 
distribution, and elimination of individual selected anthracene- and pyrene-based compounds following 
oral administration: acute toxicity trials were initiated to evaluate the short-term biological effects of 
repeated dosing of selected compounds and to define maximum tolerated chemical concentration levels: 
and chrortic ingestion studies were conducted to determine long-term individual effects of the selected 
compounds and of a mixture when admirtistered at the maximum tolerated dietary concentration.
The consensus of the results of these studies clearly indicate that the toxicity of DNP and BA is 
minimal when administered in the diet at concentrations up to 0.10% and fed to F-344 rats for a period 
of up to 80 days. These results were not anticipated, especially in light of the fact that the dinitropyrenes 
are considered to be among the most mutagertic agents ever tested W bacteria reversion assays 
(Rosenkranz and Mermelstein, 1983). Numerous studies have demonstrated the mutagertic and 
carcinogeitic effects in animal exposures to the dinitropyrenes, especially 1,6-dinitropyTene. following 
topical application, subcutaneous injections, or lung instillation (Asokan et al., 1985; Ohgaki et al.,
1984. 1985; Dpuric et al., 1988; Smith et al., 1995). In these reported studies, the toxic effects occurred 
most fiequenth' at the site of admiitistration, suggesting that cells which come first in direct contact with 
these agents are more likely targets for their genotoxic action. However, results of radioisotope binding 
studies which exantined the metabolic distribution and excretion of the dinitropyrenes and
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benz[a]anthiacene. showed that both DNP and BA were rapidly excreted. Within forn- eight hours of 
gavage administration of radioisotope-labeled dinitropyrenes or benz[a]anthiacene. 89.6% and 74.7%. 
respectiv ely, of the recovered labeled compound was detected in fecal excreta. It is unlikely that this 
high fecal elimination is due solely to unabsoibed parent compoimd passing through the G.I. tract, 
because urinary radioactiviiy was also high. However, a low er absorption rate fiom the gastrointestinal 
tract may accoimt for the lowered toxicitv shown in this stiufy compared with studies demonstrating a 
toxic response in rats and mice following either injection or direct instillation of these compounds. The 
fecal contents were not examined for parent compoimd—only for radioactivitv . Therefore, while the 
fecal contents accounted for a significant amount of the labeled compound, w hether the feces represents 
compoimd metabolized by the liver and excreted in the bile or compound simply not absorbed was not 
determined. When tissue-bound label was examined, the skeletal muscle and gastrointestinal tract were 
the tissues of greatest accumulatioiL The compounds were labeled with tritium, either generally as with 
benz[a]anthracene or at seemingly unreactive ring sites as with the dinitropyrenes. Since water 
comprises 70% of lean both mass, detection of label in skeletal muscle tissue may reflect hydrogen 
exchange with tritium rather than reactive metabolites. Distribution of the labeled compounds in the 
circulation system and in the liver of rats were similar, with each compartment accounting for less than 
8% of tissue-bound label. The low percentage of recovered label detected in the liver relative to that 
detected in the gastrointestinal tract suggests that the intestinal tract may be a primary site for the 
metabolism and detoxication of these compounds. However, since it is highly improbable that the large 
amount of label recovered in the fecal excretions is strictly unabsorbed parent compound, these results 
also suggest that rapid biliary excretion by the liv er may account for a substantial amount of the 
recovered label. Unchanged compound found in the feces may be due to: 1) incomplete absorption 
following an oral dose: 2) excretion of the compound into the bile: 3) metabolites reconverted into 
parent compound by enzymatic and nonenzymatic action, and excreted; and 4) compound passively- 
excreted into the intestinal lumen (Dayton et al.. 1983). On the other hand. PAH compounds are 
susceptible to various metabolic transformations, the end result of which is to convert them into anionic 
species which are soluble and can be excreted. Studies to further identifv the in vivo urinary, biliary.
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and fecal metabolites of these compounds will help to further explain the pathways of PAH toxication 
and detoxification and may provide a better understanding of PAH environmental contamination and the 
risks of exposures to human health.
Although insignificant decreases in animal diet intakes were observed, no decrease in body 
weight no mortality or adverse effects in general health of animals ingesting DNP- or BA-adulterated 
diet were detected under the constraints of these studies. Morphological examination of tissues at 
necropsy failed to re\ eal any gross abnormalities. Furthermore, while several immune function tests 
were examined, the results indicate that ingestion of DNP- or BA-adulterated diet for 80 days was not 
iimnunosuppressive when administered at concentrations of 0.10% of the diet Atrophy of lymphoid 
organs or depression of lymphoid cell populations were not observed. Liver absolute and relative 
weights did not differ from untreated animals and hematological and serological parameters were within 
normal range values for the rat No hepatic tumors or altered hepatocytes were observed histologically, 
and no lesions were identrSed in the examination of other tissues. The results of these studies, however, 
were not confirmed by a review of other published reports. Intragastric administration to rats of 
ben/anthracene at lOOmg/kg/day for 4 days was shown by Torronen et al. (1981) to induce cytosolic 
antidiuretic hormone levels and increased relative liver weight in exposed animals by 19% when 
compared with untreated control animals. While in another study the induction of foci of altered 
hepatocytes was shown following a 1 day intragastric administration of 180 mg/kg benzanthracene to 
rats followed by a diet containing 2-acetylaminofluorene and carbon tetrachloride (Tsuda and Farber. 
1980). However, a stuck conducted by Dziedzic (1986) found that inhalation of high concentrations 
(1500(xg m") of diesel exhaust for 8 weeks revealed no significant changes in immune responses of 
exposed guinea pigs when compared with age-matched controls. The author concluded, as was the 
conclusion of these studies, that exposure to diesel particles did not exert major effects on the 
parameters of the immune system that were measuiecL Unfortunately, no studies were found which 
examined dietary exposure to BA or DNP compounds in mammalian systems, and a direct comparison 
of these cnted studies with the present stucfy' is problematic, since the route of eqx)sure and experimental 
prot(XX)ls differ significantly.
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In contrast to the lack of toxic responses in rats following oral exposure to the dinitropvTenes or 
benz[a]anthracene. a dose dependent and temporal progression of toxic effects following dietary- 
e?^sure to 2-AA was demonstrated by- these studies in the F-344 rat. Furthermore, a ternary mixture 
composed of 2-AA DNP. and BA was shown to attenuate the toxic effects of 2-AA suggesting that one 
or more components in the mixture suppressed the activation of 2-AA to its ultimate cytotoxic and/or 
genotoxic metabolite. These results were supported at several levels of investigation.
Observation data along with intake and both- weight data during the chronic study indicated a 
temporal response in toxic effects by ingestion of 2-AA when included in the diet at a concentration of 
0.01%. and a dose response in toxic effects were observed when 2-AA was incorporated into the diet at 
0.005% and 0.0075%. Acute toxicity studies indicated that ingestion of 2-AA at a dietary- concentration 
of 0.1% might result in overt morbidity and death if administered for longer than 14 days. Similarly, in 
animals fed a diet containing 2-AA(0.01%) for 80 days a premature mortality of 30%, and overt signs of 
morbidity-, anorexia, and cachexia were observed Decreases in weight gain and diet intake showed 
significant deviations fiom control animals. On the other hand rats fed the MDC-adulterated diet 
which contained 2-AA at the same level of dietary concentration (0.01%), did not exhibit obvious signs 
of toxicity- and anorexia, and premature mortality was not observed While weight gain was slowed by 
ingestion of the mixture, weight differences were not detected until a much later point in the study .
Since the concentration of 2-AA in the mixture was the same as 2-AA in the individual diet, differences 
in intake could not be accotmted for by differences in palatability.
A comparison of clinical hematology and clinical chemistry data between 80 day 2-AA treated 
and untreated or MIX-treated rats indicated that although statistical significance was limited 2-AA- 
treated rats had decreased WBC counts primarily due to decreased numbers of circulating lymphocytes. 
Chemical evaluations detected significant elev-ations in the serum enzyme lev els of AST and ALT 
following 80 days, and enzyme levels were elevated though not significant, by following 14- and 30- 
days of dietary administration of 2-AA to rats. Differences in these enzyme levels were not detected 
following 80 days of dietary administration of the mixture. The elevation in both ALT and AST in the 2- 
AA-exposed rats was moderate with the smaller animals exhibiting the higher ALT levels. The
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implication of these results %ns suggestive, but not definitive, of hepatocellular liver disease in the 2- 
AA-exposed rats and a lack of such effects in animals fed the PAH compound mixture for 80 days.
Atrophy of thymus and spleen along with the lower WBC counts were suggestive of an 
inunimosu|^)iessi\'e effect Iw dietary exposure to 2-AA. The significantly reduced splenocytes 
populations detected following dietary administration of 2-AA at a 0.01% concentration level were 
similarly conformationaL and the increase in relative spleen weight could be explained by vascular 
changes resulting from the loss of parenchymal cells (splenocytes) within the tissue. The observed 
alterations in lymphoid organ weight and cell counts showed temporal effects becoming more 
pronounced with the duration of exposure. While animals exposed to the mixture showed a similar 
trend, differences did not attain significance. However, analysis of the lymphokine data for DL-2 did not 
support an immimosuppressrve effect by 2-AA. A similar lack of consistent results supporting immune 
suppression was fotmd for pulmonary alveolar macrophages. Although the numbers of macrophages 
obtained from lung lavage fluid were significantly reduced following 80 days ingestion of either 2-AA- 
or MDC-adulterated diet the activity of the macrophage-secreted cytokine. TNF-ou-detected in culture 
supernatants was not suppressed, once again suggesting that 2-AA is cytotoxic and not 
immunosuRiressive.
2-Aminoanthracene is a potent carcinogen and is one of the few aromatic amines found to 
induce hepatomas and skin tumors (Lennox. 1955: Shear. 1938). A decrease in liver weight at 14 days 
followed by a progressive increase in weight to significance at 80 days in rats exposed to 2-AA(0.01%) 
adulterated diet was suggestive of toxic liver insult, while the absence of such effects in rats exposed to 
the mixture of compounds was suggestive of attenuation of such effects. A temporal and dose 
progression of hepatocellular lesions was detected in liver sections of rats following dietary 
administration of 2-AA(0.01%). whereas lesions of less severity were detected in liver sections of rats 
following 80 days of dietary administration of the PAH mixture. Foci of cellular alteration following 14 
days of dietary administration which progressed to focal hepatocellirlar hyperplasia following 30 days of 
dietary administration and on to hepatocellular adenomas following 80 days of dietary administration 
was observed in rats consuming 2-AA(0.01% or 0.0075%) adulterated diet On the other hand, only
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foci of cellular alteration were observed in rats administered the mixture of PAH compounds, even after 
80 days of consumption.
Experimental models suggest that foci of altered hepatocytes and h>perplastic nodules are 
precursors of hepatocellular neoplasms, and several studies have demonstrated expression of ras and 
myc oncogene proteins in spontaneous and chemically induced rodent liver tumors (Corcos et al.. 1984; 
Cote et al., 1985; Richmond et al.. 1992). This stuck examined ras and myc in formalin-fixed paraflBn- 
embedded sections of male F-344 rat liver. However, qualitative microscopic examination could not 
detect enhanced expression of these oncogenes in PAH-treated rat liver regardless of chemical 
adulteration. The lack of substantial increases in ras and myc expression after 80 days of dietary 
treatment with 2-AA is different than that observed following exposure to other known chemical 
carcinogens in the rat liver (Spankle et al, 1996; Butteworth et al.. 1994; Goldsworthy et al.. 1994). 
These results may similarly support a cytotoxic effect rather than a genotoxic effect b>' 2-AA and the 
attenuation of these effects 1^ the mixture.
2-Aminoanthracene is a potent carcinogen, and perhaps its most unusual characteristic is its 
specifidtv- for epithelial tissues of different animal species (Mitchell. 1985). Histological evaluation bv 
light microscopy of tissues other than liver revealed a unique and currently unreported toxic effect of 2- 
AA in the rodent model—that of pancreatic toxicity and the induction of diabetes. The results of glucose 
assays indicating severe hyperglycemia and histological review of the kidneys provided further support 
for these findings. Moreover, the toxic effects induced by 2-AA in the pancreas of rats showed a similar 
dose and temporal response as did the fiver of these same animals. Whereas, rats exposed to the mixture 
of PAH compounds showed no pancreatic lesions even though 2-AA was ingested at the same 
concentration of 0.01% in the diet
Some important cytological and immunocytochemical findings were obtained in this stucfy 
which might allow the elucidation of the mechanism by which 2-AA induces pancreatic and perhaps 
fiver toxicity. The mechanisms through which chemical-induced P-cell toxicities are mediated remain 
controversial; however, two main theories emerge (Malaisse. 1986). The first mechanism of chemical- 
induced pancreatic islet-cell toxicity, for which alloxan is an example, is disnption of the plasma
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membrane integrit}-. resulting from the generation of oxygen radicals. The P-cell of the islets is 
extremely sensitive to reactive radical species (Pieper et al.. 1996. Rabinovitch et al.. 1996a.b). A 
second mechanism of chemical-induced pancreatic islet-cell toxicity, for which cyproheptadine is an 
example, is inhibition of the transfer of insulin precursors frrom the rough endoplasmic reticulum to the 
Golgi a^aratus (Hanai 1984). The cytological. immimocytochemicaL and histological results 
presented in this stuck indicate that 2-AA-induced pancreatic toxicity followed neither of these reported 
mechanisms precisely, however, a mechanism involving radical species is implicated. The nitrenium 
ion appears to be the ultimate electrophilic metabolite of arylamines that binds DNA (Rodrigues et al.. 
1993). Studies have shown that the N-acetylase acthity in the liver closely correlates with the activity of 
that enzyme in the pancreas (Martell and Weber. 1993). Furthermore, epidemiological studies indicated 
a prevalence of the rapid acetylator phenotype among IDDM patients, and the F344 rat expresses a rapid 
acetylator phenotype (Burrows et al.. 1978). A radical species may similarly explain the injury 
sustained in the exocrine pancreas by dietary exposure to 2-AA. Studies have shown that reactive 
oxygen species may contribute to acute pancreatitis and necrotic death of acinar cells (Kaiser et al..
1996; Rivard et al.. 1995).
The activation of arylamines involves N-hydroxylation by microsomal cytochrome P-450. 
notably the hepatic specific P-4501A2. and O-acetylation of the N-hydro.xylated products by cytosolic 
transferases (Kato and Yamazoe. 1994; Gorrod and Manson. 1986; Carrière. 1992). Considerable 
interindividual variation both in the level of hepatic expression and in the rate of metabolism of 
CYPl A2 substrates have been reported (Kadlubar. 1994). Phenotyping studies have suggested that three 
phenotypes of the (ZYP1A2 gene may be distributed among the human population—slow, intermediate, 
and rapid metabolizers; and that considerable variation in the distribution of these phenotypes is seen in 
individuals of different racial/ethnic groups (Kadlubar. 1994; Smith et al.. 1995). For example, 
induction of CYP1A2 by cigarette smoking was shown in Caucasians but not in Chinese or in African- 
Americans (Kadlubar, 1994; Butler et al.. 1989). The initial N-hydroxylation step is followed by O- 
acetylation (Yamazoe et al.. 1994). It has been hypothesized that the hydroxylamine is acetylated to 
form the ultimate carcinogen, and hepatic cytosol contains N-acetyltransferase enzymes which can O-
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acetylate (Traynor et al., 1991). Humans and other mammalian species (with the exception of the dog 
and fox which are not able to acetylate compounds) express a genetic polymorphism in N-acetylation 
capacity that segregates individuals of each species into rapid, intermediate, or slow acetylators (Hein, 
1988). Rats in generaL and the Fischer 344 inbred rat in particular, are often utilized to study the 
toxicity and carcinogenicity of aromatic amines (Rao and Boorman. 1990). This is because the inbred 
rat mimics the polymorphism in N-acetylation capacity exhibited in humans (Hein et al.. 1991; Martell 
and Weber. 1993). The N-acetylation polymorphism is of both clinical and toxicological importance 
because rapid or slow acetylator phenotype can influence the toxic response from aromatic amines 
(Risch et aL 1995).
The nitroarenes. such as the dinitropyrenes. are activated via reduction by microflora in the 
gastrointestinal tract to N-hy droxyarylamines and subsequently by O-acetylation of the N-hydroxylated 
products by cytosolic transferases (Rosenkranz and Mermelstein, 1983). Thus, the dinitropyrenes and 
arylamines may share common pathways of metabolism to ultimate carcinogens and may compete with 
each other for the same activating enzymes (Kiefer et al.. 1994). The mixture of PAH compounds 
contained 2-AA: DNPiBA at concentrations of 0.01%:0.1%:0.1%, respectively. Thus, the 
dinitropyTenes were represented at a 10 fold greater concentration than 2-AA. It is likely that the 10 
fold greater concentration of the dinitropyTenes in the mixture successfully competed with 2-AA for 
acéty lation, thereby conferring an attenuating effect with the mixture. Further support for this 
hypothesis comes finm studies which show that the N-acetyiation polymorphism is expressed similarly 
in the liver and pancreas of inbred rats (Martell and Wdjer. 1993).
Additional studies are neected to further identify the basis of 2-AA toxicity and the attenuation 
of these effects by the mixture. Most importantly, radioisotope binding studies are needed to examine 
the distribution and excretion of 2-AA and its metabolites in the F-344 rat. These studies may suggest 
other avenues of 2-AA toxicity. For example, microscopic examination of 2-AA-exposed rats revealed 
that hydropic cytoplasmic alterations may be present in the testes of these animale and detection of these 
lesions were suggestive of testicular degeneration. The testes of mammals contain very long-chain (20 
and 22 carbon chains) fatty acids which are susceptible to lipid peroxidation. Detection of labeled
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compound in the testes may similarly s iq ^ r t  a &ee-radical theory and provide the impetus for further 
research to examine the effects of antioxidants, such as vitamin E. and a role for dietary therapy in 
combating aiylamine activation. Exploration of the theory of competition between the nitroarenes and 
arylamines could come ffom additional feeding studies in which each of the selected compounds is 
examined in combination to assess if indeed the nitroarenes and not benz[a]anthracene offers protection 
from arylamine activatiorL Also, further e^qiloration at the biochemical level utilizing the tools of 
molecular biology. ma>- help to elucidate the basis of the proposed association between dinitropyrenes 
and 2-aminoanthracene. Further studies are needed to determine the association of 2-aminoanthracene 
and other arylamines-: mechanistic studies to determine if other arylamines and nitroarenes are 
competitive inhibitors, but also to examine other arylamines in terms of pancreatic toxicity. The rat 
pancreas has frequently been used as an animal model to study changes in islet cells in pathological 
conditions, such as diabetes mellitus and pancreatic tumors (Elayat et al.. 1995). Studies are needed to 
examine whether other species and man are also susceptible to 2-AA pancreatic toxicity and may 
contribute to the increase in the incidence of diabetes in populations. Also, while tumors were not 
observed in these studies, studies to examine tissue regeneration and recovery once 2-AA is removed 
from the diet may provide a profile of long-term or reversible toxic effects. The results of these studies 
emphasize the importance of examining multiple tissues in an integrated organism in order to evaluate 
the differing effects of individual compounds and the interactions of such compounds in mixtures.
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